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ABSTRACT 
In the context of HIV high infection rate in South Africa, an assumption can be made that 
there is a high prevalence of HIV-associated neurocognitive disorders or cognitive linguistic 
deficits. The aim of this study was to determine assess whether highly active antiretroviral 
therapy (HAART) affected the cognitive – linguistic abilities of individuals living with HIV 
and AIDS before and after HAART use; and to determine whether their functional 
performance in terms of engaging in activities of daily living was affected by HAART use. 
Adults living with HIV and AIDs were recruited through purposive convenience sampling to 
participate in the study. They were divided into three groups. The experimental and cross 
sectional group included participants who were HIV infected and initiated HAART. The 
comparison group included participants who elected not to start HAART. Participants in all 
three group were assessed using the Cognitive – Linguistic Quick Test and were also required 
to fill out a structured interview scale at baseline, four and eight months. For the experimental 
group 55 participants were tested at baseline, 55 at four months and 52 at eight months after 
HAART initiation. The comparison group included 21 participants who tested at baseline, ten 
at four months and nine at eight months. The cross sectional group included different 
participants who recruited at baseline (55) before HAART initiation, then again at four (44) 
and eight months (42) after HAART initiation.  
Descriptive analysis revealed that the mean scores for both the Cognitive – Linguistic Quick 
Test (CLQT) and the structured interview schedule (IS) in all the cognitive domains 
increased for all three groups from four  and eight months after  testing. However the severity 
ratings provided by the CLQT indicated that neurocognitive deficits were still prevalent 
among the participants after HAART intiation. The most impaired cogntive – linguistic 
ability was executive functions and the least impaired was language. One way ANOVA 
analysis on the CLQT and IS revealed that was a signiifcant difference in performance 
between the three groups at baseline, four and eight months. Repeated measures analysis 
revealed significant differences or improvements within participants across the three time 
periods. The greatest improvement  was observed from baseline to eight months especially on 
the CLQT. ANCOVA analysis on the Cognitive- Linguistic Quick Test indicated that 
education had a major impact on cognitive – linguistic abilities followed by age and CD4 
count. However, ANCOVA analysis on the structured interview scale revealed that the effect 
of time, participant group and to a lesser extent age influenced the participants cognitive – 
linguistic abilities when it came to perfroming activities of daily living. Quantitave inquiry 
using content analysis showed that participants in all three groups cited attention, followed by 
visual and language problems as hindering their abilities to perform activities of daily living. 
The implications from this study revealed that even though HAART improves cognitive –
linguistic abilities, neurocognitive deficits were still prevalent. Therefore findings suggest 
that health professionals need to monitor the neurocognitive impairments of their patients so 
as determine levels of functional performance.
1 
 
Chapter 1: Introduction 
Human immunodeficiency virus (HIV) infection results in an array of medical 
complications that particularly affect the central nervous system. It has been well documented 
that the HI virus is able to cross the blood brain barrier early on in the course of the disease 
progression and enter the central nervous system (Banks, 2005; Chiang et al., 2007; Eugenin 
et al., 2003; Fernandez, 2005; Hickey, Williams, Covey, & Woong-Ki, 2005; Kaul & Lipton, 
2007; Miller, 2005). When HIV starts affecting the central nervous system it can result in 
HIV-associated neurocognitive disorders or cognitive-linguistic deficits. HIV-associated 
neurocognitive disorders can vary in severity from asymptomatic neurocognitive impairments 
to severe, debilitating HIV-associated dementia. These neurocognitive impairments can 
present themselves as difficulties in sustained attention, mental flexibility, information 
processing, memory, executive functions, language and psycho-motor speed (Cholewińska & 
Szymańska, 2009; Cloak, Chang & Ernst, 2004). HIV-associated neurocognitive disorders 
can also have a negative impact on the quality of life of an individual in that a person may not 
be able to perform their everyday activities of daily living or participate effectively in their 
social roles. 
Despite enormous advances in the treatment of HIV-1 infection, the numbers of 
people who are HIV positive continue to rise.  Since the first cases were first identified in 
1981, almost 65 million people worldwide have been infected by HIV (Xia, Luo, Yu, Jiang & 
Liu, 2011). Among the 60 million HIV-infected individuals about 25 million of them have 
already died from the disease (Merson, 2006).  It is also estimated that about 2.5 million 
become newly infected with HIV and 2.1 million people die of AIDS-related diseases every 
year (Xia et al., 2011). Furthermore, three-quarters of all people living with AIDS live in sub-
Saharan Africa with South Africa having the highest number of HIV infections worldwide 
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(UNAIDS, 2008).  HIV and AIDS is now considered a pandemic because it can be found on 
all the continents of the world.  
HIV destroys the immune cell system of its host and eventually leads to acquired 
immunodeficiency syndrome (AIDS). There is currently no cure for HIV and AIDS, but there 
is treatment for HIV and AIDS in the form of highly active antiretroviral therapy (HAART). 
Notwithstanding the advances brought about by HAART, chronic infection of HIV-1 in the 
central nervous system (CNS) still occurs because not all antiretroviral drugs are able to 
permeate the blood brain barrier (Cholewińska & Szymańska, 2009; McArthur, 2004; Xia et 
al., 2011); hence the increased prevalence of HIV-associated neurocognitive disorders 
(HAND). Once the HIV virus enters the brain, it mainly invades the immune-fighting cells, 
microglia and macrophages in the CNS. These infected cells release neurotoxic substances 
that cause inflammation of brain tissue and nerve damage which leads to HIV-associated 
neurocognitive disorders (Cholewińska & Szymańska, 2009; Ernst et al., 2003), and in some 
cases progresses to HIV-associated dementia (HAD). HAD occurs in approximately 10-15% 
of all individuals with HIV and AIDS and is more common in the later stages of the disease 
(McArthur, 2004). The less severe disorders of asymptomatic neurocognitive impairments 
(ANI) and minor cognitive motor disorders (MCMD) are more common occurring in 30-60% 
of people infected with HIV depending on disease progression (Goodkin et al., 2001; Kaul& 
Lipton, 2007).  HIV-associated neurocognitive disorders present themselves as difficulties in 
sustained attention, mental flexibility, information processing, memory, executive functions 
and psycho-motor speed (Cholewińska & Szymańska, 2009; Cloak et al., 2004). 
Two strains or types of the virus have been detected namely, HIV-1 and HIV-2. HIV-
1 is the more virulent and pathogenic (Williamson & Martin, 2010). HIV-1 mutates very 
rapidly and has a shorter latency period. This virus is commonly found in North and South 
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America, Europe, Central, East and Southern Africa (Whiteside &Sunter, 2000; Van Dyk, 
2008). HIV-2 is associated with infections mainly in West Africa (Whiteside &Sunter, 2000; 
Van Dyk, 2008). HIV can be further classified into three groups - M, N and O. The M group 
is currently dominating the global epidemic because it is clustered in parts of the world that 
have the highest HIV and AIDS prevalence rates (Williamson & Martin, 2010).  The M 
group of HIVs can be further sub-divided into sub-types or clades. Group M HIVs can be 
further subdivided into sub types or clades. There are currently nine clades named, 
A.B.C.D.E.F, G, H, J and K (Paul et al., 2005; Williamson and Martin, 2010). There are 
different subtypes in sub-Saharan Africa, with sub-types A and D predominant in Uganda and 
sub-type C predominant in South Africa and Europe. In contrast, sub-type B predominates in 
North America and in some countries in Europe (Sacktor, Nakasujja, Skolasky, Robertson, 
Wong et al., 2006). 
Since the advent of antiretroviral therapy (ART), the effects of HAND or cognitive-
linguistic deficits have improved significantly leading to decreases in the prevalence of HIV-
related cognitive impairment (McCabe, Shread & Code, 2008). However, although ART has 
reduced the overall incidence of HIV-associated dementia, HAND continues to be a major 
clinical problem (Goodkin et al., 2001; Valcour& Paul, 2006). Although most HAND 
research has been conducted in the more developed countries of the West, the virus itself is 
most prevalent and least controlled in resource-limited countries in sub-Saharan Africa, and 
East and South Asia.   
Findings from studies conducted in Western countries derive mainly from research on 
HIV-1 clade B infection found in the Caucasian populations, and therefore might not be 
generalizable to other HIV clades and to other ethnic peoples. A few studies have reported on 
HAND in Uganda (Sacktor, Nakasujja, Skolasky et al., 2009; Sacktor, Wong, Nakasujja et 
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al., 2005), but there are no studies that have investigated how specific cognitive-linguistic 
domains are affected by HAART and how these cognitive-linguistic abilities impact upon 
activities of daily living in the South African HIV-infected population.  South Africa has the 
highest prevalence of HIV infections worldwide and is a region where HIV-1, Group M, 
clade C is predominant (Paul et al., 2005; Singh et al., 2010). Based on this information it can 
thus be assumed that HIV-associated neurocognitive disorders will also have a high 
prevalence rate in South Africa.  
This research was conducted at an HIV and AIDS outpatient treatment clinic affiliated 
with a government health hospital situated in the province of Gauteng, the most populated and 
wealthiest province of South Africa. The participants recruited for this study were 
predominantly female, black, in their late thirties and early forties, unemployed with some 
secondary education irrespective of gender. All the participants were treatment naive at 
baseline that is they had not received any antiretroviral therapy at all. Participants were 
recruited into three groups. These three groups comprised an experimental, comparison and 
cross-sectional. There was a high attrition rate from baseline (110 participants) to 55 at four 
months and 53 at eight months for the experimental group. The baseline data for the cross-
sectional group was collected from the 55 participants who did not return from the 
experimental group and had not initiated HAART. A different set of individuals was recruited 
at each time of testing at four and eight months after HAART use. The experimental and 
comparison groups were tested and followed up at baseline, four and eight months after 
HAART initiation.  The comparison group included individuals living with HIV and AIDS not 
taking HAART. However, this was very difficult to do since some individuals elected to start 
HAART, or did not meet the CD4 count requirements to initiate HAART. The use of a cross-
sectional group allowed some comparisons to be made when addressing the research aims. 
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Even though HAND have been identified in a similar HIV-infected South African cohort in 
another province using a cross-sectional design (Singh et al., 2010), to date no longitudinal 
studies investigating the effects of ARVs on cognitive-linguistic abilities have been 
conducted in South Africa. This research thus seeks to add to the body of knowledge with 
particular reference to South Africa about the assessment and treatment of HIV-related 
neurocognitive impairments. 
These HIV-associated neurocognitive disorders are purported to be consistent with 
disruptions along the fronto-striatal (cortical-subcortical) circuitry (Paul et al., 2005; Woods 
et al., 2004).  By means of various neuroimaging techniques, Ances et al. (2006), Berger et 
al. (2000), Ellis, Langford, and Masliah, (2007), Thompson, Dutton, Hayashi, Lu et al. (2006) 
and Thompson, Dutton, Hayashi, Toga et al. (2005) have documented that the HI virus can 
cause extensive damage to both the white and grey matter of the brain. HIV-associated 
neurocognitive disorders are usually identified through a number of different methods that 
include neuroimaging, cerebrospinal fluid examination, metabolic and/or toxicology 
screenings and formal neuropsychological testing.  Of these methods neuropsychological 
testing has proven to be the most efficient and cost-effective method of identifying the 
different severities of HAND. The presence of HAND can have adverse effects on a person’s 
quality of life in relation to their ability to perform functional everyday activities.  
Many clinicians only assess the severity of HAND and fail to take into account how 
these neurocognitive impairments might influence an individual’s ability to perform activities 
of daily living and participate in their immediate environment. This type of professional 
practice is under pinned by the International Classification of Functioning, Disability and 
Health Framework (ICF) of disability. HIV and AIDS can be considered a disability in that it 
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is a chronic condition - a person cannot be cured but treated. This framework was born out of 
the Biopsychosocial model or approach. Biopsychosocial model states that it is important to 
view an individual as a whole. That is in terms of how a human being interacts with his 
environment. The biopsychosocial model prescribes a systematic approach to understanding 
and treating the biological, psychological and social factors inherent in any human disease 
state (Cornwall, 2012).  Therefore the guiding premise of this research states that it is not 
sufficient just to assess and treat, but to consider psychological and social factors that may 
have or are contributing to the individual’s impairment or disability.  In this case the 
assessment of HIV-associated neurocognitive disorders and how they affect a person’s ability 
to perform activities of daily living. 
 
1.2 Significance of the study 
HIV and AIDS as a disease is here to stay unless a cure can be found to destroy the 
disease. It is well known that HIV and AIDS wreaks havoc in the body in many ways. The 
virus is able to cross the blood brain barrier and cause HIV-associated neurocognitive or 
cognitive-linguistic deficits. These HIV-associated neurocognitive disorders can range in 
severity from mild to HIV-associated dementia which is the most severe form. HIV-
associated cognitive linguistic deficits are hypothesized to be mediated by cortical-subcortical 
neuronal loops, which originate in the cortex, extend in the basal ganglia through the 
thalamus and terminate in the cortex.  It is therefore imperative that HIV-associated 
neurocognitive or cognitive-linguistic deficits are monitored for various reasons such as 
adherence to medication; and if not detected early could lead to HIV AIDS dementia a 
debilitating condition that requires substantial health services, that a country such as South 
Africa cannot extend due to the other burden of diseases already created by HIV and AIDS.  
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HIV-associated neurocognitive or cognitive-linguistic deficits can be assessed using imaging 
techniques such as functional magnetic resonance imaging (fMRI) or neuropsychological 
tests. Neuropsychological assessments are able to reveal the cognitive-linguistic skills 
(attention, memory, language, executive function and visual spatial skills) that might be 
impaired and are much cheaper to administer. This study set out to demonstrate that a 
neuropsychological test such as the Cognitive Linguistic Quick Test could be used to identify 
HIV-associated neurocognitive deficits. In the context of South Africa, which is a developing 
country, the most cost-effective, time-efficient and reliable methods of assessment are 
warranted to provide appropriate services. 
By employing a longitudinal research design the researcher was also able to show that 
cognitive – linguistic abilities of individuals with HIV and AIDS do change over time i.e. 
become less identifiable when HAART is initiated. However, despite this change cognitive-
linguistic impairments are still persistent.  Furthermore, through survey enquiry, patients 
reported that that they were able to conduct their everyday activities irrespective of cognitive-
linguistic difficulties. This is very consistent with cortical – subcortical lesions which present 
with abilities within functional limits, but impairments become more apparent with higher 
order cognitive tasks. These findings would not have become apparent if the researcher had 
only focused on the clinical abilities of the client. That is the structure and function of the 
individual as specified by the ICF. The ICF purports that it is important to determine how the 
impairments also affect an individual’s ability to perform activities and participate in their 
environment. The individuals in this study were able to perform activities of daily living 
despite, the assessment indicating impairments. This alerts clinicians to not only focus on the 
results of an assessment because it does not provide information about an individual’s 
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performance in their environment. This all forms part of the Biopsychosocial model. 
Knowing an individual’s abilities both clinically and environmentally changes the 
management of an individual in terms of finances and time spent receiving services. 
Management becomes very client specific. 
 
1.3 Assumptions 
This study assumed that this South African cohort of individuals in attendance at this 
outpatient clinic was representative of those individuals with HIV and AIDS receiving health 
services from a public government facility. Patients would be available to be retested 
especially since they were being retested on days they were due to come for their medical 
check-up and refill of prescriptions. It was also assumed that the patients in both the 
experimental and cross sectional groups would improve their cognitive and linguistic abilities 
after HAART initiation. 
 
1.4 Limitations and delimitations 
It was very difficult to recruit participants for the control group. Obtaining a true 
control group was problematic, because as the CD4 counts drop immune system less able to 
fight off infection. So when an individual gets sick will opt to initiate HAART midway 
through the study.  Attrition rate from baseline to four months was very high. Nurses at the 
clinic reported that patients in attendance at the outpatient clinic were very transient. Patients 
also did not always provide accurate contact information. 
 9 
 
This research sort to determine the presence of HAND in individuals living with HIV 
and AIDS, with a CD4 count of approximately 250 cells/mm
3
 and below,  in attendance at a 
Government outpatient clinic. The aim of this investigation was not to determine when 
HAND becomes noticeable in an individual diagnosed as HIV positive irrespective of CD 
count or where they seek treatment.  
 
1.5 Purpose of the study 
The purpose of this study was to explore the effectiveness of HAART on adults living 
with HIV and AIDS through a longitudinal and cross-sectional method. So individuals had to 
be ready to initiate HAART.  In addition the study also investigated the study whether 
HAART was able to provide any functional benefits in terms of activities of daily living in a 
South African cohort. To address this overarching aim the researcher assessed the cognitive – 
linguistic abilities of adults with HIV and AIDS before and after HAART initiation. It was 
hypothesised that HAART would positively affect the cognitive – linguistic abilities of adults 
living with HIV and AIDS due to its ability to decrease the viral load in the body.  
 
The aims of the study were as follows:  
1. To determine whether there is a significant difference in cognitive-linguistic abilities 
between the experimental, comparison and cross-sectional groups on the Cognitive-
Lingusitic Quick Test and the interview schedule. 
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2. To determine whether there will be a significant difference in cognitive-linguistic 
abilities within the participants (time effect) for the experimental and comparison 
groups on the Cognitive-Lingusitic Quick Test and the interview schedule. 
3. To determine the effect of variables on cognitive-linguistic functioning in both the 
experimental and comparison groups at baseline, four months and eight months on the 
Cognitive-Linguistic Quick Test and the interview schedule. 
4. To describe the cognitive-linguistic abilities that affect performance and activities of 
daily living in the experimental, cross-sectional and control groups. 
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Chapter 2: Literature Review 
 
2.1 Introduction 
This chapter starts by providing a contextual background for this study. The 
background begins broadly by briefly examining the epidemiology of HIV in the world, and 
then takes a detailed look at the epidemiology of HIV in Africa, specifically in sub-Saharan 
Africa with particular reference to South Africa. A conceptual model which broadly frames 
this study will be provided. An overview of the HI virus will be presented including how it is 
managed and the ways in which it can result in HIV-associated neurocognitive disorders or 
cognitive-linguistic disorders. A definition of neurocognitive disorders will be given, 
followed by how these disorders are mediated and what the relationship is between cognition 
and language. Methods of assessment will then be discussed with particular emphasis on the 
measures used in this study and treatment of HAND. The conclusion of this chapter will 
culminate in a rationale and research questions pertaining to the study. 
 
2.2 Background of HIV 
This section provides a context and background of the study. It starts broadly, with 
global trends regarding HIV and AIDS, and then proceeds to Africa and sub-Saharan Africa, 
ultimately focussing on South Africa where this research was conducted. HIV and AIDS is 
discussed in the context of the burden of the disease, and other issues that exacerbate the 
prevalence of HIV and AIDS, particularly in sub-Saharan Africa and more specifically South 
Africa which has the highest number of HIV-infected individuals (Avert, 2010).  
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The world is now more than 20 years into the HIV and AIDS crisis with no cure in 
sight.  Since the first reported cases of HIV and AIDS in 1981, more than 65 million people 
have been infected with HIV, and more than 25 million have died of AIDS (Merson, 2006). 
While numerous programmes have been set up throughout the world since the first cases 
were reported, the epidemic is nevertheless out of control. In addition this epidemic is mainly 
concentrated in the developing countries of the world such as Latin America, Africa and Asia 
where 95% of the 65 million people in the world living with HIV are located (Singhal & 
Rogers, 2003). Moreover many of the 25 million people who have died from AIDS lived in 
developing countries. On the contrary HIV infection rates and AIDS deaths have declined in 
richer and more developed countries; however infection rates continue to soar in developing 
countries (Singhal & Rogers, 2003). AIDS affects more people than it infects given that it has 
an impact on impoverished families as they try to meet the costs of patient care and funerals. 
In addition, AIDS has left behind orphans who are not only victims of the epidemic, but are 
also faced with the reality of an uncertain future.  
As indicated earlier the 95% of people infected with HIV living in these minimally -
industrialized countries, have very limited financial resources, resulting in an inability to 
manage and deal with the challenges presented by the HIV and AIDS epidemic. Furthermore 
these countries’ hard-won social and economic development is most vulnerable to the heavy 
burden that HIV and Aids places upon them (Merson, 2006). AIDS is mostly a disease of 
poor countries because of the imbalanced distribution of health resources (D’Aesky, 2004; 
Cunha, 2007; Singhal & Rogers, 2003). Most people living with HIV and AIDS are in the 
economically productive age group (15 – 49 years) (Cunha, 2007; ) and are the very 
individuals who have the potential and ability to play the financial supporting role to the 
children and elderly relatives within the family, however, sadly most will receive minimal 
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care when they finally develop AIDS-related illnesses. From many aspects the global HIV 
and AIDS epidemic is an enormous tragedy for humankind. 
 
2.2.1 Burden of disease. 
Although our understanding of the factors affecting the spread of HIV has increased, 
it seems we still do not fully contemplate why different parts of the globe have experienced 
such dissimilar HIV epidemics. Data on HIV prevalence in different countries has been 
compiled by UNAIDS (2008). Although the numbers vary greatly in quantity due to the 
discrepancies that exist in data collection (Gilks, 2001), they do, however provide us with 
some idea of the magnitude of the problem. Most care is delivered in health centres and 
community clinics, yet very little disease surveillance has been carried out at this level. 
Without knowing how much HIV and AIDS disease is presenting where and at what stage of 
disease progression, it is impossible to adequately describe the burden of care that the 
communities carry.  
In high prevalence countries the additional burden of disease for HIV and AIDS is 
very vast and as it increases it is having a significant impact on the overall healthcare services 
and delivery of the basic primary healthcare needs of the people living in these countries. 
This is because the existing, pre-AIDS diseases (such as malaria, sexually transmitted 
diseases and TB) have not diminished in any way as the epidemic of HIV and AIDS disease 
has taken off (Holmes, Losina, Walensky, Yazdanpanah & Freedberg, 2003). There is no 
denying that AIDS infection rates have increased all around the world but the increase has 
been disproportionately high in sub-Saharan Africa as presented in Table 2.1. HIV has now 
been recorded in every region of the world. Below are a few global trends: 
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Table 2.1: Adults and children newly infected with HIV by region, 2008 
Global HIV Infections, 2008 
Region Adults and 
children newly 
infected with HIV 
Global share of 
new infections 
(Percentage) 
Percent of adults 
infected with 
HIV 
Sub-Saharan Africa 1.9 million 71 5.0 
South and Southwest Asia 280 000 10.4 0.3 
Eastern Europe and Central Asia 110 000 4.1 0.8 
Latin America 170 000 6.3 0.5 
East Asia 75 000 2.8 0.1 
Middle East and North Africa 35 000 1.3 0.3 
North America 55 000 2.0 0.6 
Caribbean 20 000 0.7 1.1 
Western and Central Europe 30 000 1.1 0.3 
Oceania 3 900 0.5 0.4 
World 2.7 million 100* 0.8 
Percentages do not add to 100 due to rounding. 
Source: Global Health Council: http://www.globalhealth.org/hiv_aids/global_view/ 
Sub-Saharan Africa 
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Sub-Saharan Africa has been more heavily affected by HIV and AIDS than any other 
region in the world. An estimated 22.4 million people are living with HIV in the region which 
accounts for 67% of all people living with HIV worldwide (Avert, 2010).  In 2008 around I.4 
million died from AIDS in sub-Saharan Africa which accounted for 72% of AIDS-related 
deaths and 1.9 million people became newly infected with HIV (Avert, 2010). The nine 
Southern African countries bear a disproportionate share of the global AIDS burden, with 
each having an adult prevalence greater than 10% (African Medical and Research Foundation 
(AMREF), 2010). Since the beginning of the epidemic, more than 14 million children have 
lost one or both parents to AIDS (Klimas, O’Brien Koneru & Fletcher, 2008). HIV has truly 
become a weapon of mass destruction that has reversed many of the hard-won development 
gains of the past.  
In the absence of massively expanded prevention, treatment and care efforts, it is 
expected that the AIDS death toll in sub-Saharan Africa will continue to rise. This means that 
the impact of the AIDS epidemic on these societies will be felt most strongly in the course of 
the next ten years and beyond. Like an octopus with many tentacles, AIDS has reached and 
touched many aspects of African society, including those of socioeconomics, demographics 
and governance. 
AIDS has also changed the face of African demographics in terms of gender 
dynamics, i.e. more women than men are being infected and the life expectancy has 
decreased since the advent of HIV and AIDS (Avert, 2010). More women of child-bearing 
age are HIV-positive than men (AMREF, 2010).Women are more likely to contract HIV on 
first sexual contact than men because their role in sex is to act as the receptor in receiving 
sperm that is already infected (Danziger, 1994; Evian, 2006). Furthermore, many African 
societies tend to be patriarchal in nature, where the male figure dominates in most aspects of 
 16 
 
life. As a result sexual relationships are dominated by men, which ultimately means that 
women cannot always practise safe sex even when they are aware of the risks (Morison, 
2001), and the unfortunate implication is that more women are likely to die from AIDS. This 
leads to a number of questions. Will statistics in the next ten years indicate an excess of adult 
males? Will there be an increase in commercial sex? Will these men seek increasingly 
younger women and girls as long-term partners?   
From the above noted points and posed questions one could assume that it is evident 
that not only are more women being infected, but that the social impact of the disease is much 
greater on women than on men. While both men and women face enormous suffering as a 
consequence of the epidemic, the current social, economic, legal and political disadvantages 
experienced by women also heighten their vulnerability to the risk of HIV and AIDS 
(Danziger, 1994; De Waal, 2003; Global Health Council, 2009). For example, HIV-positive 
women are more likely to suffer violence or abandonment once their serostatus becomes 
known because they are held responsible for contracting HIV (Danziger, 1994; Gilks, 2001). 
Of course this is an absurd allegation since it ignores the fact that the sexual transmission of 
the HI virus depends upon the sexual behaviour of both partners. Rejection and stigma 
experienced by women are compounded by their economic powerlessness, and legal 
disadvantages may include the lack of legal protection of property rights (Danziger, 1994). 
Impoverishment quickly follows, and is made especially painful when the women must find 
means of supporting their children while coping with deteriorating health. 
Abandonment and rejection by the family of the husband can also occur if the 
woman’s husband dies of AIDS even though she might have been the primary caregiver of 
the husband during his sickness (Danziger, 1994). This too can lead to impoverishment, 
especially if the partner’s income was the primary source of income for the family (de Waal, 
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2003; Lurie, 2010). The issues surrounding a woman’s rejection by the husband are similar if 
not identical to her being rejected by her husband had he been alive (Danziger, 1994). 
In addition, the epidemic has also had far-reaching effects on women in their role as 
the primary caregiver within households. As the patient’s health deteriorates, the physical and 
emotional burden placed on the caregiver becomes increasingly demanding. While coping 
with these problems women must at the same time meet their responsibilities of ensuring 
adequate food for the family and nurturing the young children in the family (Danziger, 1994). 
The enormous burden of care that has been placed on women because of home-based care 
has led (in some cases) to the neglect of their own health and well-being. Even young girls 
have felt the brunt of HIV and AIDS. Young orphaned girls are usually the first to be 
withdrawn from schools to assist with home duties and the care of younger siblings when 
parents die from HIV and AIDS (Danziger, 1994). Moreover, young girls and women are 
being encouraged or coerced to engage in sexual activities as men are seeking younger 
partners in an attempt to ‘reduce their risk of HIV infection’ (Lurie, 2010). The plight of 
women suffering from the social impact of HIV and AIDS can only improve if strategies and 
or policies are put in place to reverse women’s social, economic and legal disadvantages. 
The mortality impact of AIDS has also been significant. The life expectancy in sub-
Saharan Africa before AIDS was approximately 62 years and increasing (Holmes et al., 
2003). However, since the HIV pandemic, the life expectancy has dropped drastically to 
approximately 40 years and below in some countries (Holmes et al., 2003).  The vast majority 
of people living with HIV and AIDS in Africa are between 15 and 49 and are thus in the 
prime of their working lives (Avert, 2010). This has had a profound impact on the economies 
of sub-Saharan Africa. As a result there are not enough people with sufficient work 
experience to effectively manage and operate private and government sectors.  Productivity at 
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work has also been hampered in that people are calling in sick, attending funerals or caring 
for the sick. Meanwhile, morale at work suffers due to absenteeism and declining institutional 
effectiveness (De Waal, 2003). Monies are being spent to recruit and train new personnel to 
take over from people who are seriously ill or who have died. In some instances posts are left 
unfilled.  In essence, private and government sectors are diverting funds from already 
haemorrhaging sections of the economy (De Waal, 2003) to deal with the epidemic. 
Both HIV prevalence rates and numbers of people dying from AIDS vary greatly 
between African countries.  In Somalia and Senegal, for instance, the HIV prevalence rate is 
under 1% of the adult population, whereas in Namibia, South Africa, Zambia and Zimbabwe 
prevalence rates are around 15 - 20%. In three countries the national adult HIV prevalence 
rate now exceeds 20%. These countries are Botswana (23.9%) (Avert, 2010), Lesotho, whose 
epidemic seems to have stabilized with a prevalence of 23.2% and Swaziland with one of the 
highest prevalence rate in the world of 26.1% (AMREF, 2009). West Africa has been less 
affected by HIV and AIDS, but some countries are nevertheless experiencing rising HIV 
rates. In Cameroon the HIV prevalence rate is now estimated at 5.1% and in Gabon it stands 
at 5.9% (UNAIDS, 2008). In Nigeria, HIV prevalence is low (3.1%) compared to the rest of 
Africa. However, because of its large population (it is the most populous country in sub-
Saharan Africa), this equates to around 2.6 million people living with HIV (UNAIDS, 2008). 
Adult prevalence in East Africa exceeds 5% in Uganda, Kenya and Tanzania (Avert, 2010). 
Aforementioned have been some prevalence rates on HIV infection in Africa and sub 
Saharan Africa, the discussion going forward will focus on the country in which this study 
was conducted. 
 
South Africa 
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South Africa has long suffered from the AIDS epidemic, and for decades 
epidemiologists and public health educators in South Africa have worked to understand and 
respond to the crisis. South Africa has been reported to have the highest prevalence rates of 
HIV infection in the world (Global Health Council, 2009; Gouws & Karim, 2010). The first 
two cases of AIDS were identified in South Africa in 1982 (Whiteside & Sunter, 2000). In 
the mid-1980s the first peak of the AIDS epidemic was predominantly diagnosed among 
white homosexuals. While the number of homosexuals diagnosed as HIV-positive began to 
plateau in 1989, the number of cases in the general population began to increase – so much so 
that between the years of 1990 and 1994 the number of heterosexual individuals with AIDS 
exceeded those who were homosexual (Karim & Baxter, 2010). As in most of Africa, the 
epidemic started as an urban phenomenon in South Africa that quickly spread to the rural 
areas. Since then the heterosexual epidemic has overshadowed the homosexual epidemic 
(Whiteside & Sunter, 2000). Life expectancy in South Africa is currently approaching 30 
years of age for women and 34 years of age for men (Holmes et al., 2003, Avert, 2010). The 
impact of HIV and AIDS thus continues to have a devastating effect on the people of South 
Africa. 
To understand the shape of the epidemic it must be understood that certain groups of 
South Africans are at a higher risk for HIV than others (see Table 2.2). In South Africa where 
race and socio- economic status are closely linked, the epidemic is mainly (98%) 
concentrated among the black population which makes up 90% of the total population 
(Singhal & Rogers, 2003). This has made black people more vulnerable to the infection, with 
women being at a higher risk for infection than men. Black women are more susceptible due 
to a mix of biology and gender-based power structures, as highlighted earlier, that may, for 
example, render condom negotiation with a partner difficult or impossible (Global Health 
Council, 2009).Adding to these cultural dynamics are their desperate economic situations, 
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which have forced women to become sex workers in order to survive (Karim, Karim & 
Baxter, 2010). 
 
Table 2.2 HIV Prevalence by Population Group in South Africa, 2008 
Population Group Prevalence (%) 
Black  13.6 
White 0.3 
Coloured 1.7 
Indian 0.3 
Source: http://www.avert.org/safricastats.htm 
There might be a direct link between AIDS and four decades of apartheid where a 
racial system of structural violence was aimed at keeping the white minority, particularly 
Afrikaners, in power (Williams & Gouws, 2001). As a result of apartheid the black majority 
was marginalized and poor. Apartheid prevented millions of black South Africans from 
building a safe and secure life, a life exclusively possible for white South Africans. This 
inequality was strongly felt in the Health sector, as evidenced in the  fewer hospitals, clinics, 
doctors or drugs being made available for black residents whether they lived in the townships 
or rural areas (Cunha, 2007: Gilks, 2001).  
This legacy of an inadequate health care system from the apartheid era has left its 
traces which can still be seen today.  The current  living environments for most poor South 
Africans are unhygienic and unhealthy, characterized by high exposure to ordinary, as well as 
opportunistic pathogens. These pathogens are quite capable of causing significant morbidity 
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in immunosuppressed individuals diagnosed with HIV, even in its early stages (Gilks, 2001). 
Poverty among black South Africans also influences the disease presentation and quality of 
care. With few resources available, health-seeking behaviour may be significantly 
compromised and may be delayed, resulting in late clinical presentation which inevitably 
increases mortality even in readily treatable diseases (Cunha, 2007). 
Gender inequality has been discussed with reference to the general spread of the 
disease among women in sub-Saharan Africa. However, with particular reference to South 
Africa, the issue of migration tends to add an additional dynamic to the HIV and AIDS 
burden that women tend to shoulder (see Table 2.3). In many instances poor women are 
forced to migrate from their rural areas or small towns to urban areas in search of 
employment in order to be able to support their children (Cunha, 2007). However, the 
majority of these women find that to supplement their low wages they often have to rely on 
transactional sex (Fassin & Schneider, 2003), predisposing them to sexual violence and HIV 
and AIDS.  
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Table 2.3: Estimated HIV Prevalence among South Africans by Age and Gender, 2008 
Age Male prevalence Female prevalence 
2 – 14 3.0 2.0 
15 -19 2.5 6.7 
20 – 24 5.1 21.1 
25 – 29 15.7 32.7 
30 -34 25.8 29.1 
35 -39 18.5 24.8 
40 – 44 19.2 16.3 
45 -49  6.4 14.1 
50 – 54 10.4 10.2 
55 – 59 6.2 7.7 
60+ 3.5 13.6 
Total 7.9 13.6 
Source: The South African National HIV Survey 2008, Human Sciences Research Council 
In 2007 South Africa accounted for 17% of the global burden of the disease and it 
currently has the highest prevalence of HIV-infected people in the world (Gouws & Karim, 
2010), in relation to its population size. The disease burden has resulted in 605 480 HIV-
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related deaths in South Africa from 1997 to 2006 (Avert, 2010). The South African National 
HIV Survey which was conducted by the National Department of Health in 2008 revealed 
that children, youth and adults had estimated prevalence rates of 2.5%, 8.7% and 16.8% 
respectively (Avert, 2010). The highest prevalence rate reported for women was 32.7% (25-
29 years) and 25.8% (30-34 years) for men (Avert, 2010). This could be due in part to the 
increased vulnerability of women around the age of puberty as well as to the age difference in 
sexual partners (Gouws & Karim, 2010, p. 70). Young women tend to have older male 
partners which may explain the prevalence difference in age between men and women.  
 In October 2008, Statistics South Africa published a report titled “Mortality and 
Cause of Death in South Africa, 2006”. According to this report, the number of deaths for 
2006 due to diseases or conditions attributed to HIV totalled 605, 480. The data showed that 
between the years 1997 – 2004 the death rate among men aged 30-39 years doubled, while 
that among women aged 25-34 quadrupled (Avert, 2010). In 2006, HIV was recorded as the 
cause of death in 14 783 cases. However, the Medical Research Council of South Africa 
(MRC) has cautioned against the misclassification of deaths due to HIV. The MRC believes 
that these figures are a massive underestimation because individuals do not only die from 
HIV alone but other underlying causes (Nattrass, 2008).  MRC researchers claim that many 
doctors only cite the immediate cause of death such as tuberculosis or respiratory infection 
for various reasons that could include not knowing the HIV status of their patients, or they 
may seek to conceal HIV infection to spare relatives the burden of stigmatization (Nattrass, 
2008). Whatever the reasons, more accurate recording of HIV-related causes of death needs 
to be in place. Even though data recording measures are wanting in South Africa it cannot be 
denied that individuals are dying from HIV or AIDS related deaths. In an effort to reduce 
these deaths it is important to consider risk factors that put individuals at risk of contracting 
HIV in South Africa. 
 24 
 
The two key risk factors influencing the spread of HIV infection in South are the 
migrant labour system and the high burden of other sexually transmitted diseases. South 
Africa has been recorded to have the highest prevalence of sexually transmitted infections 
(STIs) in the world (Coetzee & Johnson, 2010). Both HIV and STIs share the same mode of 
transmission - unprotected sex. Individuals with STIs are more susceptible to HIV infection 
for several reasons. Once an individual contracts an STI, the genitals are inflamed resulting in 
an increased presence of macrophages and T lymphocytes (Coetzee & Johnson, 2010; Evian, 
2006).Moreover, ulcer-causing STIs disrupt the epithelial lining or barrier of the genitalia. So 
an individual with an STI who is HIV-negative is more susceptible to contracting HIV than 
an individual who is negative without an STI (Coetzee & Johnson, 2010). It has also been 
documented that “an HIV-infected partner sheds more virus in the presence of STI, thereby 
increasing the probability of HIV transmission” (Coetzee & Johnson, 2010, p. 217). Other 
factors that have contributed to the high prevalence of HIV have also contributed to the high 
prevalence of STIs. These factors include apartheid, an entrenched migrant labour system, 
gender and socio-economic inequalities. 
In the past, South Africa’s political economy relied heavily upon the migrant labour 
system to maintain the status quo of apartheid. Even after the dismantling of apartheid, it is 
currently estimated that there are more than 2.5 million legal migrants and many more illegal 
migrants drawn to work in South Africa’s mines, factories and farms from rural areas within 
South Africa and from neighbouring countries (Lurie, 2010). According to Lurie (2010), 
“while the link between migrant labour and high-risk sexual behaviour has not been fully 
explored in detail in South Africa, it is clear that migrants’ frequent and lengthy absences 
from home have more than likely disrupted their familial and stable sexual relationships. It 
has also been argued that the migrant labour system created a system for commercial sex in 
mining towns.” (p. 149). 
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The historical and current context of HIV and AIDS in South Africa is important to 
consider because it is from this environment that the participants from this research were 
selected. Rosen, Ketlhapine, Sanne and Bachman de Silva (2008) investigated the 
characteristics of an HIV-positive urban population in South Africa who were accessing care 
and treatment from public hospitals in Gauteng and rural hospitals in Mpumalanga.  
According to the research of Rosen et al. (2008), a total of 1069 adults living with HIV and 
AIDS pre- and post-HAART were recruited to participate. They found that more women 
were diagnosed HIV-positive than men, and the majority of individuals were black, males 
were older in age (average 37.4 years) and the women were younger (average 33.6 years). 
The majority were unemployed with some secondary education. More than half the 
participants from the rural site reported that they did not read at all. They also found a low 
rate of marriage in their sample although they tended to have one long-term partner. These 
findings correlate very closely with some of the HIV and AIDS statistics that are presented in 
this chapter. 
The HIV and AIDS epidemic has wreaked havoc in the African continent, especially 
in sub-Saharan Africa. As mentioned above, South Africa has the highest rate of HIV 
infection in the world and certain risk factors such as apartheid, socioeconomic and gender 
inequalities and an entrenched migrant system have enabled the virulent spread of the 
epidemic among the population. Since South Africa has the highest prevalence rates of HIV 
infection it can be inferred that it must also have a high prevalence rate of HAND including 
HIV-associated dementia (HAD) even though there are no national statistics to support this 
assumption.  
 26 
 
Thus far the disease has been described in terms of its epidemiology with particular 
reference to South Africa, the context in which the study takes place. Following is a 
conceptual model for this study. 
 
2.3 Conceptual Model 
2.3.1 Introduction 
The conceptual model underpinning this study is the Biopsychosocial model or 
approach. The wording model or approach will be used interchangeably. The general premise 
of this model is that any disease state (whether biophysical or mental) should be viewed in 
the context of how an individual interacts with their environment. In the case of this study 
how the resultant cause of HIV infection produces HIV-associated neurocognitive disorders 
(HAND) and how HAND affects a person in the context of their environment.  
 
2.3.2 The Biopsychosocial Model 
The biopsychosocial approach was first explained by George Engel in 1977. This 
model is based on a system approach. The systems approach was developed by Weiss and 
von Bertalanffy early 1950’s (Engel, 1980). The systems theory approach basically asserts 
that “nothing exists in isolation. Whether a cell or a person, every system is influenced by a 
configuration of systems of which each is a part, that is, by its environment.” (Engel, 1980, 
p.538).The biopsychosocial model was developed as an alternative to the traditional dogmatic 
biomedical treatment approach. Dr Engel was opposed to the reductionist view of disease that 
excludes the mind and environment. The reductionist view point of disease is at the cellular 
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and molecular level of a condition (Engel, 1980); the biopsychosocial model expands on this 
and refers to the interaction between the biological, psychological and social factors in the 
experience of a disease (Covic, Adamson, Spencer, and Howe, 2003). 
The biological component of the biopsychosocial model recognises the biophysical or 
biological and mental conditions of the disease (Engel, 1977, 1980; Covic et al., 2003). The 
psychological component considers the personal psychological factors that can influence 
function and the measures an individual takes for his or her behaviours (Engel, 1977, 1980; 
Covic et al., 2003). The social recognises the importance of the environmental context, 
pressures and constraints (Engel, 1977, 1980; Covic et al., 2003).  In essence this approach 
considers the individual, their health problems or disability within his/her immediate and 
broader environment.  
. 
 
 
 
Source: Adapted from the CTC and Well Being centre. Retrieved from 
http//eitheory.com/2012/01/26/chronic-stress-and-biopsychosocial-intervention-stratgies/ 
 
Figure 2.1 Interaction of the three components of the biopsychosocial model 
 
Health 
Well Being 
 
 
 28 
 
This is conceptually a comprehensive clinical model that can be applied to HIV-
associated neurocognitive disorders especially in the context of this research as shall be 
shown with the proceeding sections of the literature review. 
 
2.4 Adult Human Immunodeficiency Virus (HIV) 
2.4.1. Introduction 
This section describes the HI virus and how it progresses to AIDS. It further describes 
how the HI virus infects a human cell and replicates in the body. The section then continues 
with a discussion of the treatment of HIV and AIDS providing a historical overview of HIV 
and AIDS antiretroviral therapy with particular reference to South Africa. It is important to 
remember in this instance that ART initially started as monotherapy and progressed to triple 
therapy or highly active antiretroviral therapy (HAART). The section also shows how HIV, 
opportunistic infections and HAART can cause central nervous system damage that can lead 
to neurocognitive disorders and consequently, cognitive-linguistic disorders. 
 
2.4.2 Human immunodeficiency virus. 
A virus is a pathogen which is an organism that causes disease. Viruses cannot 
replicate and reproduce on their own because they do not possess the biochemical 
mechanisms to do so (Fan, Conner & Villareal, 2007) .Viruses are parasites and in order for 
them to replicate and multiply they need to live in tissue or cell types of a living body.  
Viruses are nothing but inactive lifeless and harmless chemicals (Fan et al., 2007). A virus 
consists of two main components: a core and a capsule or protective shell. Within the core 
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they carry genetic material which can either be DNA or RNA (Fan et al., 2007). The capsule 
acts as a vehicle that enables the virus to be transported from one cell to another. This is 
made possible by protein projections (or glycoprotein projections) or spikes that attach 
themselves to the host cell (Van Dyk, 2008). These projections attach themselves to specific 
receptor sites (or binding sites) of a host cell. Some viruses also have a third component, a 
lipid envelope that covers the virus (Van Dyk, 2008). 
The HI virus is a retrovirus that has a circular shape. It is a retrovirus in that it 
encodes the enzyme reverse transcriptase (Fan et al., 2007). This unique enzyme is able to 
produce a DNA copy made from viral RNA, going against what is considered the normal 
flow of information, hence retro “to go back” (Morris & Cilliers, 2010). The virus is so small 
that 16 000 viruses can fit on a pin head.  Its core RNA genetic material is covered by an 
envelope that has many small projections on its surface. These projections have an attraction 
to certain target cells with so-called CD4 receptor sites. These CD4 receptors are present on 
various types of blood cells including CD4 (helper) T lymphocytes, macrophages, 
monocytes, tissue cells (such as dendritic cells present in the genital tract and ano-rectal 
region), certain brain cells (glial cells) and other cells that have receptor cells (Kaul & Lipton, 
2007).  
HIV thus enters the body and destroys important cells which control and support the 
immune system. After entering the body, HIV attaches itself to the CD4 receptors, mainly 
dendritic cells and T lymphocytes (Fan et al., 2007). HIV can also attach itself to any of the 
abovementioned CD4 cells (Step 1). After binding to the CD4 receptor, the HIV envelope 
fuses with that of the CD4 membrane (Step 2).  Once fusion has occurred, the viral capsule 
breaks open releasing the viral genetic material into the host cell (e.g. a CD4 cell) (Step 3).  
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An enzyme called reverse transcriptase converts the RNA which is a single strand to a 
double stranded DNA (proviral DNA) so that more viruses can be reproduced (Step 4). The 
proviral DNA fuses with the host DNA in the nucleus of the host cell with the help of the 
viral enzyme integrase and makes numerous copies of viral RNA and proteins (Step 5). 
Another viral enzyme protease enables these new viral DNA and proteins to assemble into 
new HI viruses (Step 6). As the new particles exit the cell, they kill the host cell in the 
process (Step 7). Then they move into the blood stream or surrounding tissue to infect more 
cells and repeat the process (Evian, 2006; Fan et al., 2007; Van Dyk, 2008). 
The body’s immune system is a complex system of blood proteins and white blood 
cells that work together to protect the body from invading organisms such as bacteria, 
parasites, viruses, fungi and cancer to mention just a few pathogens (Fan et al., 2007; Van 
Dyk, 2008). The lymphatic system, the thymus gland and the bone marrow play an important 
role in the manufacture of blood proteins and white blood cells (Fan et al., 2007).  The cells 
of the immune system can be divided into two main groups: Non-specific and specific 
defences (Fan et al., 2007; Van Dyk, 2008).  Non-specific immune cells do not specialize in 
attacking specific pathogens but just provide a general defence to the body. If they fail to 
protect against the invading pathogens the specific defences are called in. The specific 
immune cells such as lymphocytes attack specific foreign pathogens or antigens. Antigens are 
proteins present on the surface of viruses or proteins.  Lymphocytes, on the other hand, 
produce antibodies that attack specific antigens (Fan et al., 2007; Van Dyk, 2008). Antibodies 
are proteins produced in response to antigens to either destroy or deactivate them.  
The immune system is a very well established and powerful system. It takes the HI 
virus a number of years to destroy enough of the immune system to cause immune deficiency 
and immune incompetence (Evian, 2006). According to Fan et al. (2007), HIV eventually is 
 31 
 
able to overpower the body’s immune system in several ways that include high mutation rates 
and latent states of HIV reservoirs. The HI virus has such a high mutation rate that the human 
body cannot produce antibodies that are able to neutralize subsequent viruses with mutated 
envelope proteins. Thus HIV is able to keep one step ahead of the immune system and 
continue to infect (Fan et al., 2007). In terms of latent states, the HIV is able to generate a 
reservoir of infected cells that are put on hold so to speak (made latent) to be activated at a 
later time by infectious microorganisms or infected HIV cells. These latent cells are able to 
circulate in the body undetected by human antibodies. Two modes of contracting HIV have 
been identified globally. These two modes of transmission are by sexual and blood 
transmission 
2.4.3 Transmission of HIV. 
. Sexual transmission accounts for how the majority (90%) of people contract HIV, (see 
Figure 1) (Global Health Council, 2009). Sexual transmission can either be through 
heterosexual sex or homosexual sex, that is, men who have sex with men (MSM). The other 
10% of people with HIV contract the virus through blood transmission such as mother-to-
child transmission, injecting drug users and medical procedures (Global Health Council, 
2009). Since the scope of this study is on adults living with HIV, the following section on 
transmission will only discuss adult transmission. 
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Source: http://www.globalhealth.org/hiv_aids/global_view 
Figure 2.2 Global modes of HIV transmission  
Sexual transmission is by far the most common mode of transmission globally. 
During sexual contact, the virus can cross the mucosal barrier of the vagina, vulva, penis and 
rectum by first coming into contact with the immune cells that carry the virus across the 
mucosa (Evian, 2006; Klimas et al., 2008). The risk of infection during intercourse is greatly 
increased by concurrent sexually transmitted diseases, rough sex, or a partner with a very 
high viral load such as seen in primary infection and again in late stage disease. Women are 
generally more likely than men to acquire HIV during heterosexual intercourse due to the 
female physiological characteristics, such as the large amount of mucosal surface area the 
virus is exposed to which means it is two to three times more efficient in male-to-female 
transmission than female-to-male transmission (Evian, 2006; Morison, 2001). Receptive anal 
intercourse appears to be more risky than receptive vaginal intercourse with obvious 
implications for men who have sex with men (MSM) (Klimas et al., 2008). Therefore, the 
risks of HIV transmission are affected by frequency of sexual contact, condom use, 
immunological status, male circumcision and the presence of STIs (Klimas et al., 2008). 
Sexual Transmission (>90%) Blood transmission (>10%) 
Medical 
procedures 
Mother-to-child 
transmission 
Men who have 
sex with men 
Injecting drug 
users 
Heterosexual 
sex (85%) 
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HIV is also spread by contact with infected blood, most often through the practice of 
reusing or sharing syringes and needles with drugs. This is also referred to as parenteral 
transmission (Morison, 2001). Effective community outreach and needle exchange 
programmes can reduce this risk. Parenteral transmission can also occur by the transfusion of 
infected blood; thus screening blood and/or reducing unnecessary use of transfusions are 
necessary to minimize transmission by this route (Morison, 2001).  Occupational risk to 
healthcare workers also exists, mainly through accidental needle sticks or mucosal splash 
with contaminated blood (Klimas et al., 2008). The risk for occupational transmission varies 
depending on the type and severity of the exposure. The average risk of HIV transmission 
among healthcare personnel is estimated to be 0.3% after a needle stick and 0.09% after 
mucous membrane exposure (CDC, 2005).Once the HI virus is contracted via the different 
modes described, it starts to weaken the body’s immune system progressively until it causes 
full-blown AIDS. The phases of the progression of this disease are discussed below. 
 
2.4.4 Phases of HIV and clinical presentation. 
There is a very special relationship between the viral load and CD4 cell count. The 
viral load refers to the level of HI virus in the blood stream.  CD4 cells and viral load have an 
inverse “see-saw” relationship (Evian, 2006; Van Dyk, 2008). This means that the higher the 
viral load, the lower the CD4 cells because the virus destroys CD4 cells. A lower viral load 
will indicate a higher CD4 cell count, because if there are fewer viruses in the body, the 
immune system has a chance to build up CD4 cells.  
The levels of HIV in the blood are highly predictive of the rate of disease progression; 
individuals with lower viral loads or set points progress more slowly than those with high 
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viral loads. It is not quite clear how the immune system of some individuals is not able to 
curtail viral replication or gain some measure of control over the virus and end up 
progressing to full-blown AIDS within two to three years of infection (Kopinsky, Stoff & 
Rausch, 2004). These individuals are said to be rapid progressors (Morris & Cilliers, 2010).  
The intermediate progressors are able to maintain good viral control for many years, but this 
cannot be sustained and the individual ultimately progresses to full-blown AIDS. This type of 
progression accounts for the majority of infections (Morris & Cilliers, 2010). Slow 
progressors are able to remain disease-free for an extended time period, for instance 20 years. 
They exhibit good viral control, i.e. very low to negligible viral load, which is due in part to a 
relatively intact immune system. Currently in South Africa there are very few slow 
progressors or long-term non-progressors (Morris & Cilliers, 2010). 
Although HIV infection is theoretically divided into different stages, in practice these 
stages are not separate and distinct with easily identifiable boundaries. It is nevertheless 
helpful to divide HIV infection into the following stages as proposed by the World Health 
Organization (WHO) (2005): Pre-clinical stage - initial infection, clinical stage 1 - the 
asymptomatic stage, clinical stage 2 - the minor symptomatic stage, clinical stage 3 - the 
major symptomatic stage, and clinical stage 4 - AIDS-defining conditions. 
The preclinical stage is called primary HIV infection, seroconversion illness or the 
acute phase. Initial infection is said to occur when seroconversion takes place. 
Seroconversion refers to the point at which a person’s HIV status converts or changes from 
being HIV-negative to HIV-positive. This usually coincides with the time when an HIV test 
will show that a person is HIV-positive (World Health Organization (WHO), 2005). 
Seroconversion usually occurs six weeks after HIV infection.  The HIV viral load is usually 
high in the first weeks after infection. Approximately 30% – 60% of individuals will develop 
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flu-like symptoms characterized by swollen glands, sore throat, headache, fatigue and joint 
pains which disappear after a couple of weeks (Fan et al., 2007; Van Dyk, 2008). 
During the first stage of this disease an infected person displays no symptoms and the 
person is not even aware that they are carrying the HI virus. Even though the person displays 
no overt symptoms the virus remains active in the body and continues to damage and 
undermine the immune system. However, in some cases the only symptoms during this phase 
are swollen lymph glands (Evian, 2006; Fan et al., 2007). According to the WHO, a person in 
this stage can be placed on Performance scale 1, which indicates asymptomatic, normal 
activity, i.e. the person appears healthy and can carry on their work in a normal manner. This 
stage is associated with a CD4 cell count of between 500 – 800 cells/mm3. The normal CD4 
cell count in healthy, non-infected individuals is approximately 600 – 1 500 cells/mm3 
(WHO, 2005). Some individuals remain asymptomatic for long periods of time, respond well 
to medications, and undergo few infection-related complications until AIDS onset. A subset 
of these individuals, called long-term non-progressors are HIV-infected but they have a 
delayed progression toward disease as indicated by measures of CD4 cell loss, rises in viral 
load, onset to medical illness and may be to death (Kopinsky et al., 2004). 
In the second stage the early clinical signs of HIV infection start to emerge. These 
include swelling of the lymph nodes in the neck, below the jaw, armpits and groin, shingles, 
skin rashes, fungal nail infections, recurrent oral ulcerations, recurrent upper respiratory tract 
infections, weight loss of up to 10% of the usual body mass, and lethargy (WHO, 2005).  
According to the WHO Performance scale 2, the person is able to carry on with normal 
activity despite being symptomatic. The CD4 count during this stage is between 350 – 500 
cells/mm
3
At Stage 3 the viral load becomes very high while the CD4 count becomes very 
low. Signs of more severe HIV-related diseases begin to appear caused by uncontrolled 
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multiplication of HIV itself (Van Dyk, 2008). Some symptoms include persistent and 
recurrent oral and vaginal candida or thrush, recurrence of herpes zoster or shingles, cold 
sores, fevers that last a month, night sweats, chronic diarrhoea, and significant weight loss - 
more than 10% of the body weight, reactivation of tuberculosis and opportunistic diseases of 
various kinds (WHO, 2005). According to the WHO Performance scale 3, the person will 
usually be bedridden for up to 50% of the day during the past month. The CD4 cell count is 
between 200 – 350 cells/mm3. 
By Stage 4 patients become infected by rare and unusual organisms that do not 
respond to antibodies. More persistent and untreatable opportunistic conditions and cancers 
begin to manifest themselves. HIV-related organ damage is also common at this stage of 
Acquired immune deficiency syndrome (AIDS) (WHO, 2005). When an individual has AIDS 
as a result of HIV, the body has a deficiency in the immune system – it cannot defend itself 
against disease or infection. AIDS is not a specific illness but a collection of many different 
conditions that manifest because the body cannot defend itself against disease-causing 
pathogens (Van Dyk, 2008). According to the WHO performance scale 4, patients will have 
been bedridden for more than 50% of the day in the past month. CD4 cell counts are below 
200cells/mm
3
. Hence the war against HIV and AIDS is futile unless some form of 
intervention is sought (Van Dyk, 2008). 
 
2.4.5 HIV testing 
The diagnosis of HIV is based primarily on the testing of blood samples. There are two 
types of blood sample tests; those that detect antibodies in the blood and those that detect the 
virus. The two most common HIV antibody tests are the enzyme-linked immunosorbent assay 
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(ELISA) and the Western Blot (Fernandez, 2005; Van Dyk, 2005). These tests cannot detect 
the virus but they do react to the antibodies that are formed in the body when the immune 
system tries to protect itself against the virus. The ELISA test is more widely used because it is 
cheaper, and yields very few false negatives (Van Dyk, 2008).  In fact, a new generation of 
ELISA has now become available that simultaneously detects both antibodies and antigens 
(Van Dyk, 2008). Other forms of antigen testing fall under the umbrella of rapid HIV assay 
tests. These tests are more suitable for certain settings (such as rural, outreach situations or 
mobile clinics) because they are simple to perform, reliable and robust. In fact the results 
obtained from rapid tests are comparable to those conducted in a laboratory such as the 
Western Blot. Rapid HIV tests are not restricted to blood as in finger sticking, but can also use 
saliva or urine as specimens (Van Dyk, 2008). A major advantage of the rapid HIV tests is that 
results are available within 20 minutes (Puren, 2010). However, the results can only be used as 
screening measures and need to be followed up with more confirmatory tests such as ELISA. 
The two best known viral tests are the p-24 antigen and PCR (Fernandez, 2005, Puren, 2010). 
These tests yield results much faster than the antibody tests because they are not reliant on the 
body to produce antibodies.   
In South Africa, a positive HIV diagnosis can be confirmed in various ways. It can be 
confirmed by two positive HIV ELISA tests based on separate specimens.  Another method of 
diagnosis would include a positive ELISA test and a rapid HIV test. An alternative 
confirmation could include a positive ELISA test and a low CD4 cell count. The early 
diagnosis of HIV is important because in many cases the onset of AIDS can be drastically 
delayed if managed by antiviral drugs and living a healthier lifestyle (Minaar & Bodkin, 2006). 
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2.4.6 Management of HIV 
Despite the gains in treatment, only one in five people in low- and middle-income 
earning countries who need antiretroviral drugs are receiving them (Merson, 2006). To 
restore the health of an HIV and AIDS-infected person it is necessary to suppress the 
replication process of HIV and rebuild the damaged immune system.   
When HIV and AIDS was first diagnosed in 1981, antiretroviral drugs were not readily 
available. They only became available in 1987. The first antiretroviral medication approved for 
use against HIV and AIDS was AZT (zidovudine). In the mid- to late 1990s the use of triple 
drug therapy or highly active antiretroviral therapy (HAART) was introduced. The 
introduction of HAART has transformed the fatal infection into a chronic disease that is 
manageable in most patients (Egger, Boulle, Schechter & Miotti, 2005). Although the 
knowledge is available regarding the use of antiretroviral therapy, too many people especially 
in southern Africa do not have access to the drugs due to cost, lack of political will to roll out 
national treatment programmes and lack of trained personnel to effectively implement the 
treatment programmes (Egger et al., 2005; Zungu-Dirwayi, Shisana, Udjo, Mosala & Seager, 
2004). Furthermore, due to the inaccessibility of antiretroviral therapy (ARV), the vast 
majority of HIV-infected people die around eight to ten years after infection, with tuberculosis 
being the most common AIDS-related illness (Morison, 2001).   
Antiretroviral therapy (ART) is not a cure for HIV and AIDS, and it cannot prevent 
infection. The objectives of ART are to address virological, immunological, therapeutic and 
epidemiological problems that are caused by HIV and AIDS (National Department of Health 
(NDOH), 2010; Whiteside & Sunter, 2000). Virologically, ARV attempts to reduce the viral 
load as much as possible by interfering with the HIV life cycle (Van Dyk, 2008). 
Immunologically, ART serves to restore or preserve an individual’s immunological function, 
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so as to reduce opportunistic infections. Therapeutically, antiretrovirals also aim to improve 
quality of life for an individual. Lastly, they serve an epidemiological function in that they 
reduce the impact of HIV transmission in the community. Effective ART has been shown to 
reduce the number of new cells infected by HIV and minimize its ability to develop drug 
resistance (Minaar & Bodkin, 2006). 
Antiretroviral drugs are effective in reducing the presence of HIV-infected cells in the 
blood because they block the action of HIV enzymes. ART usually works in combination 
because of the nature of the replication cycle of the HI virus. When the virus enters the 
bloodstream it is harmless and needs to attach or fuse itself to a human white blood cell. The 
HI virus thus uses enzymes to fuse itself to the cell and replicate itself inside the cells 
(Mokgata, 2006). These enzymes include reverse transcriptase and protease (Minaar & 
Bodkin, 2006). Reverse transcriptase is responsible for the early stages of replication by 
transforming viral ribonucleic acid into viral DNA (Minaar & Bodkin, 2006). The viral 
protease enzyme plays the role of developing, replicating and maturing the virus.  
There are currently five major classes of drugs currently available in the world which 
works to suppress viral replication. These include nucleoside reverse transcriptase inhibitors 
(NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), 
entry inhibitors and integrase inhibitors (Lewthwaite & Wilkins, 2009). Entry and integrase 
inhibitors have been newly developed. Entry or fusion inhibitors block the fusion of the HI 
virus with the human cell plasma membrane so that the HIV core cannot enter the cell and 
infection is thus blocked at this step. Integrase inhibitors interfere with the enzyme responsible 
for HIV RNA replication into viral DNA, thus stopping viral replication (Lewthwaite & 
Wilkins, 2009). Entry and integrase inhibitors are not yet readily available in South Africa 
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(Van Dyk, 2008).  Table 2.4 provides a summary of the classes of drugs currently available in 
South Africa, their effects as well as a list of the antiretroviral drugs.  
Table 2.4: Classes of Antiviral Drugs and their Mechanisms of Actions 
Classification of Antiretroviral Drugs 
  
Nucleoside-reverse  
transcriptase 
inhibitor 
Non-nucleoside-
reverse transcriptase 
inhibitor 
Protease inhibitor 
Fusion 
inhibitors 
Abbreviations NRTIs NNRTIs PIs FIs 
Mechanism of 
action 
Reverse transcriptase Reverse transcriptase  
Protease inhibition 
Fusion 
inhibition 
 inhibition inhibition 
Specific action Mimics the Directly inhibits Inhibits late stage 
Binds to gp 41 
 
 normal building   reverse transcriptase  HIV replication 
  blocks of HIV DNA 
    
Antiretroviral 
agents available 
in South Africa  
zidovudine (AZT) nevirapine (NVP) indinavir (IDV) 
Enfuvirtide  
(T-20) 
 
   (Retrovir)     (Viramune)   (Crixivan) 
Not available in 
South Africa 
 
didanosine (ddl) efavirenz (EFV) saquinavir 
 
 
  (videx) (Stocorin or Sustiva)  (Invirase)  
 
zalcitabine(ddC) 
 
nelfinavir 
 
 
  (Hivid)  
 
 (Viracept) 
 
 
lamivudine (3TC)  ritonavir  
 
  (Epivir)   (Norvir)  
 
stavudine (d4T)  amprenavir  
 
  (Zerit)   (Preclir)  
 
abacavir (ABC)  lopinavir/ritonvir  
 
   (Ziagen)   (Kaletra)  
  tenofovir 
  atazanavir  
Source: HIV and AIDS Care and Counselling, (p. 98) A. Van Dyk, 2008, Cape Town: 
Pearson Education. Copyright 2008 by Maskew Miller Longman (Pty) Ltd. Reprinted with 
permission. 
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The National Department of Health (2010) has recommended that antiretrovirals be 
prescribed whenever possible where they provide maximum suppression of the virus so as to 
yield the best clinical results and prevent resistance.  This can only be achieved by combining 
three antiretroviral agents resulting in highly active antiretroviral therapy (HAART). The 
National Department of Health has recommended two HAART regimes for the public health 
sector. Regime in this sense refers to a schedule or course of therapy or treatment. Basically 
the regime refers to the medication schedule or routine a patient will have to follow. Regime 1 
(a) and 1 (b) consist of two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-
nucleoside reverse transcriptase inhibitor (NNRTIs) as the first line of treatment. If Regime 1 
fails, then patients are prescribed Regime 2 which consists of two NRTIs and one protease 
inhibitor (PI). If a patient fails to respond to both regimens, they are referred to an 
antiretroviral therapy specialist for individual evaluation and treatment. See Table 2.5 for 
specific drug regimes. 
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Table 2.5: National Department of Health Guidelines Treatment with Antiretrovirals 
Regime Drugs Category Indications 
1 (a) d4T plus 3TC 
and EFV 
NRTI plus NRTI and 
NNRTI 
For men as well as for women who 
are not of child-bearing potential or 
who are using injectable 
contraception plus condoms  
1 (b) d4T plus 3TC 
and NVP 
NRTI plus NRTI and 
NNRTI 
For women who are unable to 
guarantee reliable contraception 
whilst on ART 
2 AZT plus ddl 
and lopinavir-
ritonavir 
NRTI plus NRTI and PI For patients virologically failing 
Regime 1, despite demonstrated 
adherence 
Source: HIV and AIDS Care and Counselling (p. 100), A. Van Dyk, 2008, Cape Town: 
Pearson Education. Copyright 2008 by Maskew Miller Longman (Pty) Ltd. Reprinted with 
permission. 
It is important at this time to note several important facts about the success of HAART. 
These include side effects of the medications, interaction with other drugs and strict adherence.  
Like most drugs they can cause mild to severe long-term side effects depending on the 
tolerance level of the individual (Mokgata, 2006). These adverse effects are a serious concern 
to patients and health care providers. Concerns about metabolic complications, body shape 
changes and risk of cardiovascular disease are major threats to the success of HAART (Leen, 
2003). Secondly, antiretrovirals have also been known to interact with other drugs as in the 
case of some TB drugs (Minaar & Bodkin, 2006; Van Dyk, 2008). Thirdly, dosing schedules 
and regimens are usually inconvenient and intrusive in a patient’s lifestyle and may lead to 
poor adherence. Strict adherence and compliance to HAART is extremely important in 
achieving viral suppression and reducing the development of resistant strains. Fourthly, 
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delayed initiation of HAART because of the latter concerns poses certain challenges in that 
these patients present with a higher HIV viral load and a low CD4 count at HAART initiation 
and are thus likely to be more difficult to treat (Leen, 2003). Lastly, HAART at this time is 
unable to cure AIDS (Mokgata, 2006); it can, however, effectively keep viral loads to very 
low, almost negligible levels (NDOH, 2010; Fernandez, 2005). There is on going research to 
investigate the aforementioned facts and possible combination of HAART regimens to keep 
the viral load low. However, guidelines have been developed by the World Health 
Organisation (WHO) for global public health policy regarding the initiation of HAART 
(WHO, 2010). 
 
2.4.7 Initiation of treatment. 
HIV and AIDS is managed by following the progression of the disease. This is usually 
done by monitoring the virus in the blood by using PCR or p-24 testing. It is important to know 
the viral load in terms of knowing when to start antiretroviral therapy (ART), what type of 
drug therapy should be prescribed and assessing the effects of ART (Puren, 2010).  
Initial guidelines recommended by the National  Department of Health (NDOH) 
(2004) based upon WHO guidelines stated that HAART should be initiated if a patient or 
individual presents with symptomatic HIV-associated diseases such as unexplained weight 
loss, diarrhoea, and oral thrush to mention a few, regardless of CD4 count. HAART could 
also be initiated if the individual is asymptomatic with a CD4 count of 200cells/mm
3
 or less. 
However, these guidelines also stipulated that treatment could be initiated when CD4 counts 
fell between 200-350 cell/mm
3
 if the annual decline was more than the expected 20-80 
cells/year, and in the case of rape. However, in 2009 the WHO revised their guidelines to 
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promote earlier intervention that includes initiating treatment at a CD4 count of 350cells/mm
3 
for all individuals (All Africa, 2010).  
The previous 2004 guidelines by the NDOH were also amended and revised in line 
with the 2009 WHO guidelines. The guidelines came into effect in April 2010, and due to the 
high cost associated with HAART, and the high burden of people in need of it in South 
Africa, treatment guidelines were extended to include earlier intervention for pregnant 
women, infants and those individuals that are co-infected with tuberculosis and HIV (NDOH, 
2010). 
The South African Joint Health and Treasury Task Team (SAJHTTT) (2003) reported 
that it the aim of the government had been to have a million people on ARV treatment by 2008 
(SAJHTTT, 2003). Even though South Africa is considered as one of the most economically 
developed countries in Africa, this has not been reflected in the speedy roll-out of HIV 
treatment.  In April 2004 the South African government embarked on an ambitious 
antiretroviral programme in response to the HIV pandemic, two years later than countries such 
as Botswana and Nigeria that had already started to issue HAART to the public in 2002. In 
2006, 130 000 people were receiving ARV treatment in the public sector and 90 000 in the 
private sector, however approximately 79% of infected persons were still in need of ARVs in 
South Africa (Mokgata, 2006).  
The South African National AIDS Council (SANAC), formed in 2006, had announced 
that its aim was to halve the HIV infections in the country and to provide treatment to at least 
80% of the people and families living with HIV and AIDS (Van Dyk, 2008). However, 
apparently this initiative was not entirely supported by the reigning government or 
dispensation of the time. Since there is no accurate estimate of the number of people receiving 
treatment, it is difficult to determine the numbers still needing treatment currently. This is 
further complicated by the numbers of people who are initiated on ART but then drop out of 
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treatment. The best available estimates come from the Actuarial Society of South Africa model 
developed in 2003. By June 2008 it was estimated that 495 000 people were receiving ART 
with 520 000 still requiring treatment. In other words, the ART roll-out was then reaching less 
than 50% of the people who urgently required such treatment to stay alive (Aids Buzz, 
2010).  Fortunately it appears that this is changing with the 2010 figures, indicating a total of 
791 000 adults and children receiving ART against the remaining estimated 702 000 that have 
not been initiated on ART or have dropped out of the programme (and so remain sick with 
AIDS). 
Nonetheless, despite the efforts that have been made, there is still a long way to go if 
the high AIDS death toll (388 000 in 2010) is to be brought under control (Aids buzz, 2010).  
Efforts to provide ARV to people who need it have been hampered by a number of factors 
including shortage of competent staff, government’s unbalanced budgetary priority structures 
resulting in the lack of government support for poorer provinces, and gaps in the dissemination 
of information between national and provincial departments, as well as civil societies (Ndlovu 
and Daswa, 2006). Examples of these gaps include lack of information pertaining to data 
collection and management, patient outcomes, patient numbers, and community awareness to 
mention just a few (Ndlovu and Daswa, 2006). Having said this, many South Africans and 
advocacy organisations have criticized the previous government led by President Mbeki and 
the late then Minister of Health Dr. Manto Tshabala-Msimang, as having contributed to the 
lack of proper processes that would ensure distribution and access of ARVs to the South 
African populous since they were considered to have presented mixed, delaying and denialist 
tactics, particularly in their approach to what they considered as solutions to addressing the 
prevalence and management of HIV and AIDS (Nattrass, 2008).  
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The South African National AIDS Council in 2008 proposed a national strategic plan 
which included its two main goals already articulated in 2006. This plan proposed, firstly, to 
decrease the incidence of HIV in South Africa by 50% and, secondly, to make sure that at least 
80% of those eligible for ARV are accessing them (AIDS Foundation of South Africa, 2010). 
The best roll-out programmes for HIV and AIDS drugs have been in Gauteng, Western Cape 
and the North-West Province. KwaZulu-Natal and the Eastern Cape are increasing their roll-
out numbers too. The rest of the provinces have been slow in making ART available to the 
public because of “poor management and political will” (Mokgata, 2006, p.2).  
Nevertheless there now appears to be the commitment and political will of the current 
government under the leadership of President Zuma and the Minister of Health, Aaron 
Motswaledi, to correct the wrongs of the past (AIDS Foundation of South Africa, 2010). This 
positive level of commitment can only have positive outcomes for individuals living with HIV 
and AIDS in South Africa in terms of medical and neurological benefits. This also allows for 
research to be done regarding the effects of HAART on both medical and neurological 
conditions. It is imperative that research be conducted in developing countries such as South 
Africa regarding the effects of these antiviral drugs because most of the information gathered 
thus far comes from developed countries.  Hence the value of conducting this research is to 
further add to the minimal knowledge and literature that has been generated regarding the 
effects of HAART on the cognitive-linguistic abilities of adults living with HIV and AIDS in 
South Africa. 
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2.4.7 The effects of HIV on the central nervous system 
Although the HI virus has devastating effects on the body, this thesis is primarily 
concerned with how the virus affects the central nervous system to cause HIV-associated 
neurocognitive disorders that can result in cognitive-linguistic impairments. The HI virus 
impacts the CNS on three fronts - the disease, opportunistic cerebral infections due to 
bacteria, fungi and protozoa or viruses, and adverse effects caused by neurotoxicity of 
HAART (Ungvarski & Trzcianowski, 2000). However, one must bear in mind that HIV-
associated neurocognitive disorders can be caused by the HI virus in the absence of 
opportunistic infections and HAART neurotoxicity. 
There are two parts of the nervous system - the central nervous system (CNS) which 
includes the brain and spine, and the peripheral nervous system (PNS) which includes the 
nerves and muscles. The CNS has a natural protective barrier known as the blood brain 
barrier. The HI virus is able to cross the blood brain barrier (BBB) and enter the central 
nervous system within days of infection (Robertson et al., 2010). The BBB is composed 
mainly of specialized brain capillary endothelial cells (EC) in contact with astrocytes and is 
characterized by the presence of tight junction proteins between the EC and astrocytes. Low 
permeability is attributable in part to the presence of a highly developed tight junction 
between the endothelial cells and astrocytes in the absence of fenestrations (spaces) (Banks, 
2005; Miller, 2005; Eugenin et al., 2006). These cells form a dynamic interface between the 
blood and brain.  
CNS infection starts very early, in fact during the asymptomatic stage of infection. 
However, damage to the CNS seldom occurs until systemic immunosuppression is 
established (Kipnis, Derecki, Yang & Scrable, 2008; Xia et al., 2011). Infection can lead to 
brain swelling or inflammation, particularly of the brain lining or meninges. In medical terms 
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this is termed encephalopathy (Fan, Conner, &Villarreal, 2007). Monocytoid cells 
(macrophages, microglia, and monocytes) in the brain appear to be the prominent sites for 
replication. Brain inflammation can result for a couple of reasons. There can be an influx of 
immune system cells to fight the infection or a release from infected cells of the highly active 
toxic molecules called cytokines that can affect and kill brain cells (Alfano & Poli, 2002).  
Despite extensive evidence of pathological changes in the CNS of infected 
individuals, the mechanism of viral entry into the brain is still not completely understood. 
However, there have been several theories posited as to how the virus crosses the BBB. 
These include the Trojan horse theory and the late invasion bone marrow theory. According 
to the Trojan horse theory, a few peripheral HIV-infected macrophages are able to pass 
through the BBB undetected, and once they cross they start to infect other cells, until a 
reservoir of latent HIV-infected macrophages are established (Berger et al., 2000; Portegies 
& Berger, 2007). These then become active and start to replicate and excrete neurotoxins, 
cytokines and proviral proteins. Later in the course of the disease these then cause HIV-
associated dementia (HAD). Activation of this latent reservoir of infected cells can be caused 
by rising levels of HIV or viremia associated with opportunistic infections such as 
toxoplasmosis or cryptococcosis (Ungvarski & Trzcianowski, 2000).  
On the other hand, there is now research to suggest that there is no reservoir of 
infected cells in the brain. This theory proposes that there is an initial wave of a few 
peripheral infected macrophages that cross the BBB and enter the CNS, particularly the brain, 
and as the disease progresses there is a later, larger, second wave of peripheral infected 
macrophages’ that cross the BBB into the brain where they accumulate and eventually this 
leads to HAND (Fisher-Smith, Adeniyi, Rybicka, Morgello, Khalili, et al., 2004). 
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The bone marrow hypothesis suggests that HIV-infected cells make their way to the 
bone marrow where they are produced in mass. It has been suggested that this is a late-stage 
disease event (Goodkin et al., 2001).  The bone marrow is one of the sites in the body where 
blood cells, predominantly white blood cells, are manufactured, so if infected white blood 
cells are transported via blood flow to the bone marrow, those will in turn end up infecting 
other white cells where they subsequently enter the circulatory system.  Through the 
circulatory system the virus enters the brain and spinal cord (Hickey et al., 2005) and thereby 
contributes to HIV-associated neurocognitive disorders (HAND) (Goodkin et al., 2001). This, 
however, still remains to be documented either in Simian immunodeficiency virus monkeys 
or human patients. 
  Mechanisms of HIV-associated injury in the brain. 
Regarding the mechanisms of HIV-associated injury, there is growing support to 
suggest that HIV-1 rarely directly infects neurons, but HIV or immune-related toxins cause 
indirect injury or death of neurons via a potentially complex web of interaction between 
macrophages (or microglia), astrocytes and neurons (Alfano & Poli, 2002; Giunta et al., 
2006; Minagar, Shapshak, Fujimura, Ownby, Heyes & Eisdorfer, 2002; Nath, 2002)). 
Researchers claim that infected HIV white blood cells such as macrophages, monocytes and 
microglia’s in close proximity of the blood brain barrier (BBB) release noxious substances 
such as nitric oxide, cytokines and arachnoid acid that cause the BBB to become permeable 
to the infected HIV cells; these infected cells once they have crossed the blood brain barrier 
then become reservoirs of HIV in the brain and the CNS (Minagar et al., 2002; Portegies & 
Berger, 2007). Once they cross the blood brain barrier, they excite astrocytes which are 
immune-fighting cells in the BBB to release neurotoxin substances along with infected HIV 
cells (Berger & Arendt, 2000; Eugenin et al., 2006; Giunta et al., 2006; Nath, 2002). These 
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infected cells produce proviral proteins such as Tat, HIV gp 41 and HIV gp120 along with 
cytokines that are released into the extracellular spaces of the brain. Extracellular space 
within the brain comprises 20% of the total volume of the brain volume (Nath, 2002).  
Once the toxins have been released they interact with uninfected microglia’s and 
macrophages to cause apoptosis (cell death or damage) (Hickey et al., 2005, Navia & Price, 
2005).  Neurotoxins also have an effect on neurons especially on the myelin sheath (Alfano 
and Poli, 2002; Karl and Lipton, 2005; Giunta et al., 2006). Larger neurons are more 
vulnerable to damage than smaller neurons (Wohlschaeger et al., 2009). Damage to the 
myelin affects the transmission of electrical impulses. Infected cells via proviral proteins are 
also able to cause uninfected monocytoids to release noxious substances such as intracellar 
Ca2+, cytokines and glutamate (Banks, 2005; Navia & Price, 2005). The neurotoxin effects 
of HIV can be seen by MRI using 3D mapping techniques.  
There is no consensus in the literature as to whether the viral load (the amount of 
virus in the brain) and/or neuronal death corresponds to the development of HIV and AIDS 
dementia (HAD). Some researchers have suggested that there is an association between viral 
load and HAD as indicated by an association between reduction in volume of grey matter in 
the basal ganglia (Ances et al., 2006; Aylward et al., 1995; Thompson, Dutton, Hayashi, Lu,  
et al., 2006). Other researchers argue that the viral load or CD4 count does not determine the 
degree of HIV-associated neurocognitive disorders (Cook-Easterwood et al., 2007; Ellis et 
al., 2007; Price, 1998). Maybe the lack of agreement is due to the fact that most of these 
studies are conducted cross-sectionally, thereby making it difficult to come to a consensus 
about whether CD4 counts correlate with neuro-degeneration that can cause varying 
severities of HIV-associated neurocognitive disorders.  The current study will shed more light 
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on whether CD4 counts correlate with cognitive impairments observed in HIV-positive 
patients considering that part of it has been conducted longitudinally.  
However, this does not exclude the possibility that viral load at other time points 
during the course of the disease might be related to HIV-associated dementia (HAD). So if 
viral load is not consistently correlated to HAD this could suggest that secondary 
mechanisms may also play an important role in the manifestation of HAD.  Wohlschaeger et 
al. (2009) propose that loss of neurons does not correspond to the absence or presence of 
HAD, but cognitive and motor deficits identified by neuropsychological tests seem to 
correlate well with neuronal damage (Thompson, Dutton, Hayashi, Lu, et al., 2006). In fact 
Ellis et al. (2007) suggest that synaptodendritic changes in HIV correlate closely with the 
presence and severity of cognitive impairment. Synaptodendritic injury is a specific type of 
neuronal injury that is not unique to HIV - it also occurs in diseases such as Parkinson’s, 
Alzheimer’s, schizophrenia, mood disorders and amyotrophic lateral sclerosis (Ellis et al., 
2007). In HIV, although synaptodendritic injury is widespread throughout the brain, some 
regions of the forebrain show selective vulnerability. 
Synaptodendritic injury comprises various structural and chemical changes that affect 
the ends of neurons – the synapses at which they communicate and interact with one another. 
Injury or insult to the dendrite can present as retraction of dendrite spines, dendritic beading 
(bulging or knotted appearance of dendrites) or aberrant outgrowths, all of which can occur 
without neuronal death (Ellis et al., 2007). The result of these pathological processes is a 
disruption or loss of normal synaptodendritic communication. Higher cognitive functions 
depend on a highly complex synaptodendritic network, and damage to this network results in 
abnormal output, measured as deficiencies in cognitive skills and behaviour. For example, 
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neurons that undergo dendritic beading lose their capacity for long-term potentiation, a 
central process in memory formation (Ellis et al., 2007).  
Several techniques have been utilized to determine the degree of synaptodendritic 
injury. These include immunostaining, measuring synaptodendritic proteins or neuroimaging. 
The technique of immunostaining entails staining the proteins expressed in normal cell bodies 
and dendrites such as postsynaptic microtubule-associated protein 2 (MAP2) (Ellis et al., 
2007). Results have revealed a reduction of MAP2 in the striatum (which comprises the 
putamen and caudate nucleus) and the hippocampus.  This regional vulnerability parallels the 
higher burden of HIV proteins and viral RNA in the striatum and white matter connecting the 
striatum to the prefrontal cortex (Cook-Easterwood et al., 2007). Similar changes have been 
also confirmed by Cook-Easterwood et al. (2007) using SCID mice infected with the HI 
virus. They found that MAP2 expression was reduced in the brain areas immediately adjacent 
to infected macrophages.  
Another technique or approach is to measure synaptodendritic proteins released from 
damaged neurons in the extracellular space which can be detected in the cerebral spinal fluid 
(CSF) or the blood. For example, elevated CSF neurofilament protein (NFL) concentrations 
are thought to indicate injury to myelinated axons. CSF NFL has been found to be high in 
persons diagnosed with HIV-associated dementia (Gisslen, Rosengran, Hagberg, Deeks & 
Price, 2005). However, it is not known whether increased levels of NFL truly reflect neuronal 
injury or whether NFL is dependent on cell death. There is no data as yet about the 
relationship between changes in neurocognition with HIV and changes in NFL. 
Brain functioning can be impaired to varying degrees. Often the person will have 
difficulty concentrating, remembering, processing information or problem-solving. As the 
disease progresses, mental functioning can become more serious and reach a point where the 
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person becomes demented and is unable to take care of themselves. When this occurs the 
person is said to exhibit AIDS dementia complex or HIV-associated dementia (Grant, Sacktor 
& Mac Arthur, 2005).  
To summarize the process of how the HI virus  causes brain disease that results in 
varying degrees of neurocognitive impairment,  Ernst, Chang and Arnold (2003) proposed a 
three-step process. The first step involves HIV infection that causes inflammation and brain 
injury, either directly due to the neurotoxic viral proteins (gp 120 and tat) or indirectly due to 
the deleterious effects of cytokines and chemokines (e.g. macrophage inflammatory proteins) 
that are released by HIV-infected microglia and macrophages and activated astrocytes (Kaul 
& Lipton, 2006; 2007). In the second step, brain inflammation and injury lead to metabolic 
abnormalities, some of which can be detected with modern neuroimaging techniques. For 
example, HIV-infected patients commonly show glial activation and proliferation which can 
be monitored with glial neuroimaging markers such as choline containing compounds (CHO),  
myo-inositol (MI) or proton magnetic resonance spectroscopy (H¹MRS) (Chang et al., 2004; 
Cholewińska & Szymańska, 2009; Ernst et al., 2003).  In the third and final step of the model, 
cellular and metabolic abnormalities impair neural processing as evidenced by 
synaptodendritic injury and demyelization of the larger neurons (Chang et al., 2004; Ellis et 
al., 2007). To compensate for these impairments, affected individuals require increased 
attention (or neural processing) to maintain normal cognitive function, which can be detected 
and monitored  by a blood-oxygenated level-dependant functional MRI, a direct and non-
invasive technique to study brain function (Ernst et al., 2003). 
Damage to the spinal cord can result in myelopathy or peripheral neuropathy. 
Myelopathy is the swelling of the spinal cord which can lead to weakness or paralysis of the 
limbs. Weakness or paralysis occurs because nerve impulses to the muscles from the spinal 
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cord have been disrupted (Fan et al., 2007). Peripheral nerve damage or neuropathy thus 
occurs when HIV-infected individuals experience swelling of the peripheral nerves (Fan et 
al., 2007). The specific causes of peripheral neuropathy in HIV are still unknown. 
Researchers suspect that either HIV or drugs that are toxic to the nervous system or a 
combination of both may be the cause of damage. The most common peripheral neuropathy 
is distal symmetric polyneuropathy (The Well Project, 2010).  This happens when the 
communication between the nerves in the feet and/or hands to the brain and spinal cord 
becomes damaged. Individuals usually complain of numbness, burning or stinging sensation 
in the hands or feet (Fan et al., 2007; The Well Project, 2010).  Cognitive dysfunction, 
peripheral neuropathy and myelopathy are not mutually exclusive. Individual patients may 
experience a mixture of any them. Moreover, it is not uncommon for HIV-1 to also 
precipitate cerebral vascular disorders such as infarcts, intracerebral or sub-arachnoid 
haemorrhage, strokes, subdural hematoma and transient ischemic attacks which can directly 
or indirectly lead to cognitive deficits. 
Mechanisms of Opportunistic Infection- and HAART- injury to the central and 
peripheral nervous system. 
Apart from the HI virus attacking the brain, opportunistic infections (OI), can also 
cause cerebral signs and symptoms that reflect cognitive deficits. Opportunistic infections are 
infections caused by agents or pathogens that would not have had any effect if the immune 
system was intact. These pathogens include bacteria, fungi, viruses, cancers and protozoa 
(Van Dyk, 2008). Those that can cause brain damage and alter mental state and sometimes 
cause generalized seizures include crytococcal meningitis (fungal), toxoplasma encephalitis 
(protozoa), cytomegalovirus (virus) and mycobacterium tuberculosis (bacteria) to mention 
just some examples (Alfano & Poli, 2002; Fan et al., 2007; Larson, 1998; McGuire, 2010). 
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Progressive multifocal leukoencephalopathy, primary CNS lymphoma and toxoplasmosis 
account for the majority of focal diseases that produce hemiparesis, hemisensory loss, visual 
field cuts, or disturbances in language use (McGuire, 2003). Some of the cognitive problems 
experienced by opportunistic infections include memory loss, poor concentration, decreased 
problem-solving abilities, slow processing abilities, personality and mood changes (Berger et 
al., 2000; Fernandez, 2005; Larson, 1998).  A few of these disturbances have also been 
observed in patients on antiretroviral therapy (ART). 
The brain tissue damage resulting in cognitive and language problems may be a side 
effect of antiretroviral therapy (ART), either directly because of central nervous system 
(CNS) toxicity or indirectly through side effects on other organ systems that impact the brain 
(Cardenas et al., 2009). The side effects of the medications prescribed in HAART can affect 
CNS and cause individuals to exhibit poor concentration, memory loss and sometimes 
hallucinations (Southern African HIV Clinicians Society, 2008). The drugs that might cause 
these problems include efavirenz (EFV) or stocrin.  However, others such as zidovudine and 
staduvine can cause headaches, peripheral neuropathy and fatigue. Sacktor, Nakasujja, 
Skolasky, Robertson, Musisi et al. (2009) found in their study of 102 HIV-positive 
individuals, that staduvine-based HAART caused peripheral neurotoxity, i.e. peripheral 
neuropathy. Protease inhibitors have been associated with cardiovascular disease, which in 
turn has been associated with the presence of lacunar infarcts and abnormal white matter in 
the brain (Cardenas et al., 2009).   
To summarise this section, the HI virus enters the body insidiously and starts to 
replicate itself in immune cells that are supposed to be a defence mechanism against invading 
viruses or bacteria. Once an individual becomes HIV-infected, they do not automatically 
develop full-blown AIDS. There are a series of phases of symptomatology that an infected 
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person progresses through before developing AIDS. In developed countries where there are 
adequate health facilities and nutrition, the progression to AIDS is usually slower, ranging 
from 8-12 years, than in developing countries, where poverty, inadequate health services and 
poor nutrition are the prevailing norm and progression to full-blown AIDS is short - two to 
five years after diagnosis (Puren, 2010). Unfortunately access to HAART in South Africa for 
all individuals diagnosed with HIV and AIDS has not been fully realised. Once the HI virus 
is in the body its resultant effects are devastating. One of its effects on an individual is to 
cross the blood brain barrier and enter the brain and as a result cause HIV-associated 
neurocognitive disorders of varying severity. This research assumes that the presence of HIV-
associated neurocognitive disorders can give rise to cognitive-linguistic deficits. 
 
2.5 HIV-Associated Neurocognitive Disorders (HAND) 
 2.5.1 Introduction 
This section defines neurocognitive disorders and how they are classified in HIV 
starting from the most subtle, asymptomatic neurocognitive impairments to the most 
devastating HIV-associated dementia (HAD). This section proceeds to describe in more detail 
the areas of the brain most affected by HI viral infection. The brain degeneration observed in 
HAND has also been observed in Parkinson’s disease, Alzheimer’s and normal aging (Cloak 
et al., 2004; Green et al., 2002; Marinus et al., 2003).Finally this section discusses the 
management or treatment of HIV-associated neurocognitive disorders. It is valuable to note 
that neurocognitive deficits seen in patients diagnosed with HIV can be caused by the HI 
virus, opportunistic deficits or HAART. The preceding sections described the three ways in 
which the disease can bring about HIV-associated neurocognitive disorders, which are 
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through the HI virus, opportunistic infections and neurotoxicity of antiretrovirals.  The main 
focus of this section will be how the HI virus causes neurocognitive deficits that can give rise 
to cognitive-linguistic deficits. 
 
2.5.2 Definitions. 
Brain pathology that occurs due to HIV infection can produce behavioural 
impairments. These impaired behaviours are often indicative of CNS involvement and are 
termed neurocognitive processes and abilities (Dawes & Grant, 2007).  Examples of 
neurocognitive processes include psychomotor speed and attention capabilities. 
Neurocognitive abilities are often grouped in terms of verbal language skills, executive 
functioning and abstraction ability, complex perceptual motor skills, memory, motor skills, 
and sensory functions (Dawes & Grant, 2007).  When present, neurocognitive impairments 
can range in severity from subtle deficits to debilitating dementia. There are three diagnostic 
terms in common use to describe HIV-associated neurocognitive disorders (HAND). The first 
being Asymptomatic neurocognitive impairment, which refers to the presence of mild 
neurocognitive deficits that have been determined by neuropsychological testing and which 
have not progressed to the point where they interfere with everyday functioning – basically 
the individual is not aware of them (Ellis et al., 2007). The term “asymptomatic 
neurocognitive impairment” (ANI) is a more recent diagnosis in order to further differentiate 
subtle cognitive deficits from mild to moderate deficits. However, asymptomatic 
neurocognitive impairment is not a term that is widely used at present to denote 
neurocognitive deficits. Investigators tend to use the terms of mild/minor cognitive motor 
disorders (MCMD) or HIV-associated dementia (HAD) to describe HIV-associated 
neurocognitive deficits. Mild motor cognitive motor disorders indicate the presence of several 
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cognitive deficits that range from mild to moderate and which may or may not interfere with 
daily functioning (Fernandez, 2005). The majority of HIV individuals with mild motor 
cognitive motor disorders (MCMD) can typically continue to work and do other activities, 
albeit in a less than efficient manner. When the deficits are severe to profound it is termed 
HAD. These deficits render an individual incapable of living independently in the 
community. 
According to Ciccarelli et al. (2011) and Thompson et al. (2005), at least 45% of HIV 
and AIDS patients suffer from neurocognitive impairments, ranging from asymptomatic 
neurocognitive impairment (ANI) to HIV-associated dementia (HAD), often with a 
progressive trajectory leading to death. HAD’s progression to death is more rapid if the 
patient presents with advanced systemic disease, paralleling the immune defects and systemic 
effects of increasing HIV load and cytokine production (Grant et al., 2005). However, 
research has also revealed that individuals diagnosed with mild motor cognitive motor 
disorders (MCMD) are also at a high risk of mortality (Wilkie et al., 1998). It is interesting to 
note that not everyone diagnosed as HIV-positive develops dementia, and not everyone 
diagnosed with MCMD develops dementia (Thompson, Dutton, Hayashi, Lu et al., 2006). It 
is still not clear how an individual develops dementia, because high viral load has been 
detected in those areas of the brain that are the most affected, but neuro-degeneration has not 
occurred in those areas to produce cognitive impairments. Maybe this explains why not all 
HIV-positive individuals develop cognitive deficits or, if they do, they only present with 
asymptomatic neurocognitive impairment ANI or MCMD. The American Academy of 
Neurology (1991) cited in Fernandez (2005,) has developed clinical criteria for the clinical 
diagnosis of HIV-associated dementia (HAD) (see Table 2.6) and mild motor cognitive motor 
disorders (MCMD).  
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Table 2.6: Criteria for clinical diagnosis for HIV-associated dementia 
Must have one of the following: 
1. Acquired abnormality in at least two of the following cognitive abilities for at least 
one month: attention/concentration, speed of processing information, 
abstraction/reasoning, visual spatial skills, memory/learning and speech/language 
Cognitive dysfunction causing impairment of work or activities of daily living should 
not be attributable solely to severe systemic illness 
2. At least one of the following: 
(a) Acquired abnormality in motor function or performance verified by clinical 
examination, neuropsychological testing, or both 
(b) Decline in motivation or emotional control or change in social behaviour 
3. Absence or clouding of consciousness during a period long enough to establish the 
presence of item 1 
4. No evidence of another etiology, including active CNS opportunistic infection or 
malignancy, other psychiatric disorders (e.g. depression), active alcohol or substance 
use, or acute or chronic substance withdrawal 
5. HIV seropositivity (ELISA test confirmed by Western blot, polymerase chain 
reaction, or culture) 
Source: From “The Ten Myths about HIV infection and AIDS” by F. Fernandez, 2005, 
Focus: The Journal of Lifelong Learning in Psychiatry, 3, 184-192. Reprinted with 
permission. 
In patients with mild motor cognitive motor disorders (MCMD), cognitive 
impairments will manifest as changes in attention and memory registration, storage and 
retrieval as well as in psychomotor speed, information processing rate and fine motor 
function. However, these changes have minimal effects on activities of daily living and on 
functional performance status (see Table 2.7). 
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Table 2.7: Criteria for clinical diagnosis of HIV-1 associated minor cognitive motor 
disorder 
1. Cognitive/motor/behavioural abnormalities (both of the following): 
(a) At least two of the following present for at least one month  
 Impaired attention or concentration 
 Mental slowing 
 Impaired memory 
 Slowed movements 
 In-coordination 
 Personality change, irritability, or emotional lability 
(b) Acquired cognitive/motor abnormality verified by clinical neurological 
examination or neuropsychological testing (e.g. fine motor speed, manual 
dexterity, perceptual motor skills, attention/concentration, speed of processing 
information, abstraction/reasoning, visual spatial skills, memory/learning and 
speech/language    
2. Disturbance from item 1 causes mild impairment in work or activities of daily living 
3. Does not meet criteria for HIV-1 associated dementia 
4. No evidence of another etiology, including active CNS opportunistic infection or 
malignancy, severe systemic illness, active alcohol or substance use, acute or chronic 
substance withdrawal, adjustment disorder, or other psychiatric disorders  
5. HIV seropositivity (ELISA test confirmed by Western blot, polymerase chain 
reaction, or culture) 
Source: From “The Ten Myths about HIV infection and AIDS” by F. Fernandez, 2005, 
Focus: The Journal of Lifelong Learning in Psychiatry, 3, 184-192. Reprinted with 
permission. 
 
2.5.3 HAND progression. 
There is no consensus on the relationship between earlier (asymptomatic neurocognitive 
impairment and mild motor cognitive motor disorders) and later (HIV-associated dementia) 
neurological effects of HIV. Several models have been proposed in this regard:  
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 The milder neurological dysfunctions, cellular and molecular alterations seen earlier 
in HIV disease gradually accumulate, leading to full-blown dementia (Ellis et al., 
2007). In other words, asymptomatic neurocognitive impairment (ANI) and mild 
motor cognitive motor disorders (MCMD) gradually progress to HIV-associated 
dementia (HAD) as in the case of Alzheimer’s disease (Apostolova & Thompson, 
2007). According to Chang et al. (2004), the pathological process begins with an 
inflammatory response caused by neurotoxic mechanisms localized in the white 
matter and basal ganglia, and progresses to neuronal injury and eventual 
neurocognitive impairment that leads to HAD. 
  HAD only develops after some critical level of CNS damage is reached as in the case 
of Parkinson’s disease.  Parkinsonian symptoms develop only after 80% or more of 
the substantia nigra neurons are lost (Grant et al., 2005). 
  Early mild motor cognitive motor disorders (MCMD) represent a relapsing remitting 
condition early on, with progression to HAD in only a subset of HIV-positive 
individuals later on. This is similar to the progression of multiple sclerosis (Fisher-
Smith et al., 2004). 
  MCMD represents a process separate from the more HIV dementia. This is similar to 
the alcohol brain disease model – many alcoholics’ exhibit neurocognitive 
impairments. Wernicke-Korsakoff syndrome occurs in only a few later stage 
alcoholics and its pathogenesis involves mechanisms that are different from the 
common variety of neurocognitive impairments observed in other pathologies (Grant 
et al., 2005). More sophisticated research methodologies are needed that examine 
neuropsychological performance, markers of systemic immune function, and HIV 
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replication to fully understand how ANI, MCMD and HAD become evident in the 
body. 
 
2.5.4 Incidence and Prevalence Rates 
Prevalence and incidence rates of mild motor cognitive motor disorders (MCMD) and 
HIV-associated dementia (HAD) are readily available in developed countries such as the 
United States of America but not in African countries. This is due to the limited resources 
available in terms of manpower or skilled professionals and equipment to assess HIV-
associated disorders; there are thus no accurate rates available for Africa, and therefore most 
of the data that is used is based on American data. 
In terms of incidence and prevalence rates, more people are diagnosed with MCMD than 
HAD. Initially before the advent of HAART, the incidence and prevalence of HAD was 
considered to be very high. Initial reports on the prevalence of dementia in AIDS varied from 
7% to 66% depending on the referral population studied and the selection criteria used. Since 
the introduction of HAART, all reports on the incidence of HIV-associated dementia (HAD) 
indicate that HAD has decreased but not to the level where the presence of HAD has been 
eliminated (Ances et al., 2006; Shiramizu, Williams, Shikuma and Valcour et al., 2009).  
Other reports go as far as to say that the incidence and prevalence of HIV-associated 
neurocognitive disorders is on the rise, possibly due to drug resistance and limited CNS 
penetration of some antiretroviral drugs and poor drug adherence (Cysique, Maruff & Brew, 
2004; Wohlschlaeger et al., 2009). Furthermore, research has shown that HAART is unable 
to stop the infiltration of infected macrophages into the brain, and it is not able to cross the 
blood brain barrier to prevent the replication of infected cells in the brain (Kaul & Lipton, 
2006, 2007; Shiramizu et al., 2009). However, the benefits of HAART should not be 
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understated, and HAD has decreased by 50% since the introduction of HAART (Sacktor, 
Nakasujja, Skolasky, Robertson, Wong et al., 2006).  
Estimates of the percentage of HIV-infected individuals diagnosed with HIV-associated 
dementia (HAD) vary greatly (Minagar et al., 2002; Wohlschlaeger et al., 2009). The data 
collected (pre-HAART) prospectively in the Multicentre AIDS Cohort Study revealed an 
incidence of 7% within 12 months of the diagnosis of AIDS and 14% within two years of 
AIDS onset (McArthur et al., 1993). The cumulative life time risk of developing HAD was 5-
20% pre-HAART (Wohlschlaeger et al., 2009) and as many as 60% of HIV and AIDS 
patients may have some level of neurocognitive impairment by the time of death. Since the 
advent of HAART in 1996, the incidence of HIV-associated dementia (HAD) has decreased 
by 50% (20% -10%) while the prevalence rate has increased from 6.6 in 100 in 1994 
compared to 10.1 in 100 (Cook-Easterwood et al., 2007).  
The sustained prevalence of HIV-associated neurocognitive disorder might be due to 
drug resistance and poor adherence. Njamnshi et al. (2009) reported that the national 
prevalence of HIV-associated neurocognitive disorders including HAD was higher than 21%. 
They proposed that this prevalence could be the same or higher in sub-Saharan Africa. This 
may most likely be the case since initiation of HAART is rather late in terms of disease 
progression as compared to developed countries.  In addition not everyone in sub-Saharan 
Africa has access to HAART so as to reduce the prevalence of HIV-associated 
neurocognitive disorders. This high prevalence of HIV-associated neurocognitive disorders 
could also be indicative of the prevalence of cognitive-linguistic impairments. 
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2.5.5 Clinical Presentations of HIV-Associated Neurocognitive Disorders and 
Neuropathogenesis 
The clinical and neuropsychological abnormalities of HIV-associated neurocognitive 
disorders can reflect in all or one of three areas depending on the severity of the 
neurocognitive disorders. These three areas include cognition, motor and behaviour. 
Cognitive impairments are characterized by mental slowness, forgetfulness, poor 
concentration, difficulty processing and acquiring new information, difficulty with tasks 
requiring “executive functions” (i.e. complex cognitive tasks requiring planning, set shifting, 
and coping with novel situations) and poor sequential processing (Grant et al., 2005; Larson, 
1998; Storace, Dijkgraaf, Houweling, Postma & Tramarin, 1998). Motor symptoms which are 
due to basal ganglia damage include a loss of fine motor control leading to clumsiness, gait 
disturbances (poor balance), impaired postural reflexes, and tremors. Behavioural changes 
may include apathy, lethargy, depression and diminished emotional responses and 
spontaneity (Berger & Arendt, 2000; Price, 1998). Berger and Arendt (2000) further add that 
it is not uncommon to see individuals with HIV and AIDS exhibit postural instability, 
rigidity, hypomimetic facies, hypophonia, dysarthria (poorly articulated speech). Even in the 
absence of apparent cognitive impairment, HIV-infected patients may demonstrate sub-
clinical motor dysfunction indicative of basal ganglia dysfunction. Evidence of the latter 
includes slow reaction time, postural imbalance, and impairment of rapid alternating index 
finger movements and extensions (Berger & Arendt, 2000). In fact quite a few tests use 
psychomotor abilities as an early indicator of the presence of neurocognitive deficits in 
individuals living with HIV and AIDS.  
The neuropathogenesis of clinical presentations are purportedly subserved by 
neuronal loops extending from the cortex to the subcortex (Woods et al., 2004). HIV-
associated neurocognitive disorders reflect neurotoxic mechanisms that cause disruptions 
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within the circuits connecting the frontal lobes and basal ganglia (Woods et al., 2004). Due to 
advances in imaging techniques such as fMRI, PET, CT scans and physiological techniques 
such as cell recording and neuronal tracing,  substantial  evidence for  promoting the 
involvement of  subcortical structures not only in motor movement but also in cognitive and 
language processes is now emerging(Koziol & Budding, 2009). Researchers are thus now 
proposing a vertical or fronto-subcortical approach to studying HIV-associated 
neurocognitive disorders and cognitive linguistic deficits (Murdoch & Whelan, 2009).  
Technological advances have also significantly improved our understanding of 
neuronal structures, their connective patterns and how structures relate to cognitive 
functioning. Neuronal connections between regions of the cortex and basal ganglia have been 
identified. These neuronal networks provide the anatomic substrate for supporting not only 
motor, but also cognitive and behavioural functions (Middleton & Strick, 2000). The 
neuronal “loops” or circuits originate in the cerebral cortex. After passing through the various 
subcortical structures within each respective system, the circuit re-enters the cortex and 
terminates very near the same region in which the circuit originated (Koziol & Budding, 
2009). Therefore a general feature of this circuit is the fronto-basal ganglia/striatal loop of 
interaction.  
Convergent evidence for the role of fronto-basal ganglia system’s neuropathysiology 
in HIV-associated neurocognitive disorders is provided by neuroimaging studies in HIV. 
Regarding the basal ganglia,  studies have revealed atrophy of the caudate nucleus 
(Thompson, Dutton, Hayashi, Lu et al., 2006) and substantia nigra (Berger et al., 2000), and 
enlargement of ventricular spaces. In addition, smaller caudate volume is associated with 
HIV disease (Alyward et al., 1995; Ances et al., 2006), and smaller caudate volume correlates 
with poorer performance on cognitive tests in patients with advanced HIV disease 
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(Thompson et al., 2006). Due to the subcortical involvement, HIV-associated dementia is 
considered to be a “sub cortical” dementia consistent with the dementia observed in 
Parkinson’s disease and Huntington’s chorea (Berger et al., 2000; Marinus et al., 2003; 
Thurnher et al., 2000).  However, cortical regions are not spared, and investigators have 
clearly shown that in HIV and AIDS cortical damage occurs via neuronal loss and 
synaptodendritic simplification (Ellis et al., 2007). 
Cortical degeneration has been found to be consistent in patients with HIV and AIDS 
in terms of volume loss in the medial frontal and pre-motor cortices; and thinning of the 
prefrontal and parietal cortices in particular has been associated with the severity of 
neurocognitive impairment in AIDS (Thompson, Dutton, Hayashi, Toga et al., 2005). 
Thompson, et al. (2005) and Chiang et al. (2007) have extended their investigations of HIV 
and AIDS patients to include degeneration in white matter regions of the brain underlying the 
primary association and sensorimotor cortices. Degeneration in these regions has been linked 
to a reduction in information processing speed and higher cognitive deficits in HIV-positive 
individuals. Furthermore, 3D imaging techniques have revealed white matter atrophy 
especially of the frontal areas of the corpus callosum, hippocampus and cortex starting early 
in the asymptomatic stage, and accelerating in atrophy towards the latter stages of HIV 
(Apostolova & Thompson, 2007; Thompson, Dutton, Hayashi, Toga et al., 2005; Thompson, 
Dutton, Hayashi, Lu et al., 2006; Wilkie et al., 1998; Wohlschlaeger et al., 2009). Finally 
functional magnetic resonance imaging (fMRI) studies have also found functional changes in 
the prefrontal cortical regions during tasks of attention and working memory (Thompson, 
Dutton, Hayashi, Toga et al., 2005). Together all these studies provide evidence that HIV is 
associated with changes in the cortical and subcortical regions.  
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Despite all the research that is being done, there is no consensus in the literature as to 
the progression of HIV-associated neurocognitive disorders (HAND). Aylward et al. (1995) 
and Cloak et al. (2004) report that atrophy starts with the cortex and progresses to the 
subcortex, particularly the basal ganglia, whereas Wilkie et al. (1998) and Grant et al. (2005) 
are in consensus and report that damage starts as a subcortical process which then evolves 
and becomes more pronounced in the cortical structures as the disease progresses. Perhaps a 
lot depends on the sensitivity of the instrumentation utilized to examine the brain’s 
neurodegeneration. However, an assumption can be made that atrophy starts subcortically 
and progresses to the cortical regions due to the fact that patients can present with motor 
deficits without the presence of cognitive impairments.  Conversely, Aylward et al. (1995) 
argue that HIV patients can exhibit white matter atrophy, with limited grey matter 
involvement, because HIV-positive patients who exhibit dementia present with more white 
and grey matter atrophy volume. Therefore more longitudinal studies need to be designed to 
determine where and when degeneration starts and progresses to in the brain. 
 
2.6 Relationship between HIV-Associated Neurocognitive Disorders and Cognitive-
linguistic Abilities 
2.6.1 Introduction 
In this section the relationship between cognition and language is discussed, how they 
are subserved by fronto-basal ganglia circuitry, and what evidence there is to support this in 
HIV and AIDS research infers that neurocognitive functioning is directly related to cognitive-
linguistic functioning. To highlight this relationship, terms need to be defined and theories 
explored.  
 68 
 
2.6.2. Definitions. 
This research straddles the disciplines of neuropsychology and speech language 
pathology, and to some extent cognitive psychology.  There are certain terms that are specific 
to neuropsychology such as neurocognitive processes and abilities; and certain terms that are 
specific to speech language pathology such as cognitive-linguistic abilities. The 
neuropsychological perspective defines neurocognitive processes and abilities as behaviours 
that are indicative of CNS involvement due to brain pathology caused by HIV and AIDS 
(Dawes & Grant, 2007). Whereas the speech language pathology perspective would view 
cognitive-linguistic problems in light of how brain pathology, in this case diffuse brain 
damage caused by HIV and AIDS, affects the interaction between language and cognition 
(Murdoch & Whelan, 2009).  
At this point of the discussion it would be appropriate to start defining terms or 
concepts. Cognition is a general term that refers to both stored knowledge (memory) and the 
mental process of knowing, including aspects such as awareness, perception, reasoning, and 
judgment. In fact, cognition can be viewed as a company with many departments working 
together to process information (Bayles & Tomoeda, 2007). These departments, mental 
processes or domains usually include but are not limited to attention, executive functions, 
memory, visual spatial and language.  
Regarding language, certain distinctions need to be made between terms, that is, – 
communication versus linguistic communication, language, and speech. Communication is 
the exchange of ideas or thoughts between individuals that can either be verbal or non-verbal 
as in gesturing or writing(Owens, 2004; Reed, 1986).It is considered linguistic when words 
are used and non-linguistic when other symbols are used, such as writing and gesturing 
(Bayles & Tomoeda, 2007). Therefore, language refers to the symbol system by which sound 
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is paired with meaning to form words for a particular purpose (Owens, 2001).  Just as 
gesturing or writing relies upon movements in proper order, vocal speech sounds need to be 
organized in proper sequence to convey proper meaning (Bayles & Tomoeda, 2007). In this 
way, “speech” or oral language is very closely tied to motor sequencing systems.  
Vocalizations rely upon serial-order processing or motor sequencing. This fact alone 
already provides some hint that sub-cortical brain regions most likely play a role in language. 
Whereas “linguistic communication” is the cognitive process of sharing ideas through 
language (Bayles & Tomoeda, 2007), there is evidence to suggest that cognition, language 
and speech production share neural mechanisms (Pickett, Kuniholm, Protopapas, Friedman & 
Lieberman, 1998). For example, the simple act of object-naming or recognition requires 
perception, access to long-term memory, association, recognition, lexical retrieval, decision-
making, motor planning and self-monitoring (Bayles & Tomoeda, 2007). This example lends 
more support for the premise that cognition, language and speech are mediated by cortical 
and subcortical areas of the brain. 
 
2.6.3 Theories on the relationship between language and cognition. 
Few people would disagree that language and cognition are related. However, there is 
no universal agreement concerning the nature of the relationship. Several theories have been 
proposed to explain the relationship between language and cognition. There has been a body 
of work proposed by Piaget and others which postulated that cognition precedes the 
development of language and those certain cognitive precursors need to be in place before 
language can develop (Owens, 2001).  In essence cognitive growth is responsible for 
language. Therefore any linguistic behaviour has to be undergirded by cognitive processes. 
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While cognition and language are interrelated, cognition is clearly the dominant member 
(Owens, 2001). A related view of language functioning as dependant on cognition is the weak 
cognition view. This position proposes that cognition accounts for much of an individual’s 
language abilities but not all of them. There remain some aspects of language which do not 
derive directly from language such as language difficulties with expressing meaning (Reed, 
1986). 
Another point of view concerning language and cognition proposes that, although 
language and cognition are related, cognitive activity without language and language without 
underlying cognitive bases are both possible.  According to Vygotsky (1962) as cited in Reed 
(1986), language and cognition are interconnected processes that develop and occur 
simultaneously. Vygotsky theorized that thought and language have different genetic origins 
and separate curves of development. At a certain age these two processes converge and start 
to develop simultaneously (Owens, 2001). Cognition and language are processes that are 
dependent on each other. Some researchers have observed that certain cognitive and 
linguistic skills develop at the same time, but not necessarily in a predetermined order.  In 
other words, language sometimes emerges first, and in other instances cognition does. These 
observations have led to the position that language and cognition are distinct functions that 
derive from a common, but separate source – the homologue model (Reed, 1986). Therefore 
if cognition is impaired, language is inadvertently impaired too. 
Another theory that has attempted to describe the relationship between language and 
cognition is linguistic determinism proposed by Benjamin Whorf. This position states that 
“all higher thinking is dependent on language, language determines thought” and that the 
more lexical richness or breadth in a language, the more superior the resultant cognitive 
development” (Owens, 2001, p. 132). However despite all the theories that have been 
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postulated describing the relationship between cognition and language, the exact relationship 
is unknown.  Depending on what area of study one is affiliated with, cognition and language 
could be separate but related or intertwined functions (speech language pathology), or 
language is an aspect or domain of cognition (neuro- or cognitive psychology). For the 
purpose of this study, language will be considered a domain of cognition, just like memory, 
executive functioning, attention, information processing and visual perception.  
The neuropathogenesis of HIV-associated neurocognitive disorders reported in HIV 
and AIDS individuals have been likened to those observed in individuals with various brain 
pathologies such as Parkinson’s disease (Green et al., 2002; Marinus et al., 2003), 
Huntington’s Chorea (Panegyres, 2004) and mild traumatic brain injury (Murdoch & Whelan, 
2009). Individuals may exhibit relatively intact language abilities on formal or “straight” 
linguistic tasks that rely on left hemisphere damage (found in aphasics) such as naming and  
object recognition (Code & Lodge, 1987), but may exhibit difficulty with more higher level 
linguistic language skills that interface with other cognitive processes such as attention, 
information processing, memory, visual spatial and executive functions. Examples of higher 
level linguistic abilities include semantic and phonemic fluency, verbal expression, story 
retelling, correction of phonologic, syntactic and semantically anomalous sentences, and 
anomaly detection or sentence disambiguation (Bayles & Boone, 1882; Longworth, Keenan, 
Barker, Marslen-Wilson and Tyler, 2005).  
Hence based on the interdependence of cognition and language, cognitive-linguistic 
abilities would include attention, memory, executive functions, visual spatial skills and 
language. This then implies that neurocognitive deficits can give rise to cognitive-linguistic 
deficits. Thus from this point on HIV-associated neurocognitive disorders and cognitive-
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linguistic deficits will be used interchangeably depending on the studies being discussed, be 
they from the discipline of neuropsychology or speech language pathology.  
An important point to consider is that individuals with HIV and AIDS can exhibit 
difficulties on straight serial linguistic tasks particularly if they present with HIV-associated 
dementia – the severest of HIV-associated neurocognitive disorders. So far the literature 
review has only alluded to the cognitive-linguistic skills being subserved by cortical-
subcortical neuronal circuitry. How cortical-subcortical circuitry can influence cognitive-
linguistic functioning is discussed below. 
 
2.6. 4 Evidence for cortical-subcortical functioning. 
Early researchers on cognition viewed cognition as a horizontal or lateral activity of 
the cortex (Koziol & Budding, 2009). In other words, they took a cortico-centric view or 
locationist view of cognition.  They stated that cognition and language were controlled in the 
cortex and specific locations of the cortex were responsible for certain cognitive and 
linguistic processes. The sub-cortical structures such as the basal ganglia and cerebellum 
were relegated to the co-ordination of movement.  The basal ganglia was associated and still 
is associated with either hyperkinetic or hypokinetic movement disorders observed in 
Huntington’s and Parkinson’s diseases (Duffy, 2005; Freed, 2000). These pathologies are 
characterized by a general loss of voluntary control of movement in that there is either too 
much or too little movement, essentially resulting in the loss of intentional control over 
movement.  
According to Koziol and Budding (2009), this view of compartmentalizing functions 
of cognition and motor is too simplistic because it offers a false sense of security in the 
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understanding of brain-behaviour relationships. For example many regions of the posterior 
cortices participate in somatosensory functions and a substantial region of the frontal lobe 
participates in motor functioning. Hence, if the cortex plays a role in non-cognitive 
functioning surely the same can be considered of the subcortex. 
  Due to advances in imaging techniques such as fMRI, positron emission tomography 
(PET), computed tomographic (CT) scans and physiological techniques such as cell recording 
and neuronal tracing, substantial evidence for promoting the involvement of subcortical 
structures in cognitive and language processes is now emerging. Researchers such as 
Longworth et al., (2005), McCabe, Sheard and Code (2008), Melrose, Tinaz, Boer Castelo, 
Courtney and Stern (2008), Murdoch and Whelan (2009), and Woods et al.(2004) are now 
proposing a vertical or fronto-striatal approach to studying disorders of cognition and 
language. For example, in Huntington’s disease, it is not uncommon to observe changes in 
executive functioning as the initial signs of the disorder. Huntington’s disease is 
characterized by a motor incoordination and patients with this diagnosis commonly 
demonstrate cognitive deficits in working memory, set shifting and decreased information 
processing (Koziol & Budding, 2009). Furthermore, patients with posterior and inferior 
involvement of the cerebellum can also present with cognitive deficits instead of motor 
disturbances (Ito, 2008; Houk and Mugnaini, 2003; Schmahmann & Caplan, 2006; 
Schmahman & Pandaya, 1997; and van Mier and Petersen, 2002).  
Technological advances have also significantly improved our understanding of 
neuronal structures, their connective patterns and how structures relate to cognitive 
functioning. Neuronal connections between regions of the cortex and basal ganglia, and 
discrete circuitries between these areas of the neocortex and the cerebellum have been 
identified. These neuronal networks provide the anatomic substrate for supporting not only 
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motor, but also cognitive and language functions (Middleton & Strick, 2000). The circuits 
originate in the cerebral cortex. After passing through the various subcortical structures 
within the straitum, the circuit re-enters the cortex and terminates very near the same region 
in which the circuit originated (Koziol & Budding, 2009). Therefore   a general feature of 
these circuits is a cortical-subcortical-cortical loop of interaction. Within the nervous system 
loops of interaction of this type are considered to have a modulatory function. This implies 
that cortical-subcortical circuits regulate or modulate neural impulses thus changing the 
nature of input received from various cortical domains.  
Subcortical regions of the brain refer to structures positioned deep within each 
cerebral hemisphere, beneath the level of the cortical mantle. These structures include the 
basal ganglia (straitum), internal capsule, thalamus, brain stem and the cerebellum (Murdoch 
& Whelan, 2009). For the purpose of this study, only the fronto-striatal (basal ganglia) 
circuitry will be discussed because of the role it plays in mediating neurocognitive processes 
observed in HIV-associated neurocognitive abilities or cognitive-linguistic abilities. It is 
important not only to understand what HIV-associated neurocognitive disorders are but also 
how they are determined or assessed in order to monitor the neurotoxicity of HAART and 
also disease progression because HIV-associated neurocognitive disorders have been shown 
to significantly correlate with mortality (Heaton et al.,  2010; Wilkie et al., 1998). Hence this 
study serves to highlight the significance of providing a reliable and time-efficient mode of 
assessing HIV neurocognitive disorders or cognitive-linguistic abilities in the context of a 
resource-limited country such as South Africa. 
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2.7 Assessment of HIV-Associated Neurocognitive Disorders 
 2.7.1 Introduction. 
Most of what is known about HIV-associated neurocognitive disorders has been 
accomplished via neuroimaging techniques and neuropsychological testing. This section 
describes the different methods of assessment used and the risk factors that predispose HIV-
infected individuals to HIV-associated neurocognitive disorders. This section also provides a 
description and rationale for the assessment tools utilized in this study to assess the severity of 
cognitive-linguistic impairments and how they affect activities of daily living. The diagnosis of 
HIV and AIDS-related dementia (HAD) and minor cognitive motor disorders (MCMD) are 
usually made by neurologists and psychiatrists who carefully rule out alternative diagnoses.  
The preceding sections have laid the foundation for assuming that individuals living 
with HIV and AIDS in South Africa will most likely present with HIV-associated 
neurocognitive deficits because of the high prevalence of HIV infection in South Africa. We 
know that HIV and AIDS is closely linked to poverty, so we can presume that most individuals 
will initiate HAART fairly late in the course of the disease because they will be accessing 
HAART from government public hospitals or clinics which usually initiate HAART in the 
later stages of the disease. We also know from neuroimaging studies that the HI virus crosses 
the blood brain barrier almost immediately after infection - during the asymptomatic phase. 
Hence if the majority of HIV-infected South Africans are accessing HAART during the latter 
stages of HIV and AIDS, it can be assumed that brain degeneration is occurring, albeit at 
different rates because of risk factors that could be influencing the presence of HIV-associated 
neurocognitive disorders or cognitive-linguistic impairments.  
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2.7.2 Biomedical Assessments. 
The most useful tests in diagnosing neurocognitive deficits include neuroimaging, 
cerebrospinal fluid (CSF) examination, metabolic and or toxicology screen, and formal 
neuropsychological testing. Neuroimaging is usually an essential component of the evaluation 
of patients with HIV and AIDS and CNS dysfunction, including those with suspected 
neurocognitive impairments. Principally, it is used to detect evidence of brain injury and other 
pathological processes such as the mass lesions of primary CNS lymphoma or the ependymal 
signal changes of CMV encephalitis (Price, 1998). It can also detect abnormalities associated 
with HIV-associated dementia (HAD). In addition, anatomical imaging, including both 
computed tomographic (CT) scanning and magnetic resonance imaging (MRI), have been 
successful in diagnosing HAD (Berger et al., 2000) via volumetric measures (Alyward et al., 
1995).  
Other methods of neuroimaging that have been successfully used to investigate the 
brain pathogenesis of mild cognitive motor disorder (MCMD) and HAD include positron 
emission tomography (PET), proton magnetic resonance spectroscopy (¹HMRS), diffusion 
tensor imaging and computational anatomy techniques that reveal systematic patterns of brain 
changes, e.g. 3D mapping (Thompson et al., 2006). 
1
HMRS has shown sensitivity in detecting 
early changes in patients with mild cognitive motor disorder, and differentiating these patients 
from more advanced HAD (Jarvik et al., 1993) by using neuroimaging markers that are 
sensitive to the metabolites in brain cells especially glial cells such as choline-containing 
compounds and myo-inositol (Ernst et al., 2003).  
Blood-oxygen-level–dependant (BOLD),  functional MRI studies have shown that 
regional brain activity decreases within areas commonly associated with simple attention and 
memory tasks in HIV-positive patients (Chang et al., 2004; Ernst et al., 2003). The results of 
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BOLD studies have revealed reduced efficiency in the attentional and memory networks and 
the recruitment of additional neural networks to compensate for the disruption of attentional 
networks. Another novel MRI technique, arterial spin labelling (ASL), has been used to study 
baseline cerebral blood flow and results have revealed that resting cerebral blood flow is 
inversely correlated with neurocognitive impairment (Cholewińska & Szymańska, 2009) .  
Measurements of cerebral blood flow to the caudate nucleus of HIV patients with varying 
neurocognitive performances have revealed a significant decrease in blood perfusion or flow 
that correlates with neurocognitive impairment (Ances et al., 2006).  Routine cerebral spinal 
fluid (CSF) examination via lumbar puncture is the most useful in differential diagnosis rather 
than in directly supporting mild cognitive motor disorder (MCMD) or HIV-associated 
dementia (HAD), considering that findings in these patients are unspecific, that is, patients 
may not consistently exhibit the same make-up of white blood cells and protein (Cholewińska 
& Szymańska, 2009; Price, 1998). 
 
2.7.3 Neuropsychological Assessments 
In the pre-HAART era, higher CSF viral loads correlated with lower scores on 
neuropsychological tests with individuals with more advanced HIV disease. However, since 
the introduction of antiretroviral treatment, CSF viral loads have become a less reliable marker 
because individuals usually attain undetectable HIV-1 viremia values by current clinic assays 
(Cholewińska & Szymańska, 2009). Multimodal neuroimaging will thus play an increasing 
role in further understanding the neurobiology of HIV-associated neurocognitive disorders. 
Despite the accuracy of neuroimaging and cerebrospinal fluid (CSF) examination, these 
methods of assessment are expensive and sometimes time-consuming for resource-limited 
developing countries such as South Africa where long queues are the norm in order to access 
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treatment for HIV and AIDS and for the diagnostic equipment necessary to run neuroimaging 
techniques.  
Formal neuropsychological testing has provided the principal endpoint measure for 
clinical trials of HIV-associated neurocognitive disorders and antiretrovirals (Price, 1998). 
Performance on such tests is not diagnostically specific, and individual test performance is 
variable and can be affected by a variety of factors (age, education, prior drug or alcohol use, 
head injury, etc.). However,  if test performance is compared to appropriate norms and 
carefully interpreted in the particular clinical context, formal examination can help to 
determine whether symptoms truly reflect abnormal neurological function, and whether the 
character of such dysfunction conforms to that of mild cognitive motor deficits or HIV-
associated dementia (Ellis et al., 2007). 
In most cases, especially in under resourced medical settings as found in developing 
countries such as South Africa, the only method of assessing neurocognitive deficits is via 
neuropsychological testing. The role of neuropsychological assessment is to probe different 
cognitive domains and abilities such as learning, recall, attention, executive functions or 
perceptual motor skills in individuals after brain dysfunction related to trauma, disease, 
psychiatric/neurological disorders or general medical conditions (Franzen, 2000). It is 
important to remember that there is no perfect test that corresponds exactly to a putative 
cognitive ability.  
Within the area of HIV and AIDS research, neuropsychological assessment seeks to 
identify cognitive strengths and weaknesses with regard to treatment planning or monitoring as 
well as identification of the early symptomatology of HIV-related cognitive deficits (Orr & 
Pinto, 1993). Some discussion has ensued advocating greater reliance on neuropsychological 
test results to categorize asymptomatic, mild, moderate and severe impairment rather than 
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using diagnostic categorization (Corless et al., 2000). This view is supported by the knowledge 
that mild impairments can be predictors for HIV disease progression, mortality and poor 
medication adherence (Dawes & Grant, 2007; Heaton et al., 2010; Valcour & Paul, 2006; 
Wilkie et al., 1998).   
 
2.7.4 Rationale for neurological assessments. 
In essence neuropsychological tests are better suited for use in developing counties than 
expensive neuroimaging techniques for several reasons. Firstly, they are cheaper to use and can 
assess more individuals in a given timeframe whereas neuroimaging techniques are quite 
expensive. Secondly, patients are less likely to sit and wait in long queues to be assessed. 
Furthermore, neuropsychological tests are better at determining the severity of HIV-associated 
disorders than neuroimaging techniques. Neuroimaging methods can detect and observe the 
brain injury and mechanisms of brain injury but not necessarily inform on the severity of HIV-
associated neurocognitive disorders. It is important to know the severity of HIV-associated 
neurocognitive disorders because it serves as a good indicator of disease progression, mortality 
and drug adherence (Dawes & Grant, 2007; Heaton et al., 2010; Valcour & Paul, 2006; Wilkie 
et al., 1998). 
Moreover, in resource-stricken environments such as those found in most areas of 
South Africa, there is a shortage of trained health personnel. It is usually the neurologist and 
psychiatrist who diagnose mild cognitive motor disorders and HIV-associated dementia and 
they are not always on hand to diagnose HIV-infected individuals who might exhibit 
neurocognitive disorders. So the versatility of neuropsychological tests in developing countries 
such as South Africa lies in the fact that neuropsychological tests can be administered by other 
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allied health professionals such as speech language pathologists, neuropsychologists, cognitive 
psychologists and occupational therapists.  
Screenings such as the Mini Mental State Exam can be administered by nurses. 
Assessment by other professionals allows for HIV-infected individuals to receive appropriate 
referrals and treatment. The aim of citing the advantages of neuropsychological testing in 
developing countries is not to negate the importance or usefulness of neuroimaging methods in 
South Africa, but to highlight the utility of conducting neuropsychological testing in 
developing countries where neuroimaging methods are not accessible to the majority of the 
population. 
Most comprehensive neurological tests have proven to be expensive, time-consuming 
to administer and cumbersome and taxing to perform for patients at bedside or in a clinical 
setting. As a result, shorter tests and screening tools have been developed to diagnose HIV-
associated neurocognitive disorders including HIV-associated dementia (HAD). Although not 
a substitute for more comprehensive neuropsychological assessment, shorter tests or screening 
tools have yielded valuable information that significantly correlated with information obtained 
from more comprehensive tests (Struss, Meiran, Guzman, Lafleche & Willmer, 1996).  These 
shorter tests and screening tools have been found to be just as accurate as long tests in 
accurately diagnosing HIV-associated neurocognitive disorders including HIV-associated 
dementia (Struss, et al., 1996) and cognitive-linguistic disorders. Therefore, for the purpose of 
this study the Cognitive Linguistic Quick Test was utilized. 
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Rationale for the Cognitive Linguistic Quick Test 
The Cognitive Linguistic Quick Test  (CLQT) is a standardized test that was 
developed to assess the cognitive and linguistic functions of adults (18-89 years old) with 
suspected neurological dysfunction caused by degenerative diseases such as Alzheimer’s 
dementia, or vascular conditions such as strokes, or brain damage such as traumatic brain 
injury (Helm-Estabrooks, 2001). The Cognitive Linguistic Quick Test was developed in the 
United States of America in 1999 and normed on English- and Spanish-speaking adults who 
presented with stroke, traumatic brain injury and dementia. The CLQT allows for the 
assessment of the five domains of cognition, namely attention, memory, executive functions, 
language and visual spatial skills.  
The five domains are assessed through ten tasks, which include personal facts; symbol 
cancellation, confrontational naming, clock drawing, storytelling, symbol trails, generative 
naming, design memory, mazes and design generation (refer to Appendix V). These ten tasks 
are modifications or adaptations of reputable tests used in neuropsychology and speech 
language pathology. Even though the test is called “quick” it is not as brief as a screening 
measure that is narrow in focus and does not cover many cognitive domains such as the Mini 
Mental State Examination. As a test it is very versatile in that it can be used across disciplines 
such as speech language pathology, neuropsychology and cognitive psychology. 
Although the test was not normed on individuals with Parkinson’s disease, it was 
successfully utilized to determine the cognitive and linguistic abilities of patients with 
Parkinson’s disease (Parashos, Johnson, Erickson-Davies & Wielinski, 2009). Parkinson’s as 
a disease is very similar to HIV and AIDS in that it is neurogenic and degenerative in nature.  
It involves the CNS, particularly the brain, and is degenerative in that the disease gets 
progressively worse until the person becomes debilitated and reliant on others for care. The 
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neuropathogenesis of Parkinson’s disease is also very similar to HIV and AIDS. Despite the 
fact that it is generally agreed that Alzheimer’s disease, Parkinson’s disease and HIV and 
AIDS are different conditions, they form part of a neuropsychological homogeneous group in 
that they are neurogenic and degenerative in nature.  
Hence the test was deemed suitable to use with individuals with HIV and AIDS even 
though the Cognitive Linguistic Quick Test has not yet been normed on HIV-infected 
individuals. This test was also found to be suitable for use with HIV-positive individuals 
because the objective of the Cognitive Linguistic Quick Test (CLQT) is to assess higher order 
linguistic skills that are reliant on the domains of attention, memory, visual spatial skills and 
executive functions.  Moreover, the intent of the CLQT is aligned with the purpose of this 
study which was to investigate how the cognitive linguistic abilities of individuals living with 
HIV and AIDS are influenced by HAART.  
The CLQT was standardised primarily on a white population with African Americans 
and Hispanics (of South American descent) (Helm-Estabrooks, 2001). The average education 
levels included 13 to 15 years of education, though the clinical studies included individuals 
who had less than 12 years of education. So in effect, people taking the test do not need a 
high school education because half of the tasks in the test do not have high language demands 
(Helm-Estabrooks, 2001). This was done to assist in evaluating the cognitive functions of 
examinees who exhibit language deficits.  The CLQT has not previously used in assessing 
cognition and linguistic functions in adults living with HIV. The standardized population was 
very different from the HIV population utilized in this study, which was predominantly black 
African, with less than 12 years of education, coming from a low socioeconomic background.  
Normatives for the CQLT have been conducted on English- and Spanish-speaking 
adults, but the participants in this study were English, Sotho, Tswana or Zulu speakers. 
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However, this test was deemed suitable for this population based on the findings conducted 
from a pilot study pertaining to this research. The CLQT was able to identify clear deficits in 
all five cognitive domains, as reported in the literature using more expensive, elaborate and 
time-consuming neuropsychometric evaluations (e.g. Berghuis, Uldall & Lalonde, 1999; 
Savage, Jackson & Sourathathone, 2003). This suggests that the CQLT is an appropriate 
instrument for use in the initial investigation of cognitive deficits in patients with HIV or 
AIDS in South Africa (Mupawose & Broom, 2010). 
Moreover, it is well documented that HIV and AIDS patients present with both 
cortical and subcortical degeneration, and thus the tasks on the CQLT were deemed suitable 
for assessing this. For example, tasks include verbal fluency, design generation, symbol trails, 
symbol cancellation, clock drawing, and mazes which are all reliant on working memory. It 
has been suggested that working memory is mediated by fronto-striatal networks. Working 
memory is a subsystem of short-term memory, which allows the retention of information for 
brief periods (Baddeley, 1987, 2003). Working memory can be more simply defined as the 
ability to hold information cognitively “on line” for a brief period of time, temporarily, but 
sufficiently long enough for task completion (Koziol & Budding, 2009). It allows the 
individual to plan and organize higher order behaviour which is characterized by a division of 
labour between maintaining information “on line”, which is a function of the cortex, and 
updating information which is “gated” by the basal ganglia. This may also explain why some 
patients who exhibit neurocognitive deficits perform relatively well on functional everyday 
activities such as communication of needs and wants, and activities of daily living, but 
demonstrate difficulties learning or adding new to information already “on line” (Koziol & 
Budding, 2009). This research assumes that the HIV-associated neurocognitive disorders and 
cognitive-linguistic functions are underpinned by fronto-basal ganglia networks. The 
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Cognitive Linguistic Quick Test (CLQT) thus met all the assumptions and premises of the 
study. 
 
 Description of the CLQT. 
As previously mentioned, the CLQT is composed of ten tasks, which include personal facts, 
symbol cancellation, confrontational naming, clock drawing, storytelling, symbol trails, 
generative naming, design memory, mazes and design generation. These ten tasks collectively 
assess five domains: attention, memory, executive functions, visual spatial and language. 
Following is a brief description of cognition and the five domains under investigation.  
Cognition as a general term refers to stored knowledge and the process for making and 
manipulating knowledge (Bayles & Tomoeda, 2007).  According to Helm-Estabrooks (2001), 
attention is “multifaceted, multisensory behaviour that interacts with other cognitive processes 
and is essential to the performance of all daily and clinical tasks’’ (p. 3).  Attention is one of 
the cognitive areas most affected by the HI virus as the disease process progresses.  
Memory is not a single entity but rather a complex process. Without memory there 
would be no meaningful cognition as we know it. The ability to access memory stores enables 
us to interpret our ever-changing environment, modify behaviour to ensure survival and lesser 
objectives (Bayles & Tomoeda, 2007). There are three main divisions in memory functioning 
and these include working memory, learning and encoding, and recall. Working memory is 
utilized when information is required to be manipulated and processed (Baddeley, 2003; 
Koziol & Budding, 2007). It is sometimes linked to attentional resources and is an active 
memory function, as the person actively concentrates on remembering and manipulating 
information. This type of memory is usually measured by tasks of arithmetic, or memory for 
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number strings and words. The second part of memory, long-term memory, is the learning and 
encoding of information into mental representations that are able to be retrieved into conscious 
awareness at a later time that is called remembering.  
Encoding refers to the transfer of information into mental representations (Panegyres, 
2004; Lozito & Mulligan, 2006). The ability to learn is process of being able to recall or 
retrieve information (mental representations) that has stored in long term memory, and this is a 
function of working memory (Owens, 2004).Executive function is another construct of 
cognition and is a measure of a person’s ability to essentially self-regulate and direct their own 
behaviour, and which is made up of many subparts (Lezak, 1995). These subparts include the 
ability to make informed choices, planning and being able to act purposively and effectively 
(Sbordone, 2000). Within the domain of executive functioning, researchers have identified 
impairments in inhibition (Hinkin, Castellon, Hardy, Granholm & Siegle, 1999), set shifting 
(Woods et al., 2004), manipulation within working memory (Dawes & Grant, 2007), planning 
and cognitive sequencing (Sahakian, Elliott, Low, Mehta, Clark and Pozniak, 1995), reasoning 
and problem-solving. Executive functions are said to be mediated by fronto-striatal circuitry. 
Visual spatial skills “involve visual perception (the ability to scan, discriminate, 
analyse, recognize and interpret what we see) and construction (the ability to create visual 
stimuli using perceptual skills and motor responses (Helm-Estabrooks, 2001, p. 3). The ability 
to perceive visual information is dependent on healthy eyes without disease. Visual spatial 
skills are necessary to execute many clinical tasks and functional activities of daily living. 
Language refers to the symbol system by which sound is paired with meaning for a 
particular purpose (Bayles & Tomoeda, 2007). It is a uniquely human and complex behaviour 
comprising the interrelated aspects of semantics, phonology, morphology, syntax and 
pragmatics. Language can be either expressive or receptive. Expressive language entails the 
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“intentional” sharing of information by means of a symbol system that can either be linguistic 
(verbal) or non-linguistic (gestures, sign language, graphic as in written words or pictures). 
Receptive language, on the other hand, is the ability to perceive and interpret (understand or 
process) the linguistic or non-linguistic message being expressed or shared. The ability to 
perceive verbal language is dependent on healthy ears free of conditions that can impede a 
person’s ability to hear effectively. 
Cognitive domains are evaluated either through clinical tests or tasks. It is both 
simplistic and unrealistic to assume that a task can assess only one domain.  The performance 
of most tasks is reliant on the interaction of two or more domains. For example, the block 
design task requires that an individual attend to and comprehend the verbal instruction, 
perceive the spatial relationship among the components, form a visual spatial representation or 
design, be able to form different designs according to the instructions, and use motor skills to 
reproduce the design on paper (Broshek & Barth, 2000). Generally, all tasks require attention 
and receptive language to perform. While it is true that no clinical tasks call upon only one 
domain, the accomplishment of certain tasks is more reliant on specific cognitive domains. For 
example, the simple task of naming an object requires perception, access to long-term memory, 
association, decision-making, and motor planning in terms of speech output and self-
monitoring (Bayles & Tomeoda, 2007). 
 
Tasks on the CLQT and application to HIV and AIDS. 
The ten CLQT tasks were developed by reviewing procedures and tests used to assess 
cognitive functions in healthy adults and in adults with neurological functions. Most of these 
tests have been used with individuals with HIV and AIDS in developed countries and a few 
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sub-Saharan African countries to assess neurocognitive functioning. A description of the tasks 
and similar test that have been used on individuals with HIV and AIDS follows below. 
 
Personal facts: The purpose of this task is to assess episodic memory (personal facts), 
orientation to place and year, and the ability to communicate these facts through language. To 
perform this task the participant is required to answer four questions about their date and place 
of birth, current age and address (Helm-Estabrooks, 2001). The primary cognitive domains 
assessed by this task include memory (recent and long term) and language in terms of word 
retrieval, verbal language comprehension and expression (Helm-Estabrooks, 2001). It has been 
suggested that the deficits of language and memory are predictive of dementia (Bayles & 
Boone, 1982; Bayles & Tomoeda, 2007; Code and Lodge, 1987). This task can thus be found 
in tests such as the Mental State Questionnaire and the Ross information Processing 
Assessment that assess cognitive state or information processing. This sub-test is sensitive to 
organic-related (brain degeneration) dementia. Memory impairment observed might be due to 
atrophy of the hippocampus (Panegyres, 2004) as a result of neuronal loss which is known to 
occur early in HIV-1 brain infection, and this has been observed in fMRI studies of HIV-
infected individuals (Ellis et al., 2007 ; Thompson, Dutton, Hayashi, Lu et al., 2006).  
The assessment of memory is important, as it may be the initial symptom that alerts the 
clinician to the possibility of a brain disease (Panegyres, 2004). The presence of memory 
and/or orientation problems may influence new learning and functional activities. Furthermore, 
the hippocampus plays a pivotal role in new learning (Panegyres, 2004). It was hypothesized in 
this study that the participants who exhibited severe HIV-associated neurocognitive disorders 
would perform poorly on this subtest at baseline. Whereas those participants who performed 
well may not necessarily exhibit deficits in episodic memory and have HIV-associated 
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dementia, but may have milder forms of HIV-associated neurocognitive disorders or cognitive-
linguistic deficits with other types of memory not assessed by this task. 
Several tests have been used on individuals living with HIV and AIDS that assess 
learning and memory. Sacktor, Wong, Nakasujja et al. (2005) used the Rey Auditory Verbal 
Learning Test on a Ugandan sample and found that HIV-positive individuals performed worse 
than HIV-negative individuals on this test. Another test that has been used on HIV-infected 
individuals is the California Verbal Learning Test (Melrose et al., 2008). Melrose et al. (2008) 
found that there was a significant difference in neurocognitive performance between HIV-
positive and HIV-negative individuals with the California Verbal Learning Test where HIV-
positive individuals performed better. Sacktor, Nakasujja, Skolasky, Robertson, Wong et al. 
(2006), using the WHO-UCLA-Auditory Verbal Learning Test, observed that HIV-positive 
individuals living in Uganda exhibited very low mean scores for this test (indicating 
impairment) at baseline that improved with HAART.   
Similarly, Letendre, van den Brande, Hermes et al. (2007) observed very low mean 
scores with the Hopkins Verbal Learning Test-revised that improved with HAART. Low mean 
scores were also observed by Lopez, Wess, Sanchez, Dew and Becker (1998) on the Rotary 
Pursuit Learning Test and correlated with self-report measures on memory abilities.   Other 
forms of memory have also been assessed on this population such as visual and logical using 
the Wechsler Memory Scale (Lopez et al., 1998; Wilkie et al., 1998), Buschke Selective 
Reminding Test (Wilkie et al., 1998) and Figure Memory Test (Wilkie et al., 1998).  
Performance on all three measures indicated impaired visual and/or logical memory abilities 
among HIV-infected individuals. 
Verbal memory has been evaluated using the Four Word Verbal Recall Test and Word 
Verbal Free Recall Test. Cohen et al. (2001) found verbal memory to be impaired at baseline 
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with the Four Word Verbal Recall Test but improved once HIV positive individuals started 
taking HAART.  Using the Word Verbal Free Recall, Lopez et al. (1998) reported that test 
scores were low and correlated with self-report measures on memory abilities.  Overall it 
would appear that HIV-positive individuals exhibited deficits in most of the memory 
categories and these seemed to improve when individuals started taking HAART. It is 
therefore vital that memory be assessed because it is critical regarding medication adherence in 
terms of remembering instructions on medication intake (Riepe, Riss, Bittener & Huber, 2003) 
and predictive of early brain degeneration (Panegyres, 2004).    
 
Symbol cancellation: The purpose of this task is to evaluate visual attention, scanning, 
discrimination, inhibition and response shifting within quadrants of space (Helm-Estabrooks, 
2001). This task entails the participants being shown a page on which abstract symbols are 
arranged in what appears to be a random pattern, with the target stimulus appearing three 
times in each quadrant of the page. Other abstract symbols (foils) are put on the page that 
looks similar to the target abstract symbol to increase the visual attention demands. 
Examinees are instructed to cross all examples of the symbol (Helm-Estabrooks, 2001). 
 The cognitive domains that are evaluated in this task are attention and visual spatial 
skills. This task appears to be an adaptation of the Symbol Digit Modalities Test, the Digit 
Symbol subtest of the Wechsler Intelligent Scales (WAIS-DS) and the Symbol Search subtest 
of the Wechsler Intelligent Scales (WAIS-SS) which monitors psychomotor speed, attention, 
visual scanning and information processing.  Attention is an important cognitive skill 
essential to learning new information and remembering previously learnt information. 
Furthermore, if an individual cannot inhibit incorrect responses and appropriately shift 
attention, the individual will have problems with planning and problem solving.  
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Both the Symbol Digit Modalities Test (SDMT) and WAIS-Digit Symbol (WAIS-
DS) have been used to assess neurocognitive functioning such as attention, information 
processing speed, visual scanning, inhibition and response shifting in individuals living with 
HIV and AIDS. Using the Symbol Digit Modalities Test, Sacktor, Lyles, Skolasky et al. 
(1999) found that HIV-positive individuals on HAART performed better than HIV-positive 
individuals who were on monotherapy.  Cysique, Maruff and Brew (2004) found that HIV-
negative individuals performed better than HIV-positive individuals on the SDMT.  
However, they did notice a difference in performance between HIV-positive 
individuals on high CNS penetration HAART versus those on low CNS penetration. Sacktor, 
Nakasujja, Skolasky, Robertson, Wong et al. (2006) and Sacktor, , Nakasujja, Skolasky, 
Robertson, Musisi et al. (2009) showed that HIV-positive individuals living in Uganda 
exhibited very low mean scores for the Symbol Digit Modalities Test (indicating impairment) 
at baseline that improved with HAART.   
Using the Wechsler Adult Intelligence Scale Revised-Digit Symbol Test (WAIS-
DST), Sacktor, Wong, Nakasujja et al. (2005) found from their study conducted in Uganda 
that the HIV-negative individuals performed better than HIV-positive individuals. Moreover, 
Heaton et al. (2010) in their longitudinal study found that the neurocognitive impairments 
persisted even after HAART when monitored with the WAIS-DS. They also observed that 
impairments were related to the progression of the f HIV. Overall it would appear that HIV-
positive individuals, especially if they present with severe HIV-associated neurocognitive 
disorders, exhibit difficulties performing symbol-related tasks that assess attention, visual 
scanning, response shifting tasks and these seem to improve when individuals start taking 
HAART.           
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Confrontational naming: The purpose of this task is to assess the ability to name pictures 
(Helm-Estabrooks, 2001). The task requires the participants to name ten common objects. This 
task evaluates the cognitive domains of language (semantics and phonology)(Helm-
Estabrooks, 2001). The ability to name a picture requires the perception and recognition of the 
item being named and retrieval of its referent from long-term memory (Bayles & Boone, 
1982), association, word retrieval, decision-making, motor planning and self-monitoring. If an 
individual exhibits difficulty in naming, this can be indicative of dementia. Tasks or tests of 
confrontational naming are most commonly used as measures of gross language skills 
especially in expressive language. Disruptions in language usually occur along a continuum 
ranging from basic units of language, such as producing sounds, to difficulty processing higher 
language (linguistic) skills or conversational competence (Johnstone, Holland & Larimore, 
2000).  
Using the Western Aphasia Battery – naming subtest, Mathew and Bhat (2008) 
reported that the naming abilities of their HIV participants fell within the normal range. This 
came as no surprise because we would expect individuals living with HIV and AIDS to 
perform fairly well on serial linguistic tasks that do not rely heavily on other cognitive 
abilities. This type of performance is typical of individuals with brain degeneration in both the 
cortical and subcortical regions such as seen in individuals with HIV-associated cognitive-
linguistic deficits. 
 
Clock drawing: Though this task is included in the assessment, results yielded from this task 
were not used to calculate domain scores. Clock drawing thus has its own rating score. The 
purpose of this task is to determine severity of neurological decline, especially in progressive 
diseases (Helm-Estabrooks, 2001). This task requires the integration of all five previously 
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mentioned cognitive domains since all the skills of sustained attention, memory, planning, 
abstract thinking, organization; receptive language and visual spatial skills are required. As a 
task it exhibits minimal ethnic and educational bias. Research has shown that this activity is a 
good screening indicator for dementia. Results from clock drawing have correlated well with 
other dementia scales such as the Mini Mental State Examination, Blessed Dementia Scale and 
the Global Deterioration Scale (Berger, Lutz, Frölich, Weber & Pantel, 2008; Heinik & 
Shaikewitz, 2009). However, there is no research to date to determine how well clock drawing 
correlates with dementia in individuals living with HIV and AIDS. It is assumed that there is a 
significant correlation between clock drawing and HIV-associated dementia tests such as the 
International HIV Dementia Scale. This is because of the significant correlation that has been 
reported between the International HIV Dementia Scale and other dementia scales such as the 
Mini Mental State Questionnaire (Ciccarelli et al., 2011) and the Karnofsky Performance Scale 
(Sacktor, Wong, Nakasujja et al., 2005).  
 
Story telling: The purpose of this task is to determine the ability of participants to recall verbal 
information in the form of a story (Helm-Estabrooks, 2001). This task is made up of two 
components. The first entails the examiner reading aloud a short story with many details and 
the participant retelling the story including all the important details (Helm-Estabrooks, 2001). 
The second part involves the participant answering yes/no questions about the story. The 
cognitive domains being evaluated are attention, memory (verbal working memory) and 
language (language comprehension and production) (Helm-Estabrooks, 2001). The ability to 
retell a story depends on an individual’s capacity to store new information in the long-term 
memory for subsequent retrieval (Bayles & Boone, 1982) and also to retain information in 
working memory for a short period of time (Hem-Estabrooks, 2001). Bayles and Boone (1982) 
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have suggested that difficulties in story telling are also predictive of the early stages of 
dementia. Heaton et al. (2010) used this task with individuals living with HIV and the results 
revealed that performance on this task was associated with HIV disease progression. Those 
individuals with the worst disease progression performed most poorly that higher CD4 counts. 
This implied that verbal working memory which is mediated by fronto-striatal circuitry 
progressively deteriorates as the disease progresses.  
 
Symbol trails: The purpose of this task is to assess working memory, planning and mental 
flexibility without placing a demand on language (Helm-Estabrooks, 2001).. The task requires 
an individual to connect shapes, alternating between circles and triangles in order from 
smallest to largest. The main cognitive domains being evaluated here are attention, executive 
functions and visual spatial skills (Helm-Estabrooks, 2001). To be able to carry out this task 
one needs a measure of concentration and attention and planning, as well as mental flexibility 
which are all essential for everyday problem-solving (Helm-Estabrooks, 2001).These processes 
have been noted to be affected in the latter stages of HIV-associated neurocognitive disorders 
(Dawes & Grant, 2007; Fernandez, 2005). This task is an adaption of the Trail Making Test – 
Parts A and B, and Colour Trail Making Test.  
Both these tests have been used on individuals with HIV and AIDS to assess attention, 
executive functioning and visual spatial skills. Ciccarelli et al. (2011) using the Trail Making 
Test – Part B described the HIV- positive individuals as performing better on this test than 
HIV-positive individuals. Moreover, there was a difference in performance between those 
individuals on low versus high CNS-penetrating antiretrovirals. Heaton et al. (2010) reported 
that performance on the Trail Making Test (A and B) was associated with HIV and AIDS 
disease severity and co-morbid conditions. Those individuals with the worst disease 
 94 
 
progression performed the poorest. Furthermore, the impairments persisted while on ARVs. 
Singh et al. (2010), using the Trail Making Test (Parts A and B), found that HIV-positive 
participants in South Africa performed poorly on this test. The Colour Trail Making Test 
appears to have yielded similar results. Cohen et al.  2001 reported impaired abilities with the 
Colour Making Test at baseline and that continued to improve the longer the person remained 
on HAART.  Their non-HAART group which consisted of participants taking monotherapy 
performed worse than those who were prescribed HAART. Sacktor, Wong, Nakasujja et al. 
(2005) in their study in Uganda stated that the HIV-negative individuals performed better than 
HIV-positive individuals on the Colour Making Test. Sacktor, Nakasujja, Skolasky, Robertson, 
Musisi et al. (2009) further observed that HIV-positive individuals who presented with 
impaired abilities at baseline improved while on HAART.  
 
Generative naming: The purpose of this task is to evaluate a person’s ability to generate 
exemplars both semantically and phonemically (Helm-Estabrooks, 2001). This task is done in 
two parts. Firstly, the participants are required to generate as many items as possible 
belonging to a semantic category. After that they are required to name as many items starting 
with the letter “m” (phonemic fluency) (Helm-Estabrooks, 2001). This task specifically 
targets working memory, language and executive function. Generative naming or semantic 
fluency is a semantic process that taps into the cognitive functions of working memory, 
language, executive functions specifically organization (categorization) (Helm-Estabrooks, 
2001).  
This task can show up disruption in fronto-striatal processing, especially if an 
individual exhibits difficulties generating phonemic exemplars (Koziol & Budding, 2009). 
The task of performing a phonemic fluency task is cognitively more difficult because the 
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brain does not store words according to letters but according to semantic categories (Ross, 
2003; Salmon & Chan, 1994). So an individual has to develop a new strategy for retrieving 
words different from those that are semantically stored (Koziol & Budding, 2009). Therefore, 
when a person does well on category fluency and poorly on letter fluency this does not 
constitute a specific retrieval problem. Instead this implies fronto-striatal involvement 
(Woods et al., 2004).   Lastly, the area of verbal fluency is often more affected than other 
linguistic abilities, like naming, comprehension and reading lending additional support for a 
pattern of fronto-striatal deficits (Koziol & Budding, 2009). 
 
Design memory: The purpose of this task is to assess the working/immediate visual memory 
with minimal language demands (Helm-Estabrooks, 2001). This task requires participants to 
recall and point to designs that match the two target designs. The cognitive domains under 
investigation here are attention, visual memory and visual spatial skills (Helm-Estabrooks, 
2001). It has been suggested that individuals who exhibit HIV-associated neurocognitive 
deficits may present with difficulties learning new information which is an aspect of higher 
order control, automatic processing and instrumental and incidental learning, especially if 
they have been further diagnosed with HIV-associated neurocognitive disorders (Fernandez, 
2005; Koziol & Budding, 2009; Larson, 1998;). Other tests similar to this task that have been 
used on individuals living with HIV and AIDS include the Figure Memory Test (Heaton et 
al., 2010) and the Rey Figure Recall Test (Ciccarelli et al., 2011; Cysique, Maruff, Barby et 
al., 2006).  
Using the Figure Memory Test, Heaton et al. (2010) reported that performance on this 
test was associated with HIV and AIDS disease severity and associated conditions. Ciccarelli 
et al. (2011) observed in their cross-sectional study that HIV-seronegative individuals 
performed better on this test than HIV-positive individuals. It has been postulated that deficits 
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in attention and visual working memory are caused by disruptions in the fronto-striatal 
circuitry (Koziol & Budding, 2009; Woods et al., 2004), and we know that brain lesions 
occur both in the cortical and subcortical areas of the brain in HIV-infected individuals. 
Therefore it is not surprising that HIV-positive individuals performed worse than HIV-
negative individuals. 
 
Mazes: The purpose of this task is to assess executive functions while placing minimal 
demands on language (Helm-Estabrooks, 2001). In this task the examinee must plan a course 
of action, reject or inhibit incorrect choices, and any mistakes they make. This test also helps to 
assess attention and visual spatial skills (Helm-Estabrooks, 2001). This task was adapted from 
the Wechsler Intelligence Scales III – mazes subtest.  “A high score suggests good planning 
abilities that involve both maintaining a flexible mental set and impulse control. In contrast, a 
low score indicates poor visual motor coordination and impulsivity. Low scores may also 
reflect poor planning, sequencing and monitoring behaviour” (Groth-Marnat, Gallagher, Hale 
& Kaplan, 2000, p.180). These executive function deficits are often indicative of fronto-striatal 
circuitry disruptions. Interestingly, Sacktor, Nakasujja, Skolasky, Robertson, Musisi et al. 
(2009) in their longitudinal study in Uganda using HIV-positive individuals found that 
executive functions showed the most significant improvement compared to the other cognitive 
domains under investigation. This could have been due to the fact that executive functions 
responded better to HAART. 
 
Design generation: The purpose of this task is to assess the executive functions of 
productivity and creativity (Helm-Estabrooks, 2001).. Participants are asked to draw four 
straight lines to connect four dots to make a unique design. This test also helps to assess 
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attention and visual spatial skills (Helm-Estabrooks, 2001. To perform this task a person 
needs to be able to self-monitor and avoid preservations, a behaviour that has significant 
negative impact on functional actions. In addition, creative and productive thinking even 
when language is impaired is a skill that is crucial to communicating in unpredictable, 
everyday situations (Helm-Estabrooks, 2001). This task was adapted from the Wechsler 
Adult Intelligence Scale Revised – Block Design where patients have to generate designs and 
match designs (Groth-Marnat et al. 2000). In this test “high scores indicate good non-verbal 
concept formation, excellent capacity for visual spatial organisation, good concentration, and 
fast visual motor speed. Low sores may suggest difficulties working with visual spatial 
materials, problems with sustained or perceptual problems” (Groth-Marnat et al., 2000, p. 
172). Wilkie et al. (1998) used the Wechsler Adult Intelligence Scale Revised – Block Design 
(WAIS – BD) subtest in their longitudinal study with 119 HIV-positive males. This test 
showed significant impaired cognitive abilities among the HIV positive males.  
When HIV-positive individuals were compared to HIV seronegative individuals their 
performance was poorer across all five cognitive domains. Therefore, neuropsychological 
testing provides an estimate of the individual’s best cognitive performance within an isolated, 
time-limited context. However, this performance may be unrepresentative of the on-going 
demands faced in everyday situations especially in individuals with relatively mild changes in 
their cognitive-linguistic abilities (Warriner et al., 2010). As a result, a self-reporting 
interview schedule was incorporated in this study to compliment the findings of the Cognitive 
Linguistic Quick Test. The aim of this survey was to determine whether cognitive-linguistic 
abilities can affect activities of daily living, since the CLQT could only provide information 
on the impairment. 
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A summary of studies that have been conducted to investigate the presence of HIV-
associated neurocognitive disorders and the effects of HAART are presented in Table 2.8 
 
Table 2.8 Summary of HIV-Associated Neurocognitive Disorders Studies in both 
Developed and Developing countries. 
 
Authors Country Sample (N) Measure Cognitive domain Findings 
Lopez et 
al. 1998 
USA 72 HIV+ 
Mixed gender w/ 
more males 
On HAART 
Longitudinal 
WAIS 
WMS 
COWAT 
NART 
WVFRT 
TMT A 
TMT B 
RPLT 
SRSS 
(functional) 
Memory 
Language 
Exec.function 
Visuospatial 
 
Self-reported scores 
correlated with 
severity of HIV, 
depression, cognitive 
and neurological 
complaints 
Complaints of 
specific cognitive 
deficit reflected 
overall slow 
processing speed and 
psychomotor speed. 
Cohen et 
al.  2001 
USA 23 HIV+ 
Females 
On HAART 
 
Comparison 
Grp 
70 HIV+ 
Non HAART 
Longitudinal study 
GPB 
CTMT 
COWAT 
FWL 
No functional 
assessment 
 
Psychomotor 
Memory 
Language 
Exec.function 
Baseline performance 
the same.  
HAART group 
improved overall 
than non HAART grp 
HAART did not 
influence memory 
More improvement 
noted at 18 months 
than 12 months or on 
HAART 
Woods et 
al. 2004 
USA 30 HIV – 
72HIV+ 
Gender mixed with 
more males 
 
On HAART 
COWAT Language HIV+ with dementia 
performed worse than 
HIV+ without 
dementia and HIV- 
No difference in 
performance between 
HIV+ non demented 
and HIV - 
Findings support 
fronto-striatal 
damage 
Sacktor et 
al. 2006 
Uganda 23 HIV + 
Longitudinal 
 
Gender mixed w/ 
more females 
 
No comparigrp 
 
On HAART after 
baseline measure 
IHDS 
AVLT 
GPB 
SMDT 
CTMT 
WAIS-DSF 
WAIS-DSB 
KPS (QOL) 
Memory 
Psychomotor 
Visuospat 
Exec. Funct 
Attention 
 
 
Mean changes seen 
for each test. Signif. 
Improvement in 
verbal memory, 
psychomotor and 
exec. Functioning. 
HAART improves 
HIV-
associatedneurocog 
disorders including 
dementia 
Functional 
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improvement over 
time from impaired 
can’t work to total 
independence 
McCabe et 
al. 2008 
USA 2 HIV + male 
1 HIV- 
 
 
Longitudinal 
 
HAART? 
BNT 
Token Test 
RHLB-
metaphor 
RHLB – 
semantic test 
VF 
Pragmatic -
Protocol 
WAB 
No functional 
assessment 
 
Language 
Exec. function 
Memory 
Attention 
HIV + dementia 
performed worse than 
HIV+ no dementia. 
Control did better 
than HIV+ non 
dementia and 
HIV + dementia 
exhibited Pragmatic 
probs 
Intact serial linguistic 
tasks-no probs on 
WAB 
Failed letter fluency,  
metaphor 
intepretation 
Cysique et 
al. 2009 
Australia 37 HIV+ 
Longitudinal 
GPT 
PASAT 
TMT A 
TMT B 
LF 
No functional 
assessment 
Language 
Attention 
Pyschomotor 
Exec.function 
Infor.processing 
Attention 
Some individuals 
improve at 12 weeks, 
but more (41%) 
improve at 24, 36, 
and 48 % after 
HAART initiation. 
Improvements 
greatest with those 
with lowest baseline 
performance. 
Improvement 
associated with HIV 
plasma load 
Rel. ship between 
improvement and 
HAART adherence 
Sacktor et 
al. 2009 
Uganda 102 HIV + 
25 HIV- 
 
On HAART 
Longitudinal 
 
IHDS 
AVLT 
GPB 
SDMT 
CTMT 
WAIS-DSB 
WAIS –DSF 
KPS 
Memory 
Pyschomotor 
Visual spatial 
Exec.function 
ADLs – functional 
assessment 
Impairments 
improved 
Better improvement 
observed in Exec. 
funct 
CD4 counts increase 
Improved in overall 
functioning 
HIV- generally 
performed better, 
with minimal 
improvement in 
performance 
Stavudine based 
HAART caused 
peripheral 
neurotoxicity  
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Singh et 
al. 2010 
South 
Africa 
110 HIV+ 
Gender mixed w/ 
more females 
 
 Cross sectional 
 
Not on HAART 
IHDS 
WAIS-DSF 
WAIS-DSB 
TMT- A 
TMT – B 
No functional 
assessment 
Attention 
Infor.process 
Exec. Funct 
Visuospatial 
Psychomotor 
Age and gender 
(though inconsistent) 
affected performance.  
Education did not 
affect performance 
 
Performance on all 
tests were impaired. 
 
2.7.5 Psychosocial Aspects. 
Since the advent of HAART many individuals infected with HAART are living and 
coping with HIV as a chronic illness.  Frequent complaints of persistent fatigue, cognitive 
impairments and psychiatric illness, especially anxiety and depression, impose functional 
limitations on everyday activities and adversely impact quality of life (Warriner et al., 2010).  
Individuals on HAART are feeling better and they are living longer with the diseases and 
conditions that accompany a diagnosis of HIV and AIDS such as HIV-associated 
neurocognitive disorders or cognitive-linguistic disorders.  Nevertheless, neurocognitive 
deficits have not dissipated with the advent of HAART and are in fact on the increase (Heaton 
et al.2010).  Due to HIV and AIDS being a chronic condition, a person diagnosed with HIV 
and AIDS and exhibiting neurocognitive disorders can be considered to be disabled (Lawthers, 
Pransky, Peterson and Himmelstein, 2003). Hence the structured interview schedule was 
included in this study – to determine whether cognitive – linguistic impairments had a 
significant influence on an individuals’ ability to conduct activities of daily living.  
According to the World Health Organization there is a framework that can be applied 
to health states and conditions (in this case HIV-associated neurocognitive 
disorders/cognitive-linguistic deficits). This framework is called the International 
Classification of Functioning, Disability and Health (ICF) (WHO, 2002, 2005). The ICF is a 
framework that defines health-related states, disability and their consequences in multiple 
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dimensions. In addition the ICF allows health professionals across all disciplines to provide 
integrated assessment and intervention using a unified and standard language beyond the 
clinical setting. 
At the inception of the ICF in 1980 by the World Health Organization (WHO) health 
conditions and disability states were grounded in the medical model and used the terms 
“impairment”, “disability” and “handicap” to describe individuals. In other words, they 
looked at how body structure and function were impairing an individual’s ability to perform 
an activity. However, in 2001 the ICF was revised to include aspects of the social model of 
health that views disability as a part of life and validates and necessitates the inclusion of a 
person’s social and personal environment (WHO, 2001). The current version of the ICF 
integrates the biopsychosocial perspectives of health.  The ICF in its current form comprises 
two parts that include functioning and disability on the one hand, and contextual factors on 
the other. Part I consists of body structures, body functions, activity and participation. Part II 
includes contextual and personal factors.  
Components of the international classification of functioning, disability and health 
(ICF). 
Part I, describes health from the perspectives of the body, the individual and society. 
It also includes the components of body structures and body function. Body structures refer to 
the anatomical parts of the body (WHO, 2002). In the case of neurocognitive deficits, the 
anatomical body structures involved includes the central nervous system, specifically the 
regions of the brain and cranial nerves due to the diffuse damage caused by the HI virus. 
Impairments in body structures results in impairment in body function.  Body functions 
describe “the physiological functions of body systems” (WHO, 2002, p. 10). Aspects of 
impaired neurocognition within the body function would include deficits in memory, 
attention, visual spatial, executive function and language. Once an individual’s level of 
 102 
 
impairment has been determined, it is important to consider how these impairments impact on 
activities and participation in the environment. 
Activity is the execution of a task by an individual (WHO, 2002, p. 10), and 
participation encompasses how an individual participates is the environment, i.e. the social 
roles one engages in, for example mother, employer, employee, church member, student and 
so forth. Given that cognition is required for most daily activities, the impact of 
neurocognitive deficits (memory, attention, executive function, language and visual spatial) 
on functions of everyday life can be significant and limiting (Bendict, Mezhir, Walsh and 
Hewitt, 2000).  
Similarly, participation in life situations and social roles can be affected by 
neurocognitive deficits.  Some of these have been identified as social isolation (Fleishman et 
al., 2000) and loss of employment (Dray-Spira et al., 2006) as well as reduced leisure activity 
to mention just a few. To further illustrate how neurocognitive deficits can impair social 
participation, one need only take the example of employment since employment is a major 
factor in maintaining income levels and living conditions among patients with long-lasting 
chronic conditions such as HIV and AIDS.  For working individuals, employment provides 
not only financial benefits but also may be a source of structure, social support, role identity 
and meaning (Blalock, McDaniel and Farber, 2002).    
Unemployment rates are high among HIV and AIDS individuals despite the wide-
scale diffusion of HAART. Studies in Western countries have reported high unemployment 
rates among people living with HIV and AIDS ranging from 45 to 65% especially among the 
socially vulnerable populations (Dray-Spira et al., 2006). High unemployment rates could be 
attributable to neurocognitive deficits, fatigue, pain, depression, apathy and accompanying 
conditions. Moreover, activities and participation lead to interpersonal interaction and 
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relationships in major life areas and in the community, as well as providing a means of 
interacting in social and civic life (WHO, 2002, 2005).  
Part 2 of the ICF has also raised awareness of contextual factors that facilitate or 
impede body function as well as participation (Threats, 2007). These contextual factors 
incorporate both environmental and personal factors. Environmental factors “make up the 
physical, social, cultural and attitudinal environment in which people live and conduct their 
lives” (WHO, 2002, p. 10). These factors influence access to services, opportunities and 
information (Cruice, 2007; Lawthers, Pransky, Peterson & Himmelstein, 2003). 
Environmental factors relevant to neurocognitive functioning include technology, support 
from family, friends and health professionals, attitude from family, friends and society as a 
whole, availability or access to services, efficiency of systems and legislated coherent 
policies related to HIV-related conditions such as cognitive deficits (Lawthers et al., 2003; 
WHO, 2002).   
There is a burgeoning industry in tools and devices to assist individuals with 
neurocognitive impairment such as computers, word processing, home banking and 
navigation devices (McLeod & Bleile, 2003). Although these resources might not be 
available to individuals in within some areas of developing countries due to financial and 
bureaucratic barriers, home or work environments could be modified to compensate for their 
mental abilities. Support from friends, family and health professions has been documented to 
assist with coping and acceptance of diagnosis (Renwick & Friedland, 1996; Vosvick et al., 
2003). Unfortunately, societal attitudes towards individuals with HIV and AIDS are more 
often than not still negative.  
There is still a lot of stigma around the disease to the extent that HIV-positive 
individuals often do not disclose their status to partners, family or friends. This is debilitating 
for individuals who present with neurocognitive deficits because, they need the support of 
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loved ones to assist in activities that rely upon intact cognitive abilities. The services, systems 
and policies relating to individuals living with HIV and AIDS especially if they suffer from 
neurocognitive disorders can influence the well-being of the individual in terms of 
availability of drugs, treatment centres and adherence to drugs (Lawthers et al., 2003). 
Political factors can also affect the reality of intervention for individuals with HIV and AIDS. 
For example, in South Africa, the nationwide roll-out of ARVs was initially delayed by 
political debate on what constitutes AIDS, which further resulted in unnecessary and 
preventable deaths. 
Personal factors include the attributes of the person and the internal influences on 
functioning and disability (WHO, 2002). The ICF recognizes the “large social and cultural 
variance” (WHO, 2002) so gender, age, other health conditions, coping style, social 
background, education, profession and past experience which can influence how a person 
responds to the diagnosis and intervention provided to address neurocognitive disorders. 
 
Rationale for Structured Interview schedule 
Functional ability in terms of HIV-associated neurocognitive disorders is a topic that 
hasn’t been discussed in any great detail in the South African body of literature. To fill this 
lacuna, the researcher thus included an interview schedule to her study that looked at quality 
of life in terms of functional performance i.e. activities of daily living. This aspect was 
investigated by asking questions relating to initiating and completing activities of daily 
living. According to Webb and Norton (2004,) it is important to assess aspects psychosocial 
issues for several reasons:  to monitor adherence because if a patient is not functionally 
performing this could be due to an inability to follow the complicated drug regimen; to 
determine tolerance to HAART – the patient may be experiencing terrible side effects that 
affect their ability to functionally perform; to assist healthcare professionals in identifying  
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patient health changes over time and improving communication between patient and health 
provider.  
A structured interview schedule was thus included in this research to add more depth 
and supplement the cognitive-linguistic data collected. The structured interview schedule 
included mainly closed-ended questions and a few open-ended questions.  The questions 
were developed and adapted for the South African context from the Cognitive Symptom 
Checklists® developed by O’Hara, Harrell, Bellingrath and Lisicia (1993). The interview 
schedule was divided into two sections: demographic information and self-reported 
cognitive-linguistic problems (refer Appendix VII). The cognitive-linguistic problems sub-
section was further divided into attention, memory, visual spatial, language and executive 
functions thereby tapping into “real world” functional everyday activities such as work 
assessment, finances, shopping, medication management, and cooking.    
Difficulties in performing these particular activities of “real world” functioning have 
been shown to occur in the context of cognitive-linguistic abilities associated with HIV 
infection (Heaton et al., 2004). Specifically executive functions and memory skills such as 
planning, organization and abstract thinking are particularly important for successful 
management of household finances, particularly shopping (Gorman, Foley, Ettenhofer, 
Hinkin & van Gorp, 2009). In the context of this research it was deemed important to 
determine how cognitive-linguistic deficits interfaced with activities and participation within 
the framework of the International Classification of Functioning, Disability and Health (ICF). 
This was achieved by conducting a structured interview schedule. The survey comprised of 
the same cognitive-linguistic abilities as the CLQT, the difference was the interview 
generated responses pertaining to activities of daily living.  
Studies have been conducted investigating how cognitive, psychosocial and physical 
factors can influence a person’s ability to function in their environment (Gorman et al., 2009; 
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Heaton et al., 2010; Kopinsky et al., 2004; Lopez, et al, 1998; Renwick and Freidland, 1996). 
For instance, with regard to cognition, Lopez et al. (1998) reported that approximately 50% 
of their 72 HIV-infected participants indicated that they exhibited difficulty planning and 
organizing household tasks and recreational activities such as cleaning, cooking, hobbies and 
crafts. Contrary to the research results of Lopez et al. (1998), Heaton et al. (2010) found in 
their study that out of the 1555 HIV-infected participants, 617 reported neurocognitive 
deficits; and out of the 617 participants only 30% suggested that neurocognitive deficits 
significantly interfered with everyday abilities.  
 
Heaton et al. (2010), nonetheless, caution about the use of self-reports by saying that they are 
easy to obtain but may lead to false-positive classifications (e.g. exaggerated self-criticism 
due to depression) as well as false-negatives due to lack of insight or avoidance of everyday 
situations that require abilities which have become impaired. Conversely, despite the 
classifications, everyday functioning must be documented as a criterion for the impact of 
HIV-associated neurocognitive impairment. Although these studies used self-report 
measures, they were cross-sectional in nature and their participants had higher CD4 counts 
than those reported in this study.  Therefore their studies failed to provide information on the 
effects of HAART in relation to cognitive-linguistic abilities and the ability to perform 
everyday activities. 
There also appears to be a relationship between the progression of the disease and an 
individual’s ability to perform functional abilities. For example, Sacktor, Wong, Nakasujja et 
al. (2005) and Wong et al. (2007) conducted studies in Uganda using both HIV-positive and 
HIV-negative participants. These studies revealed that participants in the HIV-positive 
groups reported more functional impairments on everyday tasks than the HIV-negative 
participants. It was further reported by Wong et al. (2007) that symptomatic complaints from 
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those participants in stages 3 and 4 (who were in the majority) included depression (64%), 
memory problems (59%), headaches (59%), numbness (54%), concentration (37%) and 
balance problems (32%). The findings also revealed that the greater the severity of HIV-
associated neurocognitive deficits, the greater the number of individuals who complained of 
disease-related symptoms. Regarding their functional performance as recorded on the 
Karnofsky Performance Scale, HIV-infected patients with and without HIV-associated 
dementia reported difficulties performing functional activities, with demented patients stating 
the worst problems. In the research study by Sacktor, Wong, Nakasujja et al. (2005) it is not 
clear whether participants were taking HAART, whereas in the study by Wong et al. (2007) 
the majority were not taking HAART. Once again both these studies were cross-sectional in 
nature and failed to provide information on the effects of HAART on the cognitive-linguistic 
abilities of the participants in relation to everyday functional activities.  
Both Sacktor, Wong, Nakasujja et al. (2006) and Sacktor, Nakasujja, Skolasky, 
Robertson, Musisi et al., 2009) in their longitudinal studies with HIV –positive individuals 
reported that HAART had a positive effect on functional performance. They used the 
Karnofsky Performance Scale and found that functional abilities improved from being 
severely impaired before HAART initiation to within normal limits.  Their functional abilities 
returned to normal at the end of six months of taking HAART. Participants were able to 
return to or find work and perform everyday activities of daily living with independence. 
Many people living with HIV and AIDS find it challenging to attend to daily tasks of 
living, participate in moderate to physical activities, or have sufficient energy or vitality to 
engage in an active social life while managing HIV and AIDS (Vosvick et al., 2003). Fatigue 
is a common symptom in patients with HIV and AIDS; in fact several recent descriptive 
studies have identified fatigue prevalence rates of 60% (Paddison, Fricchione, Gandhi & 
Freudenreich, 2009; Voss, 2005). Fatigue or low energy has been associated with a CD4 cell 
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count of less than 500. This can lead to physical limitations and disability (Ferrando et al., 
1998).  
Among HIV-positive patients, disease progression is related to decreased energy and 
increased difficulties with daily activities and pain (Sarna, van Servellen, Padilla & Brecht, 
1999). Energy levels and pain can serve as internal distracters that can prevent individuals 
living with HIV and AIDS from attending to activities of daily living (Myezwa, Stewart, 
Musenge & Nesara, 2009).  These observations have been supported by a study conducted by 
Lopez et al. (1998) where 72 HIV-infected adults where studied of whom half were taking 
HAART. According to the study, the majority of the patients reported difficulty engaging in 
physical activity such as performing household tasks, climbing steps, and carrying out any 
recreational activities. They attributed their participants’ physical difficulties to psychomotor 
slowing which could be indicative of fatigue.  
Makoae et al. (2005) conducted a study on HIV-infected individuals from Botswana, 
Lesotho and South Africa to describe the presence or absence of personal factors related to 
HIV and AIDS symptoms. In all, 743 HIV-infected participants from the different countries 
were recruited to participate.  In terms of percentages, the following symptoms which were 
relevant to the context of this study were cited: Fatigue (56%), fear/worries (44%), headaches 
(42%), depression (40%), memory loss (27%), anxiety (27%), insomnia (23%), and blurred 
vision (20%). Interestingly, there were no questions regarding hearing. Hearing and auditory 
processing play a critical role with regards to interpersonal relationships and the ability to 
conduct every day affairs especially if they involve communication. Makoae et al. (2005) 
study was cross-sectional in nature, and the researchers did not comment on whether the 
participants were taking HAART and no information was collected in terms of how these 
symptoms impacted on psychosocial activities. 
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2.7.5 Risk factors for developing HIV – associated neurocognitive disorders. 
So what predisposes a person to develop neurocognitive deficits, since incidence and 
prevalence numbers indicate that not everyone diagnosed as HIV-positive develops HIV-
associated neurocognitive disorders? Prior to the HAART era, age, a diagnosis of AIDS, 
injection drug abuse and the presence of HIV RNA in the cerebral spinal fluid were all 
indicators of HIV-associated neurocognitive disorders (Grant et al., 2005). Since the advent 
of HAART, more risk factors have emerged which include gender, education, HAART 
adherence, CD4 counts, apathy, substance abuse and anaemia.   
Age has been found to significantly correlate with HIV-associated neurocognitive 
disorders (Valcour et al., 2004; Wong et al., 2007; Singh et al., 2010; Ciccarelli et al., 2011). 
Valcour et al. (2004) found that mild cognitive disorders were identified in 44.7% of older 
and in 26.3% of the younger participants. HIV-associated dementia was identified in 8.7% of 
the older participants and only in 3.2% of the younger participants when contributing factors 
such as sensory or motor findings, depressive symptoms or situational stressors and/or 
substance abuse were controlled for. Moreover, Singh et al. (2010) reported that age 
significantly correlated with attention and executive function.  Ciccarelli et al. (2011) 
observed that higher educational levels were associated with reduced risk of neurocognitive 
impairments and participants older than or equal to 65 years performed significantly poorer 
on tests that explored attention and executive function, supporting the assertion that aging 
may result in HIV-associated neurocognitive disorders. 
Contrary to these findings, studies conducted in both the developed and developing 
countries by Berguis, Uldall and Lalonde (1998), Cohen et al. (2001), Jevtovic et al. (2008), 
Njamnshi et al. (2009) and Sacktor, Wong, Nakasujja et al. (2005), have reported no 
significant association between age and HIV-associated neurocognitive disorders (HAND). 
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These studies revealed that younger age was not associated with neurocognitive deficits, or 
older age with dementia. A shortcoming of the studies conducted by Berguis et al. (1998) and 
Njamnshi et al. (2009) is that they used screening tests as opposed to full neuropsychological 
batteries.  Nevertheless, this does not diminish the importance of their findings because 
findings on screening tests have significantly correlated with full battery tests (Struss et al., 
1996). 
Gender has in some cases been identified as a predictor. It has been asserted that men 
and women respond differently to neurocognitive assessments (Njamnshi et al., 2009; Singh 
et al., 2010).  Njamnshi et al. (2009) in their Cameroonian study using 185 HIV-infected 
participants reported that that gender was significantly associated with HAND.  Singh et al. 
(2010) carried out a study in South Africa to establish population normative scores for a 
select number of neuropsychological tests that could be used in South Africa; they too found 
that gender correlated with attention and executive function. However, Singh et al. (2010) 
used a limited number of tests.  Furthermore, both studies had more female than male 
participants and this could have affected their findings.   
Regarding education, Ciccarelli et al. (2011) observed that higher education levels 
were associated with reduced risk of HIV-associated neurocognitive disorders. This was not 
observed in studies conducted by Cohen et al. (2001), Sacktor, Wong, Nakasujja et al. (2005), 
and Singh et al. (2010). Cohen et al. (2001) stated that education did not impact performance 
on neurocognitive tests. Similarly, Sacktor, Wong, Nakasujja et al. (2005) and Singh et al. 
(2010) also reported that education did not significantly correlate with reduced risk of HAND 
despite the participants having a mean education of ten years - lower than that reported by 
Cohen et al. (2001). 
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The progression of the disease has been shown to greatly impact HIV-associated 
neurocognitive disorders (HAND). Evidence to support this claim has been provided by 
Cohen et al. (2004), Valcour et al. (2004), Wong et al. (2007) and Njamnshi et al. (2009) who 
have stated that low CD4 counts or high viral loads can influence neurocognitive 
performance. Njamnshi et al. (2009) revealed that HIV-associated neurocognitive disorders 
(HAND) occurred at all stages of HIV infection but the risk increased with advanced 
infection. Furthermore the risk of HIV-associated neurocognitive disorders was four times 
higher in patients with CD4 counts of 200 cells/mm
3
 or below. This implies that patients who 
complain of fatigue need to be screened for anaemia since haemoglobin may serve as an 
independent risk factor for the development of HAND.  
In line with CD4 counts influencing neurocognitive performance, Solomon and 
Halkitis (2008) and Ettenhofer et al. (2010) maintained that medication adherence 
significantly correlated with neurocognitive functioning, especially executive functions. 
Solomon and Halkitis (2008) found that executive function (as measured by the Trail Trials 
Making Test) significantly correlated with medication adherence. The Trail Making Test 
assesses the executive function skills of planning, judgement, impulse control and decision, a 
deficit in any of these areas has potentially life- threatening consequences for individuals 
living with HIV. Such as not adhering medication regimes, and increasing their risk of HIV 
re-infection and other sexually transmitted diseases. According to Ettenhofer, Foley, 
Castellon, and Hinkin (2010), higher levels of medication adherence were predictive of 
improved functioning in attention, information processing, executive function and motor 
function. Surprisingly, improved HAART adherence was not prospectively predictive of 
better learning/memory in their study.  
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In contrast to the mentioned studies, Sacktor et al. (2005) and Jevtovic et al. (2008) 
did not find CD4 counts to significantly correlate with HIV-associated neurocognitive 
disorders. The findings of Jevtovic et al. (2008) showed that there were undetectable levels of 
HIV RNA in the plasma in 81% of their 96 HIV-positive participants. The undetectable level 
of HIV RNA did not prevent the presence of mild cognitive motor deficits or HIV-associated 
dementia. They found that undetectable viral loads did not correlate with fewer 
neurocognitive problems. Jevtovic et al. (2008) have suggested that optimal HAART 
efficiency elsewhere in the body does not necessarily translate to viral suppression in the 
CNS. 
A critical appraisal of studies investigating neuropsychological testing and associated 
risk factors has found mixed findings across all the variables under investigation in this study 
- age, gender, education and CD4 count. This could due to a number of aspects such as 
sample size, neuropsychological tests used, race and educational levels, date of onset and 
whether the participants were on HAART at the time of testing. These reasons do not 
minimize the importance of investigating the influence of risk factors on how patients with 
HIV and AIDS perform on neuropsychological functioning because their interaction can 
either have positive or negative effects on neurocognitive or cognitive-linguistic skills. 
In summarizing this section, neuropsychological testing in under resourced 
developing countries is just an important a tool as neuroimaging techniques in determining 
the neurocognitive deficits of individuals with HIV and AIDS. Since cortical and subcortical 
degeneration has been established in the HIV and AIDS population, it is important that the 
appropriate assessment tools be utilized effectively to detect the presence of neurocognitive 
deficits or cognitive-linguistic impairments. However, despite their usefulness, 
neuropsychological tests focus on impairment which is only one aspect of disability 
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according to the International Classification of Functioning, Disability and Health (ICF). As 
previously mentioned the current ICF framework was developed from the biopsychosocial 
approach for health and disability. The biopsychosocial model has been shown to be 
conceptually, a comprehensive and clinical model that can be applied to HIV-associated 
neurocognitive disorders especially in the context of this research as depicted in Table 2.9. 
The biopsychosocial model was introduced as the conceptual model that undergirds this 
study. For a detailed description on this model and its’ factors refer to the conceptual model 
section 2.3.2. 
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Table 2.9 The Relationship between the Biopsychosocial Model and the ICF; and the 
CLQT and Structured Interview Schedule. 
 
 
 
Since the assessment of HIV-associated neurocognitive disorders has been discussed in 
depth, a description will now be given of how HIV-associated neurocognitive disorders are 
BIOPSYCHOSOCIAL MODEL ICF 
Social Culture 
Contextual background 
ARV rollouts 
Management of ARVs 
 
Environmental factors 
Barriers to access 
Participation restriction 
 
Psychological Cognitive abilities:  
- Attention, Memory, 
Language, Visual Spatial, 
Executive functions 
-Neuropsychological 
methods of assessment 
 
Coping strategies 
Emotions 
 
 
Relationship between 
language and cognition 
 
Risk factors for HAND – 
education, gender, CD4 
count 
Activity 
Activities of daily living 
Participation 
Personal factors 
Internal distractors 
Social interactions 
 
Assessment: Structured 
Interview schedule 
 
 
 
 
Biological Neurophysiology: 
-Cortical and subcortical 
functioning 
-Biomedical methods of 
assessment,  
 
Tissue and organ damage: 
-HIV infection – CD4 count, 
stages 
-CNS involment 
-ARV effects 
 
Body structure and 
function 
 
Impairments 
HIV-associated 
neurocognitive disorders 
(HAND) 
 
Assessment: CLQT 
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treated. An appraisal of how effective antiretrovirals have been in treating HIV-associated 
neurocognitive disorders will also be given 
. 
2.8 Treatment of HIV-associated Neurocognitive Deficits or Cognitive- linguistic 
Deficits  
2.8.1 Introduction 
The treatment of HIV-associated neurocognitive disorders or cognitive-linguistic 
deficits can be divided into pharmacological or non-pharmacological treatment. 
Pharmacological intervention includes antiretrovirals and so-called “adjunctive” therapies 
that include neuroprotective and neuroregenerative agents. Non-pharmacological 
interventions can include psychotherapy, mind-body-spirit healing methods, cognitive 
behavioural therapy, aroma therapy, massage and therapeutic touch, and/or stress 
management techniques (Kopinsky et al., 2004; Ungrvarski & Trzcianowska, 2000).  
Adjunctive therapies and non-pharmacological interventions are beyond the scope of 
this study and hence will not be discussed. Antiretroviral therapy was introduced and 
discussed in great depth in section 2.3.4: “Management of HIV and AIDS”. The focus of that 
section was to name the different classes of antiretrovirals and describe how they acted in the 
body to suppress viral replication, to list the HAART regimens available in South Africa and 
give a contextual background of how HAART was started in South Africa and current 
government initiatives pertaining to HAART roll-out in the country and access to all who are 
HIV-infected. This section will specifically focus on how HAART impacts or treats 
cognitive-linguistic deficits. 
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Antiretroviral therapy (ARV) has greatly increased life expectancy for many of those 
infected with HIV, but as patients survive longer, there is increasing concern that chronic 
viral neurotoxicity can lead to progressive brain atrophy  and associated neurocognitive 
impairments in some patients. This concern is a valid one because the blood brain barrier 
(BBB) can prevent permeation of antiviral drugs (Xia et al., 2011). As mentioned above, once 
the HI virus enters the brain it invades the immune fighting cells such as the macrophages 
and microglia, causing inflammation, neuronal and dendritic damage which leads to HIV-
associated neurocognitive disorders. ARV classes of drugs and individual drugs within 
classes have different penetration potentials that are dependent upon a variety of biological 
and virological factors. Unfortunately, only limited data about the penetration of the most 
widely used antiretroviral agents is available from studies in humans and animals. 
Letendre et al. (2006), as cited in Price and Spudich (2008), have rated antiretrovirals 
on the basis of their CNS penetration effectiveness. They have rated them as 0 (low 
penetration), 0.5 (intermediate penetration), or 1 (high penetration).  According to Letendre et 
al. (2006), staduvine (d4t), lamiduvine (3TC) and efavirenz (EFV) have a 0.5 penetration. 
Zidovudine (AZT), neveripine and lopinavir have a rating of 1.0.  Unfortunately, even though 
efavirenz exhibits an average CNS penetration, it also can result in serious neurotoxic side 
effects as well. Cysique, Maruff and Brew (2004) found a difference in performance between 
HIV-positive individuals on high CNS penetration HAART and those on low CNS 
penetration. Those who were on high penetration CNS HAART performed better.   However, 
it is encouraging to note that the antiviral drugs included in the HAART regimens prescribed 
to individuals living with HIV and AIDS in South Africa have relatively good CNS 
penetration effectiveness. Therefore it was hypothesized that the cognitive-linguistic abilities 
of individuals infected with HIV and AIDS in this study would improve on HAART based 
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upon the relatively good CNS penetration of the antivirals used in HAART on the South 
African population seeking care at urban government hospitals.  
Nucleoside reverse transcriptase inhibitors (NRTI) act to mimic the normal building 
blocks of HIV DNA and interfere with reverse transcriptase’s ability to convert viral RNA to 
viral DNA.  Early studies carried out on zidovudine (AZT) found that individuals performed 
better on neuropsychological tests once they were given AZT. Zidovudine administered at 
higher than recommended dosages has been the most successful drug to treat neurocognitive 
disorders (Ungvarski & Trzcianowska, 2000). AZT is able to cross the BBB by passive 
diffusion, but the effects are not long lasting (Baldeweg, Catalan & Gazzard, 1998; Kaul & 
Lipton, 2006; 2007). Later studies have revealed that among NRTIs, AZT (20%)  and 
staduvine (30%) reach brain tissue at concentrations considerably higher than those of 
didanosine (<4%) (Letendre et al., 2007). 
Gibbs, Raschid and Thomas (2003) investigated the movement of lamivudine (3TC) 
across the guinea pig brain barrier. They found high levels of lamivudine accumulation in the 
choroid plexus of the guinea pig brain. They believe that the choroid plexus could be a 
possible entry point for HIV from blood to CSF and could be regarded as a potential 
reservoir. However, despite the significant accumulation of lamivudine in the choroid plexus 
there was less lamivudine observed in the cerebral spinal fluid. They detected lamivudine in 
the brain, but at very low levels, indicating that lamivudine is not easily transported through 
the BBB. They postulated that this could be due to the fact that lamivudine along with other 
NRTI bonds with human proteins that prevent it from being transported across the BBB. 
They have therefore suggested that drug treatment should focus on tackling HIV within the 
CNS, particularly the choroid plexus.  
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Non-nucleoside reverse transcriptase inhibitors (NNRTIs) serve to inhibit the enzyme 
reverse transcriptase which is responsible for the early stages of replication by transforming 
viral ribonucleic acid into viral DNA. NNRTIs are generally, as a class, more strongly 
protein-bound than NRTIs, which may limit their CNS access. A unique issue with efavirenz 
is the very common neurological complaints that have occurred when treatment is initiated. 
More than 50% of treated patients experienced sleep changes (vivid dreams, insomnia, etc.) 
(Cholewińska & Szymańska 2009). Neverapine is an attractive antiretroviral drug because of 
its high CNS penetration, which has been documented in trials. Despite having a great 
molecular weight, it exhibits approximately ten times the BBB penetration than other 
NNRTIs (Von Giesen, Koller, Thelsen & Arendt, 2002).The NNRTIs such as neveripine and 
efavirenz have also been shown to improve dementia (Jevtovic et al., 2008).  
On the other hand, the findings have been mixed regarding the effectiveness of 
efavirenz in improving neurocognitive functioning. For example, Jevtovic et al. (2008) have 
claimed that efavirenz has a positive effect on HIV-associated dementia, and Ciccarelli et al. 
(2011) have cited efavirenz as having a negative effect on HIV-associated neurocognitive 
disorders in asymptomatic HIV-infected individuals due to the neurotoxic effects of 
efavirenz. Despite Ciccarelli et al.’s findings (2011) there is acknowledgement that efavirenz 
has a relatively good CNS penetration and therefore can be used to manage HIV-associated 
neurocognitive disorders as long the potential neurotoxicity of the drug is monitored. 
Regarding the use of protease inhibitors (PI), Jevtovic et al. (2008), using 96 HIV 
patients, found that protease inhibitors (PIs) did not readily penetrate the BBB. This was due 
to their large molecular weight and their propensity to extensively bind to plasma proteins, 
leaving very little unbound drug to penetrate into the brain and cerebral spinal fluid (CSF). 
Lopinavir is an excellent example of such a drug. Conversely, Letendre et al. (2007) found 
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that when Lopinavir was combined with Ritonavir, it was able to reduce HIV RNA found in 
the cerebral spinal fluid and improve neurocognitive performance. They collected CSF and 
plasma samples from 14 participants at baseline and 11 again three weeks after taking 
Lopinavir plus Ritonavir to determine levels of HIV RNA. They also conducted 
neuropsychological testing on the 14 participants. They found five out of the 14 participants 
exhibited impaired global performance at baseline. Two of the five impaired participants 
“dropped out” of the study mid-way. When they retested the remaining three at 12 weeks 
they found that the participants’ neurocognitive performance had improved, reaching normal 
range. These findings are in contradiction to the findings of Jevtovic et al. (2008) who found 
that PI-based regimens were not able to prevent the progression of HIV-associated 
neurocognitive disorders to HIV-associated dementia. Nevertheless, Letendre et al. (2007) 
contends that the prevalence of HIV-associated disorders after taking HAART could be due 
to drug resistance, poor adherence, and the level of CNS penetration of some antiretroviral 
drugs.  
Due to antiretrovirals having different CNS penetration it has been suggested that to 
facilitate effective CNS penetration and improve neurocognitive abilities, a combination of 
different antiretroviral drugs (HAART) should be given to individuals living with HIV and 
AIDS rather than providing them with monotherapy. 
Given that the incidence of HIV-associated dementia (HAD) has reduced since the 
advent of HAART, the assumption can be made that HAART must have a definite 
neuroprotective effect (Bacellar et al., 1994). The mechanisms of chemotherapeutic 
protection against the development of CNS disease and neurocognitive impairments appear to 
be related to the suppression of HIV replication as evidenced by a decrease in the viral load 
and concomitant increase in immune function once therapy is initiated (Kipnis et al., 2008; 
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Ungvarski & Trzcianowska, 2000). These assertions are supported by the findings of Garvey 
et al. (2011) who conducted a retrospective study using 251 participants assessing the 
relationship between CNS disease and CNS penetration effectiveness of different 
antiretrovirals. They found that CNS diseases occurred more frequently in individuals whose 
HAART regimen had low CNS penetration effectiveness, than those individuals who were on 
HAART regimes with higher CNS penetration; yet, this difference was not significant. 
Although the study was not prospective in nature and only investigated CNS disease and not 
neurocognitive disorders, it highlights the relationship between CNS disease and CNS 
penetration effectiveness of different antiretrovirals. 
Another study that demonstrated how HAART could improve HIV-associated 
neurocognitive functioning even if the presence of milder forms of HIV-associated 
neurocognitive impairments persisted was conducted by Heaton et al. (2010). Part of their 
study set out to determine the frequency of HIV-associated neurocognitive disorders present 
in a 1 555 cohort of HIV-positive individuals taking HAART. They found that although 
HAART had a major impact on CNS manifestations including HIV-associated 
neurocognitive disorders (HAND), 44% of their participants continued to exhibit milder 
forms of HAND. They concluded that their patients improved while on HAART because of 
immune recovery and viral suppression – both systemically (outside the CNS) and in the 
CNS. Though their study comprised a cross-sectional analysis, it did highlight the persistence 
of HAND in the era of HAART.  
The findings of Heaton et al. (2010) which found that milder forms of HIV-associated 
neurocognitive disorders still persisted after months of HAART initiation may be explained 
by a study conducted by Cardenas et al. (2009). They conducted a longitudinal study to 
investigate the effects of HIV on the brain volume of HIV-positive patients compared to 
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seronegative controls before and 24 months after HAART. The results revealed that despite 
being on HAART, individuals living with HIV continued to display on-going brain volume 
decreases. They purported that this reflected continued viral infection in the brain despite 
effective viral suppression in the periphery. Because of the limited permeability of blood 
brain barrier (BBB) to many HAART, they hypothesized that the brain could serve as a 
reservoir for inactive infected macrophages.  So on-going brain injury might have arisen from 
continued neuronal damage secondary to activated macrophages, in the absence of the virus 
that might have begun prior to taking ARVs.  
In a further longitudinal study with 96 women, Cohen et al. (2001) investigated 
whether HAART provides functional neurocognitive benefits. They established that 
neurocognitive performance was much improved by taking HAART for more than 18 months 
rather than for 12 months or less compared to baseline. Therefore, treatment duration 
appeared to affect neurocognitive outcome positively, which is worth mentioning given 
clinical concerns regarding persistence of cognitive impairments. However, according to 
Cohen et al. (2001), improvement in cognitive performance could have been due to improved 
overall health status resulting in less fatigue and fewer physical symptoms that might have 
interfered with performance.  Moreover, the general sense of well-being may have been 
caused by the suppression of viral load and improvement in immune system (Melrose et al., 
2008). This may suggest that HAART has a lesser impact on HIV-associated neurocognitive 
disorders than on other AIDS-defining illnesses, possibly due to the poor CNS penetration of 
the many antiretroviral agents (Jevtovic et al., 2008). 
Sacktor, Nakasujja, Skolasky, Robertson, Musisi et al. (2009) conducted a 
longitudinal study in Uganda evaluating the effects of HAART, especially staduvine, on 
HIV-associated neurocognitive disorders. They recruited 102 HIV-positive individuals who 
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commenced HAART and 26-HIV negative individuals. Their participants comprised of 
mainly women, with a mean education of 9.6 years and a mean CD4 count of 129. The 
participants were asked to fill out a functional performance scale (Karnofsky Performance 
Scale) and underwent neuropsychological testing at baseline, three months and six months. 
Results revealed that there were improvements across all cognitive domains with significant 
improvements being noted in executive functions.  
However, peripheral neurotoxicity was observed in 30 participants. They presumed 
this was because of the staduvine-based HAART. Their study was very similar to the current 
study in that it was a longitudinal study, and they recruited participants with similar 
demographic characteristic in terms of the sample gender mix, education and CD4 counts.  
The main difference is that the current study utilized a measure that could ask specific 
questions about how neurocognition in terms of how cognitive-linguistic abilities impacted 
upon activities of daily living. Another difference is the strain of HIV-1 under investigation 
and the functional performance scale. In Uganda the HIV sub-type is A and D (Sacktor, 
Nakasujja, Skolasky, Robertson, Wong et al., 2006). In South Africa it is sub-type C 
(Williams & Martin, 2010). 
Cook-Easterwood et al. (2007) conducted a study using SCID mice infected with the HI virus 
to determine whether HAART had any effect on cognitive deficits caused by the HI virus. A 
SCID mouse is a strain of mice lacking in T and B lymphocytes and immunoglobulins, either 
from inbreeding with an autosomal-recessive trait or from genetic engineering, used as a 
model for studies of the immune system (Mosby, 2009). Their results revealed HAART 
reduced astrogliosis (i.e. the presence of reactive astrocytes that excrete cytokines) and 
reduced the percentage of HIV-infected cells of SCID mice. However, even though HAART 
reduced the presence of cytokines that cause neuronal damage, they did not completely 
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eliminate their presence. Overall, the results of their study suggest that neuronal dysfunction 
in infected SCID mice, as indicated by dendritic damage and impaired cognition is important 
in the early pathogenesis and may translate to the human condition. They inferred that early 
cognitive dysfunction in HAD is related to neuronal damage rather than neuronal death due to 
the presence of Map-2 which serves as a metabolic marker for dendritic simplification or 
damage. They also observed that certain viral proteins, such as tat, gp 120 and gp 41, even at 
low levels, are neurotoxic and might play a role in HIV-associated dementia pathogenesis 
which has also been suggested by Nath (2002).  
While the latter findings are encouraging, more studies designed to address treatment 
duration and the impact of HAART on neurocognitive functioning are still needed. In fact 
future research might require a focus on both HAART and so-called “adjunctive” therapies 
that include neuroprotective and neuroregenerative agents. For example, gene therapy to 
reverse existing brain injury has been tried and shown to be effective in retarding the 
progression of Alzheimer’s disease (Ellis et al., 2007). Other measures have involved the 
administration of pharmacological agents. For instance lithium has been shown to prevent the 
induction of dendritic spine loss and reduce the neurodegeneration caused by HIV-1 gp 120 
and thus improve neurocognitive functioning (Letendre, Woods, Ellis et al., 2006). 
Minocycline which is an antibiotic has been shown to reduce the activation of infected 
macrophages and microglia in rhesus monkeys, reducing the severity of encephalitis, 
suppressing viral load and dampening CNS inflammatory markers (Zink et al., 2005). Plans 
are underway to conduct trials in humans (Ellis et al., 2007). Furthermore, supplementation 
with vitamins E, B₆, and B₁₂ has been shown to improve neurocognitive function. 
Deficiencies in these vitamins can result in degenerative CNS and PNS disease that interfere 
with neurotransmission that can cause cognitive and motor impairments. 
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In summary, HAART has been shown to be the most effective means for improving 
the cognitive-linguistic abilities of adults living with HIV and AIDS. While significant 
progress has been made in treating people with HIV-related neurocognitive impairments, 
these are still occurring in the era of HAART. Considering the potential durability and 
efficacy of antiretroviral therapies, as well as their variable ability to enter the brain, new 
questions are being raised about the causes and treatment of HIV-related brain disorders and 
about the extent to which neuronal dysfunction is reversible. Due to these questions being 
raised about the treatment of HIV-associated neurocognitive disorders, it is imperative that 
continual neuropsychological assessment be done to monitor the severity of HIV-associated 
neurocognitive deficits. 
 
 
Figure 2.3 Summary of Current Relationships and Linkages Associated to HAND. 
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2.9 Rationale and Questions 
HIV and AIDS as a disease is here to stay unless a cure can be found to destroy it. At 
present the only effective treatment for HIV and AIDS is HAART. However, despite the era 
of HAART, the spread of HIV and AIDS continues unabated in Africa, especially in sub-
Saharan Africa, with South Africa having the highest prevalence rates. This is due to a 
number of factors which include the ravages of apartheid, poverty which has resulted in the 
migration of people seeking work, gender power imbalances particularly in negotiating safe 
sex practices and the political will of the government in terms of making antiretroviral 
therapy available to all who have been infected with the HI virus. So it is within this climate 
of HIV and AIDS that this study is situated. 
It is well known that HIV and AIDS wreaks havoc in the body in many ways. The 
virus is able to cross the blood brain barrier and cause HIV-associated neurocognitive or 
cognitive-linguistic deficits. These HIV-associated neurocognitive disorders can range in 
severity from mild to HIV-associated dementia which is the most severe form. HIV-
associated cognitive linguistic deficits are hypothesized to be mediated by cortical-subcortical 
neuronal loops (Woods et al, 2004), which originate in the cortex, extend in the basal ganglia 
through the thalamus and terminate in the cortex (Murdoch & Whelan, 2009). The severity of 
HIV-associated neurocognitive deficits is dependent on a number of variables that include the 
degree of brain degeneration, gender, age, and education and CD4 counts as discussed in this 
study.  
HIV-associated neurocognitive or cognitive-linguistic deficits can be assessed using 
imaging techniques such as functional magnetic resonance imaging (fMRI) or 
neuropsychological tests. In the context of South Africa, which is a developing country, the 
most cost-effective and time-efficient method of assessment is through neuropsychological 
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assessment. Neuropsychological assessment is able to reveal the cognitive-linguistic skills 
(attention, memory, language, executive function and visual spatial skills) that might be 
impaired. As has been highlighted earlier it is thus essential that neurocognitive deficits be 
assessed and monitored. 
Cognitive-linguistic deficits have been identified as a factor influencing levels in 
medication adherence. Hinkin et al. (2004) found that individuals classified as 
neurocognitively impaired were 2.5 times more likely to demonstrate poor medication 
adherence. Additionally, the cognitive domains which have been consistently associated with 
adherence include attention, executive functioning, attention/working memory, and verbal 
memory attention, and memory (Hinkin et al., 2004).  
Memory deficits have also been indicated as an early sign of brain degeneration if 
detected early (Panegyres, 2004). Antiretrovirals are important in decreasing the virus and 
diminishing its effects in the body, so medication adherence is important for general well-
being. Treatment interruptions and inconsistent drug intake can lead to inadequate virologic 
suppression or immunologic response development and spread of resistant viral strains and 
clinical disease progression (Ammassari et al., 2004). In fact Wilkie (1998) goes as far as to 
say that minor HIV-associated neurocognitive impairments can predict the risk of mortality. 
In addition, HIV-associated neurocognitive disorders, in particular HIV-associated 
dementia, can have a major impact on public health, both as a result of high levels of 
assistance required in individual disability, and as a result of the greater health care resource 
utilization it evokes (Storace et al., 1998). HIV and AIDS as a disease is already having a 
significant impact on healthcare services and by detecting neurocognitive deficits early on, 
the burden of disease in South Africa of HIV and AIDS could be alleviated.   
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Furthermore, in resource-poor environments such as South Africa there tends to be a 
shortage of trained health personnel. It is usually the neurologist or psychiatrist who 
diagnoses mild cognitive motor disorders and HIV-associated dementia, and they are not 
always on hand to diagnose HIV-infected individuals who might exhibit neurocognitive 
disorders. Therefore the versatility of neuropsychological tests in detecting cognitive-
linguistic deficits in developing countries such as South Africa cannot be understated. 
Neuropsychological tests can be administered by other allied health professionals such as 
speech language pathologists, neuropsychologists, cognitive psychologists and occupational 
therapists. Screenings such as the Mini Mental State Exam can be administered by nurses. 
Assessment by other professionals allows for HIV-infected individuals to receive appropriate 
clinical management in terms of appropriate referrals and treatment.  
By using the Cognitive-Linguistic Quick Test, a test that can be administered by 
speech language pathologists, the crucial role of speech language pathologists (SLPs) can be 
highlighted along with their importance in the multidisciplinary management of patients 
living with HIV and AIDS. SLPs are health professionals trained in the assessment and 
intervention of cognitive and linguistic disorders.  It is important that SLPS not only focus on 
the individual’s expressive and receptive language abilities. The clinician must also assist the 
individual to cope successfully with neurocognitive deficits as well since cognition and 
language are intertwined processes (Helm-Estabrooks, 2001; Murdoch & Whelan, 2009).  
Since HIV and AIDS cannot yet be cured but can be treated, it classifies as a 
disability because of its chronic nature. Moreover, due to the fact that HIV-associated 
neurocognitive disorders are still prevalent in the era of HAART, they can affect an 
individual’s quality of life in terms of being able to perform everyday activities of daily 
living. This reality falls within the framework of the International Classification of 
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Functioning, Disability and Health (ICF) which states that disability must be viewed not only 
in terms of impairment but also include activities and participation of the individual in their 
immediate environment (WHO, 2002).  
According to Webb and Norton (2004), it is important to assess quality of life for 
several reasons. Firstly, to monitor medication adherence because if a patient is not able to 
perform activities of daily living it could be due to an inability to follow the complicated drug 
regimen. In addition, tolerance to HAART – the patient may be experiencing terrible side 
effects that affect their ability to perform activities of daily living. Furthermore, assessing 
quality of life via activities of daily living identifies health changes over time and improves 
communication between patient and health provider. 
 
Bearing in mind the rationale for this research, the researcher set out to answer the 
following questions: 
Question 1: Is there a difference in the cognitive linguistic group performance of adults living 
with HIV and or AIDS 
Question 2: Do the cognitive linguistic abilities of Adults living with HIV/Aids improve after 
ARV use. 
Question 3: Do the variables of age, gender, education, CD4 counts have an influence on the 
cognitive linguistic abilities of Adults living with HIV and or AIDS. 
Question 4: What cognitive – linguistic abilities affect the activities of daily living of adults 
living with HIV and or AIDS? 
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Taking cognisance of the literature presented in this chapter, this study sort to 
investigate the cognitive-linguistic abilities of adults living with HIV and AIDS and their 
ability to perform Activities of Daily Living before and after antiretroviral therapy. Before 
the main study was conducted, a pilot study of the Cognitive Linguistic Quick Test and the 
structured interview scale was conducted to determine the reliability of using these measures 
for the study.  
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Chapter 3: Pilot Study 
 
3.1 Introduction 
This chapter describes the aims and procedures for determining the reliability of the Cognitive 
Linguistic Quick Test and the structured interview schedule for this study.  The Cognitive 
Linguistic Quick Test is a test that can be administered by speech-language pathologists, 
psychologists, occupational therapists, nursing personnel, and other professionals experienced 
in administering cognitive assessment instruments especially to adults. The researcher is a 
qualified speech-language pathologist and the research assistants were Masters Students in 
research psychology who had experience in administering psychometric tests. 
This test was standardized on American and Spanish adults who presented with an 
acquired neurological dysfunction such as traumatic brain injury, dementia, right hemisphere 
damage, cerebral vascular accidents and has not been used with an adult HIV-infected 
population that may present with neurocognitive deficits.  
As mentioned earlier, a structured interview schedule was also used to determine if 
cognitive linguistic abilities affected the way individuals conducted their everyday activities of 
daily living. Since the questions for this schedule were adapted from the Cognitive Symptom 
Checklists (1993), it was deemed important to evaluate whether the terminology or phrasing of 
the questions asked what they were supposed to.  
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3.2 Pilot Study Procedures 
3.2.1 Aims. 
1. To determine whether the Cognitive Linguistic Quick Test (CLQT) was sensitive 
enough to detect mild cognitive deficits. Since this was not a comprehensive battery 
of neurological tests, the researcher needed to determine whether the test could 
identify participants with mild or minor neurocognitive deficits.  
 
2. To determine if the instructions of the CQLT were easy to understand. Since this test 
was standardized on a different population from the one that was going to be used in 
this study, the researcher needed to determine whether the phrasing or terminology 
used in the questions would affect how the individuals comprehended the questions. 
 
 
3. To determine whether the CQLT was time efficient. Since the participants were 
recruited from queues at an outpatient HIV and AIDS treatment clinic, the researcher 
needed to use a test that would not detain the participants for too long so that they 
would not lose their place in the queue, or cause them not be interested in coming 
back for further testing. 
 
4. To determine whether the survey was phrased appropriately and “tapped” into what 
we were asking.  This was important to do since this was a schedule that the 
researcher had developed and adapted from the Cognitive Symptom Checklist 
produced by Psychological Assessment Resources Inc (1993).  
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3.2.2 Description of the participants. 
A total of 21 participants (and only 16 were analysed) were recruited from an outpatient 
clinic situated in Gauteng, a province in South Africa that dispenses antiretrovirals (ARVs). A 
purposive convenience sampling technique was used. To be included in the study the 
participants had to be HIV-positive (treatment naïve) and deemed ready to start antiretroviral 
therapy at this particular clinic. Treatment naive meant that the participants had never been 
prescribed HAART. Participants were excluded if they were below the age of 18, too sick and 
or not alert enough to participate. Descriptive statistics that include the mean, standard 
deviation, frequencies and percentages were run to describe the participants (see Table 3.1 and 
Table 3.2).  
Table 3.1 Descriptive Statistics of the Participants’ Demographic 
Characteristics.  
Variable Mean Std Dev Minimum Maximum n 
Age (in years) 37.63 12.91 20 68 16 
CD4 (cells/mm
3
) 132.53 70.51 17 243 15 
Date of Diagnosis (in 
months) 8.60 15.87 0 60 15 
Education (in years) 9.33 3.03 0 11 12 
 
 
 
Table 3.2 Frequencies of Participants’ Demographic Characteristics 
Variable n %age 
Gender 
  Female 12 75 
Male 4 25 
    
 Employment 
  Unemployed 11 79 
Employed 3 21 
    
 Education 
  Primary 1 9 
Secondary 11 91 
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3.2.3 Testing Procedure for Pilot Study. 
The nurse in charge suggested that the participants be recruited when they come for 
initiation of ARVs, i.e. their first visit for ARVs. Participants were approached by the 
researcher while in line for initiation of drugs, and asked if they would be willing to participate 
in the study. The purpose of the study was explained to them and any questions that arose were 
addressed. Once written consent was obtained to participate in the study and review their 
medical records, testing commenced.  
The CLQT and structured interview survey were administered to all participants. Two 
trained research assistants administered the test and survey. These trained research assistants- 
two MA in Research Psychology translated the CLQT and Interview questions into the 
vernacular namely IsiZulu, Sesotho or Setswana. One was well versed in English and IsiZulu 
and the in English Sesotho and Setswana. The two research assistants then met with two 
lectures from the department of languages, in the Humanities Faculties to determine if they had 
accurately translated the two instruments. One of the lectures was an IsiZulu lecturer and the 
other Sesotho and Setswana. The two lecturers felt that the translations closely approximated 
the English version of the tests. Testing took place wherever space was available, either in an 
empty doctor’s room or a cordoned-off section of the waiting area where dispensing of the 
ARVs took place. The researcher and participant sat on opposite ends of the desk and testing 
commenced. The participants were provided with a pen or pencil to perform the written tasks. 
The CQLT took approximately 40 to 50 minutes to complete. The survey was conducted face 
to face and it took approximately 25 minutes to complete. All measures were administered and 
scored according to standard procedures. 
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3.2.4. Data analysis.  
Descriptive statistics were obtained for demographics and the CLQT. The data on the 
CLQT was collected and raw scores were obtained and categories of severity (mild, moderate 
and severe) were determined by looking at what range of severity the raw score fell into. 
Frequency counts (which were converted to percentages) were used to analyse the data.   
 
3.3 Results 
Results were presented according to the aims of the pilot study: 
1. To determine whether the CQLT was sensitive to mild neurocognitive deficits. 
Table 3.3 Severity Rating of the participants Cognitive - Linguistic abilities (N=16). 
Cognitive -ling 
abilities 
        
normal    mild         moderate severe 
  n(%) n(%) n(%) n(%) 
Attention 3(19) 11(68) 0 2(13) 
Memory 3(19) 5(31) 5(31) 3(19) 
Executive Functions 3(19) 5(31) 3(19) 5(31) 
Language 8(50) 5(31) 3(19) 0 
Visual Spatial 4(25) 10(62) 2(13) 0 
 
Table 3.3 revealed that the majority of participants (68%) exhibited mild attention 
deficits. In addition, the majority of the participants exhibited mild (31%) or moderate (31%) 
memory deficits. Results also revealed that 81% of the participants had deficits in executive 
functions. Surprisingly, only 50% of the participants presented with language deficits that were 
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mainly in the mild range. Results also revealed that (63%) of the participants exhibited mild 
visual spatial deficits and 13% fell in the moderate range.  
 
Figure 3.1: Percentage severity rating of participants who exhibited deficits across all 
cognitive domains 
 
The majority of participants (87.5%) in this study presented with some form of 
cognitive deficit, and more than half of them (56%) showed mild problems. 
From the above results it was determined that the CQLT was a test that was sensitive enough 
to detect mild cognitive deficits and was therefore suitable to be used in the main study. 
 
2. To determine if the instructions of the CQLT were clear and simple to understand. 
 
Normal 
25.22% 
Severe 
13.11% 
Moderate
19.17% 
Mild 
56.50% 
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This was determined by noting how many patients asked the instructor to repeat the 
questions. Each participant was allowed a maximum of two repetitions, i.e. before the 
examiners started noting how repetitions were requested. Participants generally required no 
more than two repetitions even when presented in the vernacular.  Based upon these findings, 
the CQLT was deemed appropriate to use in the study. 
 
3. To determine whether the CQLT was time efficient. 
The examiners recorded how long it took to conduct the tests with the patients, and an 
average time was calculated. On average it took approximately 25-35 minutes to complete the 
test. This time was found to be reasonable. On further inspection it was noted that some of 
the questions were redundant and these were removed.  After revising the questions, it was 
found that the survey took approximately 10 -15 minutes to complete. This was found to be a 
reasonable time in which to complete the survey. 
 
4. To determine whether the structured survey questions were phrased appropriately and 
whether the participants understood what was being asked. 
This was determined by noting how many participants asked the instructor to repeat or 
rephrase the questions. Each participant was allowed a maximum of two repetitions, i.e 
before the examiners started noting how repetitions were requested. Some participants 
required more than two repetitions even when presented in the vernacular.  Based upon these 
findings, the questions were simplified and redundancy was eliminated. The survey was 
deemed appropriate to use in the study because it elicited information on how specific 
cognitive linguistic domains impacted upon activities of daily living. 
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3.4 Challenges 
The participants arrived very early at the clinic to queue up for their blood test(s) and 
medications. So by the time we asked them to participate in the study they were tired and 
sometimes hungry. As a result the researchers experienced difficulty getting the patients to 
come back and complete the testing once they heard their names called over the public address 
system. Due to this challenge another location within the clinic was found where participants 
could be recruited just before they were initiated in the counselling department.  
Another challenge was to persuade the doctors and nurses to assist the researchers in 
terms of allowing the patients to keep their place in the queue if they were pulled out for 
testing. This was circumvented by approaching the participant at the wellness clinic, before 
counselling sessions started. 
Reliability and consistency of the research assistants presented another possible 
challenge. After the pilot study, new research assistants were hired. However, since these 
research assistants were Master’s students in the psychology and audiology departments who 
had just enrolled in the programmes, there was little risk of them leaving before all the data 
could be collected for the main study. 
Of the 21 participants who were recruited for the pilot study only 16 response sheets 
could be analysed. This was due in part to participants not returning to complete testing and 
erroneous capturing of data. This was later rectified by recruiting patients before they entered 
the wellness counselling sessions. Erroneous data capturing was corrected by thoroughly 
training the research assistants. 
 
3.5 Conclusion 
The Cognitive Linguistic Quick Test was deemed appropriate to use in this study even though 
it had not been used on a South African adult population living with HIV and AIDS. . The 
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CLQT was able to identify clear deficits in all five cognitive domains, and as reported in the 
literature using more expensive, elaborate and time-consuming neuropsychometric 
evaluations (e.g. Berghuis, Uldall & Lalonde, 1999; Savage, Jackson and Sourathathone, 
2003). It was found to be time efficient and questions could easily be translated into the 
vernacular and understood by the clients. In addition it was easy to score and determine 
severity ratings. This suggested that the CQLT was an appropriate instrument for use in the 
initial investigation of cognitive deficits in patients with HIV or AIDS in South Africa. 
It was also decided that the structured interview schedule would be suitable for 
eliciting the responses on how cognitive linguistic abilities impact upon activities of daily 
living after questions were simplified. Once the pilot study was conducted and results 
determined, the main study was implemented.  
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Chapter 4: Methodology 
 
4.1 Introduction 
In this chapter the methodology for this study is presented. The study design, 
participant description, measures used and study procedure will be presented since the pilot 
study indicated that the measures were appropriate to use in this study. Reliability along with 
threats to reliability will also be discussed. 
It should be noted that after the data was collected, the National Department of Health 
had adjusted its criteria for initiation of HAART in line with the WHO (2010) regulations 
regarding HAART initiation. They changed them from having a CD4 count of 200cells/mm
3
 
to 350cell/mm
3
.  
 
4.2 Aims 
The aims of this study were as follows:  
1. To determine whether there is a significant difference in cognitive-linguistic abilities 
between the experimental, comparison and cross-sectional groups on the Cognitive-
Lingusitic Quick Test and the interview schedule. 
Hypothesis: There is a difference in the cognitive - linguistic abilities  of the three 
groups of adults living with HIV and or AIDS 
 
 140 
 
2. To determine whether there is a significant difference in cognitive-linguistic abilities 
within the participants (time effect) for the experimental and comparison groups on the 
Cognitive-Lingusitic Quick Test and the interview schedule. 
Hypothesis: The cognitive linguistic abilities of adults living with HIV/Aids improve 
after HAART use across the three testing times. Or There is a within group difference 
in cognitive linguistic abilities across the three testing times. 
 
3. To determine the effect of age, gender, education, CD4count on cognitive-linguistic 
functioning in both the experimental and comparison groups at baseline, four months 
and eight months on the Cognitive-Linguistic Quick Test and the interview schedule. 
Hypothesis: The four variables have an influence or effect on the cognitive- linguistic 
abilities of adults living with AIDS before and after HAART use. 
 
4. To describe the cognitive-linguistic abilities that affect performance and activities of 
daily living in the experimental, cross-sectional and control groups. 
Question: Do cognitive – linguistic abilities affect activities of daily living. 
 
 
4.3 Research Design 
The study incorporated a multiple group time series research design. The research 
design was quasi-experimental in that the participants recruited for the study were not 
obtained through true random sampling (Rosnow & Roberts, 2002). Purposive sampling was 
used in the study because the researcher had to recruit clients who were representative and 
typical of people with HIV and AIDS in South Africa. Furthermore, purposive sampling was 
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used due to time restraints and accessibility of participants. The experimental component of 
the study involved the manipulation of an independent variable (namely ARV use), pre- and 
post-testing and the use of a comparison and cross-sectional group. The dependant variable 
was the cognitive and language abilities of the participants. In addition, the time series design 
was used because the dependant variable was measured repeatedly: before HAART initiation, 
four months and eight months after HAART initiation. In this way the effects of treatment 
could be fully investigated. These time frames were chosen because they coincided with the 
times that the ARVs were dispensed to the participants.  
Cognitive and linguistic abilities are subject to the effects of time, and could be 
evolving as HIV and AIDS progresses; hence it was felt that assessing individuals over time 
would yield more realistic data on the participants’ cognitive and linguistic abilities. The 
longitudinal nature of the study allowed for each participant to serve as their own control 
which allowed the researcher to document intra-variable changes in each participant.  Since, 
the participants served as their own “controls”, there was no need for matching subjects on 
extraneous variables in the comparison and cross-sectional groups. In addition, differences in 
performance could be attributed to the use of ARVs despite differences in individual 
performance.  Furthermore, use of this design allowed for within-subject comparison which is 
said to offer greater statistical power relative to sample size (Devlin, 2006; Maxwell & 
Satake, 2006).   A comparison group was included in the study to be able to attribute any 
changes in performance in the experimental and cross-sectional groups regarding cognitive 
and linguistic abilities to the effects of the ARVs. The comparison group was included to 
reduce the confounding effects of age, gender and history such as psychosocial and medical 
diagnoses. A cross sectional group was also included to serve as a comparison reference 
group to the experimental group. 
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Even though the research design was primarily quantitative, a qualitative aspect was 
included. This was done to broaden the scope and depth of information that could be obtained 
to increase our understanding of how HIV and AIDS affects an individual’s cognitive and 
linguistic functioning. The study was quantitative in nature in that it included the use of a 
standardized test to assess the cognitive and linguistic abilities of the participants. The 
qualitative aspect of the study included the use of a structured interview schedule that 
investigated how the participant’s cognitive and linguistic abilities impacted upon their 
activities of daily living. The structured interview was included to compliment the findings of 
the Cognitive Linguistic Quick Test and so as to effectively describe the phenomena under 
investigation – the cognitive linguistic abilities of adults living with HIV and AIDS.  
 
 
 
 
 
 
 
 
 
Figure 4.1 Diagram of Research Design 
 
4.4 The Sample 
Participants were recruited from an out-patient clinic affiliated with a government 
hospital in Johannesburg, Gauteng. This hospital is a secondary level government hospital 
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under the Gauteng Province Department of Health.  The hospital is a large, urban public 
hospital housing one of the largest public sector HIV and AIDS treatment sites in South Africa. 
The out-patient clinic is a national ARV roll-out site that has been treating HIV and AIDS 
patients and dispensing ARVs for ten years. The majority of patients are referred to the clinic 
by the hospital with which it is affiliated. The patients attending the clinic have already been 
diagnosed with HIV and AIDS and are seen for general HAART or ARV drug intervention. 
The participants in the study were eligible to receive antiretrovirals from the clinic. 
4.4.1 Sampling procedure. 
A non-probability purposive sampling procedure was used to recruit potential 
participants from the out-patient clinic. Non-probability sampling was used because 
participants were selected on the basis of convenience and method of recruitment (Feild, 
Pruchno, Bewley, Lemay & Levinsky, 2006). Participants were approached as they were 
waiting in the clinic vestibule and asked whether they would be interested in participating in 
the study. These patients needed to be diagnosed as HIV-positive and be eligible for medical 
management and counselling. Participants were recruited into three groups: experimental 
(longitudinal), control (comparison) and cross-sectional. Even though the participants were not 
recruited using random measures, the sample was a representative group of the population of 
individuals with HIV and AIDS in South Africa accessing treatment from a public health site. 
They were also representative of the urban HIV population (see section 2.2) in that they were 
predominantly female, black, in their mid- to late thirties, unemployed, with some secondary 
education irrespective of gender (Rosen et al., 2008). 
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 Inclusion criteria. 
 Adult male and female HIV-positive patients with a CD4 count of < 200 cells/mm3 or 
higher, but who are symptomatic. According to the South African HIV and AIDS roll-
out policy or regulation, patients are only eligible for HAART at a CD4 count of 200 
cell/mm3 or higher but who are symptomatic. 
 Enrolled to commence HIV treatment (ARVs) at the out-patient clinic. 
 Treatment naïve, i.e. have never received HIV and AIDS treatment before. 
 Participants were required to be within the age range of 18 – 60 years. The ceiling of 60 
years was used in order to minimize the effects of age as a confounding variable. 
Individuals under 18 were not included in this study due to the different way the virus 
manifests itself in adults when compared to children (Larson, 1998; Koekkoek, 
Sonneville, Wolfs, Lichta & Geelen, 2007). Sixty years was the upper limit in age due 
to the effects of aging on cognition after 70 years. 
 Participants needed to be alert, oriented, able to provide informed consent and able to 
participate in the testing session. 
 Fluency in English was not a requirement for inclusion in the study since all 
evaluations were translated into the main vernacular languages. 
 
Exclusion criteria. 
Potential participants were excluded from the study for the following reasons: 
 If they exhibited a fever of more than 37.5⁰C, had an active psychiatric disorder, were 
alcoholics, suffered a hearing loss and/or suffered from a severe medical illness that 
would interfere with their ability to participate in the study. 
 If they were unable to provide informed consent due to limited levels of alertness. 
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 If they had or reported a history of a head injury with loss of consciousness for more 
than 30 minutes. 
 If they presented with or reported having cerebrovascular accidents, seizure disorders, 
past psychiatric history, visual defects, head injury and or pre-morbid learning 
disability as determined via demographic items. 
 
4.4.2 Demographic description of participants. 
Descriptive statistics are presented below to describe the participants recruited in this 
study. 
Experimental group. 
At baseline 110 participants were recruited and tested, but only 55 of the 110 were re-
tested at 4 months, and 51 participants were re-tested again at eight months. The 55 
participants tested at baseline who were not retested formed the baseline participants for the 
cross sectional group. The experimental group included participants who had undergone the 
necessary counselling sessions and knew they were eligible for HAART initiation. They were 
told at baseline testing that they would be followed up at four months and at eight months. 
These months coincided with their medical check-ups See Table 4.1 and Table 4.2 for a 
description of the participants. 
There was a high attrition of participants from baseline (110) to four months (55). The 
attrition occurred for a number of reasons. The participants after initial testing died, refused to 
be tested again, or were too ill to travel. In addition a number of the participants could not be 
contacted, decided not to take ARVs despite having gone through the counselling, or they had 
already gone to the clinic and refilled their prescription of ARVs. The population serviced by 
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this clinic tended to be a very migrant and some of the participants when contacted reported 
that they had moved away from the area and had decided to visit an HIV and AIDS clinic in 
the vicinity. 
 
Table 4.1 Frequencies for Gender, Race, Education, Employment and Regimen in the 
Experimental group 
    Baseline 4 months 8 months 
Group Variable N n N n N n 
Experimental Gender 55 
 
55 
 
51 
 
 
Male 
 
18(33%) 
 
18(33%) 
 
                 
17(33%) 
 
Female 
 
37(67%) 
 
37(67%) 
 
34(67%) 
        
 
Race 
      
 
Black 
 
46 (84%) 
 
      46 (84%) 
 
45(86%) 
 
Coloured 
 
9 (16%) 
 
         9 (16%) 
 
7(13%) 
        
 
Education 
      
 
Primary 
 
7(13%) 
 
7(13%) 
 
6(12%) 
 
Secondary 
 
43(78%) 
 
43(78%) 
 
39(80%) 
 
College 
 
5(9%) 
 
5(9%) 
 
4(8%) 
        
 
Employment 
      
 
Employed 
 
19(34.5%) 
 
23(42%) 
 
18(35%) 
 
Unemployed 
 
36(65.5%) 
 
32(58%) 
 
33(65%) 
        
 
Regimen 
      
 
1a 
 
0 
 
53(96%) 
 
50(98%) 
  1b   0   2(4%)   2(4%) 
 
The frequency statistics presented in Table 4.1 show that there were more male 
participants, predominantly black, with either some level of formal primary or secondary 
education and mainly jobless. The majority of the participants were on 1a HAART regimen 
that included staduvine (NRTI), lamivudine (NRTI) and efavirenz (NNRTI). 
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Table 4.2 Descriptive statistics for Age, Education and CD4 counts for the Experimental 
group. 
Group Time Variables Mean 
Std 
Dev Min Max N 
Experimental Baseline Age 37.71 8.62 23 58 55 
  
Education 9.93 2.52 2 13 55 
  
CD4 134 55.6 3 359 55 
        
 
4 months Age 38.15 8.58 23 59 55 
  
Education 9.93 2.52 2 13 55 
  
CD4 186.36 111.56 10 504 44 
 
              
 
8 months Age 38.94 8.65 25 60 51 
  
Education 9.92 2.60 2 13 51 
    CD4 190 115.20 20 600 40 
Std.Dev= standard deviation 
 “N” does not necessarily correspond with those reported in the frequency tables because not 
all participants’ files included the information e.g CD4 counts 
 
Descriptive statistics presented in Table 4.2 reveal that the average age of the 
participants in the experimental group was 37 (SD=8.62) to 39 (SD=8.65) years. The mean 
years of education for the experimental participants were nine to ten years. At baseline, mean 
CD4 count was 134 cells/mm
3 (
SD=55.6) and at eight months the mean increased to 190 
cells/mm
3   
(SD=115.2). CD4 counts are not always taken at the time of a medical check-up 
or if blood samples were drawn participants did not always return to the reception area to 
report CD4 counts; hence results were only reported at baseline and at eight months. 
Comparison group. 
These participants were recruited via the same sampling technique. This group included 
participants who for whatever reason elected not to receive ARV, but attended the clinic for 
medical monitoring on a regular basis. The comparison group was included in the study to 
make sure that any changes in the cognitive-linguistic abilities were due to the effects of the 
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ARVs. Twenty-one participants were recruited and tested at baseline, ten were re-tested at four 
months and nine were retested again at eight months. See Table 4.3 and Table 4.4 for a 
description of the participants. 
The researcher found it very difficult to recruit for this group hence the unequal sample 
size of the comparison and experimental group. Most participants despite being diagnosed as 
HIV positive had relatively high CD4 counts that did not meet the inclusion criteria. As a result 
there were not many people whom the researcher could recruit. Lastly after initial testing some 
participants became eligible to initiate ARVs because their CD4 count had dropped. Attrition 
was also high for the same reasons as the experimental group and those mentioned in the latter. 
Table 4.3 Frequencies for Gender, Race, Education, Employment and Regimen in the 
Comparison group 
    Baseline   4 months 8 months 
Group Variable N n N n N n 
Comparison Gender 21 
 
10 
 
9 
 
 
Male 
 
12(57%) 
 
4(40%) 
 
4(44%) 
 
Female 
 
9(43%) 
 
6(60%) 
 
5(56%) 
        
 
Race 
      
 
Black 
 
21(100%) 
 
10(100%) 
 
9(100%) 
        
 
Education 
      
 
Primary 
 
6(28.5%) 
 
2(20%) 
 
2(22%) 
 
Secondary 
 
12(57%) 
 
6(60%) 
 
5(56%) 
 
College 
 
2(9.5%) 
 
1(10%) 
 
1(11%) 
 
University 
 
1(5%) 
 
1(10%) 
 
1(11%) 
        
 
Employed 
      
 
Unemployed 
 
8(38%) 
 
2 
 
2(22%) 
 
Employed 
 
13(62%) 
 
8 
 
7(77%) 
        
 
Regimen 
      
 
1a 
 
0 
 
0 
 
0 
  1b   0   0   0 
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The frequency analysis (see Table 4.3) revealed that the majority of the participants 
were female, black, with some formal primary or secondary education and no formal work. 
Table 4.4 Descriptive statistics for Age, Education and CD4 counts for the Comparison 
group 
Group Time Variables Mean 
Std 
Dev Min Max N 
Comparison Baseline Age 39.48 11.47 24 60 21 
  
Education 8.38 4.70 0 14 21 
  
CD4 406.13 185.04 253 600 15 
 
              
 
4 months Age 37.00 9.19 25 54 10 
  
Education 8.40 4.87 0 14 10 
  
CD4 
   
  
 
              
 
8 months Age 37.56 9.76 25 54 9 
  
Education 8.78 5.31 0 14 9 
    CD4 265.63 137.92 100 430 8 
Std.Dev= standard deviation 
 “N” does not necessarily correspond with those reported in the frequency tables because not 
all participants’ files included the information e.g CD4 counts  
 
Descriptive statistics (see Table 4.4) revealed that the average age of the participants 
in the comparison group was 37 (SD=9.76) to 39 (SD=11.47) years. The mean years of 
education for the comparison participants were eight to nine years. At baseline, mean CD4 
count was 406 cells/mm
3
 (SD= 185.04) and at eight months the mean decreased to 265 
cells/mm
3
 (SD=137.92). CD4 counts were not always taken at the time of a medical check-up 
or if blood samples were drawn participants did not always return to the reception area to 
report CD4 counts; hence results are only reported at baseline and eight months. 
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Cross sectional group. 
A cross sectional comparison group was included in the study for several reasons: The 
attrition rate in the experimental group was high; to rule out practice effects since the time 
between testing was under six months; and to establish normative trends that could be 
compared to the experimental group in terms of the effects of HAART on cognitive-linguistic 
abilities. The participants were recruited via the same sampling technique. Furthermore, the 
frequency and descriptive stats presented by the cross sectional groups (refer to Table 4.5 and 
4.6) were comparable to those of the experimental group. Patients attending this clinic at the 
time of testing could only start ARV treatment with CD4 counts of 200cells/mm
3
 or below. 
Therefore the CD4 counts of the participants in the experimental and cross sectional were 
more or less within the same range at the scheduled medical and prescription refill 
appointment(s). Due to the aforementioned the cross sectional group was served as a 
reference comparison group. 
Fifty-five out of 110 participants who were recruited at baseline and not followed up at 
four and eight months were included as this group’s baseline. Another 43 participants were 
recruited at four months and a further 40 participants at eight months. See Table 4.5and Table 
4.6 for a description of the participants. 
 
The vertical and horizontal lines in the tables indicate three different, separate groups of 
participants recruited anew at each of the three testing time. 
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Table 4.5 Frequencies for Gender, Race, Education, Employment and Regimen in the 
Cross-sectional group 
    
Baseline  
(Group 1) 
4 months 
 (Group 2) 
8 months 
(Group 3) 
Group Variable N n N n N n 
Cross 
sectional Gender 55 
 
43 
 
39 
 
 
Male 
 
26(47%) 
 
10(23%) 
 
7(17.5%) 
 
Female 
 
29(53%) 
 
33(77%) 
 
33(82.5) 
        
 
Race 
      
 
Black 
 
54(98%) 
 
42(98%) 
 
38 (95%) 
 
Coloured 
 
0 
 
1(2%) 
 
2 (5%) 
 
White 
 
1 (2%) 
 
0 
 
0 
        
 
Education 
      
 
Primary 
 
16(29%) 
 
6(14%) 
 
8(19.5%) 
 
Secondary 
 
31(56%) 
 
27(63%) 
 
26(65%) 
 
College 
 
8(15%) 
 
10(23%) 
 
5(12.5) 
        
 
Employed 
      
 
Unemployed 
 
22(41%) 
 
10(33%) 
 
5(12.5%) 
 
Employed 
 
33(49%) 
 
33(67%) 
 
35(87.5%) 
        
 
Regimen 
      
 
1a 
 
0 
 
39(91%) 
 
36(90%) 
 
1b 
 
0 
 
2(4.5%) 
 
1(2.5%) 
  2   0   2(4.5%)   3(7.5%) 
 
The frequency statistics (see Table 4.5) showed that there were more male 
participants, predominantly black, with either some level of formal primary or secondary 
education, and mainly unemployed in the cross sectional group. The majority of the 
participants were on 1a HAART regimen that included stavudine (NRTI), lamivudine (NRTI) 
and efavirenz (NNRTI). 
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Table 4.6 Descriptive statistics for Age, Education and CD4 for the Cross-sectional 
group 
Group Time Variables mean 
Std 
Dev Min Max N 
Cross sectional 
Baseline 
(Group 1) Age 41.13 8.94 18 60 55 
  
Education 8.58 3.78 0 14 55 
  
CD4 125.76 83.51 3 392 38 
 
              
 
4 months 
(Group 2) Age 38.21 8.72 25 58 43 
  
Education 9.93 2.65 3 14 43 
  
CD4 149.20 105.19 3 570 41 
 
              
 
8 months 
(Group 3) Age 38.87 9.66 26 67 39 
  
Education 10.08 2.27 6 14 38 
    CD4 328.74 136.08 49 736 39 
Std.Dev= standard deviation 
“N” does not necessarily correspond with those reported in the frequency tables because not all 
participants’ files included the information e.g CD4 counts 
 
 
Descriptive statistics (see Table 4.6) revealed that the average age of the participants 
in the cross sectional group was 39 to 41 years. The mean years of education for the 
experimental participants were eight to ten years. At baseline, the mean CD4 count was 
125cells/mm
3
 and at eight months the mean increased to 328 cells/mm
3
.  
 The frequency and descriptive stats presented by the cross sectional groups were 
comparable to those of the experimental group. Patients attending this clinic at the time of 
testing could only start ARV treatment with CD4 counts of 200 cells/mm
3
 or below. 
Therefore the CD4 counts of the participants in the experimental and cross sectional were 
more or less within the same range at the scheduled medical and prescription refill 
appointment(s). 
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4.5 Instruments 
Research instruments included the Cognitive Linguistic Quick Test (CLQT) and a 
structured interview schedule. 
 
4.5.1 The Cognitive Linguistic Quick Test. 
The Cognitive Linguistic Quick Test (CLQT) was developed to assess the cognitive 
and linguistic functions of adults (18-89 years old) with neurological dysfunction (Helm-
Estabrooks, 2001) (see Appendix V). The CLQT enables clinicians to quickly assess the five 
domains of cognitions, namely attention, memory, executive functions, language and visual 
spatial skills.  
 Attention is crucial to a wide array of everyday tasks. Attention is multifaceted 
behaviour that includes different types of abilities such as vigilance, selection 
(sustain attention in the presence of distraction) and working memory 
(temporary storage and manipulation during information processing) (Helm-
Estabrooks, 2001). 
 Memory is a process that enables us to attend to and register new information, 
retain, process and store (learn) this information and retrieve it. 
 Executive functioning is the ability to plan, sequence, implement and 
accomplish goal-directed activities in a flexible manner. This skill is critical for 
the performance of all non-routine and independent tasks (Helm-Estabrooks, 
2001). 
 Language is a person’s ability to express thoughts and ideas and understand 
what is spoken to them. 
 154 
 
 Visual Spatial (perception) is the ability to scan, discriminate, analyse, 
recognize and interpret what is seen. 
 
The test was composed of ten tasks, which included personal facts, symbol 
cancellation, confrontational naming, clock drawing, storytelling, symbol trails, generative 
naming, design memory, mazes and design generation. The test was administered in English, 
IsiZulu and Sesotho. IsiZulu and Sesotho were chosen because of all the vernacular languages 
they are the most widely spoken and understood in Gauteng. Personal facts which had four 
items required the participant to answer questions pertaining to their date of birth, place of 
birth and address. Maximum and minimum possible scores for the participant to obtain for 
personal facts were eight and zero respectively. Symbol cancellation required the participants 
to cross out symbols that did not match the target symbol from four quadrants on the page. 
Maximum and minimum possible scores for the participant to obtain for symbol cancellation 
were 12 and zero respectively. Confrontational naming which had ten items entailed naming 
pictures. Maximum and minimum possible scores for the participant to obtain for 
confrontational naming were ten and zero respectively. Clock drawing which had 11 elements 
involved drawing a clock depicting the time participants were given. Maximum and minimum 
possible scores for the participant to obtain for clock drawing were 13 and zero respectively. 
Story retelling which was composed of 18 elements required the participants to repeat a short 
story told to them. Maximum and minimum possible scores for the participant to obtain for 
story retelling   were 18 and zero respectively. Symbol trails which had two trails and one 
scored item required the participants to draw lines that connected either circles and triangles; 
alternating circles and trials; and lastly alternating circles and triangles of increasing size. 
Maximum and minimum possible scores for the participant to obtain for symbol trails were 10 
and zero respectively. Generative naming entailed generating as many items belonging to the 
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category of animal and starting with the letter “m” under 60 seconds. Maximum and minimum 
possible scores for the participant to obtain for generative naming were nine and zero 
respectively.  Design memory which had three items involved participants matching designs to 
the target design. Maximum and minimum possible scores for the participant to obtain for 
design memory were nine and zero respectively.  Mazes included drawing lines through two 
mazes with different levels of difficulty. Maximum and minimum possible scores for the 
participant to obtain for mazes were eight and zero respectively. Design generation entailed 
generating different designs using four straight lines. Participants were provided with 13 
opportunities to generate designs. Maximum and minimum possible scores for the participant 
to obtain for design generation were thirteen and zero respectively. For a summary of 
maximum and minimum scores on these subscales refer to Table 5.8 in the results section.  
 
The validity of the CLQT was determined by test content, relation to other variables 
and internal structure.  
CLQT tasks were designed to tap specific cognitive and language skills. The tasks 
chosen had been shown by research and proven by clinical practice to tap into cognitive and 
language skills. Evidence based on test content was determined from the results of the pilot 
study. “The test was checked for evidence of construct irrelevant components and construct 
under representation by various experts including the author and others. To the degree that the 
test did not provide full construct representation or contained elements that were construct 
irrelevant (including potentially biased items), the test was modified to eliminate such 
problems.”(Helm-Estabrooks, 2001, p.126)  For example, the instruction given to the 
participants had to be modified to maximize comprehension of some the tasks. 
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To determine relationship between test scores and variables external to the CLQT 
provided another important source of validity evidence (Helm-Estabrooks, 2001). Therefore a 
correlation analysis was performed to determine the relationship between clock drawing 
severity rating and the composite severity rating of the Cognitive Linguistic Quick Test. The 
Pearson correlation coefficient was found to be 0.74 (Helm-Estabrooks, 2001). The clock 
drawing was considered to be a mini screen of cognition (Helm-Estabrooks). 
 Evidence of internal structure was compiled by performing confirmatory factor 
analysis. This was done by looking at the difference in performance between non clinical and 
clinical examinees. “Structural equation modelling was used to conduct confirmatory factor 
analysis on each of the five domain subscales. One-factor measurement models were 
constructed for each subscale and fit to the standardisation data. Absolute fit measures used to 
assess the adequacy of each model fit to data included the likelihood ratio chi-square statistic, 
the relative chi-square statistic and the Root Mean Square Error of Approximation (RMSEA).” 
(Helm-Estabrooks, 2001, p.126). Values of less than 3.00 were considered acceptable values of 
absolute fit of the model to the data. A values of less than 0.08 for the RMSEA and  greater 
than 0.09 for the Non-Normed fit Index (NNFI) were considered appropriate (Helm-
Estabrooks, 2001). The expected Cross-Validation Index (ECVI) was also derived. The 
confirmatory measurement models representing the five cognitive domains are presented in 
Appendix VI. 
To determine whether the CLQT could indicate the presence of a cognitive disorder 
between clinical and nonclinical individuals- a t-test was conducted. The results of the t-test 
procedure revealed between the matched clinical and nonclinical examinees for all 10 CLQT 
tasks and the cognitive domains (Helm-Estabrooks, 2001) refer to Appendix VI.  
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The reliability of CLQT was determined by means of test-retest correlation, standard 
error measurement (SEM) and inter-scorer agreement.  The stability or test-retest correlation 
was measured by administering the test one group of examinees on two separate occasions 
(Helm-Estabrooks, 2001). The test was administered on 46 nonclinical examinees. That is 
examinees who did not present with any brain involvement. The test –retest means and 
standard deviations, stability coefficients, standard error measurement and mean absolute score 
differences are presented in  Appendix VI.  The test-retest stability coefficients ranged between 
0.03 and 0.81 for the tasks.  The test-retest stability coefficients ranged between 0.61 and 0.90 
for the cognitive domains. The SEM ranged between 0.57 and 1.84 for the tasks.  The SEM 
ranged between 1.16 and 16.57 for the cognitive domains (Helms-Estabrooks, 2001) (refer to 
Appendix VI).  
An absolute score difference was also calculated for this test. “The results showed that 
the absolute score differences were generally small, (less than one point difference for all tasks, 
except for Symbol Trails and Design Generation), indicating high consistency of scores across 
administrations.” (Helm-Estabrooks, 2001, p.125). 
Regarding the inter-scorer agreement, only eight out of the ten tasks were objectively 
scored. The other two tasks - clock drawing and Generative Naming which required clinical 
judgement, were scored using rules that were agreed upon by the two scorers.  The overall 
correlation between two scorers for clock drawing and generative naming was 0.86 and 0 .99 
respectively. 
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4.5.2 Interview schedule. 
The semi-structured interview was included to compliment the Cognitive Linguistic 
Quick Test.  The questions used in the interview were generated from existing theory and 
research. In this case the five recognized domains of cognition (attention, executive functions, 
visual spatial, language and memory) were identified as the key concepts for initial coding 
categories. The survey questions were adapted from the Cognitive Symptom Checklist 
produced by Psychological Assessment Resources Inc. (1993). A structured interview schedule 
containing mostly closed-ended questions with an open-ended questions (refer to Appendix 
VII) was used to compliment the findings of the CLQT and explore the impact cognitive 
linguistic abilities might have on activities of daily living. Open-ended questions allowed the 
participants to expand, justify and provide their own answers to questions(Maxwell & Shitake, 
2006).The responses from the open ended questions provided more interpretation and 
discussion around activities of daily before and after HAART (Babbie & Mouton, 2001).    
Closed-ended questions served as probes to specifically explore how activities of daily 
living were being conducted under each cognitive domain (Maxwell & Shitake, 2006). Closed-
ended questions allowed for more uniformity and were easier to analyse. Interviews were 
conducted individually. The questions were asked in English, Sesotho and IsiZulu depending 
on what the participants were preferred to facilitate comprehension. 
 
The interview schedule consisted of the following two main parts: 
  Part One: Demographic information, medical and psychological 
This section was designed to include all the biographical and medical information 
pertaining to the client. Included in this section was the participant’s age to ensure that the 
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participants fell within the inclusion criteria. Address and contact information was also 
included so as to allow for ease of follow-up for post-treatment assessment. The CD4 count 
was included to document progression of the disease and also to ensure that participants fell 
within the required guidelines regarding eligibility for ARV therapy. It was considered 
important to know the participant’s medication and ART regime because some prescribed 
medications/ARV could have produced side effects that might have further exacerbated 
confusion or prevented the participant from continuing to participate in the study. All 
opportunistic infections that the participant presented with were documented so that any 
possible associations with cognitive and linguistic difficulties could be identified. 
Part Two: Reported cognitive and language problems 
Memory: This section asked questions related to whether participants experienced difficulty 
remembering everyday activities such as taking medication, turning off lights, stoves, etc., 
paying bills, and where they placed things like keys. This section included both open and 
closed ended questions. The section also asked participants what they did to remember, such as 
“Do you rely on other people?”, “Do you write things down?”, and “Do you keep all the 
information in your head?” The maximum and minimum possible scores for this section when 
closed ended responses are tallied are 13 and zero respectively. 
 
Attention: This section was divided into three aspects of attention – internal distracters, 
external distracters and sustained attention. Questions on internal distracters focused on 
eliciting information related to how internal factors such as pain, psychological and emotional 
states were affecting their ability to perform activities of daily living. Questions asked included 
– Do you experience: feeling tired (describe); headaches (describe); pain (describe); sadness, 
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tearful (describe). Questions on external distracters focused on eliciting information related to 
how external forces such as noise, voices and movement within the participant’s immediate 
environment might interfere with attending to activities of daily living. Sustained attention 
questions focused on whether individuals exhibited difficulties staying focused or interested in 
an activity for an extended period of time. Activities included listening to what doctors or 
nurses said, listening to a telephone conversation, being interested in a task for more than an 
hour. The maximum (max) and minimum (min) possible scores for this section when closed 
ended responses were tallied: 
 Attention internal distractors –zero (min) and 13(max) 
 Attention external distractors- zero (min) and three (max) 
 Sustained attention – zero (min) and five (max) 
 
Visual: This section asked questions that elicited  information on whether participants 
presented with visual problems (or not) that may have affected their ability to perform 
activities of daily living such as seeing objects in the distance or seeing spots when looking at 
something. Questions pertaining to problems with vision were included, such as burning eyes, 
painful eyes, spots when looking at something; and headaches even though it is acknowledged 
that visual spatial or visual processing is a higher order mental process. Part of processing 
visual information involves information received from the senses, namely the eye. The 
maximum and minimum possible scores for this section when closed ended responses are 
tallied are six and zero respectively. 
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Executive functions: This section asked questions related to whether participants experienced 
difficulty with adding up, making a decision, starting or completing a task, recognizing 
mistakes and correcting them. Participants were asked to solve a problem by providing two 
solutions. The maximum and minimum possible scores for this section when closed ended 
responses are tallied are eight and zero respectively. 
 
Language:  This section asked questions that included information about the participant’s 
hearing, expressive and receptive language abilities that may have been affecting their abilities 
to participate in activities of daily living. Part of processing information involves sensory 
information hence information regarding hearing was elicited even though the ability to 
process auditory information requires higher order mental processes. Hearing questions 
included: “have you ever had a hearing test?”  “Do you hear things only when they are loud?” 
Expressive language included questions such as “Do you have difficulty: talking for a long 
period; spelling words, starting a conversation and maintaining a conversation?” Receptive 
questions included: “Do you have to ask people to repeat themselves when talking?” “Do you 
have difficulty:  remembering what someone has asked you; remembering what the doctor or 
nurse said?”  The maximum and minimum possible scores for this section when closed ended 
responses were tallied: 
 Receptive language - seven (max) and zero (min). 
 Expressive language - seven (max) and zero (min). 
 
Interpersonal difficulties pertaining to cognitive and language problems: This information was 
elicited to determine what possible cognitive and language problems were impacting on the 
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participants’ abilities to interact and participate in activities. Questions included coping issues 
such as how does their diagnosis affect relationships with other people. The maximum and 
minimum possible scores for this section when closed ended responses are tallied are seven 
and zero respectively. For a summary of the participants’ maximum and minimum 
performance refer to Table 5.11.  Table 4.7 sums up the questions and variables that the 
structured interview schedule serves to investigate. 
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Table 4.7 Variables, Research Questions and Sections pertaining to the Structured Interview Schedule 
Variable Name Research question Sections on the Interview schedule 
Independent variable 
Age, CD4 count, ARVs, 
education, gender – nominal 
What independent variables affect cognition and 
language 
Items under demographic, medical  
and psychological section 
Dependant variable 
Cognitive abilities – nominal  
Open ended questions 
Do adults living with HIV and or AIDS present 
cognitive deficits and do these affect activities of  
daily living 
Items pertaining to memory attention, vision, visual 
 spatial and executive functions sections 
Dependant variable 
Language –nominal  
Open –ended questions 
Do adults living with HIV and or AIDS  present 
 language deficits and do these that affect 
 activities of daily living 
Items pertaining to hearing, expressive and  
receptive language sections 
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4.6 Procedure 
The experimental and comparison group were followed up at four-monthly intervals 
(baseline, four and eight months). These intervals were chosen because they coincided with the 
participants’ medical check-up. This was done to reduce attrition and ensure that patients 
would not incur extra costs in order to participate in the study. In other words, this study was 
conducted in three phases that included the baseline, four and eight months. In the baseline 
phase, the experimental group and comparison group were assessed using the Cognitive 
Linguistic Quick Test and were asked questions regarding their ability to perform activities of 
daily living. At baseline the participants in the experimental group had not initiated HAART. 
At four months (Phase 2) the same participants from the experimental and comparison group 
were re-assessed. The only difference was that the experimental group had now been on 
HAART for four months. For the cross-sectional group, another cohort of participants was 
recruited and tested. At eight months the experimental and comparison group were retested and 
another new cohort of participants was recruited for the cross-sectional group. 
 
Pilot study  
Prior to the commencement of the study a pilot study was conducted using the Cognitive 
Linguistic Quick Test and interview schedule. The pilot study was described in great detail in 
chapter three. 
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Experimental group testing procedures. 
Phase 1: Baseline study procedures. 
Permission was obtained from the relevant authorities to conduct the study. This 
included the superintendent of the hospital, and the director of the clinical HIV research unit at 
the clinic who oversees all research conducted at the clinic (refer to Appendix II). Once 
permission was obtained, the researchers then approached the head doctor and nurse at the 
clinic to inform them that permission had been obtained from the relevant authorities and to 
tell them about the study. The nurse in charge then proceeded to tell the researcher about when 
and how to recruit the participants for the study. 
Participants were recruited from the wellness and adherence counselling programme. 
Before patients start the ARV drugs, they have to go through a series of counselling 
programmes and one of them is the wellness and adherence programme. Patients arrive very 
early for this counselling programme which starts at 9 am. This programme is usually 
presented in a large classroom. The researcher along with the research assistants would be in 
the classroom between 7.30 am and 7.45 am and give a presentation about the purpose and 
description of the study, the basis for selection of the participants, and an explanation of the 
procedures. The patients were then invited to participate in the study. The consent form was 
explained and elaboration provided if needed. Informed consent is “the contractual obligation” 
in research. Informed consent reflects the understanding of the participants regarding what the 
study involves (Rosnow & Rosenthal, 1997). Written permission to be tested was obtained 
from the subjects with an understanding that their confidentiality would be maintained and that 
they could withdraw from the study at any time (refer to Appendix III). The patients that 
volunteered were than led out of the classroom into the quiet quadrangle area where testing 
occurred. The garden quadrangle at the clinic is very large with three long tables and benches. 
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The tables were moved far away from each other so that participants could not hear each 
other’s responses. A participant and examiner sat at each table facing each other. Three trained 
research assistants administered the test and conducted the interview.  The research assistants 
were also able to translate the questions into the vernacular, namely IsiZulu and Sesotho, to 
facilitate comprehension of the questions. (Please see Pilot study chapter 3 - on how test was 
translated section 3.2.3). The participants were also given the option of conducting the test in 
English. The participants were provided with a pen or pencil to perform the written tasks. The 
Cognitive Linguistic Quick Test took approximately 30 to 40 minutes to complete. The survey 
was conducted face to face and took approximately 25 minutes to complete.  
 
Phase 2: Four months post-baseline 
Patients who enrolled at the clinic are made aware of the fact, that the clinic is affiliated 
to a research unit (Clinical HIV Research Unit) and that any information collected will be used 
for research purposes. All patient information is collected and inputted into a database. From 
this data base the researcher was able to identify when participants were due back for their four 
month visit.  
Four months was chosen because this is the time the participants were required to come 
and refill their prescription for ARVs at the clinic. They were given a set date to come to the 
clinic. The researcher felt that it would be easier to retest the participants when they had to 
come to the clinic, rather than asking them to come to the clinic on a day that was not 
scheduled for an appointment. The research assistants would call the participants to remind 
them of the study and arrange a place to meet them at the clinic, when they came for their four 
month refill of ARVs.  Testing then proceeded as in phase 1. 
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Phase 3: 8 -10 months post-baseline 
From the data base the researcher was able to identify the scheduled dates when participants 
were due back for their eight month visit. The research assistants (RAs) would call the 
participants to remind them of the study and arrange a place to meet them in the clinic. Testing 
then proceeded as in phase 1. 
 
Comparison group testing procedures. 
Not all HIV-positive patients registered at the out-patient clinic were on ARVs for 
several reasons. Some patients elect not to go on ARVs because of the reported side effects. 
Others elect not to go on ARVs because they are asymptomatic and feel fine. However, most 
of the patients were not on ARVs because their CD4 counts were too high for initiation of 
treatment according to the WHO recommendations at the time when recruitment started. At the 
clinic there was a room devoted to patients who were not on ARVs where they came in for 
counselling and medical check-ups. In an effort to increase participant recruitment, the clerk in 
charge of the files was approached to provide information pertaining to patients who were not 
receiving ARVs. The clerk provided the researchers with the times that patients would come in 
for CD4 counts and medical check-ups. Participants were then approached while they waited 
for their medical check-ups.  Ethical and testing procedures were then adhered to as in the case 
with the experimental group. 
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Cross-sectional testing procedures 
Participants were recruited from the database at the clinic. The researcher approached the 
clerks overseeing the database to obtain information about the patients. This information 
included patient name, contact information, scheduled date for refill of ARVs at four months 
and eight months, presenting illness and treatment regimen. Once this information was 
collected, the researcher and the research assistant called patients and invited them to 
participate in the study. A date, time and place at the clinic were scheduled for the patient to 
meet with the researchers. This was done again at four and eight months using the same 
procedure as aforementioned. The only difference was that the researcher asked the database 
clerk for information pertaining to individuals who had either taking HAART for four or eight 
months.  
 
4.7 Ethical Considerations 
This research was submitted to the University of Witwatersrand University Medical 
Ethics Committee. A clearance certificate was granted on 2 March, 2007, with the protocol 
number M070201 (see Appendix I).  
Permission to conduct the study was obtained from the Head of Clinical HIV Research 
Unit affiliated with the HIV out-patient clinic (see Appendix II).  Informed and written consent 
was obtained from the participants (see Appendix III). Contribution to the transport costs was 
made to the participants at each visit. Once permission to conduct the research was granted, the 
ethical principles of confidentiality, autonomy, beneficence, non-maleficence, and justice were 
adhered to.  
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Confidentiality. 
Participants were informed that their identities would be kept confidential in that they 
would not be published or disclosed to third parties. Confidentiality was further ensured by 
coding names and keeping all response sheets and transcripts under lock and key in the 
researcher’s office. The information would also be destroyed five years after completion of the 
study. In AIDS research there is a need to balance confidentiality against the need to develop 
appropriate information. 
 
Autonomy. 
It was emphasized that participants were under no obligation to participate in the study 
and that participation was voluntary. They were informed that they could withdraw from the 
study at any stage without any negative consequences. They were also told that they were 
under no obligation to answer all the questions, and they could choose not to answer all or 
specific questions during the interview process. 
 
Beneficence and non-maleficence. 
Direct benefits or risks to the patient were seen as minimal as the information obtained was not 
going to necessarily benefit the participants but would have direct benefits for prospective 
patients at the clinic. The information being obtained had direct implications for the clinical 
management of patients and research as both these areas rely on neurocognitive data to 
generate clinical classifications of impairment (Singh et al., 2010). The only risk participants 
 170 
 
were likely to face would be to lose their place in the queue for medical consultations or 
counselling appointments. 
 
Justice. 
The participants in this study were considered a vulnerable population. They were 
considered vulnerable due to the fact that HIV and AIDS is an on-going condition that can 
adversely affect a person’s cognitive abilities and psyche. However, the exclusion criteria 
ensured that HIV-positive individuals showed adequate understanding to provide consent 
(Moser et al., 2002). Therefore, based on the fact that the majority of participants came to the 
clinic unaccompanied and used public transport, it was felt that the patients were able to 
provide informed consent. 
 
4.8 Reliability and Validity 
4.8.1 Pilot Study 
The pilot study was conducted to identify any potential problems with data collection 
and to demonstrate that the design was appropriate and feasible. The Cognitive Linguistic 
Quick Test and the structured interview schedule were pre-tested on a small sample of 
participants with similar characteristics to the target sample. The procedure and results were 
discussed in chapter 3. It was important that the interview schedule be piloted to make sure that 
items measured what they were supposed to, i.e. exhibited face validity (Babbie & Mouton, 
2001).   
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The CLQT was developed to assess the cognitive and linguistic functions of adults (18-
89 years old) with suspected neurological dysfunction as a result of strokes, traumatic brain 
injury or dementia. (Helm-Estabrooks, 2001).  This test has been used in previous studies to 
determine the cognitive abilities of individuals with Parkinson’s disease (Parashos, Johnson, 
Erickson-Davies & Wielinski, 2009) and high level cognition-based communication disorders 
in mild traumatic brain injury (Blyth, Bond, Scott & Farquhar, 2010).  Due to the fact that the 
CLQT had not been used on a South African population with suspected neurological 
dysfunction, a pilot study was conducted. The pilot study determined that the CLQT could be 
used on a South African population living with HIV and AIDS. 
Further reliability for the open-ended questions of the interview schedule was 
determined by asking another independent rater, a qualified speech language pathologist, to 
analyse 25% of the interview schedules to make sure the same themes were identified as those 
identified by the researcher were identified by the rater, thereby ensuring inter-rater reliability. 
An agreement of 97% was achieved, ensuring inter-rater reliability. Based on this finding from 
the pilot study the interview schedule was used in this study. 
 
4.8.2 Cognitive Linguistic Quick Test 
Intercorrelations of the cognitive domains scores for both the CLQT and the interview 
schedule were done and are shown in Table 5.4. All five of the cognitive domains on the 
CLQT significantly correlated with each other, ranging from r=0.3 to r=0.87. On the Interview 
schedule most of the domains are significantly correlating except for executive function with 
memory, visual spatial and attention. The strongest correlation was executive function with 
language explaining greater than 50% of the variability (r=0.87, r
2
=0.87
2
= 76% of the 
variability). However there were few weak significant correlations (e.g visual spatial [CLQT] 
with executive functions [IS] r=.22, r
2
 = 0.22
2
 = 0.05% of variability). Therefore domains from 
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each instrument were independent, demonstrating divergent validity. That is even though both 
tests were looking at the same phenomena-cognitive linguistic abilities, they basically were 
testing different aspects - one was looking at impairments and the other activities of daily 
living as purported in the ICF model of disability.  
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  Executive 
Functions 
(IS) 
Memory 
(IS) 
Visual 
Spatial 
(IS) 
Language 
(IS) 
Attention 
(IS) 
Executive
Functions
(CLQT) 
Memory 
(CLQT) 
Visual 
Spatial 
(CLQT) 
Language 
(CLQT) 
Attention 
(CLQT) 
Exec.  Funct 
(IS) 
1.00          
           
Memory (IS) 0.43***          
Vis. Spatial 
(IS) 
-0.02 0.22***         
Language (IS) 0.75*** 0.49*** -0.13*        
Attention (IS) 0.73*** 0.49*** -0.12* 0.89***       
Exec. Funct 
(CLQT) 
0.17** 0.03 0.09 0.15** 0.1      
Memory 
(CLQT) 
0.09 0.08 0.1 0.05 0 0.39***     
Vis. Spatial 
(CLQT) 
0.22*** 0.07 0.12* 0.12* 0.07 0.74*** 0.45***    
Language 
(CLQT) 
0.06 0.03 0.03 0.08 0.04 0.42*** 0.70*** 0.30***   
Attention 
(CLQT) 
0.21*** 0.07 0.08 0.15* 0.1 0.62*** 0.39*** 0.87*** 0.35*** 1.00 
p = < .05* p= <.01 ** p= <.001 ***     
    
 
Table 4.8 Correlations of the Cognitive Domain scores for the CLQT and Structured Interview Schedule 
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The reliability of the Cognitive Linguistic Quick Test and the interview schedule were 
established to determine internal consistency using the Chronbach Alpha. According to 
Spiliotoulou (2009) internal consistency refers “to whether participants are responding to the 
different items of a questionnaire in a consistent manner in a single trial” (pp.3). The most 
widely accepted indicator of internal consistency is the Chronbach alpha.   
The reliability of the measures used in this study was established to determine the 
degree to which the items of the CLQT and interview schedule examined the same construct 
(de Vos, Strydom, Fouché & Delport, 2005).  The internal consistency of the Cognitive 
Linguistic Quick Test (CLQT) and the interview schedule (IS) was calculated by looking at 
each group at the different time periods and by combining the responses from the participants 
in the experimental, cross-sectional and control group together. It was important to explore 
the internal consistency of both measures since both tests had not been standardized on a 
South African cohort. The reliability coefficients are presented in Table 4.9 according to the 
instruments used in this study.  
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Table 4.9 Internal Consistency Reliability Coefficients for the CLQT and IS according 
to Group Performance at Baseline, Four and Eight months. 
Group Instrument Base 4 months 8 months 
Experimental CLQT 0.8 0.74 0.76 
 
IS 0.96 0.94 0.9 
Comparison CLQT 0.84 0.91 0.88 
 
IS 0.72 0.79 0.55 
Cross-sectional             CLQT 0.69 0.82 0.74 
  IS 0.94 0.84 0.68 
  
From Table 4.9 one can see that the groups appear to be responding differently 
according to the instrument. The experimental and cross-sectional groups are responding in a 
similar manner which is different from comparison group. Conventionally, reliability estimates 
of 0.70 are acceptable (Huck, 2008). According to (Spiliotoulou, 2009), it is not unusual for 
tests in the therapy disciplines to exhibit Cronbach’s alphas that are lower than 0.7 as seen with 
values of 0.55, 0.68 and 0.69. The low values could have been due to several factors. A few of 
the subsections on the CLQT and interview schedule had few items assigned to them. In 
addition, sample size has been noted to affect internal consistency, for example the n=9 at 
baseline for the comparison group (Cortina, 1993; Spiliotoulou, 2009). Based on the latter, the 
reliability estimates presented in Table 4.10 were deemed acceptable for this study. 
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Table 4.10 Internal Consistency Reliability Coefficients for the CLQT and IS according 
to group performance 
Instrument Experimental N=161 Comparison N=40 Cross-sectional N=138 
CLQT 0.78 0.88 0.80   
IS 0.95 0.74 0.93 
  
The results in Table 4.10 revealed that the experimental and cross-sectional groups 
responded in a similar manner. All the reliability estimates were above 0.70, which was 
deemed acceptable for this study (Huck, 2008).  
 
4.8.2 Interview Schedule 
Validity was further established through trustworthiness.  Trustworthiness was 
determined through the process of triangulation, peer debriefing and the use of direct quotes. 
Triangulation refers to the use of both quantitative and qualitative methods that form a 
persuasive conclusion and enhance concurrent validity (Wilkins & Woodgate, 2008). The two 
approaches used in this research included a standardized test (CLQT) and an interview 
schedule.  Peer debriefing was also used which “is the process of exposing oneself to a 
disinterested peer in a manner paralleling an analytical session and for the purpose of exploring 
aspects of inquiry that might otherwise remain implicit within the inquirer’s mind” (Cohen & 
Crabtree, 2008, p. 4). This was done to reduce the effects of reactivity and bias (Leitz, Carol, 
Langer & Furman, 2006). In an attempt to remain true to the participants’ perspective, direct 
quotes were used to reduce bias from the researcher. 
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In qualitative research generalization is referred to as transferability. Transferability is 
said to occur when findings from one setting can be transferred to similar situations or 
participants (Holloway & Fulbrook, 2001). From a qualitative perspective, transferability is 
primarily the responsibility of the individual doing the generalizing. To ensure transferability 
of the findings, the researcher described in detail where the research took place, 
instrumentation, as well as the ethical and research procedures that were employed to conduct 
the research. Furthermore, the researcher made her assumptions implicitly and explicitly 
known such as that HAART would improve the cognitive-linguistic abilities of individuals 
living with HIV and AIDS and participants would exhibit cognitive-linguistic deficits due to 
disruptions of the fronto-striatal circuitry (Holloway & Fulbrook, 2001).  
As pertaining to the pilot study, reliability for the open-ended questions of the 
interview schedule was determined by asking another independent rater, a qualified speech 
language pathologist, to analyse 25% of the interview schedules to make sure the same 
themes were identified as those identified by the researcher were identified by the rater, 
thereby ensuring inter-rater reliability. An agreement of 97% was achieved, ensuring inter-
rater reliability. 
 
4.9 Power Analysis 
An apriori power analysis was conducted holding α at 0.05 and β at 0.80. For the repeated 
measures ANOVA testing differences (using the ratio one in theexperimental and one in the 
comparison group), a minimal sample size of 28 would be required to detect medium effect 
sizes (0.25). This suggests that the current sample size was adequate to test the research 
hypotheses (given a sample of over 50 across the three testing periods).  
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4.10 Data Analysis 
4.10.1 Preliminary Analysis 
Preliminary analysis was conducted to determine the reliability, validity and 
intercorrelations, of the instruments. In addition descriptive statistics were also done to identify 
any trends that could emerge from form the instruments. 
The reliability of the CLQT and interview schedule were assessed using the 
Cronbach’s alpha to determine internal consistency. The validity of the two instruments was 
checked by determining the construct validity through exploratory factor analysis. All 
reliability and validity procedures and statistics are reported in the results chapter. 
Intercorrelations were conducted between the dependant variables (cognitive domains) on the 
CLQT and interview schedule. Overall there were significant correlations observed with the 
five cognitive domains in each instrument and between each instrument. 
Descriptive statistics were used to summarize and reveal patterns that emerged 
(Bordens and Abbott, 2011) from the performance of the participants in the experimental, 
cross-sectional and control group on the Cognitive Linguistic Quick Test (CLQT) and the 
interview schedule. The raw scores on the CLQT were tallied for each task and cognitive 
domain. The composite score for each cognitive domain was determined to provide an overall 
severity rating of the individual’s performance at the three times of testing. The severity 
ratings for all the cognitive domains were determined by matching the participants’ 
composite score with the ranges of severity as shown on the CLQT (see Appendix V).   
Severity ratings are important in terms of clinical performance in the profession of 
speech language pathology. Hence severity ratings were computed for this study. For the 
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interview schedule all the responses for closed-ended questions were tallied to obtain the raw 
scores for each subtest and cognitive domain. The measure of central tendency (mean) and 
spread of variance (standard deviations) were calculated for the individual tasks and cognitive 
domains on the CLQT and interview schedule across all three groups at baseline, four and 
eight months. The median was also calculated for the cognitive domains. The severity ratings 
for all the cognitive domains were also determined by matching the participants’ cognitive 
domain score with the ranges of severity as shown on the CLQT (see Appendix V).   
 
4.10.1 Main analysis 
Inferential statistics allowed for the inferences to be made from a sample recruited for 
this study drawn from the population of urban South African individuals living with HIV and 
AIDS (Bordens & Abbott, 2011).  Inferential statistics were done on both the CLQT and the 
interview schedule. Even though the interview schedule brought a qualitative flavor to the 
design, it was able to provide quatitive information from the closed ended questions when 
responses were tallied up and raw scores obtained. Before the main analysis could be done 
parametric assumptions were tested for the all the inferential statistics used. 
A Kruskal – Wallis test to determine whether a difference in cognitive-linguistic ability 
existed between the three groups  at baseline, four months and eight months. Post hoc analysis 
included a pairwise test. To analyse whether there was a significant difference in cognitive-
linguistic abilities within  the participants (time effect) for the experimental and comparison 
groups, a one-way repeated measures analysis of variance (RM- ANOVA) was used. Post 
testing included a paired – test for repeated measures to determine where significant 
differences lay between within subjects in a group at a particular time. To determine whether 
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age, education, CD4 counts and gender had an (within and between subject) effect on the 
cognitive-linguistic functioning in both the experimental and comparison groups at the three 
testing periods a repeated measures Analysis of Covariance (ANCOVA) was used. Three co-
variance structures were run with three goodness of fit statistics. The co-variance structures or 
models included Compound symmetry, Huynh-Feldt and Autoregressive (1). The three 
goodness of fit statistics used included the Akaiake information criteria (AIC), Corrected 
Akaiake information criteria (AICC) and Bayesian information criteria (BIC).  
The data collected from the structured interview schedule was analysed both 
quantitatively and qualitatively.  Content analysis was used to address the fourth aim which 
set out to investigate whether cognitive linguistic abilities affect the performance of activities 
of daily living. To address this aim, the closed- and open-ended questions were thus analysed 
by means of quantitative and qualitative content analysis. Categories were predetermined 
based upon prior research and theory. The transcripts were coded within the predetermined 
themes. These codes were then used to determine the frequency of responses to the themes 
(categories) and sub-themes. Any text that could not be categorized under the sub-themes was 
given a code of “other” (Hsieh & Shannon, 2005). Table 4.11 summarizes the aims, 
hypothesis variables and assumptions under investigation in this study. 
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Table 4.11 Aims, Variables, Analysis and Assumptions addressed in this Research 
Aims Variables and properties Analysis and assumptions 
1. To determine whether there is 
a significant difference in 
cognitive-linguistic abilities 
between the experimental, 
comparison and cross-
sectional groups on the 
Cognitive Linguistic Quick 
Test and the interview 
schedule. 
 
Hypothesis: There are  
significant differences in 
cognitive linguistic 
performance between the 
groups 
 
-Independent variables Experimental group, Comparison 
group and Cross sectional 
 
-Dependant and interval variables at each testing period: 
Attention, Memory, Executive function, Language, 
Visual spatial 
Kruskal – Wallis was used to determine 
between group differenced 
 
Post hoc analysis included Pair-wise 
testing 
2. To determine whether there 
will be a significant 
difference in cognitive-
linguistic abilities within the 
participants (time effect) for 
the experimental and 
comparison groups on the 
Cognitive Linguistic Quick 
Test and the interview 
schedule. 
 
Hypothesis: There are 
-Independent variables: Experimental group and 
Comparison group  
 
Dependant and interval variable: 
Attention 
Memory 
Executive function 
Language 
Visual spatial 
One way Repeated Measures:  Anova 
 
Tested for Assumption of Sphericity 
and the other assumptions were verified 
from the previous analysis. 
 
For within group analysis the repeated 
measures analysis of variance was used 
 
Post hoc analysis included paired t-test 
to determine the significance between 
two related samples. 
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significant within group 
differences in cognitive 
linguistic performance across 
the three testing times. 
3. To determine the effect of 
age, gender, education and 
CD4 count on cognitive-
linguistic functioning in both 
the experimental and 
comparison groups at 
baseline, four months and 
eight months on the 
Cognitive-Linguistic Quick 
Test and the interview 
schedule. 
 
Hypothesis:  The variables of 
age, gender, education and 
CD4 count have a significant 
effect on cognitive –linguistic 
abilities. 
Independent  variables: 
Age,  education, CD4 count – continuous 
Gender - categorical 
 
Dependant variables 
Time and group 
 
Covariances 
Attention 
Memory 
Executive function 
Language 
Visual spatial 
 
 
ANCOVA 
 Assumption of sphericity and the other 
assumptions were verified from the 
previous analysis, coupled with 
residual analysis of model fit. The 
structure of the temporal random 
effects was modelled using three 
different approaches and the model 
goodness of fit was used to select the 
best fitting model. 
 
4. To describe the cognitive-
linguistic abilities that affect 
performance and activities of 
daily living in the 
experimental, cross-sectional 
and control groups. 
 
Question: Do cognitive – 
linguistic abilities affect 
activities of daily living. 
Independent variables:  
Testing periods 
Groups 
 
Dependant variable: 
Attention 
Memory 
Executive Function 
Language 
Visual Spatial 
Quantitative and qualitative Content 
Analysis: 
Pre - determined Categories: 
Attention 
Memory 
Executive Function 
Language 
Visual Spatial 
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In summary the study examined the effect of HAART on the cognitive – linguistic 
abilities of individuals living with HIV and AIDS. The research design predominately was 
quantitative in nature except for the open ended questions included in the structured interview 
schedule which provided a minor qualitative flavour to the study. The responses from the 
structured interview were meant to compliment the findings obtained from the CLQT. Three 
groups of participants were recruited to participant in this research – experimental, 
comparison and cross sectional comparison group. A cross sectional comparison group was 
recruited because of the high attrition rate observed after baseline testing and the low 
numbers of participants in the comparison group. The comparison group consisted of 
individuals who were HIV positive and had also elected not to take HAART.  The two 
measures administered in the study were described in this chapter and rationales for both their 
inclusion were indicated in the literature review section 2.7.3.1. The results from the pilot 
study facilitated the use of the Cognitive Linguistic Quick Test and the structured interview 
schedule in the main study. The pilot study highlighted the possible challenges to the main 
study. The pilot study allowed the researcher to find a more efficient way of recruiting 
participants. It also showed that the Cognitive Linguistic Quick Test could be used on a South 
African population, and be translated into the vernacular without losing face validity. The 
pilot study also permitted the researcher to slightly adjust the questions in the interview 
schedule and thereby reduce redundancy. In addition, ethical procedures, reliability and 
validity were taken into consideration so that the results from this research could be 
replicated. Lastly the data were analysed using both descriptive and inferential techniques.  
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Chapter 5: Results 
5.1  Introduction 
The primary aim of the study was to investigate the effects of HAART on the 
cognitive-linguistic abilities of adults living with HIV and AIDS before and after HAART 
initiation. A predominantly quantitative approach embedded with an interview schedule in 
order to obtain a broader understanding of the effects of HAART on the cognitive-linguistic 
abilities of adults living with HIV and AIDS.  The study was both longitudinal and cross-
sectional to determine the effects of HAART and also to establish preliminary trends in the 
description of cognitive-linguistic abilities in adults living with HIV and AIDS. Furthermore, 
the study also investigated how cognitive-linguistic abilities impact upon the ability to perform 
activities of daily living. 
 
5.2  Preliminary Analysis 
5.2.1 Parametric assumptions. 
At each of the testing time points the participants were believed not to have violated the 
assumption of iid (independently and identically distributed) assumption. It was also assumed 
the participants recruited for the experimental, comparison group and cross-sectional were 
independent samples. In addition it was also assumed that the participants’ data observed over 
time correlated (not independent) except those for the cross-sectional group which was 
comprised of different participants at each testing period. 
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Normal distribution 
The following assumption was tested - that the scores for the cognitive domains would 
be normally distributed. Normal distribution was investigated with reference to skewness, the 
Kolmogorov-Smirnov test, the Shapiro - Wilks and histograms (refer to Appendix VII). When 
the skewness values fell between +1 and -1 they were considered to be normally distributed 
(Fife-Schaw, 2010). Values of p > 0.05 on the Kolmogorov-Smirnov test and the Shapiro – 
Wilks were considered to be normally distributed, and these values ultimately determined 
whether the domain(s) was normally distributed since they are more sensitive.  
 
Cognitive Linguistic Quick Test (CLQT) 
The data was assessed for normality of distribution for each group at baseline, four 
months and eight months. 
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Table 5.1 Tests of Normality for the CLQT for the Experimental, Comparison and Cross Sectional Groups 
   
    Baseline 
  
 4 months  8 months 
Group Domains Skewness 
Kolm. 
Smir 
Shapiro-
Wilks Skewness 
Kolm. 
Smir 
Shapiro-
Wilks Skewness 
Kolm. 
Smir 
Shapiro-
Wilks 
Experimental Attention -0.77 0.02* 0.00* -1.43 <0.01** <0.01** -1.37 <0.01** <0.01** 
 
Memory 0.01 0.14 0.07 0.55 >0.15 0.19 -0.02 >0.15 0.13 
 
Exec. Functions -0.13 >0.15 0.22 -0.37 0.03* 0.05 -0.31 0.07 0.23 
 
Language 0.14 0.13 0.47 0.13 >0.15 0.42 0.16 >0.15 0.43 
  Visual Spatial -0.18 >0.15 0.09 -0.75 >0.15 0.01* -0.87 <0.01** 0.00** 
Comparison Attention -0.45 0.05 0.07 -1.19 >0.15 0.25 -0.76 >0.15 0.26 
 
Memory -0.47 0.07 0.2 0.69 >0.15 0.49 -1.32 >0.15 0.26 
 
Exec. Functions -0.15 >0.15 0.31 -0.66 >0.15 0.73 -0.19 >0.15 0.47 
 
Language  -0.13 >0.15 0.82 0.36 >0.15 0.66 -0.77 >0.15 0.81 
  Visual Spatial -0.63 >0.15 0.28 -1.48 <0.01** 0.05 -0.93 0.14 0.09 
Cross 
sectional Attention -1.29 <0.01** <0.01** -1.76 <0.01** <0.01** -2.90 <0.01** <0.01** 
 
Memory -0.96 <0.01** <0.01* -0.17 >0.15 0.62 -0.42 >0.15 0.07 
 
Exec. Functions -0.27 >0.15 0.67 3.09 <0.01** <0.01** -1.03 <0.01** 0.01* 
 
Language  -0.28 <0.01** 0.06 -0.36 <0.01** 0.05 -0.58 0.05 0.26 
  Visual Spatial -0.67 0.02* 0.03* -1.25 <0.01** 0.00** -1.60 0.02* <0.01** 
Kolm. Smir = Kolmogorov-Smirnov test, p<.05*. p<.01.** 
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Tests of normality data (Table 5.4) revealed that all the cognitive domains for the 
experimental group were normally distributed except for attention at baseline, and attention 
and executive function at four months. At eight months all were normally distributed except 
for language and visual spatial. For the comparison group, all the domains were normally 
distributed for all the testing periods except for visual spatial at four months.  Results for the 
cross-sectional group revealed that the executive function to be normally distributed at 
baseline, language and memory were normally distributed at four and eight months.  
 
Interview Schedule (IS). 
The data was assessed for normality of distribution for each group at baseline, four months and 
eight months. 
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Table 5.2 Tests of Normality for the IS for the Experimental, Comparison and Cross Sectional Group 
   
    
Baseline 
 
 4 months 
 
8 months 
Group Domains Skewness 
Kolm. 
Smir 
Shapiro-
Wilks Skewness 
Kolm. 
Smir 
Shapiro-
Wilks Skewness 
Kolm. 
Smir 
Shapiro-
Wilks 
Experimental Attention -1.42 <0.01** <0.01** -2.30 <0.01** <0.01** -2.33 <0.01** <0.01** 
 
Memory -0.92 <0.01** 0.00** -1.45 <0.01** <0.01** -1.55 <0.01** <0.01** 
 
Exec. 
Functions -1.69 <0.01** <0.01** -1.82 <0.01** <0.01** -2.14 <0.01** <0.01** 
 
Language -1.78 <0.01** <0.01** -1.63 <0.01** <0.01** -1.77 <0.01** <0.01** 
  
Visual 
Spatial -1.39 <0.01** <0.01** -2.20 <0.01** <0.01** -1.08 <0.01** <0.01** 
Comparison Attention 0.18 >0.15 0.1 0.47 >0.15 0.72 -0.96 0.05 0.1 
 
Memory -1.49 <0.01** <0.01** -1.52 <0.01** 0.00** -1.92 <0.01** 0.00** 
 
Exec. 
Functions -1.46 <0.01** <0.01** -1.18 <0.01** 0.00** -1.01 <0.01** 0.00** 
 
Lanaguage -2.34 <0.01** <0.01** -1.16 0.03* 0.01* -2.11 0.04* 0.00** 
  
Visual 
Spatial -2.83 <0.01** <0.01** -0.86 0.02* 0.02* -1.19 <0.01** 0.00** 
Cross 
sectional Attention -0.67 <0.01** 0.02* -1.15 0.01* 0.00 -0.88 <0.01** 0.00** 
 
Memory -2.12 <0.01** <0.01** -3.14 <0.01** <0.01** -1.56 <0.01** <0.01** 
 
Exec. 
Functions -0.60 <0.01** <0.01** -2.47 <0.01** <0.01** -4.24 <0.01** <0.01** 
 
Lanaguage -1.08 <0.01** <0.01** -1.71 <0.01** <0.01** -1.27 <0.01** <0.01** 
  
Visual 
Spatial -1.04 <0.01** <0.01** -3.00 <0.01** <0.01** -2.30 <0.01** <0.01** 
Kolm. Smir = Kolmogorov-Smirnov test              p<.05* , **p<.01**. 
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The statistical analysis shown in Table 5.5 revealed attention to be the only normally 
distributed domain for the comparison group.  All other domains were not normally distributed 
for the cognitive domains across all the groups at the three different testing periods. This could 
have been due to the number of items per subtest of the schedule. 
 
Homogeneity of Variance (between groups). 
The Levene’s test of homogeneity was conducted to verify the assumption of 
homogeneity of variance. The assumption was met when Levene’s test yielded a p-value of  
>0.05. 
 
Cognitive Linguistic Quick Test 
Based on the the results depicted in Table 5.3  the assumption of homogeneity of 
variance was met for all the domains except for executive functions and language at baseline. 
At four months the assumption of homogeneity of variance was met for all the domains except 
for the language and visual spatial. At eight months the assumtion of homogeneity was met for 
the domains memory and language. The null hypthesis stating that there was homogenous 
variance in the data failed to be rejected, based  on p-values greater than 0.05. Therefore the 
results were intepretated using the parametric statistics. Higlighted and bolded areas are 
significant 
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Table 5.3 Levene’s Test of homogeneity for the experimental, comparison and cross 
sectional group on the CLQT 
Cognitive domains Baseline Four Months Eight Months 
Attention 0.06 0.24 0.71 
Memory 0.09 0.16 0.04 
Executive Functions 0.05 0.36 0.24 
Language <.0001 <.0001 <.0001 
Visual Spatial 0.93 0.05 0.22 
Levene’s  p = >0.05 
 
Interview Schedule 
The results shown in Table 5.4 revealed that the assumption of homogeneity of 
variance was met for all the domains except for executive functions at baseline. At four months 
the assumption of homogeneity of variance was met for all the domains except for the 
language and visual spatial. At eight months the assumtion of homogeneity was met for the 
domains attention, executive function and visual spatial. The null hypthesis stating that there 
was homogenous variance in the data failed to be rejected based upon most of the domains 
exhibiting significant Levene’s values. Therefore the results were intepretated using the 
parametric statistics.  
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Table 5.4 Levene’s Test of Homogeneity for the Experimental, Comparison and Cross 
sectional group on the Interview Schedule 
Cognitive domains Baseline Four Months Eight Months 
Attention 0.08 0.19 0.77 
Memory 0.09 0.34 0.07 
Executive Functions 0.00 0.72 0.64 
Language 0.06 0.52 0.08 
Visual Spatial 0.18 0.03 0.30 
 
 5.2.2 Descriptive Statistics 
 
Overview of scores obtained on the Cognitive Linguistic Quick Test (CLQT) 
Table 5.5 reflects the means, standard deviations and range of scores obtained by the 
three groups of participants. The participants in the three groups were noted to have the most 
difficulties with the tasks of story retelling, phonemic categorization, symbol trails and design 
generation. 
Table 5.6 reflects an overview of the means, medians, standard deviations and range 
of cognitive scores obtained by the three groups of participants. 
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Table 5.5 Means, Standard Deviations and Range of Scores obtained by each Group on the CLQT Tasks 
 
  Max. Possible        
Tasks  score Mean STD Range Mean STD Range Mean STD Range 
Experimental 
 
Baseline (N=55)   4 months (N=55)   8 months (N= 51) 
 Personal Facts 8 7.91 0.35 6-8 7.96 0.27 6-8 8.00 0.00 8-8 
Symbol Cancellation 12 9.18 4.30 0-12 10.25 3.24 0-12 10.69 2.53 2-12 
Confrontational Naming 10 9.57 0.87 6-10 9.85 0.45 8-10 9.75 1.06 3-10 
Story Trails 10 5.87 3.50 0-10 7.07 3.30 0-10 7.22 3.26 0-10 
Symbol Retelling 10 6.95 2.11 2-10 7.29 1.89 4-10 7.76 1.85 4-10 
Generative Naming 9 4.49 1.56 2-9 4.82 1.39 3-9 4.86 1.36 2-9 
Design Memory 6 4.58 1.03 2-6 4.85 1.15 2-6 5.14 0.98 3-6 
Mazes 8 4.35 2.97 2-8 5.80 2.26 0-8 6.02 2.08 1-8 
Design Generation 13 4.27 2.26 0-8 5.05 1.76 1-9 4.98 1.73 1-10 
                      
Comparison 
 
Baseline (n=21)   4 months (n=10)   8 months (n= 9) 
 Personal Facts 8 7.95 0.22 8-8 7.50 1.27 4-8 8.00 0.00 8-8 
Symbol Cancellation 12 10.24 2.96 0-12 11.70 0.95 9-12 12.00 0.67 12-12 
Confrontational Naming 10 9.48 1.08 6-10 9.60 0.97 7-10 9.78 1.66 8-10 
Story Trails 10 7.24 2.17 5-10 7.70 2.11 3-10 8.67 2.85 6-10 
Symbol Retelling 10 5.81 3.30 2-10 6.80 3.71 0-10 7.89 1.69 3-10 
Generative Naming 9 4.19 1.47 2-7 4.90 2.13 2-9 4.89 1.01 3-8 
Design Memory 6 4.86 1.20 2-6 5.00 1.41 2-6 5.44 1.73 3-6 
Mazes 8 5.43 2.38 0-8 5.90 3.35 0-8 7.00 2.29 4-8 
Design Generation 13 4.24 2.59 2-10 4.30 2.26 0-8 6.33 57.13 3-11 
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Cross sectional 
 
Baseline (n=55)   4 months (n=43) 
 
8 months (n= 39) 
 Personal Facts 8 7.48 1.08 4-8 7.81 0.85 0-8 7.79 1.28 0-8 
Symbol Cancellation 12 9.41 4.34 0-12 10.05 3.75 0-12 10.56 3.45 0-12 
Confrontational Naming 10 9.59 0.64 8-10 9.72 0.59 8-10 9.44 1.65 0-10 
Story Trails 10 5.62 3.29 0-10 8.26 1.63 4-10 7.15 2.25 0-10 
Symbol Retelling 10 6.20 2.47 0-10 7.98 3.04 0-10 7.33 3.34 0-10 
Generative Naming 9 4.11 1.36 1-8 5.05 1.48 2-8 4.87 1.72 0-9 
Design Memory 6 4.77 1.13 2-6 4.44 1.20 1-6 4.67 1.28 0-6 
Mazes 8 4.95 2.83 0-8 5.60 2.53 0-8 5.79 2.09 0-8 
Design Generation 13 4.00 2.30 0-9 5.26 2.40 0-10 5.44 2.20 0-10 
Note: Minimum possible score on all tasks was zero
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Table 5. 6 Means, Standard Deviations, Median and Range of Domain Scores obtained by each Group on the CLQT   
 
 
Max. Possible Baseline (N=55) 
  
4 months (N=55) 
  
8 months (N= 51) 
  
Cognitive Domains  score Mean Median STD Range Mean Median STD Range Mean Median STD Range 
Experimental   Baseline (n=55) 4 months (n=55) 8 months (n= 51) 
Attention 215 144 154 47 32-209 166 175 38 59-209 173 178 34 74-210 
Memory 185 148 145 19 112-183 154 154 18 120-213 158 162 16 127-185 
Executive Function 40 19 19 7 3-31 23 42 7 7-34 23 24 6 8-34 
Language 37 29 29 3 20-36 30 29 3 24-36 30 30 3 25-37 
Visuospatial 105 66 66 19 29-99 76 77 17 31-99 80 85 16 35-100 
Comparison 
 
Baseline (n=21) 4 months (n=10) 8 months (n= 9) 
Attention 215 161 171 37 36-205 183 185 24 130-210 193 198 17 164-213 
Memory 185 147 156 22 114-183 158 164 19 123-185 166 171 19 125-189 
Executive Function 40 20 21 8 11-32 24 25 7 4-35 26 27 6 17-34 
Language 37 29 29 3 25-35 30 31 4 23-37 32 32 3 25-36 
Visuospatial 105 73 75 20 25-92 83 89 19 38-100 87 88 14 64-103 
Cross sectional   Baseline (n=55) 4 months (n=43) 8 months (n= 39) 
Attention 215 148 169 50 10-202 175 185 71 26-211 177 186 32 20-207 
Memory 185 140 145 25 80-181 155 159 20 116-197 154 157 18 113-178 
Executive Function 40 19 19 6 3-32 28 25 25 8-78 24 26 6 8-33 
Language 37 28 28 4 18-37 31 31 3 25-36 30 31 3 22-37 
Visuospatial 105 67 72 20  12-96 74 80 22 16-107 79 81 19  12-96 
Note: Minimum possible score for all cognitive domains was zero
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Severity Ratings on the CLQT 
Even though the CLQT was shown to demonstrate appropriate reliability and validity 
for this study (see preliminary statistics section) it was with caution that these severity ratings 
were applied to this South African cohort since this test has not been standardised on a large 
HIV and AIDS population.  Severity ratings have important clinical application in the 
profession of speech language pathology. Severity ratings are presented in Table 5.7 
The severity ratings presented in Table 5.7 reveal that the worst severity rating was 
initially recorded at baseline for the executive functions for all the three groups. The 
participants generally exhibited difficulty with symbol trails, mazes and design generation - 
tasks that are heavily reliant on executive function, attention and visual spatial skills. The 
least affected cognitive-linguistic ability was language for all the groups. The participants did 
not demonstrate any difficulty in naming pictures of objects, and relaying personal facts. 
However, they did demonstrate mild difficulties with story retelling and verbal fluency that 
entailed phonemic categorization.  Overall, at base line participants in all groups presented 
with global cognitive impairments ranging from severe to mild that either stayed the same or 
changed from four and eight months after taking HAART. 
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 Table 5.7 Severity Rating of Cognitive Linguistic Abilities on the CQLT at Baseline, Four and Eight months 
for all Three Groups 
 
 
      
Group Cognitive Domains 
Max. 
Possible 
Score Mean Severity Mean Severity Mean Severity 
   Baseline (n=55) 4 Months (n=55) 8 Months (n=51) 
Experimental Attention 215 143.67 Mild 166.02 Mild 173.08 Mild 
 
Memory 185 148.02 Mild 154.09 Mild 158.37 WNL 
 
Executive Functions 40 18.71 Mod 22.80 Mild 23.39 Mild 
 
Language 37 28.76 Mild 29.60 WNL 30.41 WNL 
 
Visual Spatial 105 65.89 Mild 76.29 Mild 80.22 Mild 
  
 
           Baseline (n=21) 4 Months (n=10) 8 Months (n=9) 
Comparison Attention 215 160.57 Mild 183.40 WNL 192.67 WNL 
 
Memory 185 147.24 Mild 158.40 Mild 166.33 WNL 
 
Executive Functions 40 20.00 Severe 23.90 Mild 25.56 WNL 
 
Language 37 28.71 Mild 30.10 WNL 31.67 WNL 
 
Visual Spatial 105 72.67 Mild 82.70 WNL 87.33 WNL 
  
 
         Baseline (n=55) 4 Months (n=43) 8 Months (n=39) 
Cross-sectional Attention 215 147.64 Mild 174.98 Mild 177.31 Mild 
 
Memory 185 140.41 Mild 154.81 Mild 153.87 Mild 
 
Executive Functions 40 18.68 Severe 28.44 Mild 24.46 Mild 
 
Language 37 27.79 Mild 30.67 WNL 30.21 WNL 
  Visual Spatial 105 67.25 Mild 74.16 Mild 78.51 Mild 
 Mod=Moderate; WNL=Within Normal Limits 
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 Overview of scores obtained on the Structured Interview Schedule (IS) 
Table 5.8 reflects the means, standard deviations and range of scores obtained by the 
three groups of participants. The participants in the three groups were noted to have the most 
difficulties with the tasks of story retelling, phonemic categorization, symbol trails and design 
generation. Results indicated that the overall mean scores for the tasks and domains increased 
slightly from baseline, to four months and eight months. 
Table 5.9 reflects an overview of the means, medians, standard deviations and range of 
cognitive scores obtained by the three groups of participants. Most of the mean scores were 
very close to the maximum score attainable for each task and cognitive domain except for 
language and attention. 
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Table 5.8  Means, Standard Deviations and Range of scores obtained by each group on the IS tasks 
 
  Max. Possible                   
Tasks score Mean STD Range Mean STD Range Mean STD Range 
Experimental   Baseline (n=55) 4 months (n=55) 8 months (n= 50) 
 Memory 13 10.38 3.36 1-13 10.98 2.88 2-13 11.08 2.81 2-13 
Att. Int Distraction 13 8.40 3.52 0-13 10.51 2.60 3-13 11.55 1.62 2-13 
Att. Ext Distraction 3 2.51 1.00 0-3 2.71 0.88 0-3 2.98 0.14 0-3 
Sustained Attention 5 4.38 1.24 2-5 4.53 1.30 3-5 4.88 0.52 0-5 
Visual Spatial 6 4.78 1.62 1-6 5.00 1.69 0-6 5.59 0.92 0-6 
Executive Function 8 6.02 2.70 0-8 7.11 1.75 1-8 7.29 1.75 0-8 
Hearing 4 3.44 0.96 0-4 3.64 0.95 0-4 3.84 0.61 0-4 
Expressive Language 7 5.89 1.78 1-7 6.69 0.74 2-7 6.96 0.20 0-7 
Receptive Language 7 5.93 2.03 0-7 6.69 0.69 2-7 6.84 0.37 0-7 
    
         Comparison   Baseline (n=21) 4 months (n=10) 8 months (n= 9) 
 Memory 13 11.95 1.50 8-13 12.10 1.37 9-13 12.22 1.39 9-13 
Att. Int Distraction 13 8.43 3.03 4-13 8.10 2.88 4-13 9.78 2.17 5-12 
Att. Ext Distraction 3 2.71 0.78 0-3 2.10 1.29 0-3 2.78 0.44 2-3 
Sustained Attention 5 4.95 0.22 4-5 4.80 0.63 3-5 4.78 0.67 3-5 
Visual Spatial 6 5.43 1.21 1-6 5.10 1.10 3-6 5.44 0.88 4-6 
Executive Function 8 7.57 0.75 6-8 7.00 1.41 4-8 7.44 0.73 6-8 
Hearing 4 3.86 0.48 2-4 3.50 0.85 2-4 3.89 0.33 3-4 
Expressive Language 7 6.86 0.48 5-7 6.40 0.84 5-7 6.67 0.71 5-7 
Receptive Language 7 6.90 0.30 6-7 7.00 0.00 7-7 6.44 0.73 5-7 
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Cross sectional   Baseline (n=55) 4 months (n=43) 8 months (n= 39) 
 Memory 13 10.95 2.55 1-13 11.26 1.89 2-13 12.21 0.83 9-13 
Att. Int Distraction 13 7.80 3.15 2-13 10.30 2.17 5-13 10.79 2.00 6-13 
Att. Ext Distraction 3 2.36 1.09 0-3 2.81 0.63 0-3 2.97 0.16 2-3 
Sustained Attention 5 4.29 1.29 0-5 4.88 0.50 2-5 4.97 0.16 4-5 
Visual Spatial 6 4.36 1.89 0-6 5.67 0.87 2-6 5.79 0.47 4-6 
Executive Function 8 5.34 2.97 0-8 7.07 2.03 0-8 7.49 1.43 0-8 
Hearing 4 3.20 1.17 0-4 3.86 0.41 0-4 3.77 0.63 1-4 
Expressive Language 7 5.48 1.93 0-7 6.53 1.05 2-7 6.31 0.89 4-7 
Receptive Language 7 5.50 2.10 0-7 6.74 0.69 2-7 6.51 0.68 5-7 
Att.Int = Attention Internal; Att. Ext=Attention External  
Note: Minimum possible score on all tasks was zero 
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Table 5.9  Means, Standard Deviations, Median and Range of Domain Scores obtained by each Group on the IS  
 
 
Max. 
Possible        
  Cognitive Domains  score Mean Median STD Range Mean Median STD Range Mean Median STD Range 
Experimental 
 
Baseline (n=55) 4 months (n=55) 
 
8 months (n= 51) 
 Memory 13 10.38 9.00 3.36 8-13 10.98 11.00 2.88 3-13 11.08 10.00 2.81 2-13 
Attention 21 15.29 14.00 5.02 3-21 17.75 14.00 4.20 7-21 19.41 14.00 1.87 3-21 
Visual Spatial 6 4.78 6.00 1.62 1-6 5.00 6.00 1.69 0-6 5.59 6.00 0.92 0-6 
Executive Function 8 6.02 8.00 2.70 0-8 7.11 8.00 1.75 1-8 7.29 8.00 1.75 0-8 
Language 18 15.25 20.00 4.06 4-18 17.02 20.00 1.89 7-18 17.65 20.00 0.82 3-18 
Comparison    Baseline (n=21)  4 months (n=10)  8 months (n= 9) 
 Memory 13 16.10 13.00 2.95 0-13 12.10 13.00 1.37 9-13 12.22 13.00 1.39 9-13 
Attention 21 5.43 16.00 1.21 12-21 15.00 14.00 3.43 10-21 17.33 18.00 2.45 13-20 
Visual Spatial 6 7.57 6.00 0.75 1-6 5.10 5.50 1.10 3-6 5.44 6.00 0.88 4-6 
Executive Function 8 17.62 8.00 0.80 6-8 7.00 8.00 1.41 4-8 7.44 8.00 0.73 6-8 
Language 18 6.90 18.00 1.70 15-18 16.90 17.50 1.45 14-18 17.00 18.00 1.66 13-18 
Cross sectional     Baseline (n=55) 
 
4 months (n=43)  8 months (n= 39) 
Memory 13 10.95 12.00 2.55 1-13 11.26 12.00 1.89 2-13 12.21 12.00 0.83 9-13 
Attention 21 14.45 15.00 4.37 3-21 18.00 18.00 2.62 9-21 18.74 19.00 2.01 14-21 
Visual Spatial 6 4.36 5.00 1.89 0-6 5.67 6.00 0.87 2-6 5.79 6.00 0.47 4-6 
Executive Function 8 5.34 7.00 2.97 0-8 7.07 8.00 2.03 0-8 7.49 8.00 1.43 0-8 
Language 18 14.18 16.00 4.09 3-16 17.14 18.00 1.36 13-18 16.59 17.00 1.55 12-18 
Note: Minimum possible score for all cognitive domains was zero 
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5.3 Main Analysis 
5.3.1 Inferential Statistics 
By using inferential statistics, the study examined the differences between the 
cognitive-linguistic abilities of the groups and within the participants at the different time 
periods. Inferential statistics were done on both the CLQT and the interview schedule. Even 
though the interview schedule brought a qualitative flavor to the design, it was able to provide 
quatitive information from the closed ended questions when responses were tallied up and raw 
scores obtained. The study also investigated whether gender, age, education and CD4 counts 
influenced the cognitive-linguistic abilities of the participants.  
 
AIM 1: To determine whether there is a significant difference in cognitive-linguistic abilities 
between the participants in the experimental, comparison and cross-sectional groups on the 
Cognitive Lingusitic Quick Test and the interview schedule. 
A Kruskal-Wallis (K-W) one-way analysis of variance  was run to determine whether 
a difference in cognitive-linguistic ability existed between the three groups  at baseline, four 
months and eight months. A significant difference is said to occur if p<0.05. This test was 
also  corrected for tied ranks. Follow-up post hoc tests were conducted to evaluate pairwise 
differences among the three groups at the three testing times (Green and Salkind, 2008)  
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Cognitive Linguistic Quick Test.  
At baseline. 
Results of analysis revealed significant differences between particpants in the groups 
performance for all the cognitive domains except for attention. The sigificant findings were as 
follows: Memory χ2(2, N=132)=8.16, p=0.02; Executive functions χ2(2, N=132)=13.55, 
p=0.001; Language χ2(2, N=132)=15.24, p=0.0005; Visual spatial χ2(2, N=132)=8.40, p=0.02. 
Based on these findings the researcher rejected the null hypothesis for all the cogntive domains 
domains except attention 
Using pairwise comparison post testing analysis between the cross sectional and 
experimental  groups - no significant differences for all five cognitive domains were observed.  
Post testing analysis using pairwise comparisons showed that between the cross sectional and 
comparison groups significant difference were noted for all the domains except attention. The 
significant findings were as follows: Memory χ2(1, N=77)=4.38, p=0.04; Executive functions 
χ2(1, N=77)=12.32, p=0.0004; Language χ2(1, N=77)=13.69, p=0.0002; Visual spatial χ2(1, 
N=77)=7.28, p=0.007. 
Post testing analysis using pairwise comparisons showed that between the experimental 
and comparison groups significant difference were noted for memory χ2(1, N=76)=7.20, 
p=0.007, executive functions χ2(1, N=76)=10.95, p=0.0009 and visual spatial skills χ2(1, 
N=76)=6.77, p=0.009.  
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At four months. 
Results of analysis revealed no significant differences between participants in the group 
performances on any of the five cognitive domains. Therefore the researcher failed to reject the 
null hypothesis. 
Using pairwise comparison post testing analysis between the three pairs of groups 
revealed that there were no significant differences in performance for all five cognitive 
domains.  
 
At eight months. 
Results of analysis revealed no significant differences in group performance on any of 
the five cognitive domains. Therefore the researcher failed to reject the null hypothesis. 
Using pairwise comparison post testing analysis between the three pairs of groups revealed that 
there were no significant differences in performance for all five cognitive domains.  
To summarise the univariate analysis on the CLQT, using the Kruskal – Wallis test 
revealed that significant differences between the groups mainly occured at baseline. Post hoc 
testing using pairwise comparisons showed that this mainly occurred between the cross 
sectional and comparison groups; and the experimental and comparisons groups. 
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Interview Schedule (IS) 
At baseline 
Results of analysis revealed signifinant differences in group performance for all the cognitive 
domains except for memory. The sigificant findings were as follows: Attention χ2(2, 
N=132)=25.87, p=0.0001; Executive functions χ2(2, N=132)=12.66, p=0.002; Language χ2(2, 
N=132)=14.87, p=0.0006; Visual spatial χ2(2, N=132)=10.29, p=0.005. Therefore the null 
hypothesis was rejected for all cognitive domains except memory. 
 
Post testing analysis using pairwise comparisons showed that significant difference 
were noted for all the domains except memory between the cross sectional and experimental 
groups. The significant findings were as follows: Attention χ2(1, N=111)=23.32, p=0.0001; 
Executive functions χ2(1, N=111)=6.82, p=0.009; Language χ2(1, N=111)=11.97, p=0.0005; 
Visual spatial χ2(1, N=111)=8.36, p=0.004. 
Post testing analysis using pairwise comparisons also revealed significant difference 
that between the cross sectional and comparison groups for all the domains except memory. 
The significant findings were as follows: Attention χ2(1, N=77)=10.59, p=0.001; Executive 
functions χ2(1, N=77)=9.32, p=0.002; Language χ2(1, N=77)=7.76, p=0.005; Visual spatial 
χ2(1, N=77)=4.98, p=0.03. 
Using post testing analysis between the experimental and comparison groups no 
significant differences for all five cognitive domains were observed.  
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At four months. 
Results of analysis revealed a significant difference in group performance in only one 
cognitive domain -  visual spatial abilities χ2(2, N=108)=8.58, p=0.01. Therefore the researcher 
failed to reject the null hypothesis except for the domain of visual spatial. 
Post testing analysis using pairwise comparisons showed that between the cross 
sectional and experimental groups significant difference were only noted for memory χ2(1, 
N=111)=8.44, p=0.003. 
Post testing analysis using pairwise comparisons showed that between the cross 
sectional and comparison groups; and the experimental and comparison groups there were no 
significant differences noted for all five cognitive domains.  
 
At eight months 
Results of analysis revealed a significant difference in group performance in only one 
cognitive domain -  memorys χ2(2, N=100)=6.31, p=0.04. Therefore the researcher failed to 
reject the null hypothesis except for memory. 
Post testing analysis using pairwise comparisons showed that between the three 
different pairs significant difference were only observed between cross sectional and 
experimental groups for the cognitive domains of memory χ2(2, N=91)=4.86, p=0.03 and 
language χ2(2, N=89)=8.46, p=0.004. 
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In summary, performance for the Interview schedule using the Kruskal-Wallis tests 
revealed significant differences in cogntive-linguistic abilities between the groups mainly 
occurred at baseline. Post hoc testing using pairwise comparisons revealed that cross sectional 
and comparison groups along with the cross sectioanl and experimental grouping exhibited the 
most significant differences at baseline and four months However at eight months only  the 
cross sectional and experimental groups were noted to have exhibited the most significant 
differences.  
 
AIM 2: To determine whether there was a significant difference in cognitive-linguistic 
abilities within  the participants (time effect) for the experimental and comparison groups on 
the Cognitive Lingusitic Quick Test and the interview schedule. 
One-way repeated measures analysis of variance (ANOVA) was used to analyse 
whether there was a significant difference in cognitive-linguistic abilities in the participants 
across the three testing time periods of baseline, four months and eight months in the 
experimental and comparison groups (Howell, 2008). This statistical analysis was used 
because the same group of participants were measured at different times, namely at baseline, 
four and eight months.  To use the one-way repeated measures ANOVA (RM-ANOVA), the 
data needed to meet the assumptions of sphericity. Sphericity, a special case of circularity 
assumptions, checks whether the variance/covariance matrix of the observed data follows a 
particular pattern (Chajewski, 2012). This pattern is usually identified as one with equal 
variances in the diagonal and equal covariance in the off-diagonal elements (Hamer, Wood 
Johnson & Simpson, 2000). This was determined using the Greenhouse-Geisser Epsilon (G-
G) and the Huynh-Feldt Epsilon (H-F) tests.  
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This study used the PROC GLM method in SAS® to test for sphericity by identifying 
orthogonal covariance elements. This procedure ran uncorrected RM-ANOVA F-tests which 
usually result in the inflation of Type I Errors (Chajewski, 2012).  It then ran several 
corrections most notably the Greenhouse-Geisser and Huynh-Feldt epsilon corrections. These 
do not affect the computed F-statistic, but instead raise the critical F value needed to reject 
the null hypothesis (Hamer, Wood Johnson & Simpson, 2000). For this data these 
corresponding corrective coefficients were: Greenhouse-Geisser ε = <.75 and Huynh-Feldt ε 
= >.75 (Larsson, 2012). The conditions were not met therefore corrections were not affected. 
 
 
Repeated post hoc analysis was also done using the paired t-test.  This test was run to 
test the significance of difference between two related samples, i.e. the same participants at 
the three testing periods of baseline, four and eight months. 
 
The bolded numbers in Tables 5.10; 5.11; 5.12; 5.13 indicate significance at p<0.05 
 
Cognitive Linguistic Quick Test (CLQT) 
Table 5.10 summarizes the participants’ performances. Repeated measures analysis 
revealed significant differences in performance within the individuals in the experimental 
group across all domains except for language. For within participant comparison group 
significant differences were observed for all domains except memory. Based on these findings 
the null hypothesis was rejected for the experimental group and the comparison group 
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 Table 5.10 Repeated Measures ANOVA for the Experimental and Comparison group on the 
CLQT 
 
Group Domains Observed n 
Mean 
Square df F P-value 
Experimental Memory 55 51 1046.71 2 6.27 0.003 
 
Error 
  
166.73 100 
  
 
Attention 55 51 12313.2 2 26.88 <0.009 
 
Error 
  
458.16 100 
  
 
Exec. Functions 55 51 319.26 2 31.9 <0.0001 
 
Error 
  
10.01 100 
  
 
Language 55 51 29.08 2 2.9 0.08 
 
Error 
  
-6.19 100 
  
 
Visual Spatial 55 51 2819.03 2 38 <0.0001 
 
Error 
  
74.18 100 
                  
Comparison Memory 21 9 321.6 2 1.52 0.25 
 
Error 
  
211 16 
  
 
Attention 21 9 874.33 2 4.23 0.03 
 
Error 
  
206.58 16 
  
 
Exec. Functions 21 9 36.33 2 5.42 0.02 
 
Error 
  
6.71 16 
  
 
Language 21 9 13.4 2 2.9 0.08 
 
Error 
  
4.65 16 
  
 
Visual Spatial 21 9 382.93 2 8.15 0.004 
  Error     47.01 16     
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The paired sample t-test analysis (see Table 5.11) revealed that the largest mean 
differences were observed from baseline and eight months within the participants in the 
experimental group on the CLQT. The greatest improvement from baseline was from baseline 
to four months. The smallest significant differences were noted between four and eight months. 
This could be due to a plateau effect. These trends observed in performance were similar to the 
mean scores recorded for the severity ratings (see Table 5.10) in that the severity rating of 
either mild or moderate did not change at four or eight months, even though the mean scores 
changed over time.  
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 Table 5. 11 Post hoc Paired t-test analysis of the Participants in the Experimental and Control groups on the CLQT 
 
Group Effect 
n 
Compare 
Mean 
Difference 
Standard 
Error t-value  
Experimental Memory 51 2-1 6.07 2.88 0.04   
  
 3-1 9.04 2.4 0.004   
  
 3-2 3.98 2.2 0.07   
  
 
    
  
 
Attention 51 2-1 22.35 4.29 <.0001   
  
 3-1 30.25 5.19 <.0001   
  
 3-2 8.98 2.64 0.001   
  
 
    
  
 
Exec. Functions 51 2-1 4.1 0.64 <.0001   
  
 3-1 4.69 0.8 <.0001   
  
 3-2 0.82 0.34 0.02   
  
 
    
  
 
Language 51 2-1 1.52 0.53 0.007   
  
 3-1 0.73 0.42 0.1   
  
 3-2 -0.84 0.49 0.09   
  
 
    
  
 
Visual Spatial 51 2-1 10.4 1.72 <.0001   
  
 3-1 14.63 2.1 <.0001   
  
 3-2 5 1.13 <.0001   
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Control Memory 9 2-1 3.7 7.7 0.64   
  
 3-1 11.78 7.41 0.15   
  
 3-2 7.67 3.65 0.07   
  
 
    
  
 
Attention 9 2-1 16.5 9.02 0.1   
  
 3-1 19.67 7.08 0.02   
  
 3-2 8.67 4.85 0.11   
  
 
    
  
 
Exec. Functions 9 2-1 2.1 1.17 0.12   
  
 3-1 4 1.06 0.006   
  
 3-2 1.67 1.3 0.23   
  
 
    
  
 
Language 9 2-1 1 -1.17 0.42   
  
 3-1 2.44 0.91 0.02   
  
 3-2 1.33 0.75 0.11   
  
 
    
  
 
Visual Spatial 9 2-1 8.1 2.01 0.03   
  
 3-1 12.78 3.18 0.01   
 
   3-2 4.11 3.48 0.27   
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Overall the within-participant group performances on the Cognitive Linguistic Quick 
Test were significantly better for individuals in the experimental group than for those in the 
comparison group.  
 
Interview Schedule (IS) 
The univariate analysis presented in Table 5.12 revealed that the assumption(s) of 
sphericity were met for both the experimental and control groups. Since these assumptions 
were met, the parametric statistics of repeated measure analysis were used. 
Repeated measures analysis, as presented in Table 5.12 revealed that significant 
differences in performance were observed within the individuals in all the cognitive-linguistic 
abilities except for memory in the experimental group across all three time periods. 
Conversely, a significant difference within participant performance was observed only for the 
domain of attention in the comparison group.  Based on these findings the null hypothesis was 
rejected for the experimental group and accepted for the comparison group.  This implies that 
individuals within the experimental group were experiencing greater effect changes over time - 
that is more improvement over time than the comparison group. 
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Table 5. 12 Repeated Measures ANOVA analysis for the Experimental and Comparison Groups on 
 the IS 
 
                 
Group Domains  n 
Mean 
Square df F-value P-value   
Experimental Memory  51 7.3 2 2.23 0.11   
 
Error  
 
3.28 100 
  
  
 
Attention  51 238.84 2 23.91 <0.0001   
 
Error  
 
9.98 100 
  
  
 
Exec. 
Functions  51 21.85 2 10.59 <0.0001   
 
Error  
 
0.88 100 
  
  
 
Language  51 85.77 2 14.69 <0.0001   
 
Error  
 
5.88 100 
  
  
 
Visual 
Spatial  51 9.3 2 7.54 0.0009   
 
Error   1.23 100 
  
  
                 
Comparison Memory  9 5.44 2 1.6 0.23   
 
Error  
 
3.4 16 
  
  
 
Attention  9 19.7 2 5.51 0.02   
 
Error  
 
3.59 16 
  
  
 
Exec. 
Functions  9 0.93 2 1.05 9.37   
 
Error  
 
0.88 16 
  
  
 
Language  9 85.77 2 1.28 0.3   
 
Error  
 
0.9 16 
  
  
 
Visual 
Spatial  9 1.04 2 1.79 0.2   
  Error    0.58 16       
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The paired t-test analysis (see Table 5.13) revealed that there were more significant 
differences   in cognitive-linguistic abilities over time within individuals in the experimental 
group as compared to the comparison group. The largest mean difference was noted from 
baseline to eight months. The greatest improvement from baseline was observed from baseline 
to four months for most of the cognitive domains. These domains included attention, executive 
functions and language for the experimental group, and executive functions for the comparison 
group. The smallest significant differences were observed from four to eight months between 
participants in the experimental group. This could have been due to the plateau effect in 
abilities – improvement was starting to slow down and plateau 
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Table 5. 13 Post hoc Paired t-test analysis of the Participants in the Experimental and Control Groups on the IS 
Group Effect n Compare 
Mean 
Difference 
Standard 
Error p-value  
Experimental Memory 51 2-1 0.6 0.4 0.14   
  
 3-1 0.73 0.42 0.09   
  
 3-2 0.18 0.17 0.32   
  
 
    
  
 
Attention 51 2-1 2.45 0.64 0.0003   
  
 3-1 4.27 0.68 <.0001   
  
 3-2 1.55 0.52 0.004   
  
 
    
  
 
Exec. Functions 51 2-1 1.09 0.53 0.003   
  
 3-1 1.2 0.33 0.0007   
  
 3-2 0.14 0.1 0.18   
  
 
    
  
 
Language 51 2-1 1.76 0.55 0.002   
  
 3-1 2.49 0.54 0.0001   
  
 3-2 0.61 0.21 0.005   
  
 
    
  
 
Visual Spatial 51 2-1 0.21 0.23 0.23   
  
 3-1 0.82 0.18 0.18   
  
 3-2 0.61 0.22 0.22   
               
Control Memory 9 2-1 1.4 0.91 0.16   
  
 3-1 0.78 0.43 0.11   
  
 3-2 0.78 1.04 0.48   
  
 
    
  
 
Attention 9 2-1 2 0.92 0.06   
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 3-1 2.44 1.33 0.06   
  
 3-2 -0.22 0.78 0.78   
  
 
    
  
 
Exec. Functions 9 2-1 0.4 0.5 0.44   
  
 3-1 0.56 0.5 0.03   
  
 3-2 0 0.24 1   
  
 
    
  
 
Language 9 2-1 0.1 0.41 0.81   
  
 3-1 0.67 0.41 0.41   
  
 3-2 0.56 0.47 0.28   
  
 
    
  
 
Visual Spatial 9 2-1 0.4 0.4 0.34   
  
 3-1 0.67 0.33 0.08   
 
   3-2 0.22 0.28 0.45   
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In summary, the experimental group showed more significant improvements in performing 
their activities of daily living based upon the analysis of their cognitive-linguistic skills.  
 
AIM 3: To determine the effect of age, gender, education and CD4 count on cognitive-
linguistic functioning in both the experimental and comparison groups at baseline, four months 
and eight months on the Cognitive Linguistic Quick Test and the interview schedule. 
We extended the previous analysis in aim two to control for covariates by doing 
repeated measures analysis of covariates (ANCOVA).  The three covariates structure models 
of Compound symmetry (CS), Huynh-Feldt (H-F) and Auto-regressive (1)(AR-1) were used. 
The three goodness of fit statistics used included the Akaike’s information criteria (AIC), 
corrected Akaike’s information criteria (AICC) and Bayesian information criteria (BIC). This 
analysis tested the assumption that the best fitting model would be chosen based on smaller 
AIC, AICC and BIC values and the residual distribution would be normally distributed with a 
mean of zero and a standard deviation between -1 and +1 (refer to  Appendix IX for the 
studentized residual plots).  
The ANCOVA analysis was run using Mixed Procedure in SAS®. This procedure 
was used for a number of reasons. Firstly, this procedure does not require balanced data 
across the different testing times. This enables more flexibility and allows for more power 
when handling unbalanced data (e.g., unequal sample size, inconsistent time interval, and 
missing data). This is important in longitudinal studies in which the problems of participant 
dropout and other forms of missing measurements within individuals are often encountered 
(Shek & Ma, 2011).  Secondly, it allows researchers to study both between group and within 
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group differences.  Third, this mixed procedure analyses estimates the changes in parameters 
with greater precision when the number of time waves is increased. This improves the 
reliability of the change parameters by reducing standard errors of the within-subject changes 
in the parameters estimates (Willett, Singer & Martin 1998).   The independent variables 
were age, CD4 counts, education and gender.  The dependant variables were time of testing 
and group. Covariances included all five cognitive domains – attention, memory, executive 
functions, language and visual spatial skills.  The results of the ANCOVA were discussed by 
keeping all other independent variables constant and are discussed for both the CLQT and IS. 
 
Cognitive Linguistic Quick Test (CLQT) 
According to the results (see Table 5.14), the assumption stating that the residuals were 
normally distributed with a constant variance (also see studentized residuals in Appendix IX) 
was met. Therefore we continued to interpret the results using the repeated measures 
ANCOVA analysis. 
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Table 5.14 Information Criterion among the three Covariance Structure Models on the 
CLQT 
 
Covariances Covariance structure AICC AIC BIC 
Attention Compound symmetry  (df =3) 1654.8 1654.6 1663.3 
 
Huynh-Feldt (df=7) 1636.9 1636 1653.4 
 
Auto Regressive (1) (df=3) 1661.8 1661.6 1670.3 
          
Memory Compound symmetry  (df =3) 1461.7 1461.4 1470.1 
 
Huynh-Feldt (df=7) 1468.3 1467.3 1484.7 
 
Auto Regressive (1) (df=3) 1455.6 1447.3 1464 
          
Exec. Functions Compound symmetry  (df =3) 1036.1 1035.8 1044.5 
 
Huynh-Feldt (df=7) 1035.4 1034.5 1051.9 
 
Auto Regressive (1) (df=3) 1047.3 1047 1055.7 
          
Language Compound symmetry  (df =3) 879.2 878.9 887.6 
 
Huynh-Feldt (df=7) 882 881.1 898.5 
 
Auto Regressive (1) (df=3) 878.8 878.6 887.3 
          
Visual Spatial Compound symmetry  (df =3) 1364.4 1364.1 1372.8 
 
Huynh-Feldt (df=7) 1354.6 1353.7 1371.1 
  Auto Regressive (1) (df=3) 1378.9 1378.7 1387.4 
Note: Numbers bolded indicate the best fitting model. 
 The results below were discussed according to how the variables influenced each domain as 
presented in Table 5.14. 
 
Attention:   
  The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Huynh-Feldt model. These differences were significant 
when compared to the results of a chi-square distribution with degrees of freedom (i.e. 7 
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parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best 
model in fitting the data. 
Age was found to have a significant effect on attention because as a person got older 
in years attention scores were lowered (β = 0.45, SE = 0.11, p <0.01) all other variables were 
kept constant. Gender was also found to have a significant main effect on attention when all 
other variables were kept constant. Females overall had higher scores than males (β = 5.41, 
SE = 1.85, p <0.01). Lastly CD4 count had a significant main effect on attention when all 
other variables were kept constant. As the CD4 count increased by one, attention scores 
improved (β = 0.03, SE = 0.01, p <.0001). Based on these results the null hypothesis was 
rejected for all independent variables except education. 
 
Memory 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Auto regressive (1) model. These differences were 
significant when compared to the results of a chi-square distribution with degrees of freedom 
(i.e. 7 parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Auto regressive (1) 
was the best model in fitting the data.  
The only variable found to have a significant main effect on memory was education 
when all other variables were kept constant. As education levels increased by one year of 
study, memory mean scores got higher (β = 1.64, SE = 0.64, p <.01). Based on this finding 
the null hypothesis failed to be rejected for all independent variables except education. 
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Executive functions: 
The smallest values in the three goodness of fit criterion (Akaike’s information criteria [AIC], 
corrected Akaike’s information criteria [AICC] and Bayesian information criteria [BIC]) 
were found in the Huynh-Feldt model. These differences were significant when compared to 
the results of a chi-square distribution with degrees of freedom (i.e. 7 parameters – 3 
parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best model in fitting 
the data. 
Education also had a significant main effect on memory when all other variables were 
kept constant. As education levels increased by one year of study, memory mean scores got 
higher (β = 0.86, SE = 0.17, p <.01). The researcher therefore failed to reject the null 
hypothesis for all independent variables except education. 
 
Language: 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Auto regressive (1) model. These differences were 
significant when compared to the results of a chi-square distribution with degrees of freedom 
(i.e. 7 parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Auto regressive (1) 
was the best model in fitting the data. 
The only variable to exhibit significant a main effect on language was education when 
all other variables were kept constant. As education levels increased by one year of study, 
language mean scores got higher (β = 0.38, SE = 0.1, p < .01).  The researcher therefore 
failed to reject the null hypothesis for all independent variables except education. 
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Visual Spatial 
The smallest values in the three goodness of fit criterion (Akaike’s information criteria 
[AIC], corrected Akaike’s information criteria [AICC] and Bayesian information criteria 
[BIC]) were found in the Huynh-Feldt model. These differences were significant when 
compared to the results of a chi-square distribution with degrees of freedom (i.e. 7 parameters 
– 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best model in 
fitting the data. 
Age was found to have a significant main effect on visual spatial skills because as a 
person got older in years visual spatial scores were lowered (β = -0.25, SE = 0.09, p < .01) all 
other variables were kept constant. Education was also found to have a main significant effect 
on visual spatial skills when all other variables were kept constant. As education levels 
increased by one year of study, visual spatial mean scores got higher (β = 2.14, SE = 0.18, p 
< .0001).   Since age and education had significant main effects on visual spatial skills the 
null hypothesis was rejected for these variables only. 
 
Interview Schedule 
 
The assumption stating that the residuals were normally distributed with a variance of 1 (also 
see studentized residuals in Appendix IX) was met.  Therefore we continued to interpret the 
results using the repeated measures ANCOVA analysis. 
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Table 5.15 Information Criterion among the three Covariance Structure Models on the 
IS 
Covariances Covariance structure AICC AIC BIC 
Attention Compound symmetry  (df =3) 955.2 954.9 963.6 
 
Huynh-Feldt (df=7) 928.1 927.1 944.5 
 
Auto Regressive (1) (df=3) 944.5 966 974.7 
     Memory Compound symmetry  (df =3) 833.9 833.7 842.4 
 
Huynh-Feldt (df=7) 819 818.1 835.5 
 
Auto Regressive (1) (df=3) 827.6 827.4 836.1 
     Exec Functions Compound symmetry  (df =3) 704 703.8 712.5 
 
Huynh-Feldt (df=7) 704.1 703.2 720.6 
 
Auto Regressive (1) (df=3) 695 694.7 703.4 
     Language Compound symmetry  (df =3) 808 807.8 816.5 
 
Huynh-Feldt (df=7) 733.1 732.2 749.6 
 
Auto Regressive (1) (df=3) 811.7 749.6 820 
     Visual Spatial Compound symmetry  (df =3) 578.4 578.1 586.8 
 
Huynh-Feldt (df=7) 563.1 562.2 579.6 
  Auto Regressive (1) (df=3) 585.8 585.5 594.2 
Note: Numbers bolded indicate the best fitting model. 
The results below were discussed according to how the variables influenced each domain as 
presented on Table 5.15. 
 
Attention 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Huynh-Feldt model. These differences were significant 
when compared to the results of a chi-square distribution with degrees of freedom (i.e 7 
 224 
 
parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best 
model in fitting the data. 
Univariate analysis showed that Age, CD4 counts, education and gender did not have 
a significant main effect on attention. Therefore the null hypothesis failed to be rejected. 
 
Memory: 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Huynh-Feldt model. These differences were significant 
when compared to the results of a chi-square distribution with degrees of freedom (i.e 7 
parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best 
model in fitting the data. 
Age had a significant main effect on memory abilities when all other variables were 
kept constant. As age increased by one year, attention scores lowered (β = -0.13, SE = 0.03, p 
<0.0001). The researcher therefore failed to reject the null hypothesis for all independent 
variables except age. 
 
Executive functions: 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Auto regressive (1) model. These differences were 
significant when compared to the results of a chi-square distribution with degrees of freedom 
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(i.e. 7 parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Auto regressive (1) 
was the best model in fitting the data. 
 
Univariate analysis showed that Age, CD4 counts, education and gender did not have 
a significant effect on executive functions. Therefore the null hypothesis failed to be rejected. 
 
Language: 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Huynh-Feldt model. These differences were significant 
when compared to the results of a chi-square distribution with degrees of freedom (i.e. 7 
parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best 
model in fitting the data. 
 
Age had a significant main effect on language abilities when all other variables were 
kept constant. As age increased by one year, language scores lowered (β = -0.03, SE = 0.01, p 
= 0.02). The researcher therefore failed to reject the null hypothesis for all independent 
variables except age. 
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Visual spatial: 
The smallest values in the three goodness of fit criterion (Akaike’s information 
criteria [AIC], corrected Akaike’s information criteria [AICC] and Bayesian information 
criteria [BIC]) were found in the Huynh-Feldt model. These differences were significant 
when compared to the results of a chi-square distribution with degrees of freedom (i.e. 7 
parameters – 3 parameters, ∆df = 4, p <.0001). This suggested that Huynh-Feldt was the best 
model in fitting the data. 
Age had a significant main effect on visual spatial abilities when all other variables 
were kept constant. As age increased by one year, visual spatial scores lowered (β = -0.05, SE 
= 0.01, p = 0.001). The researcher therefore failed to reject the null hypothesis for all 
independent variables except age. 
 
In summary, ANCOVA analysis revealed that the assumption of the residuals being 
normally distributed was met with a variance of 1. The ANCOVA results showed that the most 
common best fit model for the domains for both the CLQT and the interview schedule was the 
Huynh-Feldt model followed by the auto-regressive model (1). The variables that significantly 
influenced cognitive-linguistic abilities on the CLQT were observed to be education and to a 
lesser extent age (attention) and CD4 count (language). The ANCOVA results for the 
interview schedule showed the variable that most influenced the participants’ cognitive-
linguistic abilities to perform activities of daily living was age (memory, language and visual 
spatial skills). 
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5.4 Content Analysis 
The data collected from the semi-structured interview schedule was analysed using content 
analysis. This was done to provide more discussion and interpretation of the participants’ 
responses and compliment the results of the Cognitive Linguistic Quick Test. 
 
AIM 4: To investigate the cognitive-linguistic functioning that affected the ability to perform 
activities of daily living in the experimental, cross-sectional and comparison groups. 
To attend to this aim the open-ended questions were analysed using quantitative 
thematic content analysis. This analysis provided the participants’ personal experiences and 
perceptions to compliment the statistical findings from the CLQT and the Interview schedule. 
Analysis revealed four categories. These included attention, visual, expressive and receptive 
language. The responses for the category of attention were further divided into the sub- 
themes of pain, emotion and other. As previously mentioned in the literature review, the 
ability to attend to tasks of daily living can be affected by internal and external distracters. 
Internal distracters are factors that arise from within the individual that affect how an 
individual attends to activities of daily living (ADLs). External distracters would include 
factors outside of the individual in their environment that would affect how they can attend to 
a task. For participants in all three groups internal distracters greatly impacted on their ability 
to attend to ADLs. 
The other pre-determined categories of visual, expressive and receptive language 
abilities were also further divided into themes. Visual abilities were divided into the themes 
of pain, discharge and “other”. Expressive and receptive language had one sub-category each 
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that was further divided into different clusters. The categories of expressive and receptive 
language included the themes of speech and hearing respectively.  See Tables 5.17; 5.18 and 
5.19 for the frequencies of emergent themes at baseline, four and eight months. 
 
 Baseline 
Frequency statistics using percentages for all three groups were calculated for the 
participants’ responses on the interview schedule (refer to Table 5.16)
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Table 5. 16 Frequencies of Emergent Themes by the Three Groups at Baseline 
 
Cognitive –linguistic abilities Experimental Comparison 
Cross 
sectional 
 
Themes  Sub - themes N n(%age) N n(%age) N n(%age) 
Attention Pain Headaches 30 11(37) 11 4(37) 37 15(40) 
  
Feet and Hands 
 
5(17) 
 
2(18) 
 
7(20) 
  
Whole body 
 
1(3) 
 
1(9) 
 
4(11) 
  
Neck 
 
2(6) 
 
0 
  
  
Chest 
 
4(13) 
 
1(9) 
 
2(5) 
  
Abdomen 
 
1(3) 
 
0 
 
4(11) 
  
other 
 
6(21) 
 
3(27) 
 
5(13) 
 
Emotion Stress 12 2(16.5) 3 0 14 4(29) 
  
Sadness and Depression 
 
5(42) 
 
3(100) 
 
8(57) 
  
Anger 
 
3(25) 
 
0 
 
2(14) 
  Fear  2(16.5)     
 
Other Dizziness 11 3(27) 4 0 8 2(25) 
  
Blackouts 
 
0 
 
0 
 
1(12.5) 
  
Fatigue 
 
8(73) 
 
4(100) 
 
5(62.5) 
         Visual Pain   5 1(20) 0   6 3(50) 
 
Discharge 
  
1(20) 
   
0 
 
other 
  
3(60) 
   
3(50) 
         Express.lang     2 2 0 0   0 
 
Speech Hoarse 7 7(100) 
 
0 2 1(50) 
  
Intensity 
 
0 
 
0 
  
  
Rate 
 
0 
 
0 
 
1(50) 
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Rec. Lang     0 0 0 0     
 
Hearing Hearing probs 5 2(40) 0 0 3 2(67) 
  
Discharge 
 
2(40) 
 
0 
      Ringing   1(20)   0   1(33%) 
Note: The responses indicated by category may not be equal to the total number of participants recruited at each 
 time period because respondents may have reported no cognitive – linguistic problems, and those who did respond  
may have reported more than one category. 
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Participant responses shown on Table 5.16 revealed that at baseline the majority of 
the responses from all three groups cited attention as the domain most affecting their ability 
to perform activities of daily living (ADLs). Pain, emotions and “other” as an internal 
distracters were the main reasons or subthemes that emerged as to why they could not attend 
to ADLs.  Most of the complaints about pain from the participants in all groups included 
headaches, hand and foot soreness and numbness attributable to peripheral neuropathy, and 
chest pains which were attributed to a pulmonary infection. In the “other” sub-theme of pain 
respondents complained about a painful rash over the whole body or certain parts of the body.  
Under the themes of emotions different sub themes emerged – sadness, fear, anger 
and stress were cited as reasons for not being able to attend. Sadness obtained the highest 
numbers of responses in the theme of emotions from all the groups - experimental (5 out of 
the 10), comparison (3 out of 3) and cross sectional (8 out of 14). Respondents stated that 
they “[I felt] sadness after my diagnosis” and “I get sad when I think of my status.” 
Participants who reported anger (three out of 10) and stress (two out of 10) as the main 
reason why they could not attend to task said: 
… [I] get angry when I think of how I contracted HIV,”  
 … [I got] angry when I found out I was positive… 
… [I got] angry because of my husband’s death… I feel stressed with the children. 
Fear was also cited as a sub theme of emotion two out of ten responses from the 
experimental group indicated that were fearful. A respondent stated that “[I] fear when I think 
of my low CD4 count. Another said “[I’m] worried about my children.” 
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In the “other” category of attention, the majority of respondents in all three groups 
complained of fatigue as the main reason for them not being able to attend to ADLs and 
dizziness. From the experimental there were eight out of 11 responses; comparison all the 
respondents; and five out of eight responses from the cross sectional. Respondents stated that 
they felt tired and found it difficult to concentrate or even have the energy to start or 
complete an activity, The response were “[I] feel tired in the morning,” and “ [I] want to 
sleep a lot.”  Responses to the sub – theme of dizziness could have been indicative of the 
effects of HI virus in the brain since the participants had not yet started to take HAART. 
There were not many participants that indicated they had visual spatial problems. The 
few respondents in both the experimental (five) and cross sectional (six) groups indicated 
having visual problems that were affecting their ability to perform ADLs. The sub themes 
that emerged included painful eyes, discharge and other.  From the experimental group one 
out of five responses and three out of  six responses from the cross sectional group indicated 
that they had painful eyes. The ‘other’ category had the most responses from the 
experimental (three out of five) and cross sectional (three out of three) groups and they 
included comments like eye problems after meningitis, “can’t see when it is dark”, and 
“shingles in the left eye”. 
Regarding the category of   expressive language, speech emerged as the main theme 
with sub themes of hoarse, intensity and rate. All seven respondents in the experimental 
group indicated that their vocal quality was hoarse. In the cross sectional group one 
participant stated they were speaking much slower and another reporting that their spoke with 
a “low” voice.  Receptively, two out of five responses from the experimental and two out of 
three cross sectional groups reported experiencing hearing problems that is the right or left 
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ear not hearing properly. The other sub –themes that respondents commented on included, 
yellowish discharge and ringing noise in their ears. 
Surprisingly, no visual, expressive or receptive language difficulties were reported by 
the participants in the comparison group 
 
Four months 
Frequency statistics using percentages for all three groups were calculated for the 
participants’ responses on the interview schedule (refer to Table 5.17) 
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Table 5. 17 Frequencies of Emergent Themes by the Three Groups at Four months 
 
 
  Experimental Comparison 
Cross-
sectional 
Categories Themes  Sub themes N n(%age) N n(%age) N n(%age) 
Attention Pain Headaches 4 1(25) 1 0 6 2(33) 
  
Feet and Hands 
 
1(25) 
 
0 
  
  
Whole body 
 
0 
 
1(100) 
 
2(33) 
  
Neck 
 
0 
 
0 
  
  
Chest 
 
0 
 
0 
 
1(16.5) 
  
Abdomen 
 
0 
 
0 
  
  
other 
 
2(50) 
 
0 
 
1(16.5) 
 
Emotion Stress 
 
0 1 0 
  
  
Sadness and Depression 
 
0 
 
1(100) 
  
  
Anger 
 
0 
 
0 
  
 
Other Dizziness 3 1(33) 2 0 2 0 
  
Blackouts 
 
0 
 
1(50) 
 
0 
  
Fatigue 
 
2(67) 
 
1(50) 
 
2(100) 
         Visual Pain   1 0 1 0 3 2(67) 
 
Discharge 
  
0 
 
0 
 
0 
 
other 
  
1(100) 
 
1(100) 
 
1(33) 
         Express.lang     1 1(100) 0 0 0 0 
 
Speech Hoarse 2 0 0 
 
1 0 
  
Intensity 
 
1(50) 
   
1(100) 
  
Rate 
 
1(50) 
   
0 
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Rec. Lang 
  
1 1(100) 0 0 0 0 
 
Hearing Hearing probs 2 2(100) 0 
 
1 0 
  
Discharge 
 
0 
   
1(100) 
    Ringing   0       0 
Note: The responses indicated by category may not be equal to the total number of participants recruited at each 
 time period because respondents may have reported no cognitive – linguistic problems, and those who did respond  
may have reported more than one category. 
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The responses presented in Table 5.17 revealed a similar trend to the baseline results 
in that more participants complained of attentive internal distraction problems. However, the 
numbers of responses were less than at baseline especially for the experimental and 
comparison groups.   
From the category of attention, the theme of pain received more responses in the cross 
sectional group than the experimental or comparison. A respondent stated that … [I am 
experiencing] headaches more after [I] started taking ARVs …pain in right hand palm. 
 Responses from the cross sectional group (four out six) complained of either 
headaches or all over body aches. Only two individuals complained of pain and one in the 
comparison group. However, it was observed that in the ‘other’ category that the sub – theme 
fatigue was still a complaint of the participant (s) in all three groups. One participant in the 
comparison reported they had experienced a black out. Another respondent said “… [I] get 
dizzy when I take my medication.”  
Visual and language problems also reflected a decrease in responses as compared to 
baseline. Regarding the theme of visual pain two out of three responses in the cross sectional 
group indicated they their eyes were painful. One participant in all three groups indicated that 
they were having visual spatial problems in the other category. These were among same 
participants who had reported in the other category at baseline. 
The language categories yielded very few responses. One response reported 
experiencing difficulties expressing their thoughts and ideas in the experimental group. In the 
theme of speech one respondent in both the experimental and cross sectional group reported 
that they problems with the loudness of their voice. They commented that their voices were 
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soft. Only one respondent reported speech rate as a problem and that was in the experimental 
group. 
 
Eight months 
Frequency statistics using percentages for all three groups were calculated for the 
participants’ responses on the interview schedule (refer to Table 5.18) 
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Table 5.18 Frequencies of Emergent Themes by the Three Groups at Eight months 
 
 
  Experimental Comparison 
Cross 
sectional 
Categories Sub-Cat   N n(%age) N n(%age) N n(%age) 
Attention Pain Headaches 0 0 14 5(36) 3 0 
  
Feet and Hands 
 
0 
 
5(36) 
 
0 
  
Whole body 
 
0 
 
0 
 
2(67) 
  
Neck 
 
0 
 
1(7) 
 
0 
  
Chest 
 
0 
 
2(14) 
 
0 
  
Abdomen 
 
0 
 
0 
 
0 
  
other 
 
0 
 
1(7) 
 
1(33) 
 
Emotion Stress 0 0 2 2 0 0 
  
Sadness and Depression 
 
0 
 
0 
 
0 
  
Anger 
 
0 
 
0 
 
0 
 
Other Dizziness 0 0 0 0 2 0 
  
Blackouts 
 
0 
 
0 
 
0 
  
Fatigue 
 
0 
 
0 
 
2(100) 
         Visual Pain   0 0 1 0 2 1(50) 
 
Discharge 
  
0 
 
0 
 
1(50) 
 
other 
  
0 
 
1 
 
0 
         Express.lang Speech Hoarse 0 0 0 0 0 0 
  
Intensity 
 
0 
 
0 
 
0 
  
Rate 
 
0 
 
0 
 
0 
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         Rec. Lang Hearing probs   0 0 0 0 1 1(100) 
 
Discharge 
  
0 
 
0 
 
0 
  Ringing     0   0   0 
Note: The responses indicated by category may not be equal to the total number of participants recruited at each 
 time period because respondents may have reported no cognitive – linguistic problems, and those who did respond  
may have reported more than one category. 
      
 240 
 
The reported results listed in Table 5.18 showed that the comparison group reported more 
cognitive –linguistic problems especially in the domain of attention. Most of the responses (14) from 
the comparison group complained that attentive internal distractions affected their abilities to focus 
on or complete activities of daily living. The theme of pain from headaches and hands and feet were 
cited as being especially worrying among the respondents. In contrast, the experimental and cross-
sectional groups reported very few to no cognitive-linguistic difficulties.  Problems reported 
especially from the cross-sectional group included two responses from the visual spatial theme and 
another for the theme of hearing problems.  The decrease in the cognitive –linguistic complaints 
could have indicated that participants were feeling better due to the increased CD4 counts as 
presented in Table 4.6 (methodology chapter). 
  Overall, the ability to perform activities of daily living also appeared to have improved across 
the three time periods. There were more reported cognitive – linguistic problems at baseline that 
decreased with each successive testing. When the participants were asked how their cognitive-
linguistic abilities were impacting on their activities and participation in their environments, the 
category of attention with the sub themes of pain, emotions, fatigue and dizziness received the most 
responses especially at baseline and four months. The comparison group responses were higher at 
baseline and eight months. The results of inferential testing revealed that as greatest main effect 
usually occurred from baseline to eight month on the cognitive linguistic abilities. However, the 
descriptive results on the severity ratings did not concur with the reported cognitive linguistic 
abilities. For example an individual who was reported to have severe memory and executive 
problems clinically was able to use public transportation and make their way to the clinic. 
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Chapter 6: Discussion 
6.1 Introduction  
The results of this study supported the main hypothesis that HAART improves the cognitive-
linguistic abilities of adults living with HIV and AIDS over time. The main findings of this study 
revealed that significant differences between the groups mainly occured at baseline. Post hoc testing 
using pairwise comparisons showed that this mainly occurred between the cross sectional and 
comparison groups; and the experimental and comparisons groups on the Cognitive Linguistic Quick 
Test. Performance on the Interview schedule  revealed significant differences in cogntive-linguistic 
abilities between the groups mainly occurred at baseline. Post hoc testing using pairwise comparisons 
revealed that cross sectional and comparison groups along with the cross sectioanl and experimental 
grouping exhibited the most significant differences at baseline and four months.  However at eight 
months only  the cross sectional and experimental groups were noted to have exhibited the most 
significant differences.  
Significant differences in performance within the individuals in the experimental group were 
observed for all domains except language; and within the comparison group, significant differences 
were observed for all domains except memory on the CLQT. Post testing revealed the largest mean 
differences between baseline and four months and the smallest significant differences were noted 
between four and eight months. This could have been due to a plateau effect. On the Interview 
schedule significant differences in performance were observed in all the cognitive-linguistic abilities 
except for memory within individuals in the experimental group. Conversely, a significant difference 
within participant performance was observed only for the domain of attention in the comparison group.  
This implied that individuals within the experimental group were experiencing greater effect changes 
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over time - that is more improvement over time than the comparison group.  The paired t-test analysis 
(see Table 5.16) revealed that there were more significant differences cognitive-linguistic abilities over 
time within individuals in the experimental group as compared to the comparison group. The largest 
mean differences were observed from baseline to four months for most of the cognitive domains. 
These domains included attention, executive functions and language for the experimental group, and 
executive functions for the comparison group. The smallest significant differences were observed from 
four to eight months between participants in the experimental group. This could have been due to the 
plateau effect in abilities –improvement was starting to slow down and plateau. Overall the within 
group performances on the Cognitive Linguistic Quick Test were significantly better for individuals in 
the experimental group than for those in the comparison group.  
The ANCOVA results showed that the variables that significantly influenced cognitive-
linguistic abilities on the CLQT were observed to be education and to a lesser extent age and CD4 
count. The ANCOVA results for the interview schedule showed the variable that most influenced the 
participants’ cognitive-linguistic abilities to perform activities of daily living was age. Qualitative 
inquiry using content analysis showed that participants in all three groups cited attention, followed by 
visual and language problems as hindering their abilities to perform activities of daily living. Below is 
a discussion of the results  and the demographic information of the participants as well as the 
challenges encountered conducting this research. 
 
6.2 Descriptive results 
Results of the descriptive analysis revealed that as the mean scores improved over time, the 
standard deviations went down for participants in the experimental, comparison and cross-sectional 
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groups on both instruments. The findings for the experimental group and cross-sectional group were 
expected across time. Conversely, the results for the comparison group were not expected. It was 
assumed that the mean scores for the comparison group would drop instead of increasing. The 
performance of the comparison group could have been due to the higher CD4 counts of the 
participants at the three testing periods and/or the practice effect. However, the descriptive analysis of 
the cross-sectional group reflects the same trend in performance of the experimental group even 
though different participants were used across all three time periods. Therefore, based on the cross-
sectional performance, the practice effect argument for improvement in the comparison group is 
somewhat weakened.  
The severity ratings of the participants in all three groups showed that even though the mean 
scores increased over time the cognitive-linguistic deficits still persisted among the participants, 
particularly in the mild range. These results were consistent with those found by Heaton et al. (2010). 
Heaton et al. (2010), in their cross-sectional study with 1555 HIV-infected adults, reported that more 
than half of their total sample had neurocognitive impairments. They found that although HAART 
had a positive impact on CNS manifestations including HIV-associated neurocognitive disorders, 
44% of their participants continued to exhibit milder forms of HAND. They concluded that their 
patients improved because HAART probably benefitted the brain via multiple mechanisms, including 
immune recovery and viral suppression – both systemically and in the CNS. However, their 
participants had higher education levels (12.5 years) and CD4 counts (262 cells/mm
3
 – 603 
cells/mm
3
) than those in the current study.   
Another explanation for persistent cognitive-linguistic deficits even after HAART initiation 
could be due to the continued display of on-going brain volume decreases. Cardenas et al. (2009) 
purported that decreased brain volume after HAART initiation reflected continued viral infection in 
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the brain despite effective viral suppression in the periphery. This was due to the limited permeability 
of the blood brain barrier to most HAART; they hypothesized that the brain could serve as a reservoir 
for inactive infected macrophages 
 
6.3 Differences between group performances 
The results of the one way analysis of variance revealed that were significant differences 
between the experimental, comparison and cross sectional at baseline only. Most of significant 
differences occurred between the comparison - cross sectional (attention, visual spatial, executive 
functions, and language) and comparison – experimental groups on the CLQT. Whilst on the IS most 
of the significant differences occurred between the cross sectional -comparison groups and cross 
sectional-experimental groups. The results of this study were partially similar to the Sacktor et al. 
(2009) study.  The results of this were partially similar in that this study was only able to show a 
significant between group differences at baseline only and Sacktor et al. showed significant 
differences between groups at all testing times.  Sacktor et al. (2009) in their Ugandan study reported 
that there was a significant difference between HIV infected participants who had initiated HAART 
and those who had not. They followed and tested the participants in both groups at baseline, three and 
six months. They assessed both neurocognition and functional performance. Sacktor et al. also 
observed these differences on the functional performance scale (Karnofsky Performance Scale) as 
well. The differences between group performances for this study versus those of Sacktor et al. could 
have been due to the specific drugs used in the HAART cocktail or the clade type. Research 
(Baldeweg et al. 1998; Cysique, et al. 2004; Letendre et al. 2006; Letendre et al. 2008) has shown 
that antiretrovirals have different CNS penetration. Both Cohen et al. and Sacktor et al. did not 
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specify the specific drugs used in the HAART cocktail of their participants. Lastly, the clade type 
documented in Uganda is different from that in South Africa. Clades A and B are predominately in 
Uganda and C in South Africa. 
 
6.4 Within group differences or improvement. 
The results of this current study supported the hypothesis that HAART improves the cognitive-
linguistic abilities. The participants in both groups basically demonstrated improvement across the 
three testing times. Significant differences were observed on the CLQT for the experimental were seen 
on all cognitive domains except language. Whereas, significant differences or improvements were seen 
on all cognitive domains except memory for the comparison group. The participants in the 
experimental group performed better than those in the comparison group on the CLQT. However, on 
the IS significant differences in performance within the experimental group were observed for all 
domains except language. Conversely significant difference or improvement was observed in the 
domain of attention only for the comparison group. These observations were made across all three 
testing times. The results observed by the experimental group in this study were similar to those of 
Cysique et al. (2009) and Letendre et al. (2007). Both of these studies were longitudinal and used HIV 
infected individuals (males and females) who were treatment naive at baseline. Letendre et al recruited 
15 participants and assessed their neurocognitive abilities at baseline and 12 weeks after HAART 
initiation. Cysique et al used 37 participants who they tested at baseline, 24, 36 and 48 weeks after 
HAART initiation. These studies were different from this study in that they did not have a comparison 
and or control. In addition they did not assess functional performance. However findings from both 
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studies showed that there were significant differences/improvements in their participants once they 
initiated HAART as was shown in this study. 
The improvement observed in the experimental group could have been due to the neuro-
protective nature of ARVs in that they suppress HIV replication and improve the immune function by 
boosting the number of T-cells. Kipnis, Derecki, Yang and Scrable (2008) hypothesized that the 
immune system is intimately interwoven with brain function. Hence, immune malfunction may lead 
to cognitive impairment. According to these authors, neither systems (i.e. the CNS and immune 
system) can function optimally without the other; indeed, it is only because of their interactive 
functioning that the systems can coexist, and be of benefit to the individual.  In addition, the ARVs in 
the 1a regimen that the majority of participants in this study were taking have been cited as having an 
intermediate (0.5) CNS penetration effect (Letendre, Woods, Ellis et al., 2006), implying that the 
ARVS in regimen 1a had a relatively good effect on cognitive-linguistic abilities. A further 
assumption could be made that the participants were also adhering to their HAART regimen and this 
facilitated the active suppression of the virus (Cysique, Vaida, Letendre, Vaida, Letendre et al., 
2009).  
It was expected that the experimental group would not only show improvement on the CLQT 
and but also on the the IS.  These results of the experimental group were similar to the findings of 
Sacktor, Nakasujja, Skolasky, Robertson, Musisi et al. (2009) even though the methodology was 
different.  In Sacktor et al’s study the other recruited group was HIV negative individuals as opposed 
to this study that recruited HIV positive individuals who elected not to initiate HAART. They 
recruited 102 HIV positive individuals and 25 HIV negative individuals. They used a functional 
assessment test, the Karnofsky Performance Scale, which was used at baseline, three months and six 
months after HAART initiation. Improvements were observed at three and six months in the 
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performance of functional everyday tasks. Functional abilities improved in HIV positive individuals 
from being severely impaired to the extent that individuals could not continue to work; to where at 
the end of six months they were able to perform everyday activities of daily living with 
independently.  Their results possibly imply that HAART improved the participants’ abilities to 
perform functional everyday activities.   
However, it was puzzling that the comparison group showed improvement on the CLQT but 
not on the Interview Schedule. The improvement on the CLQT could be indicative of the slightly 
higher CD4 count of the comparison participants. Moreover, the results of the comparison group on 
the CLQT may have been different if the researcher had been able to recruit a “true control” versus a 
comparison group. However, due to constraints beyond the examiners control this was not possible as 
explained in the rationale. However, a lack of improvement demonstrated on the IS could have been 
indicative of an increase in viral load. Participants even though they presented with slightly higher 
CD4 counts at baseline, the counts were slowly decreasing over four and eight months because they 
had not initiated HAART. The participants may have been experiencing the effects of an increased 
viral load which were affecting their ability to perform activities of daily living. 
Even though global impairments were observed in both the experimental and comparison 
groups, memory was more affected in the experimental than the comparison group. In this study 
participants in the experimental and comparison group exhibited memory impairments. According to 
Helm-Estabrooks (2001), “memory is not a single entity, but rather a complex process that enables us 
to attend to and register new information; to retain, process, and store (learn) this information” (p. 3) 
An aspect of memory, short-term or working memory, may be defined as a “system” for the 
temporary holding and manipulation of new or previously learnt information during the performance 
of cognitive task or activity. (Helm-Estabrooks, 2001; Panegyres, 2004). Several models have been 
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proposed to explain how working memory manipulates new or previously learnt information, and the 
most widely accepted is that of Baddeley’s. Baddeley’s model of working memory states that 
information is manipulated upon through the interaction of a central executive part, phonological loop 
and a visual spatial scratch pad (Baddeley, 2003, 2009). Problems in the central executive manifest as 
difficulties in organizing new materials and applying new strategies (Panegyres, 2004). Some 
researchers purport that these difficulties are indicative of cortical-subcortical circuitry damage 
(Ernst, Chang & Arnold, 2003; Kozoil & Budding, 2009). To further substantiate fronto-striatal 
system disruption, Ernst et al. (2003) found in their study of individuals with mild HIV brain disease 
that there was a positive correlation in glial markers in the frontal white matter and grey matter with 
working memory network activation.  Their findings suggest that working memory abnormalities in 
HIV-positive individuals are driven by glial abnormalities in the white matter and basal ganglia. 
These findings lend support to the theory that cognitive-linguistic deficits exhibited by individuals 
who are HIV-positive rely on fronto-striatal circuitry and the neocortex (Cardenas et al., 2009; 
Melrose et al., 2008; Thompson, Dutton, Hayashi, Lu et al., 2006). 
Post testing using the paired sample t-test revealed that the largest differences in performance 
were from baseline to four months for all cognitive domains for both groups. On the CLQT the 
greatest improvements from baseline performance were seen with attention, visual spatial and 
memory skills; the least was observed with language with the experimental group on the CLQT. The 
smallest significant differences were observed from four to eight months between participants in the 
experimental and comparison groups. Whilst on the IS the greatest improvement from baseline was 
observed from baseline to four months for most of the cognitive domains. These domains included 
attention, executive functions and language for the experimental group, and executive functions for 
the comparison group. The smallest significant differences were observed from four to eight months 
 249 
 
between participants in the experimental group. This could have been due to the plateau effect in 
abilities. The improvement in cognitive – linguistic abilities was starting to slow down and plateau.  
These results were similar in some part to Cysique, Vaida, Letendre, Vaida, Letendre  et al. 
(2009) who reported that the greatest improvements were noted with those abilities that had the lowest 
baseline performance. However, they did not comment on which cognitive abilities they found this to 
be so. It was therefore difficult to adequately compare results fully. A study that exhibited partly 
dissimilar results to this study was conducted by Cohen et al. (2001). They showed that more 
improvement was noted at 18 months than 12 months of taking HAART. They found that of the four 
cognitive domains (psychomotor, memory, executive functions and language) tested, executive 
functions were the most impaired and language and memory the least impaired for all groups, but all 
domains improved significantly for those taking HAART. They did not assess functional performance.  
The only similarity in results in their study was language and memory being least affected and showing 
the least improvement. However results differ in terms of which domain had greatest improvement, in 
Cohen et al’s study it was executive functions. In this study it was attention. The difference could be 
explained by the length of the study, gender tested and educational levels. Cohen et al’s study was 
longer by 10 months; their participants were all women who had mean educational level of 12.5 years. 
The participants in this study were of mixed gender (even though more women were recruited) with an 
approximate mean level of 9.0 years. Furthermore, the fact that attention followed by visual spatial 
abilities and memory showed the greatest improvement from baseline could be indicative of 
synaptodendentric injury (Ellis et al., 2007). If attention is impaired then information processing is also 
impaired. The way we process information is determined by the speed of nerve impulses for one nerve 
to another. Synaptodendentric injury slows down and interrupts the speed of nerve electrical impulses 
thereby affecting attention and how we process information (Ellis et al., 2007). 
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Irrespective of similar and or dissimilar findings both findings support the theory that HIV-
associated neurocognitive deficits (HAND) are underpinned by cortical and sub cortical neuronal 
circuitry. Woods et al. (2004) and Melrose et al. (2008) have suggested that attention and executive 
function impairments are consistent with the neuropathogenesis of HIV disease which predominantly 
affects cerebral white matter, basal ganglia, and the frontal neocortex. This has been supported by the 
neuro-imaging studies conducted by Ances et al. (2006), Berger et al.( 2000), Ellis et al. (2007); 
Thompson, Dutton, Hayashi, Toga  et al (2005); Thompson, Dutton, Hayashi, Lu et al. (2006) which 
were discussed in detail in the literature review (section 2.4.3).  
It is not unusual for individuals living with HIV and AIDS to exhibit language abilities minimal 
language problems that fall within the mild to normal ranges before and after HAART initiation as 
found in this study. These results were supported by Bhat and Mathew (2008) who found in their cross 
sectional studies of eight HIV-positive individuals. The researchers showed that the participants in 
their study performed within normal limits on the Western Aphasia Battery (WAB). The WAB 
compromises mainly of “straight” linguistic processing tasks. Similar findings have also been reported 
in patients with sub-cortical damage such as Parkinson’s and Huntington’s Chorea where individuals 
exhibit normal language functioning on straight processing skills but exhibit difficulties on those 
language skills that rely heavily on higher-order thinking skills such as memory, executive functioning 
and attention such as phonemic or letter fluency (Marinus et al., 2003). Letter or phonemic fluency 
entails using new strategies to retrieve previously stored items in semantic memory and this involves 
both cortical and sub-cortical structures (Koziol & Budding, 2009). Furthermore, the language 
problems displayed by the participants in this study were indicative of impairments within short-term 
memory and long-term memory such as in answering questions pertaining to a short paragraph 
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presented to them and verbal fluency tasks, particularly letter or phonemic fluency (naming as many 
words starting with a specified letter).  
The overall findings regarding within group abilities,  indicated that once participants initated 
HAART, cognitive abilities improved along with their abilities to engage in activities of dailiy living as 
observed by means of the interview schedule. Theses observed improvements are in keeping with 
findings from other longitudinal studies using HIV-infected individuals in other parts of the world 
(Uganda, USA and Australia) ranging from 12 weeks to 18 months (Cohen et al., 2001; Cysique et al., 
2009; Lopez et al., 1998; Sacktor, Nakasujja, Skolasky, Robertson, Wong et al., 2006; Sacktor, 
Nakasujja, Skolasky, Robertson, Musisi et al., 2009).  
 
6.5 Participant Characteristics/Variables that have an effect Cognitive Linguistic Abilities 
ANCOVA analysis on the Cognitive Linguistic Quick Test indicated that education 
significantly effected cognitive-linguistic abilities to perform activities of daily living followed by age 
and CD4 count. However, the ANCOVA results for the interview schedule showed that age 
significantly influenced the participants’ cognitive-linguistic abilities to perform activities of daily 
living was age. 
The results of the ANCOVA indicated that education and, to a lesser extent, age and CD4 count 
significantly influenced cognitive-linguistic abilities on the CLQT.  These findings were consistent 
with those reported by Ciccarelli et al. (2011), Singh et al. (2010) and Wong et al. (2007), when they 
used neuropsychological tests.  Ciccarelli et al. (2011) conducted a cross sectional study in Italy that in 
part investigated the prevalence and treatment correlates of HIV-associated neurocognitive disorders 
(HAND). They recruited 148 participants, 58% were males, mean age was 46.6 years, mean was 
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education was 12.5 years, and mean CD4 529. The results of their study indicated that higher education 
level, CD4 count and age were associated with lower neurocognitive impairments. However, it must be 
noted that mean education and CD4 counts of participants who initiated HAART in this study were 
lower than those cited in Ciccarelli et al.  Another study with similar results regarding the influence of 
age and CD4 counts was conducted by Wong et al. (2007). They investigated the frequency of and risk 
factors for HIV dementia in Uganda by recruiting 78 HIV positive and 100 HIV negative participants 
in their study. The mean age of the participants was 37, CD4 count was 219, years of education was 
8.6 years and there were more females than males. These participant characteristics were very similar 
to participants recruited for this study. Wong et al.  (2007) found that CD4 count and age were 
significantly correlated with neurocognitive impairments. When Singh et al. (2010) carried out a cross-
sectional study in South Africa using 110 HIV positive adults; they found that age and gender 
correlated with the attention and executive function [Digit Span Backwards, and the Trail Making 
Tests (Parts A and B)]. The participants in their study were predominantly HIV-infected blacks, 
predominately female, and with a mean education of 10 years. Their participants’ socio-demographics 
matched the socio-demographics of participants recruited for this study. Below are explanations to 
suggest why education, CD4 counts and age were significantly associated with cognitive-linguistic 
abilities in this research. 
Education has been closely linked to neurocognitive abilities. It has been shown and 
substantiated that a person’s years of education correlates with cognitive reserve (Groth-Marnat et al., 
2000). That is, education results in greater use of brain structures involved in neurocognitive abilities. 
Education creates experiences that can be drawn upon for novel and previous situations – hence the 
term cognitive reserve. Therefore it was not surprising that education influenced cognitive-linguistic 
functioning in this study.  
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The fact that CD4 counts had some influence on cognitive-linguistic abilities can be explained 
by in part by the effect of HAART on the viral load. Patients felt better because of the neuroprotective 
nature of ARVs in suppressing HIV replication and by boosting the number of T-cells, thereby 
improving the immune function of the body. Kipnis et al. (2008) have hypothesized that the immune 
system is intimately interwoven with brain function. Hence, immune malfunction may lead to 
cognitive impairment. According to these authors, the CNS and immune system cannot function 
optimally without the other; indeed, it is only because of their interactive functioning that the systems 
can coexist, let alone be of benefit. 
Age was also found to have an influence on the cognitive-linguistic abilities of participants in 
this study. This could have been due to effects of aging on the brain, or others factors such as 
depression and situational stressors which were not controlled for in this study. 
In contrast to the findings of this research Sacktor, Wong, Nakasujja et al. (2005) did not find 
that education, CD4 counts and age significantly associated with HIV-associated neurocognitive 
abilities. The difference in findings could be related to the instruments used. Sacktor et al. used the 
dementia screening scales and not full battery neuropsychological tests to determine the association 
between variables. Jevtovic et al (2008) also found that age did not significantly correlate with 
neurocognitive abilities.  They examined the incidence of risk factors one of which was age for HIV-
associated neurocognitive disorders. They recruited 96 HIV positive patients, 80% were males and 
20% were females. Participants were taking HAART and had a mean CD4 count of 141. Their results 
revealed that having a younger age was not associated with neurocognitive deficits, or older age with 
dementia. Contrary results regarding the influence of age could have been due to duration of the 
study, gender differences and the types tests used to assess neurocognitive abilities. Jevtovic et al’s 
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study was cross sectional and there were more males recruited who had a higher education mean than 
those in this study. 
The ANCOVA results of the interview schedule also revealed that age significantly affected 
or influenced the ability to perform activities of daily living. Studies that used a functional measure 
such as Sacktor et al (2005) , Sacktor et al (2006), Heaton et al (2010), Ciccarelli et al (2011) did not 
investigate participant characteristics that may have influenced or had an impact on functional 
performances. However since age was shown to influence participant cognitive – linguistic abilities 
to perform activities of daily living in this  study; this could have been due to effects of aging on the 
brain, or others factors such as depression and situational stressors that  were not controlled for in this 
study. 
 
6.6 Reported influence of Cognitive-linguistic Abilities on Activities of Daily Living (ADLs) 
The content analysis of the structured interview schedule responses indicated that the cognitive 
domains of attention, visual spatial and language had some impact on activities of daily living. The 
results suggested that the longer the participants took ARVs, the less attention and visual problems and 
language impacted upon ADLs.  
The ability to attend to tasks of daily living can be affected by internal and external distracters. 
Internal distracters are factors that arise from within the individual that affect how an individual attends 
to ADLs. External distracters would include factors outside of the individual in their environment that 
would affect how they can attend to a task. For this group of participants internal distracters greatly 
impacted on their ability to attend to ADLs. The responses indicated that pain was one of the reasons 
the participants could not effectively engage in everyday activities. These responses concur with 
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Makoae et al. (2005) and Myezwa et al. (2009), who documented the symptoms experienced by people 
living with HIV and AIDS in Southern Africa. They reported that their participants complained of 
joint, abdominal, headache, chest and swallowing pains. Furthermore, since the majority of these 
patients were either in the third or fourth stage of disease progression before initiation of HAART, it is 
not surprising that they were experiencing pain (Sarna et al., 1999).  
Another internal distractor to attention that was cited by the participants was fatigue. Fatigue is 
a common symptom in patients with HIV and AIDS; in fact several recent descriptive studies have 
identified fatigue prevalence rates of 60% (Makoae, 2005; Paddison et al., 2009; Voss, 2005). Fatigue 
or low energy has been associated with both physical and psychological morbidity (Breibart, 
McDonald, Rosenfeld, Monkman, & Passik, 1998; Paddison et al., 2009), and poor quality of life 
(Vosvick et al., 2003).  Among HIV-positive patients, disease progression is also related to decreased 
energy levels (Sarna et al., 1999) that can impose physical limitations on how well activities of daily 
living are performed (Ferrando et al., 1998). 
Still within the domain of attention, the participants felt sad, stressed and angry which is not 
uncommon for persons with HIV and AIDS to feel (von Gisen, Bäcker, Hefter & Arendt, 2001). The 
participants in this study felt sad for several reasons. They were sad about their diagnosis and worried 
about what would happen to their children, and   about their finances since most of them were 
unemployed. According to Brashers, Neidig, Reynolds and Hass (1998), uncertainty is a chronic and 
pervasive source of psychological distress for persons living with HIV. Depression could also explain 
why a number of participants at baseline reported that they did not want to socially engage with friends 
or take part in activities except for religious-related activities. On the other hand, Paul et al. (2005) 
have suggested that depression is often mistaken for apathy in HIV and AIDS individuals. This is 
because apathy correlates with direct brain damage especially along the sub-cortical loops whereas 
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depression does not. Since it has been reported that there is a concentration of the HI virus in the sub-
cortical nuclei it is possible for circuitry between the frontal cortex and sub-cortex to be damaged 
(Berger & Arendt, 2000; Paul et al., 2005).  It has already been established that damage to the fronto-
striatal circuitry underlies cognitive-linguistic dysfunction observed in persons with HIV and AIDS.  
The participants also reported feeling stress and anger. This is not surprising considering that 
worry and stress tend to go hand in hand. Being worried about children and finances can give rise to 
undue stress in individuals.  Sometimes just knowing that one has a diagnosis of HIV and AIDS is 
stressful in itself and is further compounded by feelings of anger. The anger was mainly directed at the 
partners who infected them with HIV.  
It was also noted that four months after HAART initiation, pain in the form of headaches, 
peripheral neuropathy, dizziness and fatigue still persisted despite being reported before HAART 
initiation. These symptoms are not only HIV-related but could also be related to the effects of HAART 
such as neurotoxicity (Lewthwaite & Wilkins, 2009; Van Dyk, 2008). The side effects or neurotoxic 
effects of HAART stopped after four months. The results of this study were similar to those reported 
by Jelsma et al. (2005), in that HAART was found to greatly improve the physical and mental health of 
individuals living with HIV and AIDS and the side effects of antiretroviral drugs seemed to have a 
negligible impact on the well-being of the participants in their study. In fact, after HAART initiation 
patients reported that they had their lives back and were able to perform activities of daily living that 
they never thought they could do again (Halikitis, Shrem, Zade & Wilton, 2005). 
Participants further reported that they were experiencing dizziness and blackouts. Similarly, 
Makaoe et al. (2005) also reported that their participants were experiencing these symptoms. This was 
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probably due to the effects of the HI virus on the CNS. These symptoms disappeared after HAART 
initiation and were probably due to the positive effects of HAART. 
Regarding visual spatial abilities, very few participants indicated that they had visual problems. 
Some participants reported that they experienced painful eyes and discharge. Other participants 
reported having eye problems after contracting meningitis and shingles. Makoae et al. (2005) reported 
that patients in their study complained of blurred vision. Freeman et al. (2008) documented that visual 
problems experienced by HIV and AIDS patients are not necessarily due to cognitive deficits but are 
due to retinal dysfunction. This would appear to be the case in this study. No visual problems were 
reported four and eight months after ARV. This could indicate several possibilities: The participants 
who indicated that they had visual problems did not return for successive testing, or ARVs were 
effective in resolving the underlying conditions that had caused the visual problems. 
The participants primarily experienced expressive language difficulties in the area of speech. 
These included vocal quality (hoarse), loudness and rate.  These findings are similar to the research of 
Mathew and Bhat (2008) who found that a few of their participants living with HIV and AIDS 
presented with difficulties in vocal quality, and loudness. Larsen (1998) also stated that individuals 
living with HIV and AIDS can present with dysarthria which is a disturbance in speech production 
caused by  damage to the CNS or PNS and which has a resultant negative impact on speech production 
affecting the speech parameters of respiration, phonation, prosody, resonance and intensity (Duffy, 
2005). Loudness problems are usually indicative of respiratory system involvement whereas vocal 
quality impairments suggest vocal fold involvement (Freed, 2000). These speech problems disappeared 
after four months of taking HAART. This indicates that whatever was causing the speech problems 
was due to a compromised immune system. So as the viral load dropped due to the suppressive nature 
of HAART, the immune system improved as the CD4+ count increased in numbers, thereby warding 
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off whatever pathogens were causing respiratory and vocal problems. Another explanation could be 
that the patients who initially reported experiencing speech problems did not return for retesting. 
In terms of receptive language, the participants initially reported experiencing hearing 
difficulties which included not being able to hear, yellowish discharge and ringing in the ears. Hearing 
loss and yellowish discharge are indicative of two causes - the HI virus itself and opportunistic 
infections. The HI virus can cause damage to the cochlea, eighth nerve or both, resulting in 
sensorineural hearing loss, or central auditory disturbance (Kallail, 2008). Opportunistic infections 
such as otitis media, neurosyphilis, cytpmegalovirus, and crytococcal meningitis can result in some of 
the following symptoms: tinnitus (ringing in the ear), muffled hearing, and aural fullness (Kallail, 
2008; Larsen, 1998).  At four and eight months after HAART initiation the participants reported 
continuing ringing in the ear. This was also reported by Khoza-Shangase (2011) who found that 
participants living with HIV, three and six months after taking HAART complained of ringing in the 
ear. This was attributed to the ototoxic effects of HAART, in particular nucleoside reverse transcriptase 
inhibitors (NRTIs).  
Overall the participants’ ability to perform activities of daily living appeared to have improved. 
This was evidenced by a decrease in responses pertaining to cognitive linguistic difficulties that may 
have affected their ability to conduct activities of daily living. These results were also observed by 
Sacktor et al. (2006) who conducted a longitudinal study using 23 HIV positive. Part of their study 
incorporated the use of a functional assessment test- Karnofsky Performance Scale which was used at 
baseline, three months and six months after HAART use. Improvements were observed at three and six 
months in the performance functional everyday tasks. Functional abilities improved from being 
severely impaired to the extent that individuals could not to work to where at the end of six months 
individuals were able to perform everyday activities of daily living with independence. These results 
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implied that the effect of time influenced the participants’ abilities to perform functional everyday 
activities. Though the methodology was appropriate in that the participants acted as their own 
‘controls’, functional improvements may have been overestimated in that there was no comparison 
group to contrast functional improvement.  
There is a paucity of research that has investigated how cognitive abilities have impacted upon 
the ability of HIV-positive individuals to perform activities or participate in their environment within 
the framework of the ICF. The fact that standardized testing revealed cognitive-linguistic deficits that 
should have translated to difficulties in performing activities of daily living, but which did not occur, 
implies fronto-striatal involvement. If the participants had exhibited severe deficits maybe these would 
have translated to the participants having difficulties conducting activities of daily living (van Gorp, 
Lamb & Schmitt, 1993). The majority if not all the participants came to the clinic by themselves to get 
their medical check-ups and refill their HAART prescription using the public transport system. This 
seems to support the view that activities of daily living are automatic functional activities that are so 
embedded in long-term memory which does not require new learning and thus individuals do not have 
to actively process new information in terms of these activities, whereas neuropsychological tests 
require active participation of higher order thinking skills that rely on working memory and the 
processing of new information (Koziol & Budding, 2009). 
The results of this study revealed that if the researcher had relied solely on the information 
obtained from the CLQT she would have obtained a detailed description of what was happening with 
the participants. The researcher would have only collected information pertaining to the biological and 
not the psychological and sociological aspects of what was happening in their lives. The ICF which 
was developed from the tenements of the Biopsychosocial model states that it is important to look at all 
aspects of an individual health condition and not just stop at body structures, function and activities in 
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the clinical settings. One has to consider participation in terms of activities of daily living and 
interaction in the participant’s environment. Based on the results of the CLQT especially at baseline 
and four months an assumption could have been made that participants were not effectively performing 
activities of daily living in their immediate environments. Yet the reports from the interview schedule 
revealed that they were able to perform activities of daily living even those that involved executive 
function and memory. Reportedly, participants had developed their own strategies of compensating 
such as using a phone to remember appointments, or asking family members to assist. Participants 
reported that internal distracters related to emotions were affecting their ability to effectively attend to 
activities of daily living. If the researcher had not been guided by the biopsychosocial model of health 
she would not have obtained a true holistic picture of how HIV-associated neurocognitive deficits 
present and impact upon an individual living with HIV. 
 
6.7 Demographic Characteristics and Challenges 
The clinic where the study was conducted is situated in a government hospital and offers 
assistance to all individuals from different socio-economic levels. The clinic does not deny anyone 
access to ARVs based on education or income level. It was believed that the patients at the clinic were 
a good representative population of urban HIV-infected people. The demographic characteristics of 
participants in this study were black Africans, mainly female, with a mean age range of mid-thirties to 
early forties, a mean education of nine years and generally unemployed.  The demographics of the 
participants in this study were comparable to those in a study conducted by Rosen et al. (2008) where 
HIV-infected individuals were recruited who were accessing care and treatment from public and non-
governmental sites. They investigated the characteristics of an HIV-positive urban population in South 
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Africa and found that more women were diagnosed HIV-positive than men, and the majority of 
individuals were black aged between the early to mid-thirties, unemployed with some secondary 
education. 
In this study participants had to commit to being tested three times. In order to reduce attrition 
of participants, testing was done in a time-efficient manner and they were compensated for the 
transport costs incurred to come back for testing. Due to the high levels of attrition experienced in the 
study, the number of participants was increased from 80 at the proposal stage to 110. This resulted in 
the data collection phase lasting 18 months as opposed to 12 months. 
There was a high attrition rate of participants from baseline to four months in the experimental 
group. Ten participants died due to severe illness. Other participants were too ill to travel. A few 
decided after their first visit that they did not want to be put on a HAART regimen because of the side 
effects of HAART and they did not feel that they were sick enough to initiate HAART. Some 
participants also refused to be re-tested either because they had already come to the clinic to refill their 
prescription and weren’t keen to make the journey back to the clinic or they simply refused to be 
retested. Lastly, the main reasons for participants not returning was due to incorrect contact 
information. Some had moved to another area and had decided to go to an HIV and AIDS clinic closer 
to home.  
The researcher also found it very difficult to recruit participants for the comparison– HIV-
infected but not taking HAART. Attrition was high for this group for the same reasons as those 
described for the experimental group. Moreover, even though most of the participants had been 
diagnosed as HIV-positive, they had relatively high CD4 counts that did not meet the inclusion criteria 
of this research. As a result there were not many patients whom the researchers could recruit. Lastly, 
the participants’ CD4 count made them eligible to initiate ARVs after baseline testing. 
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In summary, in the context of the high prevalence rates of HIV and AIDS in South Africa it 
was important to investigate and describe HIV-associated neurocognitive disorders as they appeared in 
a South African context. Patients were assessed at baseline before HAART initiation and at four and 
eight months after HAART. Results revealed that the participants did present with deficits in attention, 
memory, language, executive functions and visual spatial skills at baseline. These deficits, however, 
improved at each successive testing but did not altogether disappear. Furthermore, even though the 
participants did exhibit deficits they did self-report that these deficits did not impact greatly on their 
ability to perform activities of daily living. It was also determined that the variables of education, age 
and CD4 count influenced their cognitive-linguistic performance on the CLQT. Whereas the time of 
testing and group placement (i.e. HAART use versus non HAART use) were associated with how the 
cognitive – linguistic abilities impacted upon activities of daily living on the interview schedule.  
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Chapter 7: Conclusion 
7.1 Introduction 
In this research a predominantly quantitative approach, i.e. a standardized test – the CLQT, was 
used together with a structured interview schedule (IS) that was used to compliment the results of the 
CLQT. The IS was included to obtain a broader and more descriptive understanding of the 
phenomenon under investigation, namely the effects of HAART on the cognitive-linguistic abilities of 
adults living with HIV and AIDS.  The study was both longitudinal and cross-sectional in nature. 
The results of this study draw attention to the fact that South African individuals living with 
HIV and AIDS present with cognitive-linguistic deficits. It was found in this study that all five of the 
cognitive-linguistic abilities were affected by the HI virus, the most impaired being the executive 
function and the least being language at baseline. However, performance in all five cognitive domains 
improved from baseline to eight months. There was a significant difference in performance between 
all three groups at different testing times for different cognitive domains. The independent variables 
of education, age and CD4 count had a significant influence on the cognitive-linguistic abilities for 
clinical tasks. So too did the variables of time, participant group and age also have a significant 
influence on the cognitive-linguistic abilities required for activities of daily living.  Based on the 
results of the Cognitive Linguistic Quick Test (CLQT) participants should not have been able to 
properly perform activities of daily living, but this was not the case. Most of the participants reported 
that they were able to perform their everyday activities of daily living. When participants were asked 
to report which cognitive linguistic abilities, if any, influenced their abilities to perform ADLs they 
cited attention, visual spatial and language, specifically hearing problems. However, their attention 
and visual difficulties resolved once on HAART but their hearing problems persisted, e.g. ringing in 
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the ear. Thus, the cognitive-linguistic impairments observed and recorded during testing did not 
affect how a person conducted their everyday activities. 
 
7.2 Clinical Implications 
Results from this study imply that this group of participants presented with cognitive-linguistic 
deficits that improved with ARV, but did not disappear altogether. These results strongly supported the 
literature in confirming that the HI virus is able to cross the blood brain barrier and cause irreversible 
brain and nerve damage (Fernandez, 2005). This information is very important for the clinical 
management of the patients.  Cognitive-linguistic abilities affect adherence to regimen and how 
information is processed. The fact that the participants presented with mild attention deficits implies 
that they might experience difficulty attending to complex unfamiliar information, which could lead to 
information not being processed or comprehended properly. Patients, like the participants in this study, 
would thus benefit from information being repeated and presented in different ways. If information is 
repeated and presented visually it would allow the patient enough time for the information to be stored 
in the working memory so that the executive component - a sub-division of working memory - could 
manipulate the information so that it could be acted upon. For example, most of the medical and allied 
health staff are inclined to present all the information verbally and do not utilize strategies that 
facilitate comprehension. Patients usually complain that they are too scared to ask the nurses or doctors 
to repeat what they have not understood. So there is a need for verbal messages to be repeated and for 
the information to be presented visually in pictures or printed in the vernacular. It might be useful for 
hospitals to employ interpreters because there is an assumption that all Africans in South Africa speak 
IsiZulu and Sesotho fluently which is not necessarily the case. 
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According to the results of this study, executive functions do not necessarily affect functional 
activities of daily living but they have significant bearing on work duties that require some measure of 
abstraction and executive thinking skills. Nurses and doctors thus need to refer patients for either 
speech therapy or occupational therapy so that the work environment can be assessed and cognitive 
therapy can be provided in the context of the work environment.  
Participants with HIV exhibited functional language skills in this study. In other words, they 
were able to express their basic needs and wants. However, the participants presented with language 
deficits when the context required higher order language skills that were underpinned by cognitive 
processes such as attention, memory and executive functions. This became apparent when the 
individuals were presented with complex and unfamiliar information. The individuals may not have 
readily understood the information presented to them due to minor difficulties in retaining information 
in their working memory. So it is important that information is verbally repeated and reinforced 
through other means such as visually printed materials. 
The speech problems were not severe as to affect the participants’ activities of daily living in 
terms of influencing interpersonal social interactions; however, their receptive language problems in 
terms of hearing difficulties were a concern. Therefore, it is important that the patients’ hearing be 
monitored when patients come for their routine check-ups or prescription refills. Patients should be 
asked if they are experiencing any ear problems that may be affecting their hearing, because of the 
ototoxic effects of HAART on the structures of the ear. The ability to hear is pivotal to quality of life 
since it affects how people function socially and at work. Furthermore, HAART has also been reported 
to cause neurotoxic side effects that can either directly or indirectly, through side effects on other 
systems, affect the brain (Southern African HIV Clinicians Society, 2008). These neurotoxic side 
effects can therefore greatly influence an individual’s neurocognitive performance. It is thus important 
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to find cost-effective ways of monitoring the ototoxic and neurotoxic effects of HAART. One such 
way is through periodically assessing, the cognitive-linguistic abilities of HIV-infected individuals on 
HAART by using the Cognitive Linguistic Quick Test.  
 
7.3 Research Implications 
It is important that allied health professionals especially speech language pathologists and 
neuropsychologists do not to only rely on standardized tests to diagnose the cognitive abilities of 
individuals living with HIV and AIDS. This is because standardized tests do not necessarily provide a 
holistic picture of the clients’ abilities. The client’s impairment should be viewed through the 
framework of the ICF’s definition of disability since it has already been established that HIV and AIDS 
can be termed a disability. Furthermore, a diagnosis of cognitive-linguistic deficits needs to be viewed 
in the light of how it impacts upon the individual’s functioning in the context of their activities and 
participation in their immediate environment. 
Moreover, both the Cognitive Linguistic Quick Test (CLQT) and the structured interview 
schedule (IS) highlighted the fact that the participants did not exhibit dementia, based on the mean raw 
scores of the CLQT and the IS. The scores indicated that the participants exhibited asymptomatic 
neurocognitive impairments (ANI) or minor cognitive motor disorders (MCMD). In fact, the 
participants exhibited deficits in two or more cognitive domains, but the deficits were not severe 
enough to prevent the participants from performing their everyday tasks.  
Based on functional MRI observations (Melrose et al., 2008) and the findings of this research 
and others (Woods et al., 2004), fronto–striatal functioning was deemed to be compromised in 
patients with HIV. This was confirmed by the participants’ difficulties in phonemic cueing and 
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performing tasks that relied heavily on working memory, executive function and visual spatial skills. 
The latter are tasks that are dependent on intact cortical-subcortical circuits. Therefore it is it 
important that the cognitive-linguistic assessment of individuals with HIV and AIDS not only include 
simple cortical abilities but also tap into higher order thinking skills. If this is not done many 
individuals with HAND may go undiagnosed because the tests used for assessment were not sensitive 
enough to detect the subtle and minor cognitive-linguistic deficits. 
HIV-associated neurocognitive disorders (HAND) are often overlooked by busy healthcare 
providers. So a validated instrument such as the Cognitive Linguistic Quick Test should be included in 
the regular clinical assessment of people with HIV and AIDS, particularly in the case of the most 
vulnerable patients such as those with low CD4 cell counts. It is thus important that they are diagnosed 
and monitored for several reasons: (i) they are associated with an increased risk of mortality (Grant et 
al., 2005); (ii) the presence of HAND can affect antiretroviral therapy adherence which is essential for 
the suppression of virological replication (Solomon & Halikitis, 2008; Ettenhoffer et al., 2010); (iii) 
HAND and HAD have been shown to be treatable, i.e. improve with HAART as demonstrated in this 
study and others (Cohen et al. 2001; Sacktor, Nakasujja, Skolasky, Robertson, Musisi et al., 2009); (iv) 
The diagnosis of HIV-associated neurocognitive disorders can be an indication for the initiation of 
antiretroviral therapy which could have enormous benefits for the individuals themselves, their 
families and their communities.  Moreover, it has been suggested that memory impairments can also 
alert clinicians to the possibility of brain disease (Panegyres, 2004). 
The results of this research suggested the presence of on-going brain atrophy in HIV-positive 
patients taking HAART evidenced by the continued presence of neurocognitive impairments. This 
raises the possibility that these patients may be at a greater risk for future cognitive impairments and 
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dementia (Cardenas et al., 2009). These findings further lend support for on-going assessment and 
monitoring of HAND. 
In terms of improving the quality of life of individuals living with HIV and AIDS in South 
Africa, there needs to be a more integrated approach to the treatment of HIV and AIDS. Management 
of these patients needs to encompass a more holistic approach that includes more allied health 
professionals besides nurses, doctors and social workers, but also speech therapists, occupational 
therapists, even traditional health practitioners, as well as the patients themselves.  In this way 
patients can be treated more effectively in line with the tenets of the ICF. This framework of treating 
individuals with HIV and AIDS would most probably greatly assist in curbing severe forms of 
HAND and other HIV conditions. 
 
7.4 Limitations and Future Research 
This study had a number of limitations that may have impacted on the results obtained in this research. 
Following will be a discussion of these: 
 
7.4.1 Assessment 
Most neuropsychological tests appear to be sensitive to cortical damage, but the Cognitive 
Linguistic Quick Test has proven to be sensitive to both cortical and fronto-striatal damage in this 
study in that it was able to detect both executive functions and language abilities that were heavily 
reliant on cognitive abilities such as working memory and long-term memory. Therefore, a more 
comprehensive, in-depth battery of tests was not deemed necessary. Other reasons for not using a 
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battery of tests were that they were too expensive and time-consuming to conduct on a large number of 
participants. Since initial testing occurred in the latter stages of the progression of HIV and AIDS the 
researcher needed to perform a test that would take into consideration the stamina and alertness levels 
of the participants. Ultimately a balance was struck between using a test such as the CLQT that was 
sensitive enough to detect asymptomatic neurocognitive impairments and which was not too time-
consuming to conduct.  
The same instruments, that the Cognitive Linguistic Quick Test and the interview schedule, 
were used on the same groups of participants at all three testing periods; to ensure that that responses 
or outcomes of testing could be attributed in the most part to HAART intervention and not to the use of 
other tests. In an effort to rule out practice effects the results of the longitudinal group were compared 
to those of the cross-sectional group. The cross-sectional group included different individuals at 
baseline, four and eight months that had not been exposed to the CLQT or structured interview 
schedule. The results for both the longitudinal and cross-sectional groups yielded similar results. It was 
therefore cautiously assumed that any improvements observed in cognitive-linguistic abilities were due 
to the effects of HAART and not to practice effects. 
Though the structured interview served to provide more information about the participants’ 
activities of daily living it only dealt with an aspect of quality of life. A detailed quality of life 
assessment that covered more factors of the ICF in relation to cognitive - linguistic abilities could be 
useful in under resourced areas; especially in regards to management of individuals living with HIV 
and AIDs. Lastly in regards to assessment, the participants’ exposure or experience to neurocognitive 
testing may have influenced their test scores. Even though a pilot study was conducted the participants’ 
familiarity and novelty of CLQT could still have been confounding variable(s). 
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7.4.2 Confounding variables 
Despite the corrective measures put in place to control for threats to reliability, certain 
confounding variables could not be controlled, for instance compliance with or adherence to HAART. 
It was assumed that the participants were adhering to HAART even though questions were not asked 
regarding adherence. The observed improvement in the participants’ cognitive-linguistic abilities after 
initiation of HAART suggested adherence to medication. According to Ettenhofer et al. (2010), 
medication adherence significantly predicts neurocognitive performance.   
Consultation with other forms of healers and the use of “mbejane” (traditional herbal medicine) 
before and after treatment could also not be controlled for. It is likely that some participants had used 
“mbejane” before consulting western medical practitioners. According to Gilks (2001), it is not 
uncommon for individuals living with HIV to use home remedies and traditional healers to treat their 
symptoms. The ARVs prescribed in the triple cocktail or HAART for the participant, or the type of 
diet(s) participants were eating in terms of maintaining optimal health, were also difficult to control 
for. Lastly the researcher could not regulate the drugs prescribed in conjunction with antiretrovirals 
(ARVs) to treat concurrent opportunistic infections and diseases or conditions caused by the side 
effects of HAART. 
In another attempt to control for confounding variables a matched comparison group was 
recruited as opposed to a ‘true’ matched control group. Initially the researcher attempted to recruit a 
matched control group but due to variables beyond the researchers the control group developing into a 
comparison.  Even the recruitment of the comparison group was very difficult to do due to the issues 
discussed earlier of individuals electing to start HAART, or them not meeting the CD4 count 
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requirement. So due to the comparison group sample size being so small, CD4 count differences and 
their clinical presentation of the disease (asymptomatic versus asymptomatic), comparison between the 
two groups of participants’ (i.e. experimental and comparison) could not have been conclusive. Hence 
the recruitment of a cross sectional group which served as a reference comparison group. This allowed 
a comparison between groups to be done and weakened the argument for practice effect.  
Depression, apathy, fatigue were not assessed or controlled for due to time and financial 
constraints. For example depression can cause pseudo cognitive deficits. The use of imaging 
technique(s) along with the depression measures could have been done bolstered the results; since at 
baseline the participants reported feeling sad. However, these responses decreased upon successive 
testing. This is an important area to investigate for future studies looking at neurocognitive deficits in a 
South African population. 
This was an exploratory study and more studies are needed to further substantiate what 
independent variables (gender, race, employment, economic status and education) influence cognitive 
– linguistic abilities before we can generalize across cultures, gender and other independent variables. 
Lastly, since neurocognitive impairments were observed over time, this suggests that sustained 
HAART treatment may be necessary to produce optimal neurocognitive benefit. Prospective studies 
controlling for HIV duration, HAART treatment regimen, adherence and duration of HAART use are 
needed to examine what their independent contributions are to the observed effects.  
 
 
7.4.3 Sample size 
 
In relation to sample size the sample sizes for three groups were deemed small but sufficient for 
the context. Ideally a larger group, using more government clinics in the region would be 
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recommended. This study was both exploratory and descriptive in nature and therefore was focused on 
one clinic using convenient sampling procedures. The latter could have influenced the generalizability 
of results and statistical significance of results. To increase sample size, future research may need to 
include several sites for comparison of cognitive-linguistic abilities across different South African 
cohort populations. 
For example, this research used a cohort from a government urban hospital. The question is 
thus - would the results have been similar if the cohorts had been from rural district hospitals, private 
clinics or even other government urban clinics? Presumably private clinics would yield a different set 
of demographics as compared to public clinics, e.g. a more educated cohort of participants. Since 
participants yielded mild to severe deficits across all five cognitive domains at baseline that improved 
after HAART use, further research is warranted to explore how and to what extent individuals 
compensate for early cognitive-linguistic impairment and gradual decline. This research also relied on 
standardized testing and an interview schedule to determine the extent of cognitive-linguistic 
impairments. However, the use of quantitative magnetic resonance imaging procedures for determining 
the effects of HAART on HIV-associated neurocognitive disorders might lead to interesting 
discoveries that could aid treatment. 
 
7.4.4 Strengths 
Limitations notwithstanding, the greatest strength of this study was the fact that it was both 
longitudinal and cross-sectional in design. The use of both designs allowed for some comparisons to 
be made regarding the effects of HAART and reduced the possible effects of some of the 
confounding variables such as age, gender, education, and practice effect.   
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Another strength of this study was the use of two different but complimentary methods that 
highlighted the same phenomena of investigating cognitive-linguistic abilities of individuals living 
with HIV and AIDS. The Cognitive Linguistic Quick Test (CLQT) was able to provide information 
regarding clinical cognitive-linguistic performance and confirm the hypotheses. It was deemed an 
efficient and reliable test for monitoring the effects of HAART on cognitive-linguistic abilities of 
individuals living with HIV and AIDS. Since the HIV positive sample in this study was recruited 
from a voluntary counselling and testing clinic, and an ARV outpatient clinic, assessment needed to 
be time efficient and inexpensive - which it was. Participants could complete the test relatively 
quickly so that they were able to re-join the queue without losing their place for either counselling, 
treatment and/or prescription pick-up.   The test was considered to be reliable, thorough and sensitive 
enough to detect a range of cognitive-linguistic deficits ranging from mild to severe. Furthermore, the 
CQLT was found to represent a good balance between longer, but less practical batteries and shorter 
but less sensitive screening tests. Moreover, the test could be used by other trained allied health 
professionals besides speech pathologists and psychologists. Due to the cognitive – linguistic results 
obtained from the CLQT, it was found suitable for use in monitoring the neurocognitive abilities of 
individuals living in under resourced settings in South Africa.  
It was within the framework of the ICF that the researcher found it important to not only 
assess and document the severity of HIV-associated neurocognitive disorders/cognitive-linguistic 
impairment exhibited by the patients before and after HAART use, but also to investigate whether 
these neurocognitive impairments influenced a person’s activity and participation in activities of daily 
living (ADLs). This could only be achieved by conducting an interview schedule that allowed the 
individuals to self-report on how cognitive impairments were affecting their everyday activities. 
Though neuropsychological tests can provide information about the severity of an individual’s 
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neurocognitive deficits, they cannot conclusively describe how these deficits influence a person’s 
quality of life in terms of their activities and participation in their environment. The -structured 
interview schedule provided more in-depth information than the CLQT on how the cognitive-
linguistic deficits influence activities of daily living. 
The interview schedule was able to provide information on how cognitive-linguistic 
impairments were impacting upon activities of daily living.  The participants’ performance on the 
CLQT did not necessarily reflect how participants were able to perform their activities of daily living. 
The results from the interview schedule showed that while activities of daily living improved after 
HAART initiation, most of the participants were still able to carry out their functional activities prior 
to HAART initiation. Therefore even though the CLQT indicated cognitive – linguistic deficits, they 
did not tell the whole. The participants were still able to carry out their activities of daily living 
despite having impairments. Despite the limitations of this study, the results of the study were able to 
reveal that cognitive-linguistic deficits do improve but do not completely disappear when an 
individual is taking HAART. 
 
7.5 Concluding comments 
The Biopsychosocial model of disease states that as health professionals we need to look at a health 
condition in terms of how it interacts with the biological, psychological and sociological factors 
(Engel, 1980. This study in some measures was able to embrace that by not only investigating the 
biological aspects but also the psychological and to a minimal extent the sociological. This study 
followed the ICF framework which is undergirded by the biopsychosocial model (BM) (WHO, 
2010). 
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The biological factor of the biopsychosocial model encompasses the body structures and parts 
of body functions of the ICF. The literature review showed that for an individual living with HIV to 
present with HIV-associated neurocognitive disorders the HI virus will have entered the CNS and 
caused damage to the brain cells (Eugenin et al., 2006). Imaging studies and the theory of cortical-
subcortical circuitry were presented to substantiate the latter premise (Ernst, 2003; Murdoch & 
Whelan, 2009; Thompson et al., 2006). When structures of the CNS in particular the brain are 
affected certain body functions are impaired. In the case of this study those were the cognitive – 
linguistic abilities under investigation - attention, language, visual spatial skills, memory and 
executive functions. The body functions were assessed using the Cognitive Linguistic Quick Test. 
The body’s diseased structures were treated using HAART. 
Psychological factor that included aspects of body function, activities and participation 
features of the ICF were also affected by HAND in terms of the participants’ abilities to perform 
activities of daily. The psychological factor was assessed using the structured interview schedule.  
The assessment revealed from the responses obtained that participants deal with personal and 
physical issues before and sometimes after treatment. Treatment for this was HAART. The 
sociological factor that included aspects of the ICF (environmental and personal contexts) were also 
impacted by HAND. Some of the questions from the structured interview schedule obtained 
information regarding how activities of daily living impacted upon the participants’ immediate 
environment and personal relationships.  The overall results obtained from the interaction of the three 
factors of the BM appeared to show that HAART improves the cognitive-linguistic abilities of adults 
with HIV and AIDS and their ability to perform activities of daily living.  
This topic is and will continue to be of substantial relevance to the further understanding and 
treatment of HIV. The results of this study will add to the current body of knowledge on 
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neurocognitive deficits in HIV patients living in South Africa and can be used to enhance current 
intervention strategies as well as inform the development of new programmes in the management of 
individuals with HIV and AIDS. If health care providers were made aware of neurocognitive deficits 
in their patients, they could start incorporating adherence techniques and memory strategies that 
patients could use at home and at work to improve their lives. Neurocognitive tests along with a 
functional measure are useful tools that should be incorporated into routine check-ups and that can be 
carried out by primary healthcare providers fairly easily with little cost attached, but with potentially 
important benefits for the patient. 
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Appendix III - Information and consent sheets 
INFORMATION SHEET 
Hello, my name is Anniah Mupawose and I am a university lecturer. I am currently studying for my 
postgraduate degree at the University of the Witwatersrand. As part of my research work, I am 
investigating the language functions of adults living with HIV/Aids before and after receiving 
antiretroviral therapy. 
I would like to invite you to participate in my study, by answering questions concerning your language 
and communication abilities and how they may have affected your quality of life. This will take 
approximately30 minutes. If you agree, your responses will be videotaped to allow for observing your 
communication behaviours. However the video tapes will be destroyed after completion of the study. 
Participation in the study is entirely voluntary. There will be no negative consequences if you do not 
wish to participate and your treatment at the hospital will not be affected in any way. If you choose to 
participate, you may withdraw from the study at any time. 
If you choose to take part you will be assisting me to gain insight and knowledge about the thinking 
and communication skills of people living with HIV/Aids before and after receiving antiretroviral 
therapy.  
If you agree to take part in the study, I will also require permission to refer to your medical files for 
your medical history, and CD4 count. All information will be kept confidential and will be reported on 
anonymously in my research report. Your name will not be used in the study; instead a number will be 
used. This is to ensure that nobody will know you were a part of this study. 
If you wish to be informed of the results in this study, please feel free to request the results and these 
will be provided to you. 
If you are concerned about anything in the questionnaire, or wish to discuss anything with me, please 
feel free to do so. If you have any further queries, please do not hesitate to contact me on 082 351 9410 
 
Thank you for taking the time to consider participating in my study. 
 
Anniah Mupawose 
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CONSENT FORM 
I, ______________________________________ am willing to participate in this study. The study 
procedures and my rights as a research participant have been explained to me in full, and 
understand her explanation. The questions I have asked were answered to my satisfaction. I 
understand that my participation is entirely voluntary and that I can stop participating in the 
study at any time should I wish to do so. 
 
___________________________________________              __________________ 
Participant’s Signature      Date 
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Consent Form to Review Medical Records 
I hereby confirm that I give consent for the researcher to review my medical records as part of the 
data collection for her PhD research. It has been explained to me that the information collected by the 
researcher Anniah Mupawose will serve to add information to her research on the language functions 
of adults living with HIV/Aids before and after antiretrovirals.  I understand that efforts will be made 
to conceal my identity, and that full anonymity will be guaranteed 
 
I understand that I may view the material obtained by arrangement with Anniah Mupawose.  
However, once the material is made available for research, I realize that recovery of the material may 
not be possible. 
 
I confirm that the purpose for which the material may be used has been explained to me in terms 
which I have understood.  It has been made clear to me that refusal to consent will in no way affect 
my medical care.  I confirm that I am over 16 years old, of sound mind and that I am not signing 
under any form of duress. 
 
 
In the space at the bottom of this letter please indicate whether you want or do not want your medical 
records to be reviewed 
 
_____________________________________________________________ 
 
 
I do/do not give permission for them to be reviewed 
 
_______________   Date 
 
__________________________________________   Signature 
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Appendix IV - Interpreter’s confidentiality form 
 
INTERPRETER’S CONFIDENTIALITY FORM: 
 
 
I, ___________________________________________ understand the purposes and procedures of 
the study and I promise that I shall not divulge any information that I may learn in my capacity 
as an interpreter for this project. 
 
_____________________________________________        __________________ 
Signature         Date 
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Appendix V - The Cognitive Linguistic Quick Test Response form 
 
 319 
 
 
 320 
 
 
 321 
 
 
 322 
 
 
 323 
 
 
 324 
 
 
 325 
 
 
 326 
 
 
 327 
 
Appendix VI - Reliability and validity tables pertaining to the CLQT 
Table: Test-Retest Means, Standard Deviations, Stability Coefficients, Standard Error of 
Measurements and Mean Absolute Score Differences for Each Task and 
Cognitive Domain (n = 46) 
 
1st 2nd Mean Absolute 
Administratio
n 
Administration Score Maxim
um Task Mean SO Mean SD <-12
a
 SEM Difference
6
 
Points 
Personal Facts 8.00 0.00 8.00 0.00  __  0.00 8 
Symbol 
Cancellation 
11.13 2.99 11.74 0.74 0.62 1.84 0.87 12 
o fron ation 
Naming 
9.98 0.15 10.00 0.00 —  0.02 10 
Clock Drawing 12.35 1.23 12.57 1.00 0.74 0.63 0.48 13 
Story Retelling 8.33 1.43 8.61 1.20 0.62 0.88 0.89 10 
Symbol Trails 9.15 1.78 9.43 1.28 0.14 1.65 1.02 10 
Generative 
Naming 
6.61 1.74 6.39 1.76 0.81 0.76 0.83 9 
*         Desig  Memory 5.72 0.58 5.72 0.46 0.03 0.57 0.39 6 
Mazes 7.30 1.28 7.33 1.28 0.43 0.97 0.67 8 
Design Generation 8.13 2.27 8.93 2.46 0.63 1.38 1.72 13 
Cognitive Domain         
Attention 193.0
7 
29.76 200.85 12.35 0.69 16.57 11.74 215 
Memory 169.7
4 
11.53 171.22 10.03 0.61 7.20 7.39 185 
Executive 
Functions 
31.20 4.65 32.09 5.02 0.90 1.47 1.85 40 
Language 32.91 2.67 33.00 2.57 0.81 1.16 1.22 37 
Visuospatial Skills 93.48 9.99 96.13 7.33 0.71 5.38 5.26 105 
"Because the standard deviation was 0.00 on the second test administration, it was not possible to calculate a correlation 
coefficient. 
b
Difference Scores can be positive or negative. Taking the mean of both positive and negative scores yields a number misleadingly close 
to zero. Therefore, the absolute value of each score difference was taken and the mean absolute difference was calculated. 
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Table: CLQT Goodness-of-Fit Statistics for Confirmatory Factor Analyses 
 
Domain chi-squaredf chi-square/df NNFI RMSEA ECVI 
 
Attention 25.22 9 2.80 0.01 0.97 0.15 0.76 
Memory 2.46 2 1.23 0.29 0.99 0.05 0.33 
Executive Functions 3.06 2 1.53 0.21 0.99 0.08 0.33 
Language 0.92 3 0.30 0.81 1.00 0.00 0.28 
Visuospatial Skills 6.81 5 1.36 0.23 0.99 0.06 0.46 
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Table: Comparison of a Matched Set of CLQT Nonclinical (n = 38) and 
Clinical (n = 38) Research Sample Task Means and Standard Deviations 
 
Sample 
Task  Nonclinical Clinical t 
Personal Facts Mean 
SD 
7.97 
0.16 
6.37 
2.33 
4.24* 
Symbol Cancellation Mean 
SD 
11.05 
2.73 
7.79 
4.97 
3.55* 
Confrontation Naming Mean 
SD 
9.97 
0.16 
9.28 
1.63 
2.62* 
Clock Drawing 
« 
Mean 
SD 
11.95 
1.71 
8.50 
3.77 
5.14* 
Story Retelling Mean 
SD 
7.68 
1.51 
4.74 
2.52 
6.18* 
Symbol Trails Mean 
SD 
8.71 
2.34 
4.66 
3.47 
5.98* 
Generative Naming Mean 
SD 
6.00 
1.45 
2.92 
1.71 
8.45* 
Design Memory Mean 
SD 
5.42 
0.79 
3.97 
1.17 
6.30* 
Mazes Mean 
SD 
6.84 
1.62 
4.05 
2.81 
5.30* 
Design Generation Mean 
SD 
7.00 
2.09 
3.55 
2.19 
7.02* 
*(#=37, p< .01 
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Table: Comparison of a Matched Set ofCLQT Nonclinical (n = 38) and Clinical (n = 38) 
Research Sample Cognitive Domain Means and Standard Deviations 
 
Sample 
Cognitive Domain Nonclinical Clinical 
 
Attention Mean 
SD 
186.18 
30.00 
121.26 
63.06 
5.73* 
 
Memory Mean 
SD 
162.13 
13.35 
115.66 
37.06 
7.27* 
 
Executive Functions Mean 
SD 
28.55 
5.04 
15.18 
7.78 
8.89* 
 
Language Mean 
SD 
31.63 
2.45 
23.30 
6.78 
7.12* 
 
Visuospatial Skills 
*(#=37,p<.01
Mean 
SD 
88.74 
13.07 
56.50 
25.68 
6.90* 
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Appendix VII - Structured Interview Schedule 
INTERVIEW SCHEDULE REGARDING THE IMPACT OF COGNITIVE-LINGUISTIC 
ABILITIES ON THE QUALITY OF LIFE OF PERSONS WITH HIV/AIDS. 
 
PART ONE: INFORMATION FROM RECORD REVIEW AND INTERVIEW 
Demographic Information, medical and psychological History: 
Date:  Number:  
Name 
 
 
 
 
 
Telephone # 
 Address 
 
 
 
 
 
Name of  friend 
or Relative 
 Contact #  
CD4 count: 
 
 Age  
Gender  Date of Onset   
Time in months 
or years since 
diagnosis 
   
Education : 
 
Highest grade 
completed: 
 Present 
Occupation: 
 
Working 
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What were your 
best subjects: 
 
What were your 
worst subjects: 
 
 
Did you need 
remedial help? 
 
 
Reasons for 
leaving High 
school? 
 
 
 
What other 
qualifications do 
you have ? 
 
 
(How long) 
Job duties: 
 
Not working 
(How long) 
 
Previous 
occupation: 
 
Job duties: 
Marital Status? 
Married, single, 
divorced 
 
 Have you ever 
injured your 
head? 
How? 
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Number of years 
married? 
 
Number and 
ages of 
Children? 
 
 
 
 
 
 
Have you ever 
been 
hospitalised? 
 
 
Medication: 
 
 
 
 
 
 
 
Opportunistic Infections and related Medical Pathologies: 
E.g. Meningitis, encephalopathy, other 
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PART TWO: INFORMATION FROM THE INTERVIEW PERTAINING TO 
COGNITION AND LANGUAGE: 
Memory: 
Do you have difficulty remembering: 
Yes No 
To take you medication on time   
To turn off the lights or stoves   
To lock the doors   
To pay bills, fees etc.   
Where you placed things e.g. keys   
Directions to a new place   
To keep appointments   
The day, month, year or time of day   
To arrive on time   
Things you do to remember. 
 Do you rely on other people to help you remember? 
 
 
 
 Do you write things down? 
 
 
 
 Do you keep all the information in your head? 
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Attention: 
Internal Distractors: 
Do you experience: 
Yes No 
feeling tired (describe) 
 
  
headaches (describe) 
 
  
pain (describe) 
 
  
dizziness   
Fear or scared   
anger (describe) 
 
  
sadness, depression, tearfulness (describe) 
 
 
  
Have you taken medicine for depression or other emotional problems? 
What was the cause? 
 
  
Have you ever thought of committing suicide?   
Do you worry about dying?   
Do you worry about finances?   
Do you worry about keeping your job?   
Do you worry about your children?   
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External Distractors: 
Do you have difficulty:  
focusing if there’s a lot of movement   
focusing on a task or person if more than one person is speaking   
focusing if the radio or tv is playing in the background   
Sustained Attention: 
Do you have difficulty: 
staying interested in a task for more than an hour   
staying focused on a telephone conversation 
 
  
staying focused on what the doctor or nurse says   
staying focused on complex information   
Do you find that you are easily distracted?   
Visual: 
Do you experience difficulty :                                                                                                                                                      
Yes              No 
Blurred vision   
Spots when you look at something   
Seeing objects that are not there   
Eye pain, headaches, vomiting, dizziness   
Bumping into objects/walls   
Seeing objects in a distance   
Executive functions: 
Do you have difficulty: 
Adding up or doing maths in your head   
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Answering questions quickly   
Understanding what you hear the first time you hear it   
Making decisions   
Starting a task?      
Completing or finishing a task?   
Seeing your mistakes and correcting them?   
following directions?   
Solving a problem e.g. 
If you were lost what would you do? A least two solutions 
 
 
 
 
 
Language: 
Hearing:                                                                                                                                                                                         
yes         no 
Have you ever had your hearing tested?   
Do you hear things only when they are loud?   
Do you have difficulty hearing a person when there is background noise?   
Do you experience nausea, dizziness, pain in the ear, ringing or buzzing?   
Expressive Language: 
Do you have difficulty: 
talking for a long period of time   
spelling words correctly   
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writing   
starting a conversation   
speaking on the telephone   
maintaining a conversation   
Do people finish your words for you?   
Receptive language:   
Do you have to ask people to repeat themselves when talking to you?   
Do you have difficulty :   
remembering what someone has asked you   
remembering a telephone conversation   
understanding what the doctor or nurse said   
remembering information you have read (newspaper, magazine, book)   
understanding directions   
understanding jokes   
Impact of Cognitive and Language problems 
Do you feel nervous and anxious when you talk to people? 
 
Yes No 
Do you feel like you are burden to your family? If so why? 
 
 
  
Does your diagnosis or other problems affect your job ?Describe 
 
 
  
Does your diagnosis or other problems affect your relationships with other 
people including family? Describe 
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Do people act differently how people (family, friends, etc.) act around you? 
Describe 
 
 
  
Has your diagnosis or other problems affected you self-worth? Describe 
 
 
  
Does your diagnosis or other problems affect your social life i.e how you interact 
with people, places you visit etc? 
 
 
 
 
  
Are you able to cope with your problems (cognitive i.e. memory, attention etc. 
and language)? Describe how you are coping. 
 
 
 
 
  
 
 
Thank You 
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Appendix VIII - Normality of data 
 
 
Experimental–CLQT-Baseline-
Attention 
 
Experimental–CLQT-Baseline-Memory 
 
 
 
Experimental–CLQT-Baseline-
Executive Function 
 
Experimental–CLQT-Baseline-Language 
 
 
 
Experimental-CLQT–Baseline-Visual 
Spatial 
 
Experimental – IS-Baseline-Memory 
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  Experimental –IS–Baseline-Attention 
   Experimental – IS–Baseline-Visual 
Spatial 
 
 
 
Experimental–IS–Baseline–Executive 
Function
 
 Experimental–IS–4 months -Language 
 
Experimental–CLQT-4months-
Attention 
 
 Experimental –CLQT–4 Months –Memo 
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Experimental-CLQT-4months-
Executive Function 
Experimental-CLQT-4months-Language 
 
 
 
 Experimental –CLQT–4 months –
Visual Spatial 
 
Experimental –IS-4 months-Memory 
 
 
 
  Exeperimental-IS-4months-Attention  Experimental-IS-4months-Visual Spatial 
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Experimental–IS–4 months–Executive 
Function 
Experimental–IS–4 months -Language 
 
 
 
 Experimental – CLQT-8 months-
Attention 
 
Experimental-CLQT-8months-Memory 
 
 
 
Experimental-CLQT-8months-Executive 
Function 
 Experience-CLQT-8months-Langauage 
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Experimental-CLQT-8months-Visual 
Spatial 
Experimental – IS- 8 months- Attention 
 
 
 
 Experimental-IS- 8months-Memory 
 Experimental- IS- 8 months-Visual 
Spatial 
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Experimental-IS-8months-Excecutive 
Function 
 
Experimental-IS-8months-Language 
 
 
 
Cross Sectional–CLQT-Attention  Cross Sectional- CLQT- Baseline- 
Memory 
 
 
 
 
 Cross Sectional – CLQT- Baseline- 
Executive Function 
 Cross Sectional- CLQT- Baseline-
Language 
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  Cross Sectional- CLQT-Baseline-VS  Cross sectional –IS- Baseline-Memory 
 
 
 
 
 Cross Sectional- IS -Baseline-Executive 
Function 
 
Cross Sectional- IS -Baseline- Language 
 
 
 
  Comparison- CLQT -Baseline-
Attention 
 
Comparison – CLQT- Baseline- Memory 
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Comparison- CLQT -Baseline- 
Executive Function 
 
Comparison-CLQT -Baseline- Language 
 
 
 
 
 Comparison- CLQT- Baseline-Visual 
Spatial 
 
Comparison – IS- Baseline -Memory 
 
 
 
  Comparison –IS -Baseline-Attention  Comparison –IS Baseline-Visual Spatial 
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Comparison-IS-Baseline-Executive 
Function 
Comparison- IS-Baseline-Language 
 
 
 
 Comparison- CLQT-4 months-
Attention 
 
Comparison – CLQT-4 months-Memory    
 
 
 
  Comparison-CLQT-4 months- 
Executive Function 
 
Comparison-CLQT-4 months-Language 
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Comparison-CLQT-4 months-Visual 
Spatial 
 Comparison – IS-Baseline -4 months-
Memory 
 
 
 
Comparison-IS-Baseline- 4 months-
Attention 
 Comparison-IS-Baseline-4 months-Visual 
Spatial 
 
 
 
 Comparison- IS-Baseline-4 months-
Executive Function 
 Comparison-IS-Baseline-4 months-
Language 
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Comparison – CLQT – 8 months- 
Attention 
Comparison-CLQT-8months-Memory 
 
 
 
 
 Comparison-CLQT- 8months-
Executive Function 
 
Comparison- CLQT- 8months-Language 
 
 
 
Comparison-CLQT-8 months-Visual 
Spatial 
 
Comparison – IS - 8 months-Memory 
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 Comparison- IS-8 months-Attention 
 
Comparison- IS-8 months-Visual Spatial 
 
 
 
 
Comparison-IS -8 months-Executive 
Function 
 
Comparison-IS-8months-Language 
 
 
 
 Cross Sectional-CLQT-4 months-
Attention 
 
Cross Sectional-CLQT-4months-Memory 
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Cross Sectional –CLQT-4 months-
Executive Function 
 Cross Sectional-CLQT-4 months-
Language 
 
 
 
 
 Cross Sectional-CLQT-4 months-
Visual Spatial 
 
Cross Sectional-IS- 4 months-Memory  
 
 
 
Cross Sectional-IS-4 months-Attention 
 Cross Sectional-IS-4 months-Visual 
Spatial 
 
 
 
 353 
 
 Cross Sectional-IS-4 months-Executive 
Function 
 
Cross Sectional-IS-4 months-Language 
 
 
 
Cross sectional – CLQT -8 months-
Attention  
 
Cross Sectional-CLQT-8months-Memory 
 
 
 
 Cross Sectional-CLQT-8months-
Executive Function 
 Cross Sectional-CLQT-8 months-
Language 
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Cross Sectional-CLQT-8months-Visual 
Spatial 
Cross sectional – IS- 8 months-Memory 
 
 
 
 Cross Sectional-IS-8months-Attention 
 Cross Sectional-IS-8 months-Visual 
Spatial 
 
 
 
Cross Sectional-IS-8 months-Executive 
Function 
 
Cross Sectional-IS-8 months-Language 
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Appendix IX - Ancova Studentized Residuals 
CLQT - Attention 
Huynh-Feldt 
 
CLQT-Memory 
Auto regressive 
(1)
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CLQT –Executive Functions 
Huynh-Feldt 
 
CLQT -  Language 
Autoregressive 1 
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CLQT – Visual Spatial 
Huynh-Feldt 
 
Interview schedule – Attention 
Huynh-Feldt 
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Interview Schedule – Memory 
Huynh-Feldt 
 
Interview Schedule – Executive Function 
Autoregressive 1 
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Interview Schedule - Language 
Huynh-Feldt 
 
 
Interview Schedule – Visual Spatial 
Huynh-Feldt 
 
 
 
